ID,Entry,Status,Protein names,Gene names,Length,Mass,Sequence
1,A0A024R3C5,Druggable,D(2) dopamine receptor (Dopamine D2 receptor),DRD2,443,50619,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
2,P35790,Druggable,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),CHKA ,457,52249,MKTKFCTGGEAEPSPLGLLLSCGSGSAAPAPGVGQQRDAASDLESKQLGGQQPPLALPPPPPLPLPLPLPQPPPPQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV
3,A0A024R645,Druggable,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB,436,48710,MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKAGPHVGNKLVMLFSVNIECDGTVNQNPTMWPERKSNNN
4,A0A0C5B5G6,Druggable,Mitochondrial-derived peptide MOTS-c (Mitochondrial open reading frame of the 12S rRNA-c),MT-RNR1,16,2175,MRWQEMGYIFYPRKLR
5,A0A0D9SBU1,Non Druggable,Histamine H1 receptor,HRH1,487,55592,MTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPFCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVAVNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
6,A0A0J9YWR0,Druggable,Adenosine receptor A3,ADORA3,123,13255,MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVSSISPTL
7,A0A1U7QEW2,Non Druggable,Histamine H1 receptor,Hrh1,489,55786,MSLPNISSAFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQHPLRYLRYRTKTRASATILGAWFLSFLWIIPILGWHHFMSPASELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRQHCQHRQLTNGSLPSFSEIKLKSEDVKEGTKKPGKESPWGVLKRPSRDTSGGLDQKSTSKDPKSTNSPAVFSQEEDRETVSRHCFHLDITQTQTVTKGGGRGSEANDQVLSQPKMDEQSLNTCRRISETSEDQTLVDRQSFSRTTDSDTSIEPGVGKDKMRSGSNSGLDYIKITWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIHS
8,P35503,Druggable,UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3),UGT1A3 ,534,60338,MATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVVLTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNMSLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDLDFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQREVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
9,P43088,Druggable,Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor),PTGFR,359,40055,MSMNNSKQLVSPAAALLSNTTCQTENRLSVFFSVIFMTVGILSNSLAIAILMKAYQRFRQKSKASFLLLASGLVITDFFGHLINGAIAVFVYASDKEWIRFDQSNVLCSIFGICMVFSGLCPLLLGSVMAIERCIGVTKPIFHSTKITSKHVKMMLSGVCLFAVFIALLPILGHRDYKIQASRTWCFYNTEDIKDWEDRFYLLLFSFLGLLALGVSLLCNAITGITLLRVKFKSQQHRQGRSHHLEMVIQLLAIMCVSCICWSPFLVTMANIGINGNHSLETCETTLFALRMATWNQILDPWVYILLRKAVLKNLYKLASQCCGVHVISLHIWELSSIKNSLKVAAISESPVAEKSAST
10,P43354,Druggable,Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor),NR4A2 ,598,66591,MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSFSTFMDNYSTGYDVKPPCLYQMPLSGQQSSIKVEDIQMHNYQQHSHLPPQSEEMMPHSGSVYYKPSSPPTPTTPGFQVQHSPMWDDPGSLHNFHQNYVATTHMIEQRKTPVSRLSLFSFKQSPPGTPVSSCQMRFDGPLHVPMNPEPAGSHHVVDGQTFAVPNPIRKPASMGFPGLQIGHASQLLDTQVPSPPSRGSPSNEGLCAVCGDNAACQHYGVRTCEGCKGFFKRTVQKNAKYVCLANKNCPVDKRRRNRCQYCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF
11,A0A1U7TVX5,Non Druggable,Histamine H1 receptor,HRH1,487,55391,MTLPNSSCLLEDNMCEGNKTTMANPQLMPLVVVLSTISLITVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLLSEWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHRFMPQTSGHREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVNAKKPGKESPWEVLKMKPKDAGGGSVLKPPSQDPEETNSPVVFSQEENEAVGKPHCFPLNIVQLQTVAEGSSEDYITVTQAQSQLKMDESDLNVHGVSEMSEDQTLGDSQSFSRTDSDTPTEPAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGCIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
12,P35504,Druggable,UDP-glucuronosyltransferase 1A5 (UGT1A5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-5) (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E),UGT1A5 ,534,60071,MATGLQVPLPQLATGLLLLLSVQPWAESGKVLVVPTDGSHWLSMREALRDLHARGHQVVVLTLEVNMYIKEENFFTLTTYAISWTQDEFDRLLLGHTQSFFETEHLLMKFSRRMAIMNNMSLIIHRSCVELLHNEALIRHLHATSFDVVLTDPFHLCAAVLAKYLSIPAVFFLRNIPCDLDFKGTQCPNPSSYIPRLLTTNSDHMTFLQRVKNMLYPLALSYLCHAVSAPYASLASELFQREVSVVDLVSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANGKPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
13,A0A1V4JVS7,Non Druggable,Histamine H1 receptor,HRH1 ,475,54359,MSKNTTVNFTNSQLALLGLFLGSISIITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYFLRSAWTLGLPACSFWLSMDYVASTASIFSLFVLCIDRYRSVQQPLKYLKYRTKMRALLIILGVWLLSFMWVIPILGWHVFARNGERTVNENKCETEFSEVISFKVLTAIINFYLPSILMLWFYYKIFRAVRKHCKHRELTDGSYQSSSENTTIHHSKTKDEQNTCLQKQILEENTPPKDKQSSSQPKNMEAEVDFSKPDKSSKVFVSKSNRKVLKWGCFSLTAAQSKPGMDKAGKKSVCVTNGNENEEEPCSQDSDVSNASDNHSFTDEVTCREPSNSNPERASSPQEKAENRDFRGLAYLRKTWQGLQTHSKRHMQGLRGNRERKAAKQLGVIMAAFMLCWLPYFVLFTIKAFHTNERILEFHMFTIWLGYMNSALNPFLYPLCNQNFKKTFKKILHIQ
14,A0A1Y8EK52,Druggable,D(2) dopamine receptor (Fragment),DRD2,7,789,MDPLNLS
15,A0A218UNW4,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,374,41787,MRIISDTMDPCYNHTSSQKSNHTSSQVFPLQVLVGFCLFTLIVVTLCGNIIVCLAVTLDRRLRSLTNCIIVSLAITDLLLGLLVLPFSALYELTKEWPFGSVLCNIYTSLDVMLCTASILNLLMISLDRYFAVTTPLRYRQVVTPSRVAVGLAVIWTVSLMVSFLPIHLGWNTNGTAVQNTGPTCSKECTLAVNLVYGLVDGLLTFYIPLGIMCITYYRILKIAREQAKRINHTWGNAPTPPMVKEHKATVTLAVVLGAFVVCWLPYFTMFTYRGVWGDSGVKGTPMSIVLWLGYANSALNPILYGTLNRDFRVAYQHLLHCWRTRHPRNSHLPPLQKAQPRGRQGQGRQEGKPLKLEVRNEKGTLLTDGALKR
16,A0A218UP75,Non Druggable,Histamine H1 receptor,HRH1 ,466,52817,MDAAGTKDTAPLPTPTCLLLGGISLVTIVMNILVLCAVKMEKKLQTVGNLYIVSLSIADLIVGVAVMPLNIVDLLSPAWPLGLEACLFWLSMDYVASTASIFNLFILCVDRYRSVQQPLQYLKYRTKMRASLLILGVWLLSFTWVIPILGWHLFANNGQRTVEENKCETEFFKVTWFKVLAAIFNFYLPSLLMLWFYCKIFRAVQKHCQHRELNNRSHLSSTEKNTVQQTKTKDDKNICLQEQIIGENSPGVDKENSPEPQKVEAELHFSHPDKASKALCNGKVMKWSCFSLTTAKPEPGLDKAEKRGACATKKPGAKEQPDCQDSDSSGASDNHTFTEVVPQAEPSPEGACHPQGSTERRDSRETTFLRKTWHALHSHSRSIHRHGNRERKAAKQLGVIMAAFMICWIPYFVLFMVITFHDHKQLLELHRGAIWLGYVNSTLNPFLYPLCNQNFKKTFKKILHIH
17,A0A220XIT2,Druggable,DRD2 (Fragment),DRD2,94,9951,FLSVINLLEHHANVHARNKVGWTPAHLAALKGNTAILKVLVKAGAQLDVQDGVSCTPLQLALRSRKQGIMSFLEGKEPSVATLGGSKPGAEMEI
18,A0A286Y4E3,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,47719,MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAITDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNRKLSVSCTMCFSNILSCCKNLWGLRFLQRHLGDPLEEQPEEPLSEKTQTTPDQEEMRALPSEAV
19,A0A286YF88,Druggable,Alpha-1B adrenergic receptor (Fragment),ADRA1B,35,3712,MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNS
20,A0A286ZR00,Non Druggable,Histamine H1 receptor,HRH1,506,57549,MRKTSQSSAGSEQELEATLVPMTFPNSSFTLEDNMCEANKTTMANPKLMPLVVVLSAVSLVTVGLNLLVLCAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILVAWLFSFLWVIPILGWHRFVSRTSRRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELINGSLPSFSEIKLKPENPKVGAKKAGKESPWEVLKRKPKDAGGGPVLKPSSQDSVEMKSPGVSSQEDGELDKFHCFTLNIVQTQMEAEGSSKGYVAVIHSQSQLEMDEQGLNMRGANEISEDQTLGDSQSSRTDSDTPTEPVPGKSKPRSGSSTGLDYIKLTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
21,P40145,Druggable,Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase),ADCY8,1251,140122,MELSDVRCLTGSEELYTIHPTPPAGDGRSASRPQRLLWQTAVRHITEQRFIHGHRGGSGSGSGGSGKASDPAGGGPNHHAPQLSGDSALPLYSLGPGERAHSTCGTKVFPERSGSGSASGSGGGGDLGFLHLDCAPSNSDFFLNGGYSYRGVIFPTLRNSFKSRDLERLYQRYFLGQRRKSEVVMNVLDVLTKLTLLVLHLSLASAPMDPLKGILLGFFTGIEVVICALVVVRKDTTSHTYLQYSGVVTWVAMTTQILAAGLGYGLLGDGIGYVLFTLFATYSMLPLPLTWAILAGLGTSLLQVILQVVIPRLAVISINQVVAQAVLFMCMNTAGIFISYLSDRAQRQAFLETRRCVEARLRLETENQRQERLVLSVLPRFVVLEMINDMTNVEDEHLQHQFHRIYIHRYENVSILFADVKGFTNLSTTLSAQELVRMLNELFARFDRLAHEHHCLRIKILGDCYYCVSGLPEPRQDHAHCCVEMGLSMIKTIRYVRSRTKHDVDMRIGIHSGSVLCGVLGLRKWQFDVWSWDVDIANKLESGGIPGRIHISKATLDCLNGDYNVEEGHGKERNEFLRKHNIETYLIKQPEDSLLSLPEDIVKESVSSSDRRNSGATFTEGSWSPELPFDNIVGKQNTLAALTRNSINLLPNHLAQALHVQSGPEEINKRIEHTIDLRSGDKLRREHIKPFSLMFKDSSLEHKYSQMRDEVFKSNLVCAFIVLLFITAIQSLLPSSRVMPMTIQFSILIMLHSALVLITTAEDYKCLPLILRKTCCWINETYLARNVIIFASILINFLGAILNILWCDFDKSIPLKNLTFNSSAVFTDICSYPEYFVFTGVLAMVTCAVFLRLNSVLKLAVLLIMIAIYALLTETVYAGLFLRYDNLNHSGEDFLGTKEVSLLLMAMFLLAVFYHGQQLEYTARLDFLWRVQAKEEINEMKELREHNENMLRNILPSHVARHFLEKDRDNEELYSQSYDAVGVMFASIPGFADFYSQTEMNNQGVECLRLLNEIIADFDELLGEDRFQDIEKIKTIGSTYMAVSGLSPEKQQCEDKWGHLCALADFSLALTESIQEINKHSFNNFELRIGISHGSVVAGVIGAKKPQYDIWGKTVNLASRMDSTGVSGRIQVPEETYLILKDQGFAFDYRGEIYVKGISEQEGKIKTYFLLGRVQPNPFILPPRRLPGQYSLAAVVLGLVQSLNRQRQKQLLNENNNTGIIKGHYNRRTLLSPSGTEPGAQAEGTDKSDLP
22,A0A287BCR2,Non Druggable,Histamine H1 receptor,HRH1,498,56802,MRSEQELEATLVPMTFPNSSFTLEDNMCEANKTTMANPKLMPLVVVLSAVSLVTVGLNLLVLCAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILVAWLFSFLWVIPILGWHRFVSRTSRRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELINGSLPSFSEIKLKPENPKVGAKKAGKESPWEVLKRKPKDAGGGPVLKPSSQDSVEMKSPGVSSQEDGELDKFHCFTLNIVQTQMEAEGSSKGYVAVIHSQSQLEMDEQGLNMRGANEISEDQTLGDSQSSRTDSDTPTEPVPGKSKPRSGSSTGLDYIKLTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
23,A0A2C9F1F6,Non Druggable,Histamine H1 receptor,HRH1,482,54987,MTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
24,A0A2H4P6E7,Druggable,Purinergic receptor P2Y G-protein coupled 12 transcript variant 1,P2RY12,342,39380,MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTPDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM
25,A0A2I0LW52,Non Druggable,Histamine H1 receptor,HRH1 ,475,54502,MSKNTTANFTNSQLALLGLFLGSISMITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYFLRSAWTLGLPACSFWLSMDYVASTASIFSLFVLCIDRYRSVQQPLKYLKYRTKMRALLIILGVWLLSFMWVIPILGWHVFARNGERTVNENKCETEFSEVTCFKVLTAIINFYLPSILMLWFYYKIFRAVRKHCKHRELIDGSYRSFSEKTSIHQSKTKDEQNTCLQKQILEENTPPKDKQSSPQPKNMEAEVHFDKPDKSSKVFVSKSNREVLKWGCFSLTAAQSEPGMDKAGKKAVCVTKSNENEEEPCSQDSDVSNASDNHSSTDEVTCREPSNPNPETACSPQEKAENRDFRGLAYLKKTWQRLQTHSKRHMQGLRANRERKAAKQLGVIMAAFMLCWLPYFVLFTIKAFHTNEQILEFHMFTIWLGYMNSALNPFLYPLCNQNFKKTFKKILHIQ
26,A0A2I2UDT1,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,482,53241,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPIRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHNAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDRKPALSCTVCSSNLLSCCKSLWGLRFLQRHVRGPSEEQPGEPLSEEPLRTPPQEAPGSSKNTLTPACSCQPLDSTTYLQFPFLAPPASCIPACAAHLAQETSWVWPGELSPQHPAGAHVSPRRK
27,P41222,Druggable,Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (L-PGDS) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2),PTGDS ,190,21029,MATHHTLWMGLALLGVLGDLQAAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQ
28,A0A2I2UE68,Non Druggable,Histamine H1 receptor,HRH1,501,57184,MLGREPQLEAALVPMTLPNSSCVVEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPVSGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPWEVLKRKSKDASGEPVMKPPSQDSEEMKCPGVFSQEEDKEMDKLHCFPLNIVQMQTEAEGSGRSYAAINQSQGQLEIDEQSLRMRAANEISEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSSTGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
29,Q9ULU8,Druggable,Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1),CADPS ,1353,152786,MLDPSSSEEESDEIVEEESGKEVLGSAPSGARLSPSRTSEGSAGSAGLGGGGAGAGAGVGAGGGGGSGASSGGGAGGLQPSSRAGGGRPSSPSPSVVSEKEKEELERLQKEEEERKKRLQLYVFVMRCIAYPFNAKQPTDMARRQQKISKQQLQTVKDRFQAFLNGETQIMADEAFMNAVQSYYEVFLKSDRVARMVQSGGCSANDSREVFKKHIEKRVRSLPEIDGLSKETVLSSWMAKFDAIYRGEEDPRKQQARMTASAASELILSKEQLYEMFQNILGIKKFEHQLLYNACQLDNPDEQAAQIRRELDGRLQMADQIARERKFPKFVSKEMENMYIEELKSSVNLLMANLESMPVSKGGEFKLQKLKRSHNASIIDMGEESENQLSKSDVVLSFSLEVVIMEVQGLKSLAPNRIVYCTMEVEGGEKLQTDQAEASKPTWGTQGDFSTTHALPAVKVKLFTESTGVLALEDKELGRVILHPTPNSPKQSEWHKMTVSKNCPDQDLKIKLAVRMDKPQNMKHSGYLWAIGKNVWKRWKKRFFVLVQVSQYTFAMCSYREKKAEPQELLQLDGYTVDYTDPQPGLEGGRAFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSHKPVPPTQVQKLNAKGGNVPQLDAPISQFYADRAQKHGMDEFISSNPCNFDHASLFEMVQRLTLDHRLNDSYSCLGWFSPGQVFVLDEYCARNGVRGCHRHLCYLRDLLERAENGAMIDPTLLHYSFAFCASHVHGNRPDGIGTVTVEEKERFEEIKERLRVLLENQITHFRYCFPFGRPEGALKATLSLLERVLMKDIVTPVPQEEVKTVIRKCLEQAALVNYSRLSEYAKIEENQKDAENVGRLITPAKKLEDTIRLAELVIEVLQQNEEHHAEPHVDKGEAFAWWSDLMVEHAETFLSLFAVDMDAALEVQPPDTWDSFPLFQLLNDFLRTDYNLCNGKFHKHLQDLFAPLVVRYVDLMESSIAQSIHRGFERESWEPVKSLTSNLPNVNLPNVNLPKVPNLPVNIPLGIPQMPTFSAPSWMAAIYDADNGSGTSEDLFWKLDALQTFIRDLHWPEEEFGKHLEQRLKLMASDMIESCVKRTRIAFEVKLQKTSRSTDFRVPQSICTMFNVMVDAKAQSTKLCSMEMGQEHQYHSKIDELIEETVKEMITLLVAKFVTILEGVLAKLSRYDEGTLFSSFLSFTVKAASKYVDVPKPGMDVADAYVTFVRHSQDVLRDKVNEEMYIERLFDQWYNSSMNVICTWLTDRMDLQLHIYQLKTLIRMVKKTYRDFRLQGVLDSTLNSKTYETIRNRLTVEEATASVSEGGGLQGISMKDSDEEDEEDD
30,Q9Y2K6,Druggable,Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2),USP20 KIAA1003,914,102003,MGDSRDLCPHLDSIGEVTKEDLLLKSKGTCQSCGVTGPNLWACLQVACPYVGCGESFADHSTIHAQAKKHNLTVNLTTFRLWCYACEKEVFLEQRLAAPLLGSSSKFSEQDSPPPSHPLKAVPIAVADEGESESEDDDLKPRGLTGMKNLGNSCYMNAALQALSNCPPLTQFFLECGGLVRTDKKPALCKSYQKLVSEVWHKKRPSYVVPTSLSHGIKLVNPMFRGYAQQDTQEFLRCLMDQLHEELKEPVVATVALTEARDSDSSDTDEKREGDRSPSEDEFLSCDSSSDRGEGDGQGRGGGSSQAETELLIPDEAGRAISEKERMKDRKFSWGQQRTNSEQVDEDADVDTAMAALDDQPAEAQPPSPRSSSPCRTPEPDNDAHLRSSSRPCSPVHHHEGHAKLSSSPPRASPVRMAPSYVLKKAQVLSAGSRRRKEQRYRSVISDIFDGSILSLVQCLTCDRVSTTVETFQDLSLPIPGKEDLAKLHSAIYQNVPAKPGACGDSYAAQGWLAFIVEYIRRFVVSCTPSWFWGPVVTLEDCLAAFFAADELKGDNMYSCERCKKLRNGVKYCKVLRLPEILCIHLKRFRHEVMYSFKINSHVSFPLEGLDLRPFLAKECTSQITTYDLLSVICHHGTAGSGHYIAYCQNVINGQWYEFDDQYVTEVHETVVQNAEGYVLFYRKSSEEAMRERQQVVSLAAMREPSLLRFYVSREWLNKFNTFAEPGPITNQTFLCSHGGIPPHKYHYIDDLVVILPQNVWEHLYNRFGGGPAVNHLYVCSICQVEIEALAKRRRIEIDTFIKLNKAFQAEESPGVIYCISMQWFREWEAFVKGKDNEPPGPIDNSRIAQVKGSGHVQLKQGADYGQISEETWTYLNSLYGGGPEIAIRQSVAQPLGPENLHGEQKIEAETRAV
31,Q9Y2T5,Druggable,G-protein coupled receptor 52,GPR52,361,41354,MNESRWTEWRILNMSSGIVNVSERHSCPLGFGHYSVVDVCIFETVVIVLLTFLIIAGNLTVIFVFHCAPLLHHYTTSYFIQTMAYADLFVGVSCLVPTLSLLHYSTGVHESLTCQVFGYIISVLKSVSMACLACISVDRYLAITKPLSYNQLVTPCRLRICIILIWIYSCLIFLPSFFGWGKPGYHGDIFEWCATSWLTSAYFTGFIVCLLYAPAAFVVCFTYFHIFKICRQHTKEINDRRARFPSHEVDSSRETGHSPDRRYAMVLFRITSVFYMLWLPYIIYFLLESSRVLDNPTLSFLTTWLAISNSFCNCVIYSLSNSVFRLGLRRLSETMCTSCMCVKDQEAQEPKPRKRANSCSI
32,A0A2I2UHN9,Non Druggable,Histamine receptor H3,HRH3,405,44790,MALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWPFSRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVQKMVMVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFHNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRVRLDGARDPEPPPEAQPSPPPAAPGCWGCWQKGRGEAVPLHRYGVGVGEAAPGAEAGEAAPGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMASQSITQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKIQPHSSLEHCWK
33,A0A024RAP7,Druggable,Proteinase-activated receptor 1 (Thrombin receptor),F2R ,425,47441,MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT
34,A0A087X173,Druggable,Adenosine receptor A1,ADORA1,210,24084,MVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
35,A0A0C5B5G6,Druggable,Mitochondrial-derived peptide MOTS-c (Mitochondrial open reading frame of the 12S rRNA-c),MT-RNR1,16,2175,MRWQEMGYIFYPRKLR
36,A0A2I2UN27,Non Druggable,Histamine H1 receptor,HRH1,514,58567,MPVAGENALETQDGDRREPQLEAALVPMTLPNSSCVVEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPVSGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPWEVLKRKSKDASGEPVMKPPSQDSEEMKCPGVFSQEEDKEMDKLHCFPLNIVQMQTEAEGSGRSYAAINQSQGQLEIDEQSLRMRAANEISEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSSTGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
37,A0A024R3I6,Druggable,D(2) dopamine receptor (Dopamine D2 receptor),DRD2 ,414,47347,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
38,A0A2I2Y6Q5,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,46948,MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDRKPALSCTTCSSNLLSCCKSLWGLRFLQRHMGGPSEELSGEPLSEEPQKRPPQKAVRTLPSEAV
39,P40337,Druggable,von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),VHL,213,24153,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD
40,A0A2I3LV21,Non Druggable,Histamine H1 receptor,HRH1,489,55881,MPMTLPNSSYLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
41,A0A2J8WDE4,Non Druggable,Histamine H1 receptor,HRH1,487,55588,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFRQQISVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQKHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTVAEGSSRDYVAINQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
42,A0A0A0MSE3,Druggable,Type-1 angiotensin II receptor,AGTR1,388,44205,MLTFTSECGCTTFGVFDIVFATNSTQVIKMILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
43,A0A2K5DLE1,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,380,42466,MAPNGTASSFCLDSIAFKITISVVLGILIFITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVTISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTPKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLKGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLASRNSHKTSLRSNASQLSRTQSREPRPQEEKPLKLQVWSGTEVTAPQGATDRNPGEDHEKRIPHGIQRSGSRL
44,Q9UNN8,Druggable,Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201),PROCR ,238,26671,MLTTLLPILLLSGWAFCSQDASDGLQRLHMLQISYFRDPYHVWYQGNASLGGHLTHVLEGPDTNTTIIQLQPLQEPESWARTQSGLQSYLLQFHGLVRLVHQERTLAFPLTIRCFLGCELPPEGSRAHVFFEVAVNGSSFVSFRPERALWQADTQVTSGVVTFTLQQLNAYNRTRYELREFLEDTCVQYVQKHISAENTKGSQTSRSYTSLVLGVLVGSFIIAGVAVGIFLCTGGRRC
45,A0A287AYG3,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,364,40919,MASNSTASSSCLDPLAFKVTVSLILILLIFITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVLIWVISITLSFLSIHLEWNSSRMDPSGVNHTISKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHNISSWRAATIREHKATVTLAAVMGAFIICWFPYFSVFVYRGLKGDEAVDETVEAIVLWLGYANSALNPILYAALNRDFRTAYQQLFRCSPTSHNAHRTPLRSNSSQLMRNQSQETRWQEERPLRLQVWSGAEVAAAQEATDREFGE
46,A0A287B9V8,Non Druggable,Histamine receptor H3,HRH3,455,49340,MERSPPDGPLNASGALAGEAAAAAAAAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWPFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRVRLDGAREAAAPELPPEAQPSPPAAVPSCWGCWQKGCGEAVPLHRCGVGVGEGAPGTEAREAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSVTQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGRCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFAKLLCPQKLKLQPHSSLEHCWK
47,A0A024R638,Druggable,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB hCG_2026806,532,59480,MNKSTCLMAAETPSKRWRLHCLAFSQRFVRAGPACSSREACSSPRAGWNPAGFRLPGRWSPFVALHLVCQIREALKLRSGHRTPSGAGSSMQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKSCLCCWCQSFEEKQSLEEKQSCLKFKANDHGYDNFRSSNKYSSS
48,A0A2K5E0H0,Non Druggable,Histamine H1 receptor,HRH1,486,55208,MIFPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLCAVRSERKLHTMGNLYIVSLSAADLIVGAVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMRQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGSVKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPEEMKSPVVFSQEDDGEVDKLRCLPLDTAQMQTAAEGSSRDYAASNQSHGQLKMEEQGLNTHGASETSEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNCETKAAKQLGFIMAAFILCWIPYFILFMFIAFCKSCCNEHLHMFTILGYINSTLNPLIYPLCNENFKKTFKRILHIHS
49,P30542,Druggable,Adenosine receptor A1,ADORA1,326,36512,MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
50,A0A2K5KHA6,Non Druggable,Histamine H1 receptor,HRH1,487,55605,MILPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPVCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSILKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
51,A0A2K5XVJ2,Non Druggable,Histamine H1 receptor,HRH1,487,55592,MTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDNGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
52,P29274,Druggable,Adenosine receptor A2a,ADORA2A ,412,44707,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
53,P30542,Druggable,Adenosine receptor A1,ADORA1,326,36512,MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
54,P30542,Druggable,Adenosine receptor A1,ADORA1,326,36512,MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
384,Q99497,Non Druggable,Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124),PARK7,189,19891,MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD
56,A0A2K6JWI9,Non Druggable,Histamine H1 receptor,HRH1,489,55879,MPMTLPNSSYLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFKQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENFKGGAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHEASEMPEDQTLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
57,A0A2K6NFP3,Non Druggable,Histamine H1 receptor,HRH1,489,55879,MPMTLPNSSYLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFKQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENFKGGAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHEASEMPEDQTLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
58,P29275,Druggable,Adenosine receptor A2b,ADORA2B,332,36333,MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLAAADVAVGLFAIPFAITISLGFCTDFYGCLFLACFVLVLTQSSIFSLLAVAVDRYLAICVPLRYKSLVTGTRARGVIAVLWVLAFGIGLTPFLGWNSKDSATNNCTEPWDGTTNESCCLVKCLFENVVPMSYMVYFNFFGCVLPPLLIMLVIYIKIFLVACRQLQRTELMDHSRTTLQREIHAAKSLAMIVGIFALCWLPVHAVNCVTLFQPAQGKNKPKWAMNMAILLSHANSVVNPIVYAYRNRDFRYTFHKIISRYLLCQADVKSGNGQAGVQPALGVGL
59,A0A2K6S722,Non Druggable,Histamine H1 receptor,HRH1,487,55658,MTFPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMRQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGGVKKPGKESPWEVLKRKPKDAGGGCILKSPSQTPEEMKSPVVFSQEDDGEVDKLHCLPLDIVQMQTEAEGSSRDYAASNQSHGQLKMEEQGLNTHGASETSEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
60,A0A2R8Y748,Druggable,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB,409,45803,MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKVRDYPKIKSSL
61,A0A2R8YGF7,Druggable,Endothelin receptor type B (Fragment),EDNRB,162,18597,KLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQLSVGIGLYWYQHGFTEFLH
62,A0A2R8ZS93,Non Druggable,Histamine H1 receptor,HRH1,487,55661,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLHCFPLDIVHMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
63,A0A2U3XM60,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,46824,MVPNGTASSFCLDSPPCKITVSVVLTVLILITIAGNVVVCLAVGLTRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSGSKNSSFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARHQAKRIHHMGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLVGDDDINEAIEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPTSHSAQETTRRAGSSQLTRNQSREPMQQEEKPLKLQVWSGTEVTAPRGASDRKPALSCTVCSSNLLSCCKSLWGLRFLQRHMRGPSEEQPGEPLSEEPLRTPPQEAVRTLPSEAV
64,P29033,Druggable,Gap junction beta-2 protein (Connexin-26) (Cx26),GJB2,226,26215,MDWGTLQTILGGVNKHSTSIGKIWLTVLFIFRIMILVVAAKEVWGDEQADFVCNTLQPGCKNVCYDHYFPISHIRLWALQLIFVSTPALLVAMHVAYRRHEKKRKFIKGEIKSEFKDIEEIKTQKVRIEGSLWWTYTSSIFFRVIFEAAFMYVFYVMYDGFSMQRLVKCNAWPCPNTVDCFVSRPTEKTVFTVFMIAVSGICILLNVTELCYLLIRYCSGKSKKPV
65,A0A2Y9EE52,Non Druggable,Histamine H1 receptor,HRH1,487,55397,MTLPNSSSVLEDKMCEGNKTTTPNPQMTPLVVVLSAISLVTVGLNLLVLYAVCSERKLHTVGNLYIVSLSVADLIVGAVVMPVNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSIFILCVDRYRSVQQPLGYLRYRTKTRASATILAAWFLSFLWVIPILGWHRFMSKTSGRREDKCETDFYDVTWFKVMTAIVNFYLPTLLMLWFYAKIYRAVQQHCQHRELIGGSLPSFSEDKLKPEDLKVGAKKPGKESPWEVLKRKPKDAGGGPVLKTASQDPKEIKSPGVFRQEKDGELDRVHCSPPNIVQTQMEADGRGREYVAISQSQSQLETGEQGLNMHGAKEILEDQILGDSHSFSRTDSDTPTELAPGKAKSKSESSRGLDYIKFTWKRLCSHSRQYMSVLQMNRERKAAKQLGFIMVAFIVCWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
66,A0A2Y9HG85,Non Druggable,Histamine H1 receptor,HRH1,487,55514,MTLPNSSRAFEDKMCEGNKTTIANPQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHRFMSQSSGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSHPSFSEIKLKSENPKAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDPGEMKSPGVFSREEDKEVDRLQCFPLNIVQVQTEAEGSGRSYVVFNQSQSLLGMDEQSLNMHGANEMSEDQILGDSQSFSRTDSDTPTESASGKGKPTSGSSIGLDYIKFTWKRLCSHSKQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKYCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
67,P30542,Druggable,Adenosine receptor A1,ADORA1,326,36512,MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
68,A0A2Y9M8G8,Non Druggable,Histamine H1 receptor,HRH1,487,55427,MTLPNSSSVLEDKMCEGNKTTTPNPQMMPLVVVLSAISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPVNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCVDRYRSVQQPLRYLRYRTKTRASATILAAWFLSFLWVIPILGWHRFMSKTSGHREDRCETDFYDVTWFKVMTAIINFYLPTSLMLWFYAKIYKAVQQHRQQRELINGSLPPFSEDKLKPENLRVGAKKPGKESPWEVLKRKPKDAGGGPVLKPASQDPKEIKSPGVFRQEKDGGLDKFHCSPVNIVQTQMEADGTGREYVAISQSQSQLEMGEQGLNMHGAKEILEDQILGDSQSFSRTDSDTPPELARGEAKSKSESSTGLDYIKFTWKRLCSHSRQYASVLHTNRERKAAKQLGFIMVAFIVCWIPYFIFFMVIAFCESCCNQHVHMFTVWLGYINSTLNPLIYPLCNGNFKETFRKILHIRS
69,C9JQD8,Druggable,Adenosine receptor A2 (Fragment),ADORA2A,365,40096,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGL
70,A0A341B180,Non Druggable,Histamine H1 receptor,HRH1,487,55354,MTLPNSSSVLEDEMCEGNKTTTPNPQMMPLVVVLSAISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAIVMPVNILYLLTSRWSLGRPLCLFWLSMDYVASTASIFSIFILCVDRYRSVQQPLRYLRHRTKTRASATILAAWFLSFLWVIPILGWHRFVSKTSGHREDRCETDFYDVTWFKVMTAIINFYLPTSLMLWFYAKIYKAVQQHRQRRELIDGSLPSFSEDKLKPENLRVGAKKPGKESPWEVLKRKPKDAGGGPVSKPASQDPKEIKSPGVFSQEKDGGPDKFHCSPINIVQTQMEADGSGRECVAISQSQSQLEMGEQGLNTHGAKEILEDQILGDSQFFSRTDSDTPPELARGEAKSKSESSTGLDYIKFTWKRLCSHSRQYVSVLHTHRERKAAKQLGFIMVAFIVCWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
71,A0A341C2T1,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,46997,MASNGTTSSFCLDPAALKITVSVVLTLFILVTIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFHQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPTLVTPVRVTISLVLIWVISITLSFLSIHLGWNSRTETSSTNHTVPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIAWDQAKRIHNVGSWRAATIREHKATVTLAAVMGAFIVCWFPYFTVFVYRGLKGDNAINETFEAVVLWLGYANSALNPILYAALNRDFRTAYQRLFCCSPSDHSTHRTSLKSNSSQPTRIPSRGPRWQEERSLRLQVWSGTEVTAPEGATDRKPAMSCTLCSSNLLSCCKSLWALSFLQRHVGGPLEEQPGEPLSEELLRTLAQESVRMLPSEAV
72,A0A369NIV7,Non Druggable,Dopamine dehydroxylase (EC 1.1.-.-),dadH ,1017,115026,MGNLTMSRRTFVKTAAITGAAAAAFGASTHTALAEETYSSVSGNDTVAVKTCCRGCGKMECGVKVIVQNGRAIRVEGDEGAFQSMGNCCTKSQSSIQAAYHPDRLHYPMKRTNPKGEEPGWQRISWDEAMQSIVDNFMDIKAKHGGEAIACQVGTSRIWCMHSESILKNMLETPNNVEAWQICKGPRHFATTMVSQFAMSWMETITRPKVYVQWGGASELSNYDDSCRTTVDVASRADVHISVDPRMANMGKEADYWQHLRPGTDGALALAWTNVIIEKKLYDELYVKKWTNAPFLVCEDMEPSGFPTVRTDGSYWDVKTALLKESDIKEGGSPYKFLVYDNNWEKLKAEGVEHEYGAFTWFNADQEGVIDETGGFWEGENYDSEKARQGREAAQDNLLPGQTQGWLPDPMPFDPAIDPALEGEFEITLKDGKTVKVKPVWEHYKARAAEYKPEVAAEITGIPASEIEAAATAYGTRIDPSTGYGNGGIQYMLAVEHFCSAIQNCRAFDNLVGITGNMDTPGGNRGPTIVPIDGDLQGFSAWAPGATTPPEEVNRKQIGIDKFPLLGWWQYWCDSHSLWDAVITGDPYPVRALWNESGNFMSQTNTTRAWEALCSLDFYVDLNLWHTPQNDTADIILPVAHWIELNSPRASQGSAGAMGATVKCVQPPAEAKYDPEIVMDLARRMNWKWTDEPGNEWPDINWQLDDSIKLLTDDELTYTTWHVENGKPTFERHGVPMAEVTPKYKTWDEYVKAFQEHGWWQAKDIEPRNWGTYRRYQTGAMRARDRVWGRLDYTAGKGIGDWKPGWFTPTMKQEIWSTVMESHHPDHPEWRLPTYTEPPHGPKDGDRIKEYPLTATTGRRIPVYFHSEHRQLPWCRELWPVPRVEINPKTAAEYGIEQGDWVWIETEWGKIREVADLYYGVKEDVINLEHTWWYPEVKDAGHGWQFSQVNQLIDHYAQDPHSGTSNLRAYQVKIYKATPENSPFNNPVPCDSTGTPIIHTSDDPRLKEWLPTYEGRE
73,A0A384CNS8,Non Druggable,Histamine H1 receptor,HRH1,487,55515,MTLPNSSCSFEDKMCEGNKTTIASPQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHHFMSQSSGHRDDRCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDPDETKSPGVFSQEEDREVDKLQCFPLNIVQMQTEAEGSGRSFIAIDQSQSPVGMDEQSLNMHVANEMSEDQILGDSQSFSRTDSDTPTESASGKGKPRSGSSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
74,A0A3Q2IHJ7,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,580,64120,MASNGTAPPYCLDSTACKVTVSVVLIVLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCTWGFGEVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVVISLVLIWVISITLSFLSIHLGWNSRSENSSSELLTGVNHTASKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQARRIHHVGSWKAATIKEHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDEAVNEVIEAVVLWLGYANSALNPILYAALNRDFRTAYQQLFHCRLAGCNARETFLRSNSSQLSRNQSPEPRRQEEKPLKLQVWSGTEVTVPRGATDRLCLGLPQCWSMRLTHSFIHSFIHLQTFVSFPPRAGNCAEHWGCRSDLFGLCCDEQVWEVNCVAAISALPSLTLWLEQVLAPLGPQSPHVLECGVCPHAAGPAGLPELPEARELRDANRPYDPSWDARPLSSSEQQPREKQADTADPHTLWILPSVEDCGGQTVQLDTRASWPLWSLQQPGAECSPLALGPGPSTLAVLSCWNKLLHSASSWPPCL
75,A0A3Q2YCA5,Non Druggable,Histamine H1 receptor,HRH1,509,58546,MLHSLNSLLSINHTFPVHGGLHSALLGVSLGFLSLLTIIMNLLVLYAVKTEKSLHTVGNLYVVSLSVADLIVGATVMPLSLVYLLQDEWKLGRAVCQFWLIMDYVASTASIFSLFILCLDRYRSVRQPLKYLKYRTRGKASVMITGAWLLSLSWIFPILGWRSFTRVELKPEEENKCDTDFRFVTWFKVLTAVFNFYVPSILMLWFYTHIYLAVRQHLRDRERIIHPTDSFGEKDNEQNAESSNDSKSAQKECEAPVKLLKRQLDQKLLDETYSLEEFDKNKSSLSRSHRKIGAQCSKPGLLAVTTKEDRVTSKPGRDSLAPEEKRPDAAVSLNSACLPPENVTSERNRESSLNECHVTVPNSVNGVCDISQVQKYTSVLCNKYNSGRSLPWSKAADDTELDPDNEVTLRQTWRRFLEHSRERLHSLRIHKEHKAARQLGFIIAAFLLCWIPYFIAFMVMAFCRDCVHHDLHMFTIWLGYMNSTLNPFIYPLCNRNFKRVFKNILHKNL
76,A0A3Q3ARJ8,Non Druggable,Histamine H1 receptor,HRH1,530,60742,MMESGLSPFTDFLDLNTNYSNKNWSSLLRHSHNQTLHNPFHYALLGVSLGLLSLLTIIMNLLVLYAVKKEKTLHTVGNLYIVSLSVADLIVGATVMPLNLMYLLEDEWKLGRAVCQFWLIMDYVASTASIFSLFILCLDRYRSVRQPLKYLKYRTRGKASVMISGAWLLSMMWIIPILGWRSFTHVDLKPEEENKCDTDFRFVTWFKVITAVFNFYVPSILMLWFYTHIYLAVRQHLRDRERIIHPADSFGENENGGNAQSPKKSDSKSPKIENDSSVKTSKKERLLDQNTLDQTYSLEEADKSKAAPFRAHRKIGVKCQQTSLLTMTTKRLRMARKAKTCSLSPEERQPDAEIPLSRPSAPQDTTCSGGNNEAKLQASLNECHVTVTNSVSRVCGSSQVSDVQRYTSVLYNSYDPSQALPWPKEGAEDAKIDPDNAVTLKQAWHRFIDQSRHRIQSLRIHKEHKAAKQLGFIIAAFLLCWIPYFIVFMVMAFCPECVHHDLHMFTIWLGYMNSTLNPFIYPLCNGNFKR
77,C9JFS2,Druggable,Adenosine receptor A2 (Fragment),ADORA2A,87,9106,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVL
78,A0A3Q3M8P3,Non Druggable,Histamine H1 receptor,HRH1,534,61661,MMESGLSPSTDPLHISTNTYVNYSNKNWSGLLDSDSLRSNHTLTLYDRFHSAFLGIFLGLLSLLTIIMNLLVLYAVKREKSLHTVGNLYIVSLSVADLMVGTTVMPLNLVYILEDEWKLGRAVCQFWLIMDYVASTASIFSLFILCLDRYRSVRQPLKYLKYRTRGQASVMISGAWLLSMTWIIPILGWRSFTHVDLKPEEQNKCDTDFRFVTWFKVITAVFNFYVPSILMLFFYIHIYLAVRQHLRDRERIIHPTDSFGENENGRNSQTPEKNDSKSPKRESEIPIKLSKKQLLDQNTLDQTYSLKEADKTTASLRAHKTTGVKCKAPLLDMTTKQIQMVRKAKRCSLSPAEKQPNTEIPLSRPQDMICPEGNHENKQTVPNSVGGVCDISQVSDVQRFTSVLYNNYDFSHALPWTEEGVVEDNLDPANAVTLKQTWQRFIDQSRQRIQTLRIHKEHKAAKQLGFIIAVFLLCWIPYFIAFMVTAFCRECVHHDLHMFTIWLGYINSTLNPFIYPLCNGNFKRVFRNILNIRL
82,C9J3T2,Druggable,Adenosine receptor A2a (Fragment),ADORA2A,64,6734,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAI
83,A0A481NV25,Non Druggable,L-tyrosine decarboxylase (TDC) (EC 4.1.1.25) (Levodopa decarboxylase) (L-dopa decarboxylase) (EC 4.1.1.-),tdc mfnA_1,611,69341,MKDMDIKAVFIGDKAENGPVYKMLLNKMVDEHLGWRENYIPSDMPAISEGDKLTPDYLATRDHMIEVLDEVSQRLRAGSIPWHSAGRYWGQMNAETLMPALLAYNYAMLWNPNNVALESSMATSQMEAEVGQDFASLFNMADGWGHIAADGSIANLEGLWYARCIKSIPLAVKEVLPEKVKNMSEWALLNLSVEEILEMTESFTDEEMDEVKAASSRSGKNIQKLGKWLVPQTKHYSWMKALDICGVGLDQMVAIPVQEDYRMDINALEKTIRELADQKIPILGVVAVVGTTEEGQVDSVDKIIQLREKLKDEGIYFYLHVDAAYGGYARSLFLNEAGEFVPYASLAEFFEEHHVFHHYVTIDKEVYEGFRAISEADSVTIDPHKMGYVPYAAGGIVIKHKNMRNIISYFAPYVFEKSVKAPDMLGAYILEGSKAGATAAAVWTAHRVLPLNVTGYGQLIGASIEAAQRFREFLEQLHFTVKGKTIEVYPLNHPDFNMVNWVFKVQDCTDLNAINELNEKMFDRSSYMDGDVYGERFITSHTTFTQEDYGDSPIRFIERMGLSKEEWQKEQQITLLRAAIMTPYLNDDRIFNFYTKEIAKAMEKKLNEIIK
84,D3DNG8,Druggable,Type-1 angiotensin II receptor,AGTR1,394,44919,MKKMNHKSTDSPKAPQLRGGVFDIVFATNSTQVIKMILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
85,A0A4W2BUX4,Non Druggable,Histamine H1 receptor,HRH1,491,55961,MTCPNSSCVFEDKMCEGNKTAPANNAQLTPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILGWRHFQPKTPEPREDKCETDFYNVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDMKMKPENLQVGTKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSPGVFSQEKEEKDGELGKYYCFPLDTVQAQPEAEGSGRGYAAINQSQNQLEMGEQGLSMPGAKEALEDQILGDSQSFSRTDSDTPAEPALAKGKSQSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIICWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
86,A0A4W2C7Q1,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,363,40483,MAANGTASSSCLDPTAFKVTVTVVLILLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLEWNSRPENHSDSHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFRIAREQARRIHNVGPWRAATLREHKATVTLAAVMGAFIVCWLPYFTVFVYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGQDARRTSLGSNSSQLVRHPGQGPRWPEERPLRLQVWSGTELTAPQGATDREFGE
87,A0A4W2GBU8,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,419,46408,MAANGTASSSCLDPTAFKVTVTVVLILLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLEWNSRPENHSDSHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFRIAREQARRIHNVGPWRAATLREHKATVTLAAVMGAFIVCWLPYFTVFVYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGQDARRTSLGSNSSQLVRHPGQGPRWPEERPLRLQVWSGTELTAPQGATDRNPARSSTACSSNLLSCCKSLWALRFLQRHEGGPWGEQPGAPLSEEPPTAPAQESVRTLPS
88,Q6UXB2,Druggable,C-X-C motif chemokine 17 (6-Cys CXCL17) (Dendritic cell and monocyte chemokine-like protein) (DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17],CXCL17 ,119,13819,MKVLISSLLLLLPLMLMSMVSSSLNPGVARGHRDRGQASRRWLQEGGQECECKDWFLRAPRRKFMTVSGLPKKQCPCDHFKGNVKKTRHQRHHRKPNKHSRACQQFLKQCQLRSFALPL
89,A0A4W2GRU6,Non Druggable,Histamine H1 receptor,HRH1,491,55927,MTCPNSSCVFEDKMCEGNKTAPANNAQLTPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILGWRHFQPKTPEPREDKCETDFYNVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDMKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSPGVFSQEKEEKDGELGKFYCFPLDTVQAQPEAEGSGRGYAAINQSQNQLEMGEQGLSMPGAKEALEDQILGDSQSFSRTDSDTPAEPAPAKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIICWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
90,A0A4X1SM86,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,364,40919,MASNSTASSSCLDPLAFKVTVSLILILLIFITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVLIWVISITLSFLSIHLEWNSSRMDPSGVNHTISKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHNISSWRAATIREHKATVTLAAVMGAFIICWFPYFSVFVYRGLKGDEAVDETVEAIVLWLGYANSALNPILYAALNRDFRTAYQQLFRCSPTSHNAHRTPLRSNSSQLMRNQSQETRWQEERPLRLQVWSGAEVAAAQEATDREFGE
91,Q12988,Druggable,Heat shock protein beta-3 (HspB3) (Heat shock 17 kDa protein) (HSP 17) (Protein 3),HSPB3 ,150,16966,MAKIILRHLIEIPVRYQEEFEARGLEDCRLDHALYALPGPTIVDLRKTRAAQSPPVDSAAETPPREGKSHFQILLDVVQFLPEDIIIQTFEGWLLIKAQHGTRMDEHGFISRSFTRQYKLPDGVEIKDLSAVLCHDGILVVEVKDPVGTK
92,Q13107,Druggable,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog),USP4 ,963,108565,MAEGGGCRERPDAETQKSELGPLMRTTLQRGAQWYLIDSRWFKQWKKYVGFDSWDMYNVGEHNLFPGPIDNSGLFSDPESQTLKEHLIDELDYVLVPTEAWNKLLNWYGCVEGQQPIVRKVVEHGLFVKHCKVEVYLLELKLCENSDPTNVLSCHFSKADTIATIEKEMRKLFNIPAERETRLWNKYMSNTYEQLSKLDNTVQDAGLYQGQVLVIEPQNEDGTWPRQTLQSKSSTAPSRNFTTSPKSSASPYSSVSASLIANGDSTSTCGMHSSGVSRGGSGFSASYNCQEPPSSHIQPGLCGLGNLGNTCFMNSALQCLSNTAPLTDYFLKDEYEAEINRDNPLGMKGEIAEAYAELIKQMWSGRDAHVAPRMFKTQVGRFAPQFSGYQQQDSQELLAFLLDGLHEDLNRVKKKPYLELKDANGRPDAVVAKEAWENHRLRNDSVIVDTFHGLFKSTLVCPECAKVSVTFDPFCYLTLPLPLKKDRVMEVFLVPADPHCRPTQYRVTVPLMGAVSDLCEALSRLSGIAAENMVVADVYNHRFHKIFQMDEGLNHIMPRDDIFVYEVCSTSVDGSECVTLPVYFRERKSRPSSTSSASALYGQPLLLSVPKHKLTLESLYQAVCDRISRYVKQPLPDEFGSSPLEPGACNGSRNSCEGEDEEEMEHQEEGKEQLSETEGSGEDEPGNDPSETTQKKIKGQPCPKRLFTFSLVNSYGTADINSLAADGKLLKLNSRSTLAMDWDSETRRLYYDEQESEAYEKHVSMLQPQKKKKTTVALRDCIELFTTMETLGEHDPWYCPNCKKHQQATKKFDLWSLPKILVVHLKRFSYNRYWRDKLDTVVEFPIRGLNMSEFVCNLSARPYVYDLIAVSNHYGAMGVGHYTAYAKNKLNGKWYYFDDSNVSLASEDQIVTKAAYVLFYQRRDDEFYKTPSLSSSGSSDGGTRPSSSQQGFGDDEACSMDTN
93,Q13167,Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,399,44112,MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLLCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGNPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGTFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
94,Q13258,Druggable,Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor),PTGDR,359,40271,MKSPFYRCQNTTSVEKGNSAVMGGVLFSTGLLGNLLALGLLARSGLGWCSRRPLRPLPSVFYMLVCGLTVTDLLGKCLLSPVVLAAYAQNRSLRVLAPALDNSLCQAFAFFMSFFGLSSTLQLLAMALECWLSLGHPFFYRRHITLRLGALVAPVVSAFSLAFCALPFMGFGKFVQYCPGTWCFIQMVHEEGSLSVLGYSVLYSSLMALLVLATVLCNLGAMRNLYAMHRRLQRHPRSCTRDCAEPRADGREASPQPLEELDHLLLLALMTVLFTMCSLPVIYRAYYGAFKDVKEKNRTSEEAEDLRALRFLSVISIVDPWIFIIFRSPVFRIFFHKIFIRPLRYRSRCSNSTNMESSL
95,A0A4X1UIH2,Non Druggable,Histamine H1 receptor,HRH1,485,55318,MTFPNSSFTLEDNMCEANKTTMANPKLMPLVVVLSAVSLVTVGLNLLVLCAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILVAWLFSFLWVIPILGWHRFVSRTSRRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELINGSLPSFSEIKLKPENPKVGAKKAGKESPWEVLKRKPKDAGGGPVLKPSSQDSVEMKSPGVSSQEDGELDKFHCFTLNIVQTQMEAEGSSKGYVAVIHSQSQLEMDEQGLNMRGANEISEDQTLGDSQSSRTDSDTPTEPVPGKSKPRSGSSTGLDYIKLTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
96,A0A4X1UIH7,Non Druggable,Histamine H1 receptor,HRH1,498,56802,MRSEQELEATLVPMTFPNSSFTLEDNMCEANKTTMANPKLMPLVVVLSAVSLVTVGLNLLVLCAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILVAWLFSFLWVIPILGWHRFVSRTSRRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELINGSLPSFSEIKLKPENPKVGAKKAGKESPWEVLKRKPKDAGGGPVLKPSSQDSVEMKSPGVSSQEDGELDKFHCFTLNIVQTQMEAEGSSKGYVAVIHSQSQLEMDEQGLNMRGANEISEDQTLGDSQSSRTDSDTPTEPVPGKSKPRSGSSTGLDYIKLTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
97,Q8IVJ1,Druggable,Solute carrier family 41 member 1,SLC41A1,513,54901,MSSKPEPKDVHQLNGTGPSASPCSSDGPGREPLAGTSEFLGPDGAGVEVVIESRANAKGVREEDALLENGSQSNESDDVSTDRGPAPPSPLKETSFSIGLQVLFPFLLAGFGTVAAGMVLDIVQHWEVFQKVTEVFILVPALLGLKGNLEMTLASRLSTAANIGHMDTPKELWRMITGNMALIQVQATVVGFLASIAAVVFGWIPDGHFSIPHAFLLCASSVATAFIASLVLGMIMIGVIIGSRKIGINPDNVATPIAASLGDLITLALLSGISWGLYLELNHWRYIYPLVCAFFVALLPVWVVLARRSPATREVLYSGWEPVIIAMAISSVGGLILDKTVSDPNFAGMAVFTPVINGVGGNLVAVQASRISTFLHMNGMPGENSEQAPRRCPSPCTTFFSPDVNSRSARVLFLLVVPGHLVFLYTISCMQGGHTTLTLIFIIFYMTAALLQVLILLYIADWMVHWMWGRGLDPDNFSIPYLTALGDLLGTGLLALSFHVLWLIGDRDTDVGD
98,Q8IVQ6,Druggable,Palmitoyltransferase ZDHHC21 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 21) (DHHC-21) (Zinc finger DHHC domain-containing protein 21),ZDHHC21,265,31385,MGLRIHFVVDPHGWCCMGLIVFVWLYNIVLIPKIVLFPHYEEGHIPGILIIIFYGISIFCLVALVRASITDPGRLPENPKIPHGEREFWELCNKCNLMRPKRSHHCSRCGHCVRRMDHHCPWINNCVGEDNHWLFLQLCFYTELLTCYALMFSFCHYYYFLPLKKRNLDLFVFRHELAIMRLAAFMGITMLVGITGLFYTQLIGIITDTTSIEKMSNCCEDISRPRKPWQQTFSEVFGTRWKILWFIPFRQRQPLRVPYHFANHV
99,Q8N6S5,Druggable,ADP-ribosylation factor-like protein 6-interacting protein 6 (ARL-6-interacting protein 6) (Aip-6) (Phosphonoformate immuno-associated protein 1),ARL6IP6 ,226,24676,MSFAESGWRSALRRRGPGTPGPVARPSYSSFTQGDSWGEGEVDEEEGCDQVARDLRAEFSAGAWSEPRKRSVLPPDGNGSPVLPDKRNGIFPAAAGSRAQPRRWPVQVLSILCSLLFAILLAFLLAIAYLIVKELHAENLKNEDDVDTGLLGFWTLLIISLTAGFSCCSFSWTVTYFDSFEPGMFPPTPLSPARFKKLTGHSFHMGYSMAILNGIVAALTVAWCLM
100,Q8NHY3,Druggable,GAS2-like protein 2 (GAS2-related protein on chromosome 17) (Growth arrest-specific protein 2-like 2),GAS2L2,880,96520,MSQPAGGRRKPRTLGPPVCSIRPFKSSEQYLEAMKEDLAEWLRDLYGLDIDAANFLQVLETGLVLCQHANVVTDAALAFLAEAPAQAQKIPMPRVGVSCNGAAQPGTFQARDNVSNFIQWCRKEMGIQEVLMFETEDLVLRKNVKNVVLCLLELGRRAWRFGVAAPTLVQLEEEIEEEVRRELALPPPDPSPPAPPRRQPCHFRNLDQMVQSLVSHCTCPVQFSMVKVSEGKYRVGDSNTLIFIRILRNHVMVRVGGGWDTLGHYLDKHDPCRCTSLSHKPGSFLKPPAPPVQHEVRVQDGPSQTQPTMTISRSQSPPPPVDWKTYTSSDRRLRPPTPSSPRPRRERGAGTGASREMAPFLRCQERSLIPSWRQPTAGDSPPSPQSSSTQKGRDPQCTSSGKREERYPPELPRGRIPTSWVHEETDSWGTDAGNPTPQRLRAIEATTKGISARGPSPLPRSFGPAECLGLRLPLRDEAKGAFFQFREPESVRSPTPVQGLTKIPIRLPPARPPTPGRSFPGATSGSPRTELGRDPIPLRAVTVDLAGSTHGDCSVEVRQEDQQLDIQVMAEARESWDLGLQEQEGRYTPLPLGGNKEQAIYCSLEEEILGNMKLLEVRSACPQGTRSGVIPRSGVYIPRLAGQWPEPGGPYDKAIQELAQGSPSLLKVDLEAWKAAPTGSPKPAVTPGPGSLKGKLGARQSGPRTKASLSAKGTHMRKVPPQGGQDCSASTVSASPEAPTPSPLDPNSDKAKACLSKGRRTLRKPKRVPSIYKLKLRPRIRPRRDHRPEKQPSRIPRPLAYVFLGPARQPPKDRLLRAVLGSKGGEASRVDGASVGEEEEEGKEEKEPAAPLESSPQPPEGLQPHWLNQAPLPPEEESWV
101,A0A4X2KZ23,Non Druggable,Histamine H1 receptor,HRH1,495,57322,MTPPTSSCLQEGTMCEVNRTADAANKPHLVPLVMVLSSISLVTVGLNLLVLYAVRTEKKLHTVGNLYIVSLSVADLIVGAAVMPLNIVYLFRSLDRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRAIVTILFTWFLSSLWIIPILGWRSFWPDTDKFNVTAGDKCETDFYKVTWFKVMTAIINFYLPTLLMLWFYSRIYRAVQQHCQHREFINASFPSFSDGNISHKKHKICLPKQEKDDNQETLKKKPEDTHYHMSNSIPTKVRDPAKESHPEKKTPQGFEQEDEAVVVKDHYFPIDIVQPQTRMEETGRYMSIHQNQPDPRELSPAIQYASETSEETIFAEAFSHPADFNAITESATDMPAEGQAKTKTTFGLDYLTMTWKRLRSHSRQYIKGLHMNRERKAAKQLGCIMAAFIVCWIPYFIFFMVIAYCTKCCNEHVQMFTMWLGYINSTLNPLIYPLCNENFKKAFKKIFHIRS
102,A0A5F5Y339,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,373,41457,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPIRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHNAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDRDLCISGMLPALLID
103,A0A5F5Y6J8,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,436,47853,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPIRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHNAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDRGAQSSFPLRKGPGRPPAHWNPTGCFVTSASVPGCYPAKLLGYSPASGVELGSPSRSPTPPLLTGSQRYPALCAPATF
104,B0ZBE0,Druggable,Alpha-1D adrenergic receptor (Alpha-1D adrenoreceptor),ADRA1D ,572,60463,MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI
105,A0A5F7ZLG1,Non Druggable,Histamine H1 receptor,HRH1,489,55821,MPMTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
106,A0A5F9CR42,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,492,54554,MEPNDTANDTASSSCLESTAFKVTLSVVLTILILITAAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCRWSFGKVFCNIYISLDVMLCTASILNLFMISIDRYCAVTDPLRYPVLVTPGRVTISLVSIWVISITLSFLSIHLGWNSRNTTSEGHHTSPKCKFQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQARRINHISSWQAATIREHKATVTLAAVMGAFIVCWFPYFTTFVYRGLKGDDAINEVVEAVVLWLGYANSALNPILYAALNRDFRNAYQQLFCCRLAGRGSHETCLRFNNALLPKSQSQEPRRQEEKPLKLQVWSGTEATAPQGATDRKPALPHPVRSSDLLSCCKSLWGLRFPQRHTGGPLEEQPREPLPEGLLRTLRCCAWSPRLNSWNLSGPSSQDAPEPESGGSQNTQQSAGVLAPPAEHQVPRPASQTHAQDASGPEHAESDGFKTQHRCWP
107,Q0VAB0,Druggable,Thromboxane A2 receptor (Prostanoid TP receptor),TBXA2R,259,26619,MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGLHCPDSAAKPACHEPRRAAVPHHGEGAAHLLARGHLEPDPGPLGVYPVPPRRAPASPASPQHPAQVAVPPAPAHAALRAAVGSGQSAPPAPFRGALGPSDSPSACSEDSGAGGAGWTVGISSRVLG
108,A0A671EEV7,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,360,40042,MASNNTASCLDSAAFKATVGAVLTVLIVITVAGNVVVCLAVGLTRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWSFGRVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPMLVTPARVAVSLVLIWVVSVTLSFLSIHLGWNSRSDTSVVNHTTLHCKVQVNLVYGLVDGLVTFYLPLLVMCVTYYRIFKIARDQAKRIHLVSSWKAATFQEHKATVTLAAVMGAFVVCWFPYFTVFVYRGLRGDDSVNRAFEAVVLWLGYANSALNPILYAALNRDFRLAYQQLLPCRAPGRHAHQTFLRSNSCRLSRTQSREATRQEEKSVKLQVWSGREGTAPRGAIDSSHT
109,A0A672U9W6,Non Druggable,Histamine H1 receptor,HRH1,475,54381,MSKNTTDNSTITQPAVLGVLLGSISLITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGSAVMPLNIVYLLSSQWILGLPACLFWLSMDYVASTASIFNLFILCIDRYRSVQQPLKYLKYRTKKRASVMILGVWLLSFMWVIPILGWHVFANNGKRKVTETKCETEFSEVTWFKVLTAIMNFYIPSIMMLWFYCKIFRAVRKHYQHQELINGSHQPFSEKNSIHHSKTKDKQNICLQNQILDENSSPKDKQSSPQPKNMEAELQFSNPDKSSKAFVSKSNTEVLKWGRFPLTTAQSEPGQDKAGKKHVCITEENETEEEPCSQDTDLSDASDSQSFSDEVPNGEHSNPNPERAGSPQEKTEKRDCKGLAYLRKTWQSLHAQSKRHIQGLHVNRERKAAKQLGVIMAAFMLCWIPYFVLFMVIAFQGRERFAQLHMFTIWLGYVNSTLNPFLYPLCNQNFKKTFKKILHIR
110,A8K7T1,Druggable,cDNA FLJ76055,,342,39487,MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIFIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTRDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM
111,B2RE67,Druggable,"cDNA, FLJ94014",,342,39409,MQAVDNLASAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTRDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM
112,A0A673TCT6,Non Druggable,Histamine H1 receptor,HRH1,516,58770,MGRLTLMPCPLSICCCPGWEPQLEAALMPMTLPNSSCIVEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMTRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFLSFLWVIPILGWHHFMSSASGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPCEVLKRKTKDASGKPVMKPPSQDSEEMKCPGVFCREEDREMDRLHCFPTNIVQMQTEAEGSDGSYVAITQSHGQLDMEEESLSMHVANEVSEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSATGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
113,A0A674JR67,Non Druggable,Histamine H1 receptor,HRH1,486,55493,LTFPSLRQKMCETKNSTVAHPIPLGLALGSISLITVIMNILVLYAVKRERKLHTVGNLYIVSLSVADLIVGVAVMPLNIMYLLNHEWVLGRPACQFWLSMDYVASTASIFSLFILCIDRYRSVQQPLKYLKYRTKSRALVMISGAWLISLLWIIPILGWHAFANGGKWQVEENTCETEFSKVTWFKVLTAIVNFYVPSLLMLWFYAKIYKTVRKHYQHRELINGSFRSFSENKCIHRDKVQEKQNICHKKPNKDINMSLLKGSSVDPCCNVNLYFPQSKSMGAKLELSSFDKPPKALITEDDSKVVKLSCFPLAITQIQPGPDKVGMKYVPVKKGPCSQAPELTQSDTSDEHTFIEGASCKNDSDLTPIPATSSAEEKTNKDPAGLSYLKSTWRRLRTQSMQGMHVNRERKAAKQLGFIMAAFMLCWIPYFVLFMVIAYCQSCCNYSFHMFTIWLGYVNSTLNPFIYPLCNENFKKTFKKIFHIHS
114,A0A674MX35,Non Druggable,Histamine H1 receptor,HRH1,547,62934,MIKGTRSVMESGPSPSAGPLRLSTRGSEANWSIVVHTASLKSNHTPTFPSHLHTGLLAVSLGLLSLVTVIMNMLVLYAVKKEKSLHTVGNLYIVSLSVADLIVGTTVMPLNLLYLLEEEWKLGRTICQFWLIMDYVASTASIFSLFILCLDRYRSVRQPLKYLKYRTWGRASAMIAGAWLLSMLWIIPILGWRLFTHVDLKPEEENKCDTDFRFVTWFKVVTAVFNFYMPSVLMLWFYRHIYLTVRQHLKDRGRIIHPTNSFEENENEHNAHTPVSEHKSSKKDCNVARELSKEQHPTDPQTNPSSDGDKTKKASSRSHRKIGVKGQQTRSLLAIKERQHRLVRKVKGCSLTPEEKQQTVMRSAGNHQSITDRPQAPLDDYHVSGPKLASGICDLTRVSDMQKKTCALSKIHTVPWTEEEEADPFKPAYAKSLRQTWQKFIGQSRHRVQSLKIHKEHKAAKQLGFIISAFFLCWIPYFITFMVMAFCRECVHHELHMFTIWLGYINSTLNPFIYPLCNGNFKRVFKKFLRIPCCKVEKRREPSRMTV
115,O75030,Druggable,Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32),MITF,526,58795,MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKSSSSAEHPGASKPPISSSSMTSRILLRQQLMREQMQEQERREQQQKLQAAQFMQQRVPVSQTPAINVSVPTTLPSATQVPMEVLKVQTHLENPTKYHIQQAQRQQVKQYLSTTLANKHANQVLSLPCPNQPGDHVMPPVPGSSAPNSPMAMLTLNSNCEKEGFYKFEEQNRAESECPGMNTHSRASCMQMDDVIDDIISLESSYNEEILGLMDPALQMANTLPVSGNLIDLYGNQGLPPPGLTISNSCPANLPNIKRELTACIFPTESEARALAKERQKKDNHNLIERRRRFNINDRIKELGTLIPKSNDPDMRWNKGTILKASVDYIRKLQREQQRAKELENRQKKLEHANRHLLLRIQELEMQARAHGLSLIPSTGLCSPDLVNRIIKQEPVLENCSQDLLQHHADLTCTTTLDLTDGTITFNNNLGTGTEANQAYSVPTKMGSKLEDILMDDTLSPVGVTDPLLSSVSPGASKTSSRRSSMSMEETEHTC
116,A0A6I8NM26,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,426,46260,MDVELLPSLALDSPPPCPKPGACPGVGGWAPPAPRPGSGRPGMTNLPGANPWNSTVSQVVGGITLGTLILVVIGGNVVVCLAVGLDRRLRSPTNCFTVSLAVTDLLLGILVLPLSAILELSQTWVFSQTLCKIHASLDVMLCTASILNLFMISLDRYYAITAPLRYPAVVTPARVGTALAGIWTVSLLFSFLPIHMGWNAQNAQMPPHPNQCKVEVNKAYGLVDALVTFYFPLLVMSATYYRIFKIAREQAKRINQAGSRGQGLGPCSPAVKEHKATVTLAAVMGVFIICWFPYFTVFVYRGVRGDEAINKTLEAVVLWLGYANSALNPLLYAALNRDFRAAYRRLFSCRGTRSSAHLESTSWREKRSLGPLVRNETETSLDPEPPDRPGKPERRPRISSAVIDKENLSGDGMKLCEHCLSSPTDD
117,A0A6I9I102,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,421,46754,MASNSTDPSSCLNHTAFRVTVSLVLTALILITIAGNVVVCLAVGLTRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFHELSCQWGFGEAFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPFRVAISLVLIWVISITLSFLSIHLGWNSRAETNNTNHTVSKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRVHHINSWRTATLREHKATVTLAAVMGAFIVCWFPYFTVFVYRGLRGDDAINETFEAIVLWLGYANSALNPILYATLSRDFRTAYQRLFRCRPAGHIADRTSLRDSSSQLKRNQSQEPGWQEERPLRLQVWSGTEVAAPQGATDRRLALSCTTCSSNLLSCCKSLWGIRFLQRHVGGPSEEQLGEAAVQGAPENAAFRGCLASAPGH
118,Q12802,Druggable,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),AKAP13 ,2813,307550,MKLNPQQAPLYGDCVVTVLLAEEDKAEDDVVFYLVFLGSTLRHCTSTRKVSSDTLETIAPGHDCCETVKVQLCASKEGLPVFVVAEEDFHFVQDEAYDAAQFLATSAGNQQALNFTRFLDQSGPPSGDVNSLDKKLVLAFRHLKLPTEWNVLGTDQSLHDAGPRETLMHFAVRLGLLRLTWFLLQKPGGRGALSIHNQEGATPVSLALERGYHKLHQLLTEENAGEPDSWSSLSYEIPYGDCSVRHHRELDIYTLTSESDSHHEHPFPGDGCTGPIFKLMNIQQQLMKTNLKQMDSLMPLMMTAQDPSSAPETDGQFLPCAPEPTDPQRLSSSEETESTQCCPGSPVAQTESPCDLSSIVEEENTDRSCRKKNKGVERKGEEVEPAPIVDSGTVSDQDSCLQSLPDCGVKGTEGLSSCGNRNEETGTKSSGMPTDQESLSSGDAVLQRDLVMEPGTAQYSSGGELGGISTTNVSTPDTAGEMEHGLMNPDATVWKNVLQGGESTKERFENSNIGTAGASDVHVTSKPVDKISVPNCAPAASSLDGNKPAESSLAFSNEETSTEKTAETETSRSREESADAPVDQNSVVIPAAAKDKISDGLEPYTLLAAGIGEAMSPSDLALLGLEEDVMPHQNSETNSSHAQSQKGKSSPICSTTGDDKLCADSACQQNTVTSSGDLVAKLCDNIVSESESTTARQPSSQDPPDASHCEDPQAHTVTSDPVRDTQERADFCPFKVVDNKGQRKDVKLDKPLTNMLEVVSHPHPVVPKMEKELVPDQAVISDSTFSLANSPGSESVTKDDALSFVPSQKEKGTATPELHTATDYRDGPDGNSNEPDTRPLEDRAVGLSTSSTAAELQHGMGNTSLTGLGGEHEGPAPPAIPEALNIKGNTDSSLQSVGKATLALDSVLTEEGKLLVVSESSAAQEQDKDKAVTCSSIKENALSSGTLQEEQRTPPPGQDTQQFHEKSISADCAKDKALQLSNSPGASSAFLKAETEHNKEVAPQVSLLTQGGAAQSLVPPGASLATESRQEALGAEHNSSALLPCLLPDGSDGSDALNCSQPSPLDVGVKNTQSQGKTSACEVSGDVTVDVTGVNALQGMAEPRRENISHNTQDILIPNVLLSQEKNAVLGLPVALQDKAVTDPQGVGTPEMIPLDWEKGKLEGADHSCTMGDAEEAQIDDEAHPVLLQPVAKELPTDMELSAHDDGAPAGVREVMRAPPSGRERSTPSLPCMVSAQDAPLPKGADLIEEAASRIVDAVIEQVKAAGALLTEGEACHMSLSSPELGPLTKGLESAFTEKVSTFPPGESLPMGSTPEEATGSLAGCFAGREEPEKIILPVQGPEPAAEMPDVKAEDEVDFRASSISEEVAVGSIAATLKMKQGPMTQAINRENWCTIEPCPDAASLLASKQSPECENFLDVGLGRECTSKQGVLKRESGSDSDLFHSPSDDMDSIIFPKPEEEHLACDITGSSSSTDDTASLDRHSSHGSDVSLSQILKPNRSRDRQSLDGFYSHGMGAEGRESESEPADPGDVEEEEMDSITEVPANCSVLRSSMRSLSPFRRHSWGPGKNAASDAEMNHRSSMRVLGDVVRRPPIHRRSFSLEGLTGGAGVGNKPSSSLEVSSANAEELRHPFSGEERVDSLVSLSEEDLESDQREHRMFDQQICHRSKQQGFNYCTSAISSPLTKSISLMTISHPGLDNSRPFHSTFHNTSANLTESITEENYNFLPHSPSKKDSEWKSGTKVSRTFSYIKNKMSSSKKSKEKEKEKDKIKEKEKDSKDKEKDKKTVNGHTFSSIPVVGPISCSQCMKPFTNKDAYTCANCSAFVHKGCRESLASCAKVKMKQPKGSLQAHDTSSLPTVIMRNKPSQPKERPRSAVLLVDETATTPIFANRRSQQSVSLSKSVSIQNITGVGNDENMSNTWKFLSHSTDSLNKISKVNESTESLTDEGVGTDMNEGQLLGDFEIESKQLEAESWSRIIDSKFLKQQKKDVVKRQEVIYELMQTEFHHVRTLKIMSGVYSQGMMADLLFEQQMVEKLFPCLDELISIHSQFFQRILERKKESLVDKSEKNFLIKRIGDVLVNQFSGENAERLKKTYGKFCGQHNQSVNYFKDLYAKDKRFQAFVKKKMSSSVVRRLGIPECILLVTQRITKYPVLFQRILQCTKDNEVEQEDLAQSLSLVKDVIGAVDSKVASYEKKVRLNEIYTKTDSKSIMRMKSGQMFAKEDLKRKKLVRDGSVFLKNAAGRLKEVQAVLLTDILVFLQEKDQKYIFASLDQKSTVISLKKLIVREVAHEEKGLFLISMGMTDPEMVEVHASSKEERNSWIQIIQDTINTLNRDEDEGIPSENEEEKKMLDTRARELKEQLHQKDQKILLLLEEKEMIFRDMAECSTPLPEDCSPTHSPRVLFRSNTEEALKGGPLMKSAINEVEILQGLVSGNLGGTLGPTVSSPIEQDVVGPVSLPRRAETFGGFDSHQMNASKGGEKEEGDDGQDLRRTESDSGLKKGGNANLVFMLKRNSEQVVQSVVHLYELLSALQGVVLQQDSYIEDQKLVLSERALTRSLSRPSSLIEQEKQRSLEKQRQDLANLQKQQAQYLEEKRRREREWEARERELREREALLAQREEEVQQGQQDLEKEREELQQKKGTYQYDLERLRAAQKQLEREQEQLRREAERLSQRQTERDLCQVSHPHTKLMRIPSFFPSPEEPPSPSAPSIAKSGSLDSELSVSPKRNSISRTHKDKGPFHILSSTSQTNKGPEGQSQAPASTSASTRLFGLTKPKEKKEKKKKNKTSRSQPGDGPASEVSAEGEEIFC
119,A0A6I9JQJ4,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,368,41534,MAGLGGHLHVLGPSLRCRLRHARRLARITISMILMVLIFITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAIYQLSSNWSFGQIFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNMTINVNYNISKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKIARDQAKRINHISSWNAATIKEHKATVTLAAVMGAFIVCWFPYFTVFVYRGLRGDEAINEVIEAIVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRSTSYNSHDASLRSTNSQLSRSQSREHKGQEEKPLKLQVWCGTEVTALQGATDR
120,B2RA17,Druggable,cDNA FLJ94656,,309,34056,MNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQQWTETRIYMTNLAVADLCLLCTLPFVLHSLRDTSDTPLCQLSQGIYLTNRYMSISLVTAIAVDRYVAVRHPLRARGLRSPRQAAAVCAVLWVLVIGSLVARWPLGIQEGGFCFRSTRHNFNSMAFPLLGFYLPLAVVVFCSLKVVTALAQRPPTDVGQAEATRKAARMVWANLLVFVVCFLPLHVGLTVRLAVGWNACALLETIRRALYITSKLSDANCCLDAICYYYMAKEFQEASALAVAPSAKAHKSQDSLCVTLA
121,A0A6I9KFD0,Non Druggable,Histamine H1 receptor,HRH1,485,55688,MTLLPNSSRTLEDKMCQNKTTMTNSQLMPLVVVLSTISLVTVGLNLLVLYAVWCERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMTKWPLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRALATILGAWFLSFLWIIPILGWHHFVPGVSKYLEEKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELTNGAVPSFLEISLRQENPKMGSKKPGKESPWEILRRKPKDASDGPVSKPPSQDPEEMKSPVVFSQEEDGEMARLHCSAPNMVQMQTMVEENSSEYVATNESQLETDMQDLNIPAATEISEDQTIGDSQSFSRTDSDTPTEPASGKNKSRSGSATGLDYIKLTWKRLRSHSRQYVSGLHMNREWKAAKQLGCIMAAFILCWIPYFIFFMVIAFCEKCCNEQVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
122,Q03135,Druggable,Caveolin-1,CAV1 ,178,20472,MSGGKYVDSEGHLYTVPIREQGNIYKPNNKAMADELSEKQVYDAHTKEIDLVNRDPKHLNDDVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWFYRLLSALFGIPMALIWGIYFAILSFLHIWAVVPCIKSFLIEIQCISRVYSIYVHTVCDPLFEAVGKIFSNVRINLQKEI
123,A0A6J0ALV6,Non Druggable,Histamine H1 receptor,HRH1,486,55282,MTFPNSSSVSEDTMNDRNKTATADPQLMPLVVVLSAVSLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVRQPLKYLKYRTKTRASATILAAWFLSFLWVIPILGWHRFISKPLQHREGKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKTVRRHCQHRELVNGSLPSFSEIKPKPENPKVGTKKQRKESPWEVLKRKPKDAGGGPVLKPPSQDPKEIKSLGVSSPEDGELDKFHCLSLNVVQPQTEAEGSGEGRAAVNQSQSQLETDEQGLNMHGVTEILEGQILGDSQSFSRTDSDTPTEPTPGKSKSRSGSNTGLDYIKFTWKRLRSQSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCESCSNQHVHMFTIWLGYLNSTLNPLIYPLCNENFKKTFKKILHIRS
124,O75436,Druggable,Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26),VPS26A ,327,38170,MSFLGGFFGPICEIDIVLNDGETRKMAEMKTEDGKVEKHYLFYDGESVSGKVNLAFKQPGKRLEHQGIRIEFVGQIELFNDKSNTHEFVNLVKELALPGELTQSRSYDFEFMQVEKPYESYIGANVRLRYFLKVTIVRRLTDLVKEYDLIVHQLATYPDVNNSIKMEVGIEDCLHIEFEYNKSKYHLKDVIVGKIYFLLVRIKIQHMELQLIKKEITGIGPSTTTETETIAKYEIMDGAPVKGESIPIRLFLAGYDPTPTMRDVNKKFSVRYFLNLVLVDEEDRRYFKQQEIILWRKAPEKLRKQRTNFHQRFESPESQASAEQPEM
125,A0A6J0CNF1,Non Druggable,Histamine H1 receptor,Hrh1,489,56110,MSLPNISSAFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMAKWYLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPALEPREDKCETDFYNVTWFKIMTAIINFYLPTVLMLWFYVKIYKAVRRHCQHRQLTNGSLPSFLEIKLKSEDVKEGTKKPGKESPWGVLKRPSRDPSGGLDQKSISEDPKKINSPTVFSQEEDRETVTHHCFHRDTMQTQTMAEGGGRGSEAIDQALSQPKREEQNLNTCRRISETSEDQTLVDRQSFSRTTDSDTSIEPGLGRDKLRSGSNSGLDYIKITWKRFRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCNSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
126,A0A6J0IA87,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,362,40629,MDPCYNHTSSQERMDFPLQLLVGSCLIILIMITLCGNIIVCLAVTLDRRLRSLTNCIIVSLAITDLLLGLLVLPFSAFYELAREWPFGSTLCNIYSSLDVMLCTASILNLFLISLDRYIAVTTPLRYCQLVTPPRVAVGLVVIWTVSLMVSFLPIHLGWNTNGTAVQNTVPICNKECTLEVNPVYGLVDALLTFYIPLVIMCVTYYRILKIAREQAKRINHTWCNTPMSPMVKEHKATVTLAVVLGAFIVCWFPYFTVFTYRGMWGDSRVKGTPMSVVLWLGYANSALNPILYGTLNRDFRVAYQHLLHCWRTGGPRSSCLPPLQKAQSRGGQGQGRQEGKTLKLEMRNEKGILLTDGAHKR
127,Q04759,Druggable,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),PRKCQ ,706,81865,MSPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVESENGQMYIQKKPTMYPPWDSTFDAHINKGRVMQIIVKGKNVDLISETTVELYSLAERCRKNNGKTEIWLELKPQGRMLMNARYFLEMSDTKDMNEFETEGFFALHQRRGAIKQAKVHHVKCHEFTATFFPQPTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCTGSAINSRETMFHKERFKIDMPHRFKVYNYKSPTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANLCGINQKLMAEALAMIESTQQARCLRDTEQIFREGPVEIGLPCSIKNEARPPCLPTPGKREPQGISWESPLDEVDKMCHLPEPELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMERLIS
128,Q13425,Druggable,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),SNTB2 ,540,57950,MRVAAATAAAGAGPAMAVWTRATKAGLVELLLRERWVRVVAELSGESLSLTGDAAAAELEPALGPAAAAFNGLPNGGGAGDSLPGSPSRGLGPPSPPAPPRGPAGEAGASPPVRRVRVVKQEAGGLGISIKGGRENRMPILISKIFPGLAADQSRALRLGDAILSVNGTDLRQATHDQAVQALKRAGKEVLLEVKFIREVTPYIKKPSLVSDLPWEGAAPQSPSFSGSEDSGSPKHQNSTKDRKIIPLKMCFAARNLSMPDLENRLIELHSPDSRNTLILRCKDTATAHSWFVAIHTNIMALLPQVLAELNAMLGATSTAGGSKEVKHIAWLAEQAKLDGGRQQWRPVLMAVTEKDLLLYDCMPWTRDAWASPCHSYPLVATRLVHSGSGCRSPSLGSDLTFATRTGSRQGIEMHLFRVETHRDLSSWTRILVQGCHAAAELIKEVSLGCMLNGQEVRLTIHYENGFTISRENGGSSSILYRYPFERLKMSADDGIRNLYLDFGGPEGELTMDLHSCPKPIVFVLHTFLSAKVTRMGLLV
129,Q13596,Druggable,Sorting nexin-1,SNX1,522,59070,MASGGGGCSASERLPPPFPGLEPESEGAAGGSEPEAGDSDTEGEDIFTGAAVVSKHQSPKITTSLLPINNGSKENGIHEEQDQEPQDLFADATVELSLDSTQNNQKKVLAKTLISLPPQEATNSSKPQPTYEELEEEEQEDQFDLTVGITDPEKIGDGMNAYVAYKVTTQTSLPLFRSKQFAVKRRFSDFLGLYEKLSEKHSQNGFIVPPPPEKSLIGMTKVKVGKEDSSSAEFLEKRRAALERYLQRIVNHPTMLQDPDVREFLEKEELPRAVGTQTLSGAGLLKMFNKATDAVSKMTIKMNESDIWFEEKLQEVECEEQRLRKLHAVVETLVNHRKELALNTAQFAKSLAMLGSSEDNTALSRALSQLAEVEEKIEQLHQEQANNDFFLLAELLSDYIRLLAIVRAAFDQRMKTWQRWQDAQATLQKKREAEARLLWANKPDKLQQAKDEILEWESRVTQYERDFERISTVVRKEVIRFEKEKSKDFKNHVIKYLETLLYSQQQLAKYWEAFLPEAKAIS
130,Q6ZMG9,Druggable,Ceramide synthase 6 (CerS6) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291),CERS6 ,384,44890,MAGILAWFWNERFWLPHNVTWADLKNTEEATFPQAEDLYLAFPLAFCIFMVRLIFERFVAKPCAIALNIQANGPQIAPPNAILEKVFTAITKHPDEKRLEGLSKQLDWDVRSIQRWFRQRRNQEKPSTLTRFCESMWRFSFYLYVFTYGVRFLKKTPWLWNTRHCWYNYPYQPLTTDLHYYYILELSFYWSLMFSQFTDIKRKDFGIMFLHHLVSIFLITFSYVNNMARVGTLVLCLHDSADALLEAAKMANYAKFQKMCDLLFVMFAVVFITTRLGIFPLWVLNTTLFESWEIVGPYPSWWVFNLLLLLVQGLNCFWSYLIVKIACKAVSRGKVSKDDRSDIESSSDEEDSEPPGKNPHTATTTNGTSGTNGYLLTGSCSMDD
131,Q6ZMP9,Druggable,cDNA FLJ16773 fis,,394,43309,MTAGRSQERRAQEMGRGSVQGLDLKGDLEFFTAPMLSLRSFVFVGVGSGLTSSHIPAQRWAEWGQCLAPPARSLLTSGSLCCPRTMNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQQWTETRIYMTNLAVADLCLLCTLPFVLHSLRDTSDTPLCQLSQGIYLTNRYMSISLVTAIAVDRYVAVRHPLRARGLRSPRQAAAVCAVLWVLVIGSLVARWLLGIQEGGFCFRSTRHNFNSMAFPLLGFYLPLAVVVFCSLKVVTALAQRPPTDVGQAEATRKAARMVWANLLVFVVCFLPLHVGLTVRLAVGWNACALLEMIRRALYITSKLSDANCCLDAICYYYMAKEFQEASALAVAPRAKAHKSQDSLCVTLA
132,A0A6J0IQK9,Non Druggable,Histamine H1 receptor,HRH1,478,54532,MKKMSKNTTDNSTNPHSALLGLFLGSISLITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLSPVWPLGLPVCLFWLSMDYVASTASIFNLFILCIDRYRSVQQPLKYLKYRTKMRASLMILGIWLLSFMWVIPILGWHVFANNGERKVKKNKCETEFSEVTWFKVLTAIVNFCLPSILMLWFYYKIFRAVRKHCQHRELINGSDGSSSDKNFIQRSKTKDEQNVCLQKQILDENTLPKDKQSSPQPENAEAELHFSNPDKSSTAFDGKNNGKVFKWRCFPLSTAQSERGLDKAGKNYMCAMKESANEKEPCSQDSDSSVASDNQTFPEVVPCGENSNPNSERACSAQEKTENRDFRGLTYLRKTWQSLHTHSKGNIQGLHGNRERKAAKQLGVIMAAFMLCWIPYFVSFMVIAFHDHEQFSKLHMVTVWLGYVNSTLNPFLYPLCNQNFKKTFKQILHIH
133,O95069,Druggable,Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1),KCNK2 ,426,47093,MLPSASRERPGYRAGVAAPDLLDPKSAAQNSKPRLSFSTKPTVLASRVESDTTINVMKWKTVSTIFLVVVLYLIIGATVFKALEQPHEISQRTTIVIQKQTFISQHSCVNSTELDELIQQIVAAINAGIIPLGNTSNQISHWDLGSSFFFAGTVITTIGFGNISPRTEGGKIFCIIYALLGIPLFGFLLAGVGDQLGTIFGKGIAKVEDTFIKWNVSQTKIRIISTIIFILFGCVLFVALPAIIFKHIEGWSALDAIYFVVITLTTIGFGDYVAGGSDIEYLDFYKPVVWFWILVGLAYFAAVLSMIGDWLRVISKKTKEEVGEFRAHAAEWTANVTAEFKETRRRLSVEIYDKFQRATSIKRKLSAELAGNHNQELTPCRRTLSVNHLTSERDVLPPLLKTESIYLNGLTPHCAGEEIAVIENIK
134,A0A6J1XDT2,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,436,47626,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHQIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHNAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEATAPQGATDRGAQSSSPLTKGPGRPPAHWNPTGCSVTSASVPGCYPAKLLGYSPASGVELGSPSRSPTPPLLTGSQRYPALCAPATF
135,Q13424,Druggable,Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Pro-TGF-alpha cytoplasmic domain-interacting protein 1) (TACIP1) (Syntrophin-1),SNTA1 ,505,53895,MASGRRAPRTGLLELRAGAGSGAGGERWQRVLLSLAEDVLTVSPADGDPGPEPGAPREQEPAQLNGAAEPGAGPPQLPEALLLQRRRVTVRKADAGGLGISIKGGRENKMPILISKIFKGLAADQTEALFVGDAILSVNGEDLSSATHDEAVQVLKKTGKEVVLEVKYMKDVSPYFKNSTGGTSVGWDSPPASPLQRQPSSPGPTPRNFSEAKHMSLKMAYVSKRCTPNDPEPRYLEICSADGQDTLFLRAKDEASARSWATAIQAQVNTLTPRVKDELQALLAATSTAGSQDIKQIGWLTEQLPSGGTAPTLALLTEKELLLYLSLPETREALSRPARTAPLIATRLVHSGPSKGSVPYDAELSFALRTGTRHGVDTHLFSVESPQELAAWTRQLVDGCHRAAEGVQEVSTACTWNGRPCSLSVHIDKGFTLWAAEPGAARAVLLRQPFEKLQMSSDDGASLLFLDFGGAEGEIQLDLHSCPKTIVFIIHSFLSAKVTRLGLLA
136,A0A6J1Y0X2,Non Druggable,Histamine H1 receptor,HRH1,487,55748,MTLPNSSCVIEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPASGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPWEVLKRKSKDASGEPVMKPPSQDSEEMKCPGVFSQEEDREMDKLHCFPLNIVQMQTEAEGSGRSYVAINQSQGQLEIDEQSLRMRVANEISEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSSTGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
137,Q0VAA9,Druggable,TBXA2R protein,TBXA2R,105,11280,MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLY
138,A0A6P3J1E8,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,359,40021,MAANGTASSSCLDPTAFKVTVTVVLILLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLEWNSRPENHSDSHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFRIAREQARRIHNVGPWRAATLREHKATVTLAAVMGAFIVCWLPYFTVFVYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGQDARRTSLGSNSSQLVRHPGQGPRWPEERPLRLQVWSGTELTAPQGATDR
139,A0A6P3J813,Non Druggable,Histamine H1 receptor,HRH1,491,55928,MTCPNSSCVFEDKMCEGNKTAPANDAQLTPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILGWRHFQPKTPEPREDKCETDFYNVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDMKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSPGVFSQEKEEKDGELGKFYCFPLDTVQAQPEAEGSGRGYAAINQSQNQLEMGEQGLSMPGAKEALEDQILGDSQSFSRTDSDTPAEPAPAKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIICWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
140,Q12791,Druggable,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)",KCNMA1 ,1236,137560,MANGGGGGGGSSGGGGGGGGSSLRMSSNIHANHLSLDASSSSSSSSSSSSSSSSSSSSSSVHEPKMDALIIPVTMEVPCDSRGQRMWWAFLASSMVTFFGGLFIILLWRTLKYLWTVCCHCGGKTKEAQKINNGSSQADGTLKPVDEKEEAVAAEVGWMTSVKDWAGVMISAQTLTGRVLVVLVFALSIGALVIYFIDSSNPIESCQNFYKDFTLQIDMAFNVFFLLYFGLRFIAANDKLWFWLEVNSVVDFFTVPPVFVSVYLNRSWLGLRFLRALRLIQFSEILQFLNILKTSNSIKLVNLLSIFISTWLTAAGFIHLVENSGDPWENFQNNQALTYWECVYLLMVTMSTVGYGDVYAKTTLGRLFMVFFILGGLAMFASYVPEIIELIGNRKKYGGSYSAVSGRKHIVVCGHITLESVSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEALFKRHFTQVEFYQGSVLNPHDLARVKIESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSWNWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNEMYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLGFFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRPKMSIYKRMRRACCFDCGRSERDCSCMSGRVRGNVDTLERAFPLSSVSVNDCSTSFRAFEDEQPSTLSPKKKQRNGGMRNSPNTSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSGHVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVSILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIGVLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDDDPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEENALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRLRDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCLMQFDHNAGQSRASLSHSSHSSQSSSKKSSSVHSIPSTANRQNRPKSRESRDKQKYVQEERL
141,A0A6P5CF01,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,363,40483,MAANGTASSSCLDPTAFKVTVTVVLILLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLEWNSRPENHSDSHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFRIAREQARRIHNVGPWRAATLREHKATVTLAAVMGAFIVCWLPYFTVFVYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGQDARRTSLGSNSSQLVRHPGQGPRWPEERPLRLQVWSGTELTAPQGATDREFGE
142,Q05C92,Druggable,Thromboxane A2 receptor (Prostanoid TP receptor) (Fragment),TBXA2R,156,16772,MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLV
143,A0A6P3QZC0,Non Druggable,Histamine H1 receptor,HRH1,486,55286,MTHPNSSSVLKDNMCEENKTTMASPQLMPLVVVLSTISLVTVGLNLLVLCAVQKERKLHTVGNLYIISLSVADLIVGAVVMPMNILYLLMSKWSLGWPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHRFMPQTAGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHREFINGSLPSFSEIKLKPENPKAGAKKPGKESPLEVLKRKPKDAGGGHVLKPPSQDSKEMNSPDVRSQEEDKEVYKLHCFPLNIVQTQTEAEGSGSGYIASNQSQSQLETDEQGLNMHGASELLEDQILGDSQSSPTDSDTPTELASGKGKPRSGSSIGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
144,Q07021,Druggable,"Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32)",C1QBP ,282,31362,MLPLLRCVPRVLGSSVAGLRAAAPASPFRQLLQPAPRLCTRPFGLLSVRAGSERRPGLLRPRGPCACGCGCGSLHTDGDKAFVDFLSDEIKEERKIQKHKTLPKMSGGWELELNGTEAKLVRKVAGEKITVTFNINNSIPPTFDGEEEPSQGQKVEEQEPELTSTPNFVVEVIKNDDGKKALVLDCHYPEDEVGQEDEAESDIFSIREVSFQSTGESEWKDTNYTLNTDSLDWALYDHLMDFLADRGVDNTFADELVELSTALEHQEYITFLEDLKSFVKSQ
145,A0A6P4U7M8,Non Druggable,Muscarinic acetylcholine receptor,HRH3,563,61477,MPDMYCCGDKDCQGRLQNIDSHKDNHGQLHRDFRVAALYTDFPLTCPSIPYSPHNRPDSRRGPAGVAGEPGGAAAERSWLGLRRPGGHAALSVVLPAPGGAGXAGGRRAPRPGARLLGPGSPPAAERSWLGLRRPGGHAALSVTGRRQGQGQGCRSRESGRCATPRSCLSLHCGGFDPRPLSSHGPPWPYSPTGAFCIPLYVPYVLTGRWPFSRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVQKMVMVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRVRLDGARDPEPPPEAQPSPPPAAPGCWGCWQKGRGEAVPLHRYGVGVGEAAPGAEAGEAALAGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMASQSITQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKIQPHSSLEHCWKKTKKKTRP
146,Q96CW1,Druggable,AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein),AP2M1 ,435,49655,MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKRSNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGYPQNSETGALKTFITQQGIKSQHQTKEEQSQITSQVTGQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVSGRVVMKSYLSGMPECKFGMNDKIVIEKQGKGTADETSKSGKQSIAIDDCTFHQCVRLSKFDSERSISFIPPDGEFELMRYRTTKDIILPFRVIPLVREVGRTKLEVKVVIKSNFKPSLLAQKIEVRIPTPLNTSGVQVICMKGKAKYKASENAIVWKIKRMAGMKESQISAEIELLPTNDKKKWARPPISMNFEVPFAPSGLKVRYLKVFEPKLNYSDHDVIKWVRYIGRSGIYETRC
147,A0A6P4UCU6,Non Druggable,Histamine H1 receptor,HRH1,487,55734,MTLPNSSCVVEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPASGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPWEVLKRKSKDASGEPVMKPPSQDSEEMKCPGVFSQEEDREMDKLHCFPLNIVQMQTEAEGSGRSYVAINQSQGQLEIDEQSLRMRVANEISEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSSTGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
148,A0A6P4UG15,Non Druggable,Histamine H1 receptor,HRH1,514,58623,MPVAGENALETQDGDRREPQLEAALVPMTLPNSSCVVEDKMCEGNKTTIANPQLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSPASGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKVGAKKPGKESPWEVLKRKSKDASGEPVMKPPSQDSEEMKCPGVFSQEEDREMDKLHCFPLNIVQMQTEAEGSGRSYVAINQSQGQLEIDEQSLRMRVANEISEDQILGDSQSFSRTDSDTPPESASGKSKPRSGSSTGLDYIKYTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
149,Q13162,Druggable,Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4),PRDX4,271,30540,MEALPLLAATTPDHGRHRRLLLLPLLLFLLPAGAVQGWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN
150,A0A6P4W476,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,359,40010,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHHAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDR
151,A0A6P4W5L0,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,46878,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHHAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDRKPALSCTVCSGNLLSCCKSLWGLRFLQRHVRGPSEEQPGQPLSEEPLRTPPQEAVRTLPSEAV
152,P00813,Druggable,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),ADA,363,40764,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL
153,A0A6P4WEL0,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,436,47787,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHHAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDRGVQSSSPLTKGPGRPLAHWNPPGCFVTSASVPGCYPAKLLGYSPASGVELGSPSRSPTPPLLTGSQRYPALCAPATF
154,A0A6P5JXT0,Non Druggable,Histamine H1 receptor,HRH1,506,58399,MEVTRKSESFLWHPMTPPTSSGLQEGTMCEVNKTADAANKPHLVPLMVVLSSISLVTVGLNLLVLYAVRIEKKLHTVGNLYIVSLSVADLIVGAAVMPLNIVYLFRSLERPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQHPLKYLRYRTKTRAIVTILVTWFLASLWIIPILGWRSFWPETDKLNEDKCETDFYKVTWFKVMTAIINFYLPTLLMLWFYSRIYRAVQQHCQHREFINASFPSFSDGNMSHKKHRICLPKQEQDANLETLKRKPEGTYYHISNSIPTKARDPAKESHPEKKMPQGFEQEDEEVVVKDHYFPIDIVQPQPGIEETGKYMSIHQSLPDPKELSPAIQYASETSEETIFAEASSHPTDSIAVTESATDMPAEGQAKTKATFGLDYLAFTWKRLRSHSRQYIKGLHMNRERKAAKQLGCIMAAFILCWIPYFIFFMVIAYCTKCCNEHVQMFTMWLGYINSTLNPLIYPLCNENFKKAFKKIFHIRS
155,O60656,Druggable,UDP-glucuronosyltransferase 1A9 (UGT1A9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-9) (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (lugP4),UGT1A9 ,530,59941,MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLILRGHEVVVVMPEVSWQLGRSLNCTVKTYSTSYTLEDLDREFKAFAHAQWKAQVRSIYSLLMGSYNDIFDLFFSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIVAKYFSLPSVVFARGILCHYLEEGAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLLCHRFFKNALEIASEILQTPVTEYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
156,O75781,Druggable,Paralemmin-1 (Paralemmin),PALM ,387,42076,MEVLAAETTSQQERLQAIAEKRKRQAEIENKRRQLEDERRQLQHLKSKALRERWLLEGTPSSASEGDEDLRRQMQDDEQKTRLLEDSVSRLEKEIEVLERGDSAPATAKENAAAPSPVRAPAPSPAKEERKTEVVMNSQQTPVGTPKDKRVSNTPLRTVDGSPMMKAAMYSVEITVEKDKVTGETRVLSSTTLLPRQPLPLGIKVYEDETKVVHAVDGTAENGIHPLSSSEVDELIHKADEVTLSEAGSTAGAAETRGAVEGAARTTPSRREITGVQAQPGEATSGPPGIQPGQEPPVTMIFMGYQNVEDEAETKKVLGLQDTITAELVVIEDAAEPKEPAPPNGSAAEPPTEAASREENQAGPEATTSDPQDLDMKKHRCKCCSIM
157,P00813,Druggable,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),ADA ADA1,363,40764,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL
158,A0A6P5R0L3,Non Druggable,Histamine H2 receptor (Gastric receptor I),Hrh2,371,41819,MEPNGTVHSCCLDSIALKVTISVVLTTLIFITVAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVMPFSAIYQLSFKWSFGQVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGMVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAVNEVVEGIVLWLGYANSALNPILYATLNRDFRMAYQQLFHCKLASHNSHKTSLRLNNSLLSRSQSREGRWQEEKPLKLQVWSGTEFTHPQGSPVREQTDHDFTDDGKP
159,A0A6P6DP12,Non Druggable,Histamine H1 receptor,Hrh1,482,54896,MTPVTPFNSSCMPEDRMCEGNRTDTPNPQLVPLVVVLSSVSLITVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLYRSVWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHFIAPTPGAQGNKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYARIYKAVRRHCQHRQLINGSFPSFSEMKLRSESTKVDTRRPGKESPWEDPKRLSKDTSEACTLRPSPQRPMEMPSVAVFSDDEGGEAGTLQMPMVAVGDSRCSEALDHMQSRLRPSGQIQATHNNSARPEDWTMVDGQSFSRTTDSDTSIEVASGGGQPRSGSNTGLDYIKFTWRRLRSHSRQYVSGLHLSRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKNCCSEPVHMFTIWLGYFNSTLNPLIYPLCNENFRKTFKRILRIPP
160,Q96B67,Druggable,Arrestin domain-containing protein 3 (TBP-2-like inducible membrane protein) (TLIMP),ARRDC3 ,414,46395,MVLGKVKSLTISFDCLNDSNVPVYSSGDTVSGRVNLEVTGEIRVKSLKIHARGHAKVRWTESRNAGSNTAYTQNYTEEVEYFNHKDILIGHERDDDNSEEGFHTIHSGRHEYAFSFELPQTPLATSFEGRHGSVRYWVKAELHRPWLLPVKLKKEFTVFEHIDINTPSLLSPQAGTKEKTLCCWFCTSGPISLSAKIERKGYTPGESIQIFAEIENCSSRMVVPKAAIYQTQAFYAKGKMKEVKQLVANLRGESLSSGKTETWNGKLLKIPPVSPSILDCSIIRVEYSLMVYVDIPGAMDLFLNLPLVIGTIPLHPFGSRTSSVSSQCSMNMNWLSLSLPERPEAPPSYAEVVTEEQRRNNLAPVSACDDFERALQGPLFAYIQEFRFLPPPLYSEIDPNPDQSADDRPSCPSR
161,Q96EV8,Druggable,Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein),DTNBP1,351,39493,MLETLRERLLSVQQDFTSGLKTLSDKSREAKVKSKPRTVPFLPKYSAGLELLSRYEDTWAALHRRAKDCASAGELVDSEVVMLSAHWEKKKTSLVELQEQLQQLPALIADLESMTANLTHLEASFEEVENNLLHLEDLCGQCELERCKHMQSQQLENYKKNKRKELETFKAELDAEHAQKVLEMEHTQQMKLKERQKFFEEAFQQDMEQYLSTGYLQIAERREPIGSMSSMEVNVDMLEQMDLMDISDQEALDVFLNSGGEENTVLSPALGPESSTCQNEITLQVPNPSELRAKPPSSSSTCTDSATRDISEGGESPVVQSDEEEVQVDTALATSHTDREATPDGGEDSDS
162,A0A6P7D5Z0,Non Druggable,Histamine H1 receptor,HRH1,489,55675,MTCPNSSCIFEDEMCEGNKTAPASDAQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLRCRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILSWRHFQLKTPEPLGHKCETDFYKVTWFKIMTAIVNFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDVKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSLGVFSQEKDGEPDNFYCFPLDTVQTQPEAEGSGRGYAAINQSQNQFEMGEQGLNMPGAKEALEDQIQGDSQSFSRTDSDTPAEPAAPGKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIVCWIPYFVFFMVVAFCESCSNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
163,A0A7K7UAK7,Non Druggable,Histamine H1 receptor (Fragment),Hrh1 ,475,54497,MSKNSTENSTNPHSAPLGLFLGSISLITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLSGVWTLGLPACLFWLSMDYVASTASIFNLFILCIDRYRSVQQPLQYLKYRTKMRALVMILGVWLLSFMWVIPILGWHVFANNGERKVKENKCETEFSQVTWFKVLTGILNFYLPSIMMLWFYYKIFRAVRKHCQHRELNNGSGWSFSEKKSIDHAKRKDKQNICLQKQILCENNPPKDKQSSPQPKNMETELHFSNSDKSSKAFVGKSNRKVLKWSCLPFTTAQSEPGLDKAGKKCVSVTEENENEEEPCSQDSDLSDASDNHTFTEEVPCGEHSNPNPERACSPPEKTENRDFGRLTYLRKTWQSLHSNSKRRIQGLHGNRERKAAKQLGVIMAAFMLCWIPYFVLFMVIAFHGHKQFSQLHMFTIWLGYVNSTLNPFLYPLCNQNFKKTFKKILHIH
164,Q96L92,Druggable,Sorting nexin-27,SNX27 ,541,61265,MADEDGEGIHPSAPHRNGGGGGGGGSGLHCAGNGGGGGGGPRVVRIVKSESGYGFNVRGQVSEGGQLRSINGELYAPLQHVSAVLPGGAADRAGVRKGDRILEVNHVNVEGATHKQVVDLIRAGEKELILTVLSVPPHEADNLDPSDDSLGQSFYDYTEKQAVPISVPRYKHVEQNGEKFVVYNVYMAGRQLCSKRYREFAILHQNLKREFANFTFPRLPGKWPFSLSEQQLDARRRGLEEYLEKVCSIRVIGESDIMQEFLSESDENYNGVSDVELRVALPDGTTVTVRVKKNSTTDQVYQAIAAKVGMDSTTVNYFALFEVISHSFVRKLAPNEFPHKLYIQNYTSAVPGTCLTIRKWLFTTEEEILLNDNDLAVTYFFHQAVDDVKKGYIKAEEKSYQLQKLYEQRKMVMYLNMLRTCEGYNEIIFPHCACDSRRKGHVITAISITHFKLHACTEEGQLENQVIAFEWDEMQRWDTDEEGMAFCFEYARGEKKPRWVKIFTPYFNYMHECFERVFCELKWRKENIFQMARSQQRDVAT
165,A0A7K9B7R8,Non Druggable,Histamine H1 receptor (Fragment),Hrh1,472,54167,MSENTTKTSTDPHSAPLGVFLGSISLITIVMNILVLWAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLVNHTWLLGVPACLFWLSMDYVASTASIFSLFILCIDRYRSVQQPLKYLRYRTKMRASLMILGAWLLSFLWVIPILGWHAFTEKRKQGNKCETEFSEVTWFKLLTAIVNFYLPSIIMLWLYFKIFRAVRKHCQHRELIDGSFRSFSENKSIHHSKTKDEQKICPPKQILDENTPPKEQHNSPQPKNMEARLHLDNTNKSSKAFDSRSDGKVFRWSCFPLTTAQSKPDLDKAGKQYVCVTKGNQNEEEPCSQDSDLSNTSIDQTSAEEVSCRNDSNPDPKGACSPQGKTEDKDFTGLTYLKRTWQRLHSHSKRRIPGLHVNRERKAATQLGVIMAAFILCWIPYFVLYMVIAFHGHEQFSKLHMFTIWLGYVNSTLNPFLYPLCNENFKKTFKKILHIP
166,A0A7L3DGQ0,Non Druggable,Histamine H1 receptor (Fragment),Hrh1,477,54914,MSKNSSENSTSPHSAPLGLFLGSISLITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLSDVWTLGLPACLFWLSMDYVASTASIFNLFILCIDRYRSVEQPLQYLKYRTKMRALLMILGVWLLSFMWVIPILGWHVFANKGERKVDENKCETEFSEVTWFKVLTAIVNFYLPSILMLWFYYKIFRAVRKHCQHRELINGSRWSFSEKKNTDHSKTKDKESVSPQKQILYDNNPPKDKQSSPEPKNIEAELHFSDPDKSSKAFVAKRNRKVLKWSCFPPTAAQSEPGLDKAGKKCVRVTEENENEEEPCSQDSDLSDASDNHTFTEEVPCKEHSSPNLEKACSPQEKTENRDFGRLTYLRKTWQSLHTHSKRNSHIQGLHGNRERKAAKQLGVIMAAFMLCWIPYFVLFMVIAFHGHKQFSQLHMFTIWLGYVNSTLNPFLYPLCNQNFKKTFKKILHIH
167,O95622,Druggable,Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5),ADCY5,1261,138908,MSGSKSVSPPGYAAQKTAAPAPRGGPEHRSAWGEADSRANGYPHAPGGSARGSTKKPGGAVTPQQQQRLASRWRSDDDDDPPLSGDDPLAGGFGFSFRSKSAWQERGGDDCGRGSRRQRRGAASGGSTRAPPAGGGGGSAAAAASAGGTEVRPRSVEVGLEERRGKGRAADELEAGAVEGGEGSGDGGSSADSGSGAGPGAVLSLGACCLALLQIFRSKKFPSDKLERLYQRYFFRLNQSSLTMLMAVLVLVCLVMLAFHAARPPLQLPYLAVLAAAVGVILIMAVLCNRAAFHQDHMGLACYALIAVVLAVQVVGLLLPQPRSASEGIWWTVFFIYTIYTLLPVRMRAAVLSGVLLSALHLAIALRTNAQDQFLLKQLVSNVLIFSCTNIVGVCTHYPAEVSQRQAFQETRECIQARLHSQRENQQQERLLLSVLPRHVAMEMKADINAKQEDMMFHKIYIQKHDNVSILFADIEGFTSLASQCTAQELVMTLNELFARFDKLAAENHCLRIKILGDCYYCVSGLPEARADHAHCCVEMGMDMIEAISLVREVTGVNVNMRVGIHSGRVHCGVLGLRKWQFDVWSNDVTLANHMEAGGKAGRIHITKATLNYLNGDYEVEPGCGGERNAYLKEHSIETFLILRCTQKRKEEKAMIAKMNRQRTNSIGHNPPHWGAERPFYNHLGGNQVSKEMKRMGFEDPKDKNAQESANPEDEVDEFLGRAIDARSIDRLRSEHVRKFLLTFREPDLEKKYSKQVDDRFGAYVACASLVFLFICFVQITIVPHSIFMLSFYLTCSLLLTLVVFVSVIYSCVKLFPSPLQTLSRKIVRSKMNSTLVGVFTITLVFLAAFVNMFTCNSRDLLGCLAQEHNISASQVNACHVAESAVNYSLGDEQGFCGSPWPNCNFPEYFTYSVLLSLLACSVFLQISCIGKLVLMLAIELIYVLIVEVPGVTLFDNADLLVTANAIDFFNNGTSQCPEHATKVALKVVTPIIISVFVLALYLHAQQVESTARLDFLWKLQATEEKEEMEELQAYNRRLLHNILPKDVAAHFLARERRNDELYYQSCECVAVMFASIANFSEFYVELEANNEGVECLRLLNEIIADFDEIISEDRFRQLEKIKTIGSTYMAASGLNDSTYDKVGKTHIKALADFAMKLMDQMKYINEHSFNNFQMKIGLNIGPVVAGVIGARKPQYDIWGNTVNVASRMDSTGVPDRIQVTTDMYQVLAANTYQLECRGVVKVKGKGEMMTYFLNGGPPLS
168,A0A7L3UHD5,Non Druggable,Histamine H1 receptor (Fragment),Hrh1 ,472,54421,MSKNSTDNSTNPYSAPLGLFLGSISLTTIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLSRVWTLGLPACLFWLSMDYVASTASIFNLFILCIDRYRSVQQPLQYLKYRTKMRASLMILGVWLLSFMWVIPILGWHVFASNGERKVEKNKCETEFSEVTWFKVLTAIVNFYIPSIMMLWFYYKIFRAVRKHCQHRELINGSRQSFSEEKNIHHSKKDKQNICLQKQILYENSSPKDKQSSPQPKDMETELHFSNPDKSSEAFVGKNTSEVVKWSCFPLTTAQSEPDEAEKKCACVTEENENEEEPCSQDSDLSDASDNQTFTEEVPCTQHSSPNPERACSPQEKTENRDFRGLTYLRKTWQSLHAHSKRHIQGLHGKRERKAAKQLGVIMAAFMLCWIPYFLLFMVIAFHGHKKFSELHMFTIWLGYVNSTLNPFLYPLCNQNFKKTFKKILHIH
169,A0A7N4UWY1,Non Druggable,Histamine H1 receptor,HRH1,484,55818,MCEVNRTDIANKPHLVPLVVVLSTISLVTVGLNLLVLYAVRTEKKLHTVGNLYIVSLSVADLIVGAAVMPLNIVYLLKSLVRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRATITILITWFLASLWIIPILGWRSFWSDNNTSKSYDNVFGDKCETDFYKVTWFKVMTAIINFYLPTLLMLWFYSRIYRAVRQHCQHREFINGSFPSFSEGTVNHKKHRICLPKQGKDASLEALKRKPEDNFYPINNSIPPKTQDPARELSPEEKAPKGFEQEEGEVVVKDHYYHVDLVQAEPGMEETEKYMSIHESQSNSKELSPATQYASETSEETIFAEAPSNPIDSNAIAESATVMSAEDQAKTKATFGLDYLTFTWKRLRSHSRQYIKGLHMNRERKAAKQLGCIMAAFILCWIPYFIFFMVIAYCKKCCNEDVQMFTMWLGYINSTLNPLIYPLCNENFKKAFKKIFHIRS
170,Q15599,Druggable,Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1),SLC9A3R2 ,337,37414,MAAPEPLRPRLCRLVRGEQGYGFHLHGEKGRRGQFIRRVEPGSPAEAAALRAGDRLVEVNGVNVEGETHHQVVQRIKAVEGQTRLLVVDQETDEELRRRQLTCTEEMAQRGLPPAHDPWEPKPDWAHTGSHSSEAGKKDVSGPLRELRPRLCHLRKGPQGYGFNLHSDKSRPGQYIRSVDPGSPAARSGLRAQDRLIEVNGQNVEGLRHAEVVASIKAREDEARLLVVDPETDEHFKRLRVTPTEEHVEGPLPSPVTNGTSPAQLNGGSACSSRSDLPGSDKDTEDGSAWKQDPFQESGLHLSPTAAEAKEKARAMRVNKRAPQMDWNRKREIFSNF
171,A0A7N5JJ18,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,46565,MVPNSTASSLCLDSPPCKITVSVVLTVLILITIAGNVVVCLAVGLTRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWGFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRSESSSSNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCVTYYRIFKIAREQAKRIHHVGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLIGDDAINEAIEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHGAQETTQRSGGSQLARNQSREAMQQEEKPLKLQVWSGTEVTAPRGAADRKPALPCTVCSGNLLICCKSLWGLGFLQRHMRGPSEEQPGEPLSEEPLRTPPQEAVRTLPSEAV
172,A0A7N5K3U7,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,374,41229,MVPNSTASSLCLDSPPCKITVSVVLTVLILITIAGNVVVCLAVGLTRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWGFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLGWNSRSESSSSNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCVTYYRIFKIAREQAKRIHHVGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLIGDDAINEAIEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHGAQETTQRSGGSQLARNQSREAMQQEEKPLKLQVWSGTEVTAPRGAADSESRLTRAASGMLIQG
173,A0A803KEZ7,Non Druggable,Histamine H1 receptor,hrh1,499,57551,MWQTNQSIVQNGTEIHSASLGLALGTISALTVVLNILVLYAVRTERKLHTVGNLYIVSLSIADLIVGAAVMPLNIVYLLNREWILGRPACLFWLSMDYVASTASIFSLFILCIDRYRSIQQPLRYLKYRTKTRASLMISGAWLLSFTWVVPILGWHVFANGGIRSVPESTCETEFHKVTWFKVLTATLNFYIPSLLMLWFYAKIYKAVREHYQHREVVNGSFQLFYDSKLVQSVRVLKGQQSCTKTQCKDGNLTVPEMNFPAQYTPISKEFRQSRSTQEKDPVEDYGKQKGFSHCDNNVFKLHCFPLAIIQGSPQECRNYVTVTRGALEEHNCLRPRQREEISEEHTFAEAASCMVDLSQVGKSNMEAPGRTEARLSGNFRYLKHTWERFRTHSKQHIQGLHMNRERKAAKQLGFIMAAFMLCWIPYFVLFMVIAFCHNCCNHNFHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKIFHVELNCGECKKENRASCPYA
174,A0PJF5,Druggable,Prostaglandin E2 receptor EP4 subtype (Prostanoid EP4 receptor) (Fragment),PTGER4,229,25262,MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHH
175,A1A4V4,Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,400,44220,MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSHICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYEVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPPQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
176,A8K2J1,Druggable,cDNA FLJ77971,,340,37463,MLSGSRAVPTPHHGSEELLKYMLHSPCVSLTMNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQQWTETRIYMTNLAVADLCLLCTLPFVLHSLRDTSDTPLCQLSQGIYLTNRYMSISLVMAIAVDRYVAVRHPLRARGLRSPRQAAAVCAVLWVLVIGSLVARWLLGIQEGGFCFRSTRHNFNSMAFPLLGFYLPLAVVVFCSLKVVTALAQRPPTDVGQAEATRKAARMVWANLLVFVVCFLPLHVGLTVRLAVGWNACALLETIRRALYITSKLSDANCCLDAICYYYMAKEFQEASALAVAPSAKAHKSQDSLCVTLA
177,B3Y5T0,Non Druggable,Histamine H1 receptor,Hrh1,488,55682,MSLPNTSSASEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFLSFLWVIPILGWHHFTPLAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPTFLEIKLRSEDAKEGAKKPGKESPWGVQKRPSRDPTGGLDQKSTSEDPKVTSPTVFSQEGERETVTRPCFRLDVMQTQPVPEGDARGSKANDQTLSQPKMDEQSLSTCRRISETSEDQTLVDRQSFSRTTDSDTSIEPGLGKVKARSRSNSGLDYIKVTWKRLRSHSRQYVSGLHLNRERKAAKQLGCIMAAFILCWIPYFIFFMVIAFCNSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
178,B5BUP4,Druggable,D(2) dopamine receptor (Dopamine D2 receptor) (Fragment),DRD2,414,47275,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
179,C8WLC6,Non Druggable,Uncharacterized oxidoreductase Elen_0471 (EC 1.-.-.-) (Dopamine dehydroxylase homolog) (Inactive dopamine dehydroxylase),Elen_0471,1017,114957,MGNLTMSRRTFVKTAAITGAAAAAFGASTHTALAEETYSSVSGNDTVAVKTCCRGCGKMECGVKVIVQNGRAIRVEGDEGAFQSMGNCCTKSQSSIQAAYHPDRLHYPMKRTNPKGEEPGWQRISWDEAMQSIVDNFMDIKAKHGGEAIACQVGTSRIWCMHSESILKNMLETPNNVEAWQICKGPRHFATTMVSQFAMSWMETITRPKVYVQWGGASELSNYDDSCRTTVDVASRADVHISVDPRMANMGKEADYWQHLRPGTDGALALAWTNVIIEKKLYDELYVKKWTNAPFLVCEDMEPSGFPTVRTDGSYWDVKTALLKESDIKEGGSPYKFLVYDNNWEKLKAEGVEHEYGAFTWFNADQEGVIDETGGFWEGENYDSEKARQGREAAQDNLLPGQTQGWLPDPMPFDPAIDPALEGEFEITLKDGKTVKVKPVWEHYKARAAEYKPEVAAEITGIPASEIEAAATAYGTRIDPSTGYGNGGIQYMLAVEHFCSAIQNCSAFDNLVGITGNMDTPGGNRGPTIVPIDGDLQGFSAWAPGATTPPEEVNRKQIGIDKFPLLGWWQYWCDSHSLWDAVITGDPYPVRALWNESGNFMSQTNTTRAWEALCSLDFYVDLNLWHTPQNDTADIILPVAHWIELNSPRASQGSAGAMGATVKCVQPPAEAKYDPEIVMDLARRMNWKWTDEPGNEWPDINWQLDDSIKLLTDDELTYTTWHVENGKPTFERHGVPMAEVTPKYKTWDEYVKAFQEHGWWQAKDIEPRNWGTYRRYQTGAMRARDRVWGRLDYTAGKGIGDWKPGWFTPTMKQEIWSTVMESHHPDHPEWRLPTYTEPPHGPKDGDRIKEYPLTATTGRRIPVYFHSEHRQLPWCRELWPVPRVEINPKTAAEYGIEQGDWVWIETEWGKIREVADLYYGVKEDVINLEHTWWYPEVKDAGHGWQFSQVNQLIDHYAQDPHSGTSNLRAYQVKIYKATPENSPFNNPVPCDSTGTPIIHTSDDPRLKEWLPTYEGRE
180,C9J0Z4,Druggable,Adenosine receptor A2a (Fragment),ADORA2A,76,7883,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHG
181,E1BBS2,Non Druggable,Histamine receptor H4,HRH4,405,46045,MYTHGINSSHVMPFTNDTNSSAVMPASKDIYSFSNIALAFLMSLLAFAIMLGNAVVILAFVVDKNLRHRSNYFFLNLAISDFFVGMISIPLFIPHKLFNWEFENNICVFWLTTDYLLCTASVYNIVLISFDRYQSVSNAVSYRARHTGTLKTVTLMVAVWVAAFLVHGPILVSEVRKELRGDCKPEFLKKKHILALTLVFEFLIPVLLVAYFNMYIYWSLWKRSHLSRGHSGFISAPSISSGRSFRNGLFSRPSLSNLEESAASLRSEKSGRKSSLFSSLRTQVNSLTASKTSSLSHSDSLVLHQREHLELCRGKKLAKSLAILLGVFAVCWAPYSLFTIIHSCHGTLSDFLNPVYEFTFWLQWFNSFVNPFLYPLCHKRFQKAFLKLFRVKKQSISSHNRSTSS
182,E1BK27,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,419,46408,MAANGTASSSCLDPTAFKVTVTVVLILLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCQWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAVSLVLIWVISITLSFLSIHLEWNSRPENHSDSHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFRIAREQARRIHNVGPWRAATLREHKATVTLAAVMGAFIVCWLPYFTVFVYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGQDARRTSLGSNSSQLVRHPGQGPRWPEERPLRLQVWSGTELTAPQGATDRNPARSSTACSSNLLSCCKSLWALRFLQRHEGGPWGEQPGAPLSEEPPTAPAQESVRTLPS
183,E9PCM4,Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,367,40730,MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLMPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
184,F1LNK8,Non Druggable,Histamine H2 receptor (Gastric receptor I),Hrh2,371,41755,MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFKWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIREQTHHDVTDEGKP
185,F1MML8,Non Druggable,Histamine receptor H3,HRH3,408,45251,MALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWPFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVQKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRVRLDGVREAATTELPPEAQPSPPPAAPSCWGCWQKGCGEAVPLHRYGVGVSEVTPGPEAGEVALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKIQPHSSLEHCWK
186,Q14160,Druggable,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),SCRIB ,1630,174915,MLKCIPLWRCNRHVESVDKRHCSLQAVPEEIYRYSRSLEELLLDANQLRELPKPFFRLLNLRKLGLSDNEIQRLPPEVANFMQLVELDVSRNDIPEIPESIKFCKALEIADFSGNPLSRLPDGFTQLRSLAHLALNDVSLQALPGDVGNLANLVTLELRENLLKSLPASLSFLVKLEQLDLGGNDLEVLPDTLGALPNLRELWLDRNQLSALPPELGNLRRLVCLDVSENRLEELPAELGGLVLLTDLLLSQNLLRRLPDGIGQLKQLSILKVDQNRLCEVTEAIGDCENLSELILTENLLMALPRSLGKLTKLTNLNVDRNHLEALPPEIGGCVALSVLSLRDNRLAVLPPELAHTTELHVLDVAGNRLQSLPFALTHLNLKALWLAENQAQPMLRFQTEDDARTGEKVLTCYLLPQQPPPSLEDAGQQGSLSETWSDAPPSRVSVIQFLEAPIGDEDAEEAAAEKRGLQRRATPHPSELKVMKRSIEGRRSEACPCQPDSGSPLPAEEEKRLSAESGLSEDSRPSASTVSEAEPEGPSAEAQGGSQQEATTAGGEEDAEEDYQEPTVHFAEDALLPGDDREIEEGQPEAPWTLPGGRQRLIRKDTPHYKKHFKISKLPQPEAVVALLQGMQPDGEGPVAPGGWHNGPHAPWAPRAQKEEEEEEEGSPQEEEEEEEEENRAEEEEASTEEEDKEGAVVSAPSVKGVSFDQANNLLIEPARIEEEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRERMVEPENAVTITPLRPEDDYSPRERRGGGLRLPLLPPESPGPLRQRHVACLARSERGLGFSIAGGKGSTPYRAGDAGIFVSRIAEGGAAHRAGTLQVGDRVLSINGVDVTEARHDHAVSLLTAASPTIALLLEREAGGPLPPSPLPHSSPPTAAVATTSITTATPGVPGLPSLAPSLLAAALEGPYPVEEIRLPRAGGPLGLSIVGGSDHSSHPFGVQEPGVFISKVLPRGLAARSGLRVGDRILAVNGQDVRDATHQEAVSALLRPCLELSLLVRRDPAPPGLRELCIQKAPGERLGISIRGGARGHAGNPRDPTDEGIFISKVSPTGAAGRDGRLRVGLRLLEVNQQSLLGLTHGEAVQLLRSVGDTLTVLVCDGFEASTDAALEVSPGVIANPFAAGIGHRNSLESISSIDRELSPEGPGKEKELPGQTLHWGPEATEAAGRGLQPLKLDYRALAAVPSAGSVQRVPSGAAGGKMAESPCSPSGQQPPSPPSPDELPANVKQAYRAFAAVPTSHPPEDAPAQPPTPGPAASPEQLSFRERQKYFELEVRVPQAEGPPKRVSLVGADDLRKMQEEEARKLQQKRAQMLREAAEAGAEARLALDGETLGEEEQEDEQPPWASPSPTSRQSPASPPPLGGGAPVRTAKAERRHQERLRVQSPEPPAPERALSPAELRALEAEKRALWRAARMKSLEQDALRAQMVLSRSQEGRGTRGPLERLAEAPSPAPTPSPTPVEDLGPQTSTSPGRLSPDFAEELRSLEPSPSPGPQEEDGEVALVLLGRPSPGAVGPEDVALCSSRRPVRPGRRGLGPVPS
187,Q15363,Druggable,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),TMED2 ,201,22761,MVTLAELLVLLAALLATVSGYFVSIDAHAEECFFERVTSGTKMGLIFEVAEGGFLDIDVEITGPDNKGIYKGDRESSGKYTFAAHMDGTYKFCFSNRMSTMTPKIVMFTIDIGEAPKGQDMETEAHQNKLEEMINELAVAMTAVKHEQEYMEVRERIHRAINDNTNSRVVLWSFFEALVLVAMTLGQIYYLKRFFEVRRVV
188,Q15910,Druggable,Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6),EZH2,746,85363,MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP
189,Q16082,Druggable,Heat shock protein beta-2 (HspB2) (DMPK-binding protein) (MKBP),HSPB2,182,20233,MSGRSVPHAHPATAEYEFANPSRLGEQRFGEGLLPEEILTPTLYHGYYVRPRAAPAGEGSRAGASELRLSEGKFQAFLDVSHFTPDEVTVRTVDNLLEVSARHPQRLDRHGFVSREFCRTYVLPADVDPWRVRAALSHDGILNLEAPRGGRHLDTEVNEVYISLLPAPPDPEEEEEAAIVEP
190,F1NEN2,Non Druggable,Histamine H1 receptor,HRH1,474,54461,MSKNTTENSNYTHSALLGFLLASISLITVVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLNRVWTLGLTACLFWLSMDYVASTASIFSLFILCLDRYRSVQQPLKYLQYRTKMRASLVILGAWLLSSLWVIPILWWHDSANDEKRKGKANCDTQFSHVTWFKVLTAIVNFYLPSIIMLWLYCKIFRAVRKHCQQREVVTGSYCSFSENKNVIHGKTKDKQNICLQKQILHENTSHKDKQMSSEHKSTAAKYHFSNSDKSSKAFVSSSNSKAFQCSCLPLTTAQSEPDLEKAGKKCVCVKKDNKNEEDPHSQDSDLSATSDSDTFTENVPSGEQSNPNPDRACSPQENKENRDFRGLSYLRKTWQTLHTHSKSRLRRQHVSREWKAAKQLGVIMAAFMLCWIPYFVLYMVTVFQHREQFYTLHMFTIWLGYVNSTLNPFLYPLCNENFKKTFKKILHIQ
191,F1NUQ9,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,377,42122,MDPCSNLTDPSKTMDFPLQLLVGSCLALLITFTLCGNIIVCLAVTLDRRLRSLTNCIIVSLAITDLLLALLVLPFSAYYELTSEWPFSSTLCNIYLSLDVMLCTASILNLFIISLDRYFAVTTPLRYQQLVTRSRVAVGLVVIWTVSLMVSFLPIHLGWNTNGTMVQNTTPNCTRECKLEVNSVYGLVDSLLTFYIPLVIMCITYYRIFKIAREQAKRINHTWCCSSNGPMPPMVKEHKATVTLAVVMGAFIICWFPYFTVFTYRGVWGDSSVKGIPMSIVLWLGYANSALNPILYGTFNRDFRVAYQHLLQCWRTGDPKSSLQKGQPRGRSCGESLDGQEGKCLKLEMRNGKGTLLADGALQRIPVLVPGTCCLPR
192,P49407,Druggable,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ,418,47066,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR
193,P49407,Druggable,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ,418,47066,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR
194,P49407,Druggable,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ,418,47066,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR
195,F1NVX2,Non Druggable,G_PROTEIN_RECEP_F1_2 domain-containing protein,HRH3,420,47115,EERWAMESGGELNGSAAASGRFATAGTAALGALMALLIAVTVAGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWIFGRSLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGNTRRAVLKMVLVWVLAFLLYGPAIISWEYISGESIIPTGECYAEFFYNWYFLMTASTLEFFTPFISVMFFNLSIYLNIQKRTKLRLDVFHEVHNRSFAEEMEMSPEAKLSSKCYKWEQKEPAETLGLSKSKAQAAASSAAEDLLTATAGGSQCCNKKGCKNSASALSLEKRVKVVSQGVTQRFRLSRDKKVAKSLAIIVGIFGICWAPYTLLMIIRAGCHGHCISDYWYETSFWLLWINSAVNPVLYPLCHYSFRRAFIKLLCPKKLKIQPHDPLQNCWK
196,F1SBA8,Non Druggable,Histamine receptor H4,HRH4,390,44495,MSAINDTNTNTLPLNTRIALAFLMSLLALVIMLGNAVVILAFVVDKNLRHRSNYFLLNLAISDFFVGVISIPLYIPHTLFKWKLEDNICAFWLIIDYLLCTASVYNIVLISFDRYQSVSNAVSYRTQHTGILKIVALMVGVWVLAFLVHGPVILVSEAWKQGKQDCEPGFLKEWYVLAITLFFEFLAPVLLVAYFNLYIYWSLWKRGHLSRCQSHCGLTPVSSGSWGHSFRCGLFSRTSLSDPKEAAASLHSERPRRKSTLWFSLRTRMSSLTASNKGFLSHSDSLALHQKEHLELLRARKLARSLAILLGVFAICWAPYSLLTIIRSVYPTNPFPSTAVYKFAFWLQWFNSCVNPFLYPLCHKRFQKAFLKIFCLKKQSTLSHNRSTSS
197,F1SQA5,Non Druggable,Histamine H1 receptor,HRH1,485,55318,MTFPNSSFTLEDNMCEANKTTMANPKLMPLVVVLSAVSLVTVGLNLLVLCAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILVAWLFSFLWVIPILGWHRFVSRTSRRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELINGSLPSFSEIKLKPENPKVGAKKAGKESPWEVLKRKPKDAGGGPVLKPSSQDSVEMKSPGVSSQEDGELDKFHCFTLNIVQTQMEAEGSSKGYVAVIHSQSQLEMDEQGLNMRGANEISEDQTLGDSQSSRTDSDTPTEPVPGKSKPRSGSSTGLDYIKLTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
198,F2Z2Z6,Druggable,Prostaglandin F2-alpha receptor (Prostanoid FP receptor),PTGFR,297,33545,MSMNNSKQLVSPAAALLSNTTCQTENRLSVFFSVIFMTVGILSNSLAIAILMKAYQRFRQKSKASFLLLASGLVITDFFGHLINGAIAVFVYASDKEWIRFDQSNVLCSIFGICMVFSGLCPLLLGSVMAIERCIGVTKPIFHSTKITSKHVKMMLSGVCLFAVFIALLPILGHRDYKIQASRTWCFYNTEDIKDWEDRFYLLLFSFLGLLALGVSLLCNAITGITLLRVKFKSQQHRQGRSHHLEMVIQLLAIMCVSCICWSPFLGYRIILNGKEKYKVYEEQSDFLHSDKTLNEK
199,F6PS14,Non Druggable,Histamine H1 receptor,HRH1,486,55652,MTCLNSSSDLEDKMCEGNKTTIASPQLMPLVVVLSTISLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLFTSKWPLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFLSFLWVIPIWGWHHFVSQTWNRQEDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYTKIYKAVRQHCQHRDLINGSLPSFSDVKLKPENPKVDAKKSEESPWEVLKRKPKDAGGGSVLKLPSEDPKEMKSPAVFSQEEVGEVDNLHCFPLNTVQMHTEAEGNDRGYVAINQSQSQLEMGEQGLNMREANEMPEDQILGDSPSFSQTDLDTPPEPASGKGKPRGGSNTGLDYIRFTWKRLRSHSRQCVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
200,Q53YY0,Druggable,Type-1 angiotensin II receptor,AGTR1 ,359,41061,MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
201,F6QB56,Non Druggable,Histamine receptor H4,HRH4,388,44614,SDNIMPFNQGTLVILSILMAFLAFSIVLGNGLVIIAFVVDKNLRLRSNFFFLNLAISDFFVGAICIPLYIPYETQGRWDAGNKLCVFWLVIDYLLCTTSVYNIVLISYDRYQSVCNAISYRNKPSSISRTATFMVAVWVLAFMVHGPAILSGSKDQTEKTECRNQLLFTDYYIITTSILEFLIPTILVTYFNYCIYWSLHSRSRVRGSLVSTPNISSSVQGNSMTCAFFPMVRLPKPDEEVPSSSVKKIRKKSLFASFRTREEEETASAELTSLSHSNSVPIVLRAQHELLRDRKIAKSLAIILGAFVFCWAPYILFTIIRFACNQRRDNSWYTFTFWLQWFNSFLNPFLYPLCHKRFRIAFMKIFCKKKHTASTQVSLFTQGQCRKI
202,F6QJP0,Non Druggable,Histamine H1 receptor,HRH1,487,55593,MTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
203,Q5JY77,Druggable,G-protein coupled receptor-associated sorting protein 1 (GASP-1),GPRASP1 ,1395,156865,MTGAEIESGAQVKPEKKPGEEVVGGAEIENDVPLVVRPKVRTQAQIMPGARPKNKSKVMPGASTKVETSAVGGARPKSKAKAIPVSRFKEEAQMWAQPRFGAERLSKTERNSQTNIIASPLVSTDSVLVAKTKYLSEDRELVNTDTESFPRRKAHYQAGFQPSFRSKEETNMGSWCCPRPTSKQEASPNSDFKWVDKSVSSLFWSGDEVTAKFHPGNRVKDSNRSMHMANQEANTMSRSQTNQELYIASSSGSEDESVKTPWFWARDKTNTWSGPREDPNSRSRFRSKKEVYVESSSGSEHEDHLESWFGAGKEAKFRSKMRAGKEANNRARHRAKREACIDFMPGSIDVIKKESCFWPEENANTFSRPMIKKEARARAMTKEEAKTKARARAKQEARSEEEALIGTWFWATDESSMADEASIESSLQVEDESIIGSWFWTEEEASMGTGASSKSRPRTDGERIGDSLFGAREKTSMKTGAEATSESILAADDEQVIIGSWFWAGEEVNQEAEEETIFGSWFWVIDAASVESGVGVSCESRTRSEEEEVIGPWFWSGEQVDIEAGIGEEARPGAEEETIFGSWFWAENQTYMDCRAETSCDTMQGAEEEEPIIGSWFWTRVEACVEGDVNSKSSLEDKEEAMIPCFGAKEEVSMKHGTGVRCRFMAGAEETNNKSCFWAEKEPCMYPAGGGSWKSRPEEEEDIVNSWFWSRKYTKPEAIIGSWLWATEESNIDGTGEKAKLLTEEETIINSWFWKEDEAISEATDREESRPEAEEGDIIGSWFWAGEEDRLEPAAETREEDRLAAEKEGIVGSWFGAREETIRREAGSCSKSSPKAEEEEVIIGSWFWEEEASPEAVAGVGFESKPGTEEEEITVGSWFWPEEEASIQAGSQAVEEMESETEEETIFGSWFWDGKEVSEEAGPCCVSKPEDDEEMIVESWFWSRDKAIKETGTVATCESKPENEEGAIVGSWFEAEDEVDNRTDNGSNCGSRTLADEDEAIVGSWFWAGDEAHFESNPSPVFRAICRSTCSVEQEPDPSRRPQSWEEVTVQFKPGPWGRVGFPSISPFRFPKEAASLFCEMFGGKPRNMVLSPEGEDQESLLQPDQPSPEFPFQYDPSYRSVQEIREHLRAKESTEPESSSCNCIQCELKIGSEEFEELLLLMEKIRDPFIHEISKIAMGMRSASQFTRDFIRDSGVVSLIETLLNYPSSRVRTSFLENMIRMAPPYPNLNIIQTYICKVCEETLAYSVDSPEQLSGIRMIRHLTTTTDYHTLVANYMSGFLSLLATGNAKTRFHVLKMLLNLSENLFMTKELLSAEAVSEFIGLFNREETNDNIQIVLAIFENIGNNIKKETVFSDDDFNIEPLISAFHKVEKFAKELQGKTDNQNDPEGDQEN
204,F6UMY9,Non Druggable,Histamine receptor H3,HRH3,452,49428,MERSPPDGPLNASGALAGEAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWPFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVQKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRVRLDGAREAAGPEPPPEAQPSPPPAVPGCWGCWQKGRGEALPLHRYGVGVGEAAPGAEAGEMALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKIQPHSSLEHCWKKKTTHP
205,Q16261,Druggable,ETB1 protein (Fragment),ETB1,30,3480,VLSLCALSIDSLKYNSIFIFRYRAVASWSR
206,Q16512,Druggable,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),PKN1 ,942,103932,MASDAVQSEPRSWSLLEQLGLAGADLAAPGVQQQLELERERLRREIRKELKLKEGAENLRRATTDLGRSLGPVELLLRGSSRRLDLLHQQLQELHAHVVLPDPAATHDGPQSPGAGGPTCSATNLSRVAGLEKQLAIELKVKQGAENMIQTYSNGSTKDRKLLLTAQQMLQDSKTKIDIIRMQLRRALQAGQLENQAAPDDTQGSPDLGAVELRIEELRHHFRVEHAVAEGAKNVLRLLSAAKAPDRKAVSEAQEKLTESNQKLGLLREALERRLGELPADHPKGRLLREELAAASSAAFSTRLAGPFPATHYSTLCKPAPLTGTLEVRVVGCRDLPETIPWNPTPSMGGPGTPDSRPPFLSRPARGLYSRSGSLSGRSSLKAEAENTSEVSTVLKLDNTVVGQTSWKPCGPNAWDQSFTLELERARELELAVFWRDQRGLCALKFLKLEDFLDNERHEVQLDMEPQGCLVAEVTFRNPVIERIPRLRRQKKIFSKQQGKAFQRARQMNIDVATWVRLLRRLIPNATGTGTFSPGASPGSEARTTGDISVEKLNLGTDSDSSPQKSSRDPPSSPSSLSSPIQESTAPELPSETQETPGPALCSPLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC
207,Q4LEK1,Druggable,Prostanoid FP receptor (Fragment),PTGFR,93,10239,VTMANIGINGNHSLETCETTLFALRMATWNQILDPWVYILLRKAVLXNLYKLASQCCGVHVISLHIWELSSIKNSLKVAAISESPVAEKSAST
208,Q6UWT4,Druggable,Uncharacterized protein C5orf46,C5orf46 ,87,9693,MAVSVLRLTVVLGLLVLFLTCYADDKPDKPDDKPDDSGKDPKPDFPKFLSLLGTEIIENAVEFILRSMSRSTGFMEFDDNEGKHSSK
209,F6XK97,Non Druggable,Histamine H1 receptor,HRH1,563,62970,MEVWNACNKQCDDGATGVGCYRISGKKLHKEEEPRGSRMERATGHLSSPRLKSGSLPSPVPMVTTAPLCHQGETMCEGNELTPINTTQTHLAPLAVVLGGVSLVTVSLNLLVLYAVKTDRKLHTVGNLYIVSLSVADLIVGAAVMPLNIMYLLEPPKTFGQPLCLFWLSMDYVASTASIFSVFILCVDRYRSVQQPLKYLKYRTKTRASTMISGAWLLSLLWIIPILGWRGAQGEKSGAGDTKCETGFHKVTWFKVMTAIINFYLPTFLMLWFYTKIYKAVRRHCQHRELINGSFRSFSEVKLMQDKKVCTKKQKKKPGPKSSGPPVDPSCHANNNLAPRQDPVVTLQPAEKSAKVVIKEQDGDVVVKEQDGEGVTQHCFPITIVQNQPPLEEAEGESVPAKRDQPSQENLAPATLEPSDTSDEHTFADLTSCQTDSESPVEPAAAPESQEQPKGPSGLGGYLKYTWKRLRSHSRQYLPALHMNRERKAAKQLGFIMAAFIICWIPYFVFFMVIAFCTDCCNENFHMFTIWLGYVNSTLNPLIYPLCNENFKKTFKRILHLRS
210,F6YL33,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,366,40908,MATSSHDSIWRQALIGLVLILLILITVLGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAACELGQACNFAKPLCKIYTSLDVMLCTASILNLFMISLDRYYAITAPLRYSMVVTPKRVVIALTLIWVISITFSFLPIHLEWNIQNLTNSNLTPYKCKLQVNKAYGLVDGLITFYVPLLVMCATYYRIFKIAREQAKRINHSYYNKAVTIREHKATVTLAVVMGAFIICWFPYFTVFVYRGIWGDIDETLEAIVLWLGYVNSALNPILYAALNRDFRTAYQCLFCCRRGAITSRGSSLSPTTSRRSRSQSHQVTLGLQEETSLRQAVQNGSEAPFPQESDNYGTSTLAGQSSGQFS
211,Q6U736,Druggable,Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13),OPN5 ,354,39727,MALNHTALPQDERLPHYLRDGDPFASKLSWEADLVAGFYLTIIGILSTFGNGYVLYMSSRRKKKLRPAEIMTINLAVCDLGISVVGKPFTIISCFCHRWVFGWIGCRWYGWAGFFFGCGSLITMTAVSLDRYLKICYLSYGVWLKRKHAYICLAAIWAYASFWTTMPLVGLGDYVPEPFGTSCTLDWWLAQASVGGQVFILNILFFCLLLPTAVIVFSYVKIIAKVKSSSKEVAHFDSRIHSSHVLEMKLTKVAMLICAGFLIAWIPYAVVSVWSAFGRPDSIPIQLSVVPTLLAKSAAMYNPIIYQVIDYKFACCQTGGLKATKKKSLEGFRLHTVTTVRKSSAVLEIHEEWE
212,F6Z8L3,Non Druggable,Histamine receptor H4,HRH4,395,45021,MMSATNSTNILSLSARVTLAFLMSLLAFAIVLGNAVVILAFVVDKNLRHRSNYFFLNLAISDFFVGMISIPLYIPYKMFDWKFGTKICAFWLIIDYLLCTASVYNIVLISYDRYQSVSNAISYRTQHTGILKIVAQMVAVWVLAFLVHGPVILVSESWKETEKGCEPGFFSQWYILVITSFLEFLVPVFSVAYFNMYIYWRLWKRGNLSRGPSHPGIASSVSSSNCGCSCKCRLFSSTSLPEVKEAGEAAAPLHSKKQGRKNSLFFSLRTQNSNIIASKMCSLSPSDSLLLRQKEQLELLKARKLAKSLAILLAVFVVCWAPYSLFTIVHSTYPSDQRPATIWYEIAFWLQWFNSFINPFLYPLCHKSFQRAFLKLFCRKKQPISSYNQSMSSQR
213,Q5BKX8,Druggable,Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein),CAVIN4 ,364,41899,MEHNGSASNADKIHQNRLSSVTEDEDQDAALTIVTVLDKVASIVDSVQASQKRIEERHREMENAIKSVQIDLLKLSQSHSNTGHIINKLFEKTRKVSAHIKDVKARVEKQQIHVKKVEVKQEEIMKKNKFRVVIFQEKFRCPTSLSVVKDRNLTENQEEDDDDIFDPPVDLSSDEEYYVEESRSARLRKSGKEHIDNIKKAFSKENMQKTRQNLDKKVNRIRTRIVTPERRERLRQSGERLRQSGERLRQSGERFKKSISNAAPSKEAFKMRSLRKGKDRTVAEGEECAREMGVDIIARSESLGPISELYSDELSEPEHEAARPVYPPHEGREIPTPEPLKVTFKSQVKVEDDESLLLDLKHSS
214,Q5J8X5,Druggable,Membrane-spanning 4-domains subfamily A member 13 (Testis-expressed transmembrane protein 4),MS4A13,152,17307,MIGIFHIFMWYFLLVLYMGQIKGAFGTYEPVTYKTGCTLWGIFFIIAGVFLIRVTKYPTRSGIISTLIINIICIITTITAVTLTIIELSHFNSVSYRNYGQAKLGREVSRILLFFYGLEFSIALTHSIYSCSNLFRRQNDLTSVTEEAESTP
215,Q5KU21,Druggable,G-protein coupled receptor,KPG_007,307,34152,MNSTTCNSTLTWPASVNNFFIIYSALLLVLGLLLNSVALWVFCYRMHQWTETRIYMTNLAVADLCLLCSLPFVLYSLKYSSSDTPVCQLSQGIYLANRYMSISLVTAIAVDRYVAVRHPLRARELRSPRQAAAVCVALWVIVVTSLVVRWRLGMQEGGFCFSSQTRRNFSTTAFSLLGFYLPLAIVVFCSLQVVTVLSRRPAADVGQAEATQKATHMVWANLAVFVICFLPLHVVLTVQVSLNLNTCAARDTFSRALSITGKLSDTNCCLDAICYYYMAREFQEASKPATSSNTPHKSQDSQILSLT
216,Q5T9L3,Druggable,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI) (Putative NF-kappa-B-activating protein 373),WLS,541,62253,MAGAIIENMSTKKLCIVGGILLVFQIIAFLVGGLIAPGPTTAVSYMSVKCVDARKNHHKTKWFVPWGPNHCDKIRDIEEAIPREIEANDIVFSVHIPLPHMEMSPWFQFMLFILQLDIAFKLNNQIRENAEVSMDVSLAYRDDAFAEWTEMAHERVPRKLKCTFTSPKTPEHEGRYYECDVLPFMEIGSVAHKFYLLNIRLPVNEKKKINVGIGEIKDIRLVGIHQNGGFTKVWFAMKTFLTPSIFIIMVWYWRRITMMSRPPVLLEKVIFALGISMTFINIPVEWFSIGFDWTWMLLFGDIRQGIFYAMLLSFWIIFCGEHMMDQHERNHIAGYWKQVGPIAVGSFCLFIFDMCERGVQLTNPFYSIWTTDIGTELAMAFIIVAGICLCLYFLFLCFMVFQVFRNISGKQSSLPAMSKVRRLHYEGLIFRFKFLMLITLACAAMTVIFFIVSQVTEGHWKWGGVTVQVNSAFFTGIYGMWNLYVFALMFLYAPSHKNYGEDQSNGDLGVHSGEELQLTTTITHVDGPTEIYKLTRKEAQE
217,F7C4E6,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,363,40533,MAPNGTASSFCLDSTACKITITVVLAVLILITIAGNVVVCLAVGLNRRLRNLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSVRSNASQLSRTQSREPRQQEDKPLKLQVWSGTEVTAPQGATDREFGE
218,F7D2C8,Non Druggable,G_PROTEIN_RECEP_F1_2 domain-containing protein,HRH3,429,48945,MERALPDGALNVSWGPSAGEAAAPGFSAAWTVVLAVLMALLIVATVVGNALVMLAFVVDSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGKWTFGRSFCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVAYRAQQGNTRQAVQKMVLVWVLAFLLYGPAILSWEYLSGESIIPEGECYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQKRTRDRLDVGREEPGRLFNHESETNPKFSLKCWEWEQKMPRETLNLHKYEAHPADKPDGARDSPTSSSNSSTHAPEKPRSLKRSYKPSASTSSLEKRMKMMSQSITQRFRLSRDKKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWVNSAVNPILYPLCHYSFRRAFMKLLCPKKLKIQPHNSLEHGWK
219,F7DVD0,Non Druggable,Histamine H1 receptor,HRH1,487,55607,MTFPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMRQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGGVKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPEEMKSPVVFSQEDDGEVDKLHCLPLDIVQMQTVAEGSSRDYAASNQSHGQLKMEEQGLNTHGASETSEDHMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFRKTFKKILHIRS
220,F8VUV1,Druggable,D(2) dopamine receptor (Dopamine D2 receptor),DRD2,442,50520,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
221,F8WAN1,Druggable,Cytospin-A,SPECC1L,911,101514,MKKASRSVGSVPKVSAISKTQTAEKIKPENSSSASTGGKLVKPGTAASLSKTKSSDDLLAGMAGGVTVTNGVKGKKSTCPSAAPSASAPAMTTVENKSKISTGTASSTKRSTSTGNKESSSTRERLRERTRLNQSKKLPSAGQGANDMALAKRSRSRTATECDVRMSKSKSDNQISDRAALEAKVKDLLTLAKTKDVEILHLRNELRDMRAQLGINEDHSEGDEKSEKETIMAHQPTDVESTLLQLQEQNTAIREELNQLKNENRMLKDRLNALGFSLEQRLDNSEKLFGYQSLSPEITPGNQSDGGGTLTSSVEGSAPGSVEDLLSQDENTLMDHQHSNSMDNLDSECSEVYQPLTSSDDALDAPSSSESEGIPSIERSRKGSSGNASEVSVACLTERIHQMEENQHSTSEELQATLQELADLQQITQELNSENERLGEEKVILMESLCQQSDKLEHFSRQIEYFRSLLDEHHISYVIDEDVKSGRYMELEQRYMDLAENARFEREQLLGVQQHLSNTLKMAEQDNKEAQEMIGALKERSHHMERIIESEQKGKAALAATLEEYKATVASDQIEMNRLKAQLENEKQKVAELYSIHNSGDKSDIQDLLESVRLDKEKAETLASSLQEDLAHTRNDANRLQDAIAKVEDEYRAFQEEAKKQIEDLNMTLEKLRSDLDEKETERSDMKETIFELEDEVEQHRAVKLHDNLIISDLENTVKKLQDQKHDMEREIKTLHRRLREESAEWRQFQADLQTAVVIANDIKSEAQEEIGDLKRRLHEAQEKNEKLTKELEEIKSRKQEEERGRVYNYMNAVERDLAALRQGMGLSRRSSTSSEPTPTVKTLIKSFDSASQVPNPAAAAIPRTPLSPSPMKTPPAAAVSPMQMESSSVAHAGMQWRDLGSLQPLPPGFK
222,G1KJV1,Non Druggable,Histamine H1 receptor,HRH1,483,55757,MCVNERETDKNSTQVQSVLGLVLGGISLTTVVMNILVLYAVKTEKKLQTVGNLYIVSLACADVIVGAAVMPLNIVYLLKDKWVLAREACLFWLSMDYVASTASIFSLFVLCIDRYHSVQQPLQYLKYRTKTRASVMISIAWLLSFMWVIPILGWHKFTHDNSTISRTNNETICETDFCKVTWFKVLTAMINFYVPSALMLWFYAKIYTTVRRHCQQREFVNGLFRSASDRTVVHNGKLQEIQQTYPQSLNKEVDCVMKGNNPNKRMEDQYPLSKFIKIPNGFQRGGDQEVGVVKLSCFPQTIAQDDMSIGRTDSKYAYVNDHIQNTESHCPQDYEFSKVSEELTFADRYSSRKNSNSTQEQDCSLGNCFSQHTNKKDSTSLQYLKKPWRRLRTHSISSQGLHGNKERKAAKQLGVIMVTFMLCWFPYFVLFLVMAYCGNCYNRTVHMFTIWLGYLNSTLNPIIYPLCNENFKKAFKKIFHIKF
223,G1MLN9,Non Druggable,Histamine H1 receptor,HRH1,512,58105,MAGENALETQGGDGREPQLEAALVPMTLPNSSCTFEDKMCEGNKTTIASPQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASVTILGAWFLSFLWIIPILGWHHFMSQSSGHRDDRCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDPDEMKSPGVFSQEEDREVDKLQCFPLNIVQVQTEAEGSGRSFVAIDQSQSPVGMDEQSLNMHVPNEMSEDQILGDSQSFSRTDSDTPTESTSGKGKPRSGSSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
224,G1N021,Non Druggable,Histamine H1 receptor,HRH1,436,50334,QLFISLITVVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVYLLNHVWTLGFTACLFWLSMDYVASTASIFSLFILCLDRYRSIQHPLKYLQYRTKMRASLVILGAWLLSSLWVIPILWWHDSANDEKRKGKAKCETEFSHVTWFKVLTAIVNFYLPSVIMLCLYCKIFRAVRKHCQQREVINGSYCSFSENKNVIHSKAKDKQNICLQKQSLHENTTHKDKQMSSECRSMAAKPLFINSDKSSKAFVSSSSNSKAFKSNGLTLTTAQSQPDLDKEGKKSMCVKKDNKNEEDPHLQDSDLSGASDSDTFTENVPSGENFRGLTYLRKTWQTLHTHSKRHLRRQHVSREWKAAKQLGVIMAAFMLCWIPYFVLYMVTVFQHREQFYKLHMFTIWLGYVNSTLNPFLYPLCNENFKKTFKKILHIQ
225,Q5TCQ9,Druggable,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",MAGI3 ,1481,162949,MSKTLKKKKHWLSKVQECAVSWAGPPGDFGAEIRGGAERGEFPYLGRLREEPGGGTCCVVSGKAPSPGDVLLEVNGTPVSGLTNRDTLAVIRHFREPIRLKTVKPGKVINKDLRHYLSLQFQKGSIDHKLQQVIRDNLYLRTIPCTTRAPRDGEVPGVDYNFISVEQFKALEESGALLESGTYDGNFYGTPKPPAEPSPFQPDPVDQVLFDNEFDAESQRKRTTSVSKMERMDSSLPEEEEDEDKEAINGSGNAENRERHSESSDWMKTVPSYNQTNSSMDFRNYMMRDETLEPLPKNWEMAYTDTGMIYFIDHNTKTTTWLDPRLCKKAKAPEDCEDGELPYGWEKIEDPQYGTYYVDHLNQKTQFENPVEEAKRKKQLGQVEIGSSKPDMEKSHFTRDPSQLKGVLVRASLKKSTMGFGFTIIGGDRPDEFLQVKNVLKDGPAAQDGKIAPGDVIVDINGNCVLGHTHADVVQMFQLVPVNQYVNLTLCRGYPLPDDSEDPVVDIVAATPVINGQSLTKGETCMNPQDFKPGAMVLEQNGKSGHTLTGDGLNGPSDASEQRVSMASSGSSQPELVTIPLIKGPKGFGFAIADSPTGQKVKMILDSQWCQGLQKGDIIKEIYHQNVQNLTHLQVVEVLKQFPVGADVPLLILRGGPPSPTKTAKMKTDKKENAGSLEAINEPIPQPMPFPPSIIRSGSPKLDPSEVYLKSKTLYEDKPPNTKDLDVFLRKQESGFGFRVLGGDGPDQSIYIGAIIPLGAAEKDGRLRAADELMCIDGIPVKGKSHKQVLDLMTTAARNGHVLLTVRRKIFYGEKQPEDDSSQAFISTQNGSPRLNRAEVPARPAPQEPYDVVLQRKENEGFGFVILTSKNKPPPGVIPHKIGRVIEGSPADRCGKLKVGDHISAVNGQSIVELSHDNIVQLIKDAGVTVTLTVIAEEEHHGPPSGTNSARQSPALQHRPMGQSQANHIPGDRSALEGEIGKDVSTSYRHSWSDHKHLAQPDTAVISVVGSRHNQNLGCYPVELERGPRGFGFSLRGGKEYNMGLFILRLAEDGPAIKDGRIHVGDQIVEINGEPTQGITHTRAIELIQAGGNKVLLLLRPGTGLIPDHGDWDINNPSSSNVIYDEQSPLPPSSHFASIFEESHVPVIEESLRVQICEKAEELKDIVPEKKSTLNENQPEIKHQSLLQKNVSKRDPPSSHGHSNKKNLLKVENGVTRRGRSVSPKKPASQHSEEHLDKIPSPLKNNPKRRPRDQSLSPSKGENKSCQVSTRAGSGQDQCRKSRGRSASPKKQQKIEGSKAPSNAEAKLLEGKSRRIAGYTGSNAEQIPDGKEKSDVIRKDAKQNQLEKSRTRSPEKKIKRMVEKSLPSKMTNKTTSKEVSENEKGKKVTTGETSSSNDKIGENVQLSEKRLKQEPEEKVVSNKTEDHKGKELEAADKNKETGRFKPESSSPVKKTLITPGPWKVPSGNKVTGTIGMAEKRQ
226,G1Q3X1,Non Druggable,Histamine H1 receptor,HRH1,487,55591,NDSPNSSSILEDKMCEGNKTTMASHQLIPLVVVLSTISLVTVGLNLLVLCAVRSERKLHTVGNLYIISLSVADLIVGAVVMPMNIIYLFMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLKYRTKTRASATILGAWFLSFLWIIPIQGWRHFMPHNLKPREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRRHCQHRELMNGSLPSFSEIKVKPENPKIGAMKPGKKSLWEVLKRKQKVAGGEPVSKSPSQDPNEMKSSGVYSQEEDEEVDKLHCFPLNIVQTQTEAEGSGKDYIAINQSQSQLEIDEQSLTIHGASEVSEDQTLGDSQSFSPADSDIPTESASGKGKPRSESSIGLDYIKFTWKRLRSHSRQYMSGLQLNRERKAAKQLGFIMAAFILCWSPYFIFFMVIAFCKSCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
227,G1SB86,Non Druggable,Histamine H1 receptor,HRH1,487,55551,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPVCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRLHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
228,Q68CZ1,Druggable,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),RPGRIP1L ,1315,151201,MSGPTDETAGDLPVKDTGLNLFGMGGLQETSTTRTMKSRQAVSRVSREELEDRFLRLHDENILLKQHARKQEDKIKRMATKLIRLVNDKKRYERVGGGPKRLGRDVEMEEMIEQLQEKVHELEKQNETLKNRLISAKQQLQTQGYRQTPYNNVQSRINTGRRKANENAGLQECPRKGIKFQDADVAETPHPMFTKYGNSLLEEARGEIRNLENVIQSQRGQIEELEHLAEILKTQLRRKENEIELSLLQLREQQATDQRSNIRDNVEMIKLHKQLVEKSNALSAMEGKFIQLQEKQRTLRISHDALMANGDELNMQLKEQRLKCCSLEKQLHSMKFSERRIEELQDRINDLEKERELLKENYDKLYDSAFSAAHEEQWKLKEQQLKVQIAQLETALKSDLTDKTEILDRLKTERDQNEKLVQENRELQLQYLEQKQQLDELKKRIKLYNQENDINADELSEALLLIKAQKEQKNGDLSFLVKVDSEINKDLERSMRELQATHAETVQELEKTRNMLIMQHKINKDYQMEVEAVTRKMENLQQDYELKVEQYVHLLDIRAARIHKLEAQLKDIAYGTKQYKFKPEIMPDDSVDEFDETIHLERGENLFEIHINKVTFSSEVLQASGDKEPVTFCTYAFYDFELQTTPVVRGLHPEYNFTSQYLVHVNDLFLQYIQKNTITLEVHQAYSTEYETIAACQLKFHEILEKSGRIFCTASLIGTKGDIPNFGTVEYWFRLRVPMDQAIRLYRERAKALGYITSNFKGPEHMQSLSQQAPKTAQLSSTDSTDGNLNELHITIRCCNHLQSRASHLQPHPYVVYKFFDFADHDTAIIPSSNDPQFDDHMYFPVPMNMDLDRYLKSESLSFYVFDDSDTQENIYIGKVNVPLISLAHDRCISGIFELTDHQKHPAGTIHVILKWKFAYLPPSGSITTEDLGNFIRSEEPEVVQRLPPASSVSTLVLAPRPKPRQRLTPVDKKVSFVDIMPHQSDETSPPPEDRKEISPEVEHIPEIEINMLTVPHVPKVSQEGSVDEVKENTEKMQQGKDDVSLLSEGQLAEQSLASSEDETEITEDLEPEVEEDMSASDSDDCIIPGPISKNIKQSLALSPGLGCSSAISAHCNFRLPGSSDFPASASQVDGITGACHHTQPSEKIRIEIIALSLNDSQVTMDDTIQRLFVECRFYSLPAEETPVSLPKPKSGQWVYYNYSNVIYVDKENNKAKRDILKAILQKQEMPNRSLRFTVVSDPPEDEQDLECEDIGVAHVDLADMFQEGRDLIEQNIDVFDARADGEGIGKLRVTVEALHALQSVYKQYRDDLEA
229,Q6GMV3,Druggable,Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1),PTRHD1 ,140,15805,MHRGVGPAFRVVRKMAASGAEPQVLVQYLVLRKDLSQAPFSWPAGALVAQACHAATAALHTHRDHPHTAAYLQELGRMRKVVLEAPDETTLKELAETLQQKNIDHMLWLEQPENIATCIALRPYPKEEVGQYLKKFRLFK
230,Q6LDH7,Druggable,D(2) dopamine receptor (Dopamine D2 receptor) (Fragment),DRD2,177,20091,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNA
231,G3GX48,Non Druggable,Histamine H1 receptor,Hrh1 ,489,55994,MSLPNVSSTFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMAKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQHPLRYLRYRTKTRASTTILGAWFLSFLWVIPILGWHHFMSPASELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRQHCQHRQLTNGSLPSFLEIKLKSEDVKEDTKKPGKESPWGVLKRPSRDTSGELEQKSTSKDPKNPNSPTVFSQEEDRETVSRHCFHLDVTRTHTVAEGGGRGSEANDQVLSQPKMDEQSLNTCRRISETSEDQTLVDRQSFSRTTDSDTSTEPGLGKDKLRSGSNSGLDYIKVTWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
232,G3SUW5,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,354,39604,MAPSDTPSSIASKITISVVLTILILITVAGNVIVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCNWSFGQIFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVTISLVFIWVISITLSFLSIHLGWNSRNKTIGSNHTTSQCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIARDQAKRINHISSWNSATIKEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDEAINEVIEAIVLWLGYANSALNPILYAALNRDFRTAYQQLFCCRSTSHNSRDTSLRFTDSQVSRSESRNHKGQEEKPLKLQVWSGTEVTAPQGATDR
233,Q5TCQ9,Druggable,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",MAGI3 ,1481,162949,MSKTLKKKKHWLSKVQECAVSWAGPPGDFGAEIRGGAERGEFPYLGRLREEPGGGTCCVVSGKAPSPGDVLLEVNGTPVSGLTNRDTLAVIRHFREPIRLKTVKPGKVINKDLRHYLSLQFQKGSIDHKLQQVIRDNLYLRTIPCTTRAPRDGEVPGVDYNFISVEQFKALEESGALLESGTYDGNFYGTPKPPAEPSPFQPDPVDQVLFDNEFDAESQRKRTTSVSKMERMDSSLPEEEEDEDKEAINGSGNAENRERHSESSDWMKTVPSYNQTNSSMDFRNYMMRDETLEPLPKNWEMAYTDTGMIYFIDHNTKTTTWLDPRLCKKAKAPEDCEDGELPYGWEKIEDPQYGTYYVDHLNQKTQFENPVEEAKRKKQLGQVEIGSSKPDMEKSHFTRDPSQLKGVLVRASLKKSTMGFGFTIIGGDRPDEFLQVKNVLKDGPAAQDGKIAPGDVIVDINGNCVLGHTHADVVQMFQLVPVNQYVNLTLCRGYPLPDDSEDPVVDIVAATPVINGQSLTKGETCMNPQDFKPGAMVLEQNGKSGHTLTGDGLNGPSDASEQRVSMASSGSSQPELVTIPLIKGPKGFGFAIADSPTGQKVKMILDSQWCQGLQKGDIIKEIYHQNVQNLTHLQVVEVLKQFPVGADVPLLILRGGPPSPTKTAKMKTDKKENAGSLEAINEPIPQPMPFPPSIIRSGSPKLDPSEVYLKSKTLYEDKPPNTKDLDVFLRKQESGFGFRVLGGDGPDQSIYIGAIIPLGAAEKDGRLRAADELMCIDGIPVKGKSHKQVLDLMTTAARNGHVLLTVRRKIFYGEKQPEDDSSQAFISTQNGSPRLNRAEVPARPAPQEPYDVVLQRKENEGFGFVILTSKNKPPPGVIPHKIGRVIEGSPADRCGKLKVGDHISAVNGQSIVELSHDNIVQLIKDAGVTVTLTVIAEEEHHGPPSGTNSARQSPALQHRPMGQSQANHIPGDRSALEGEIGKDVSTSYRHSWSDHKHLAQPDTAVISVVGSRHNQNLGCYPVELERGPRGFGFSLRGGKEYNMGLFILRLAEDGPAIKDGRIHVGDQIVEINGEPTQGITHTRAIELIQAGGNKVLLLLRPGTGLIPDHGDWDINNPSSSNVIYDEQSPLPPSSHFASIFEESHVPVIEESLRVQICEKAEELKDIVPEKKSTLNENQPEIKHQSLLQKNVSKRDPPSSHGHSNKKNLLKVENGVTRRGRSVSPKKPASQHSEEHLDKIPSPLKNNPKRRPRDQSLSPSKGENKSCQVSTRAGSGQDQCRKSRGRSASPKKQQKIEGSKAPSNAEAKLLEGKSRRIAGYTGSNAEQIPDGKEKSDVIRKDAKQNQLEKSRTRSPEKKIKRMVEKSLPSKMTNKTTSKEVSENEKGKKVTTGETSSSNDKIGENVQLSEKRLKQEPEEKVVSNKTEDHKGKELEAADKNKETGRFKPESSSPVKKTLITPGPWKVPSGNKVTGTIGMAEKRQ
234,Q6N075,Druggable,Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2),MFSD5 ,450,49765,MLVTAYLAFVGLLASCLGLELSRCRAKPPGRACSNPSFLRFQLDFYQVYFLALAADWLQAPYLYKLYQHYYFLEGQIAILYVCGLASTVLFGLVASSLVDWLGRKNSCVLFSLTYSLCCLTKLSQDYFVLLVGRALGGLSTALLFSAFEAWYIHEHVERHDFPAEWIPATFARAAFWNHVLAVVAGVAAEAVASWIGLGPVAPFVAAIPLLALAGALALRNWGENYDRQRAFSRTCAGGLRCLLSDRRVLLLGTIQALFESVIFIFVFLWTPVLDPHGAPLGIIFSSFMAASLLGSSLYRIATSKRYHLQPMHLLSLAVLIVVFSLFMLTFSTSPGQESPVESFIAFLLIELACGLYFPSMSFLRRKVIPETEQAGVLNWFRVPLHSLACLGLLVLHDSDRKTGTRNMFSICSAVMVMALLAVVGLFTVVRHDAELRVPSPTEEPYAPEL
235,Q6RW13,Druggable,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),AGTRAP,159,17419,MELPAVNLKVILLGHWLLTTWGCIVFSGSYAWANFTILALGVWAVAQRDSIDAISMFLGGLLATIFLDIVHISIFYPRVSLTDTGRFGVGMAILSLLLKPLSCCFVYHMYRERGGELLVHTGFLGSSQDRSAYQTIDSAEAPADPFAVPEGRSQDARGY
236,G3UCK0,Non Druggable,Histamine H1 receptor,HRH1,485,55157,MTLPNSSRVIEDKMCEGNKTTTDSPQLMPLVVVLSSISLVTVGLNLLVLYAIRNERKLHTVGNLYIVSLSVADLIVGAVVMPMNIIYLHRSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATIMGAWFLSFLWIIPILGWHRFISGGSKYQQDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELTDGSLPSFSEIRQRPENPKVGAKKPGRESFSEVLKRKCKDASGGPALKPPSQDPGEMKSPVVFSQEEDGEVAKLHGFPLNVVPIQTMVEEGGREYVAINQTQLEIDKQGLNTHGAGKTSEDQTLGKSQPFSKADLNTHTEPASGKGKLKSGPGTSLDYIKFTWKRLRSHSRQFVSGLHVNRERKAAKQLGFIMAAFIICWTPYFIFFMVIAFCESCFSERAHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIHC
237,G3V6X5,Non Druggable,Histamine H1 receptor,Hrh1,486,55693,MSFANTSSTFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFFSFLWVIPILGWHHFMPPAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPSFSELKLRSDDTKEGAKKPGRESPWGVLKRPSRDPSVGLDQKSTSEDPKMTSPTVFSQEGERETRPCFRLDIMQKQSMAEGDVRGSKANDQALSQPKMDEQSLNTCRRISETSEDQTLVDQQSFSRTTDSDTSIEPGPGRVKSRSGSNSGLDYIKITWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
238,G3XAL6,Druggable,"Coagulation factor II (Thrombin) receptor, isoform CRA_b (Proteinase-activated receptor 1)",F2R ,102,11276,MGPRRLLLVAACFSLCGPLLSARTRARRPVTFRWGVPPPSRAQPMPLWTRSWRVQPACHGVLDMEEDGAEAPWGSLQSCVALVIVFLPGPPPKRKALTLLHQ
239,G4XH60,Druggable,Purinergic receptor ,P2RY13,354,40819,MTAAIRRQRELSILPKVTLEAMNTTVMQGFNRSERCPRDTRIVQLVFPALYTVVFLTGILLNTLALWVFVHIPSSSTFIIYLKNTLVADLIMTLMLPFKILSDSHLAPWQLRAFVCRFSSVIFYETMYVGIVLLGLIAFDRFLKIIRPLRNIFLKKPVFAKTVSIFIWFFLFFISLPNMILSNKEATPSSVKKCASLKGPLGLKWHQMVNNICQFIFWTVFILMLVFYVVIAKKVYDSYRKSKSKDRKNNKKLEGKVFVVVAVFFVCFAPFHFARVPYTHSQTNNKTDCRLQNQLFIAKETTLFLAATNICMDPLIYIFLCKKFTEKLPCMQGRKTTASSQENHSSQTDNITLG
240,G7NYT3,Non Druggable,Histamine H1 receptor,HRH1,489,55821,MPMTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
241,H0XET7,Non Druggable,Histamine H1 receptor,HRH1,482,55044,MTLPNSSCIFEDNMCEGNKTTMASPQWMPLVVVLSTISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHRFMSNTSARRQDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKVGAKKPGKESSWEVLKMKLKDAGGGPVLKPPRRDSKEVKSPVSFSQEEDGEVAKGDITQMQIVEEADGEGYLAVTQSETQLEMDEQGLDTHGVRKISEDLVLGDSQSFSQTESDTPTGPAARKGKLKSGSNTALDYIKFTWKRFRAHSREYVSGLQLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCENCCNEHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
242,Q6NUP5,Druggable,Type-1 angiotensin II receptor,AGTR1,359,41089,MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKRAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
243,H0Z158,Non Druggable,Histamine H1 receptor,HRH1,486,54931,MTERPRPGRPLRFSLCEPAKKMSNNTTQASSNTPPALLGLLLGGISLVTIVMNILVLCAVKMEKKLQTVGNLYIVSLSIADLIVGAAVMPLNIVDLLSPAWPLGLEACLFWLSMDYVASTASIFNLFILCVDRYRSVQQPLKYLKYRTKMRASLLILGVWLLSFTWVIPILGWHLFANNGQRTVEENKCETEFFKVTWFKVLAAIFNFYLPSLLMLWFYCKIFRAVQKHCQHRELNNRSHWSSTEKNTVHQSKTKDDKNICLQEQILGENTPGADKKNSPETQKVEAELHFSHPDKASKALCDGKVLKWSCFSLTTAKAEPGLDKAGKRGACATKKPGDKEQPDCPDSDSSGASDNHTFTEVAPQAEPSPEGACLPQGSTRDSRGTTFLRQTWHALHSHSRSIHRHGNRDRKAAKQLGVIMAAFMICWIPYFVLFMVITFHDHKQLLELHRGTIWLGYINSTLNPFLYPLCNQNFKKTFKKILHIH
244,H2LIA2,Non Druggable,Muscarinic acetylcholine receptor,HRH1,544,62690,MDSGLSPSADLLHFNTNSCVNYSNTWRGLPHGDTLRHNHTLTLHDHLHNALLGVFLGLLSLLTVIMNLLVLYAVKKEKSLHTVGNLYIVSLSVADLIVGATVMPLNLVYLLEDEWRLGRTVCQFWLIMDYVASTASIFSLFILCLDRYRSVRQPLKYLKYRTRGKASVMICGAWLLSMTWIIPILGWRSFTHVDLKPEEESRCDTDFRFVTWFKVITAVFNFYVPSIMMVWFYTHIYLAVRQHLRDRERIIHPTDSFGEIENGENVPCPEGQKSKSPKTDIEDSIKRLKREKLLDQNTIEQTYSLEDSDKTKAAPFRAPRKIGVKCQQTSLLSMTTKRLRMVHKDKRPLEERHPCAETSLSPPSAPQDGTCSGGNPESKLQTSLNECHVTVPNSVSRVCDISQVSDMQRYSDVLYNSFDPSQALPWPEEGVDDAKIDPENGVTLRQAWHRFIDQSRHRIQSLRIHKEHKAAKQLGFIIAAFLLCWIPYFIAFMVMAFCKQCVHHDLHMFTIWLGYFNSTLNPFIYPLCNGNFKRVFKNIMKIHF
245,P05026,Druggable,Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1),ATP1B1 ,303,35061,MARGKAKEEGSWKKFIWNSEKKEFLGRTGGSWFKILLFYVIFYGCLAGIFIGTIQVMLLTISEFKPTYQDRVAPPGLTQIPQIQKTEISFRPNDPKSYEAYVLNIVRFLEKYKDSAQRDDMIFEDCGDVPSEPKERGDFNHERGERKVCRFKLEWLGNCSGLNDETYGYKEGKPCIIIKLNRVLGFKPKPPKNESLETYPVMKYNPNVLPVQCTGKRDEDKDKVGNVEYFGLGNSPGFPLQYYPYYGKLLQPKYLQPLLAVQFTNLTMDTEIRIECKAYGENIGYSEKDRFQGRFDVKIEVKS
246,H2QED2,Non Druggable,Histamine receptor H4,HRH4,390,44405,MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTADYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASLHSERQRRKSSLMFSSRTKMSSNTIAAKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLLSQHSRSVSS
247,H2R2N9,Non Druggable,Histamine receptor H3,HRH3,445,48643,MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
248,P05305,Druggable,Endothelin-1 (Preproendothelin-1) (PPET1) [Cleaved into: Endothelin-1 (ET-1); Big endothelin-1],EDN1,212,24425,MDYLLMIFSLLFVACQGAPETAVLGAELSAVGENGGEKPTPSPPWRLRRSKRCSCSSLMDKECVYFCHLDIIWVNTPEHVVPYGLGSPRSKRALENLLPTKATDRENRCQCASQKDKKCWNFCQAGKELRAEDIMEKDWNNHKKGKDCSKLGKKCIYQQLVRGRKIRRSSEEHLRQTRSETMRNSVKSSFHDPKLKGKPSRERYVTHNRAHW
249,H2R8F8,Non Druggable,Histamine H1 receptor,HRH1,487,55593,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLHCFPLDIVPMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
250,H9GIP4,Non Druggable,Histamine H2 receptor (Gastric receptor I),hrh2,420,47518,MNSTNVTDSSLHQVLIGITLTILVVVTVCGNVMVCLVVCFNRRLRSLTNCFIVSLAFTDLLLGLLVMPFSATYEISSHTWSMGITWCNIYISLDVMLCTASILNLFVISLDRYYAITAPLRYHSVVTPFRAGVALVLIWVVSLMVSFLPIHLGWNTNNTTIQNTHVMDRKQECMLEVNALYVLVDGLLTFYLPLVVMCITYYRIFKIAREQAQRINYTSCCTSTRNALPTLKEHKATVTLAAVMGAFIICWFPYFTVFMYRGIQGAVCETLMTIVLWLGYANSALNPILYAALNRDFRTAYQRLLRCRKVVPDARKIPLNQEMRDKTSNQTQCKLEDNSLQLHTMDEKGNSLVQDSLERNLNPARDKTSSAIVSCCQCFWLAKILPKKVVWIPVFEEPGANGQNTRQSSAQQRVIYCVVS
251,P05305,Druggable,Endothelin-1 (Preproendothelin-1) (PPET1) [Cleaved into: Endothelin-1 (ET-1); Big endothelin-1],EDN1,212,24425,MDYLLMIFSLLFVACQGAPETAVLGAELSAVGENGGEKPTPSPPWRLRRSKRCSCSSLMDKECVYFCHLDIIWVNTPEHVVPYGLGSPRSKRALENLLPTKATDRENRCQCASQKDKKCWNFCQAGKELRAEDIMEKDWNNHKKGKDCSKLGKKCIYQQLVRGRKIRRSSEEHLRQTRSETMRNSVKSSFHDPKLKGKPSRERYVTHNRAHW
252,I3L760,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,423,47237,MASNSTASSSCLDPLAFKVTVSLILILLIFITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVLIWVISITLSFLSIHLEWNSSRMDPSGVNHTISKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHNISSWRAATIREHKATVTLAAVMGAFIICWFPYFSVFVYRGLKGDEAVDETVEAIVLWLGYANSALNPILYAALNRDFRTAYQQLFRCSPTSHNAHRTPLRSNSSQLMRNQSQETRWQEERPLRLQVWSGAEVAAAQEATDRKPALSCTVCSNNLLSCCKSLWALRFLQRHVGGPSEEQPGEPLAEEPPKTPPQEAVRTLPSEAV
253,I3MPH4,Non Druggable,Histamine H1 receptor,HRH1,488,55871,MTLPNSSYVLEDKMCEGNKTTMASPQLMPLVVVLSSISLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLVMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWHHFMSHTSRRRDDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYFKIYKAVRRHCQHRELINGSLPTFSEIKQKPENSKVGPKKSEKESPWEAPKRESKDASGGPIFKPSFQDTKEKKSPDSLSQEEDGEAAKLPCFPLDLVETQTAAKGDGRGCEAVDKSQSQLKTEGQSLNTRRVSEISVDHTLVESQSIGRMTDSDTSTEPALGRDKLRSGSNPGLDYIKFTWKRLRSHSRQYISGLHVNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCESCCNEQVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
254,J7GQ11,Non Druggable,L-tyrosine decarboxylase (TDC) (EC 4.1.1.25),tdc,626,70507,MEKSNRSLKDLDLNALFIGDKAENGQLYKDLLNKLVDEHLGWRKNYIPSDPNMIGPEDQNSPAFKKTVGHMKTVLDQLSERIRTESVPWHSAGRYWGHMNSETLMPALLAYNYAMLWNGNNVAYESSPATSQMEEEVGQEFARLMGYDYGWGHIVADGSLANLEGLWYARNIKSLPFAMKEVNPELVAGKSDWELLNMPTKEIMDLLENAGSQIDEVKKRSARSGKNLQRLGKWLVPQTKHYSWMKAADIIGIGLDQVVPVPIDSNYRMDIQALESIIRKYAAEKTPILGVVGVAGSTEEGAVDGIDKIVALRQKLQKEGIYFYLHVDAAYGGYARALFLDEDDQFIPYKNLQKVHAENHVFTEDKEYIKPEVYAAYKAFDQAESITIDPHKMGYVPYSAGGIVIQDIRMRDTISYFATYVFEKGADIPALLGAYILEGSKAGATAASVWAAHHTLPLNVTGYGKLEGASIEGAHRYYDFLKNLKFEVAGKRISVHPLISPDFNMVDYVLKEDGNDDLIEMNRLNHAFYEQASYVKGSLYGKEYIVSHTDFAIPDYGDSPLAFVESLGFSEVEWRHAGKVTIIRASVMTPYMNQRENFDYFAPRIKKAIQADLEKVYASVNQKENV
255,K7ER80,Druggable,Thromboxane A2 receptor (Prostanoid TP receptor),TBXA2R,259,26672,MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGLHRPDSAAKPACHEPRRAAVPHHGEGAAHLLARGHLEPDPGPLGVYPVPPRRAPASPASPQHPAQVAVPPAPAHAALRAAVGSGQSAPPAPFRGALGPSDSPSACSEDSGAGGAGWTVGISSRVLG
256,K7EXK3,Non Druggable,Histamine H1 receptor,HRH1,482,54583,CPDFCSVTLGKKMCELNKNTTNNSTVTHPIPLGLVLGSISLITVIMNILVLYAVKTERKLQTVGNLYIVSLSVADLIVGAAVMPLNMMYLLKGKWVLGSLACLFWLSMDYVASTASIFSLFILCIDRYRSVQQPLNYLKYRTKTRALVMISGAWLISLLWIIPIQGWHAFANIRNRTVGEVTCETEFSQVTWFKVLTAIVNFYVPSLLMLWFYAKIYKAVRKHCQHRELINGSFRSFSENKSVHHKGQEKQKICHKKSNKDIPSSLLKGSSADPCCNVNLHFPQSKRMEAKLQLGSFDNCPNTLITEDDSKVVNRSCFPLAIAQTQSGPDKVGIKYVSVKKGPELSDTSDEHTFIEGVLCKNDSYSTLEPTSSAEDKTNKGLGYLKSTWLRLRTQSMQGVHLNREKKAAKQLGFIMAAFMLCWIPYFVLFMVIAYCQSCCNQGFYMFTIWLGYVNSTLNPFIYPLCNENFKTTFKKILHIHS
257,M3WE71,Non Druggable,Histamine receptor H4,HRH4,397,45519,MSASTNSTIALLPSTHIFLVFLMCLVAFAIMLGNAVVILAFVVDQKLRHRSNYFFLNLAIADFFVGMISIPLYIPHTLYGWSSESKLCVFWLTVDYLLCTTSVYNIVLISYDRYQSVSNAISYRTQHIGILKIVALMVAVWVLAFLVHGPIILVSESWNNSSVRVSEKKDCEPGFISKWYILAITSFLEFVVPVLSVAYFNIYIYWRLWKRGNLSRWQSQPGLTSPTPPNNCGPLLRGGLFSRTSLPELKETATSVPSKRHGRKRSLLFSLRAQTNTNIIASKMASLSHCDSLCLHQREHIELLRARKLAKSLAILLGVFAFCWAPYSLFTIIRSFLSPEQRPQTIWYEITFWLQWFNSLVNPFLYPLCHKHFQKAFLRIFHVKKQPIPTQNRSMSS
258,M3WUE0,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,387,43285,MVPNGTASSFCLDSPPCRITVSVVLAVLILITVAGNVVVCLAVGLNRRLRSLTNCYIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPIRVAVSLVLIWVISITLSFLSIHLGWNSRNETSNFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHIGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLRGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCGPASHNAHDTTLRSGSSQLARNQSREPTRQEDKPLKLQVWSGTEVTAPQGATDSLWDELPVCPLVTYICWDMTFHQSGRTRC
259,M3Z8R7,Non Druggable,Histamine H1 receptor,HRH1,487,55530,MTLPNSSCTFEDKMCEGNKTTIASPQLMPLVVVLSAISLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSWGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHHFMSQSSGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSDIKMKPENPKAGPKKSGKESPWEVLKRKSKDASGEPVLKPPSQDPEEMKSPGVFSREEDREVDKLPCFPLNIVQVQTEAEGSGRSYVAIDQSQGPLGMDEQSVNMHGANEISEDQIIGDSQSFSRTDSDTPTESASGKGKPRSASSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
260,O00180,Druggable,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),KCNK1 ,336,38143,MLQSLAGSSCVRLVERHRSAWCFGFLVLGYLLYLVFGAVVFSSVELPYEDLLRQELRKLKRRFLEEHECLSEQQLEQFLGRVLEASNYGVSVLSNASGNWNWDFTSALFFASTVLSTTGYGHTVPLSDGGKAFCIIYSVIGIPFTLLFLTAVVQRITVHVTRRPVLYFHIRWGFSKQVVAIVHAVLLGFVTVSCFFFIPAAVFSVLEDDWNFLESFYFCFISLSTIGLGDYVPGEGYNQKFRELYKIGITCYLLLGLIAMLVVLETFCELHELKKFRKMFYVKKDKDEDQVHIIEHDQLSFSSITDQAAGMKEDQKQNEPFVATQSSACVDGPANH
261,O00472,Druggable,RNA polymerase II elongation factor ELL2,ELL2,640,72324,MAAGGTGGLREEQRYGLSCGRLGQDNITVLHVKLTETAIRALETYQSHKNLIPFRPSIQFQGLHGLVKIPKNDPLNEVHNFNFYLSNVGKDNPQGSFDCIQQTFSSSGASQLNCLGFIQDKITVCATNDSYQMTRERMTQAEEESRNRSTKVIKPGGPYVGKRVQIRKAPQAVSDTVPERKRSTPMNPANTIRKTHSSSTISQRPYRDRVIHLLALKAYKKPELLARLQKDGVNQKDKNSLGAILQQVANLNSKDLSYTLKDYVFKELQRDWPGYSEIDRRSLESVLSRKLNPSQNAAGTSRSESPVCSSRDAVSSPQKRLLDSEFIDPLMNKKARISHLTNRVPPTLNGHLNPTSEKSAAGLPLPPAAAAIPTPPPLPSTYLPISHPPQIVNSNSNSPSTPEGRGTQDLPVDSFSQNDSIYEDQQDKYTSRTSLETLPPGSVLLKCPKPMEENHSMSHKKSKKKSKKHKEKDQIKKHDIETIEEKEEDLKREEEIAKLNNSSPNSSGGVKEDCTASMEPSAIELPDYLIKYIAIVSYEQRQNYKDDFNAEYDEYRALHARMETVARRFIKLDAQRKRLSPGSKEYQNVHEEVLQEYQKIKQSSPNYHEEKYRCEYLHNKLAHIKRLIGEFDQQQAESWS
55,A0A2K6ARN1,Non Druggable,Histamine H1 receptor,HRH1,487,55579,MTLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLTSKWLLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVVPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQQHCQHRELINGSLPSFSEIKLRPENPKVGTKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTAAEGSSRDCVADNQSHGQLKTDEQGLNTHEASEMPEDQMLGDSQSFSRTDSDTITETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILRIRS
262,O14745,Druggable,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),SLC9A3R1 ,358,38868,MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL
263,O15155,Druggable,BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18),BET1,118,13289,MRRAGLGEGVPPGNYGNYGYANSGYSACEEENERLTESLRSKVTAIKSLSIEIGHEVKTQNKLLAEMDSQFDSTTGFLGKTMGKLKILSRGSQTKLLCYMMLFSLFVFFIIYWIIKLR
264,O15354,Druggable,Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR),GPR37,613,67114,MRAPGALLARMSRLLLLLLLKVSASSALGVAPASRNETCLGESCAPTVIQRRGRDAWGPGNSARDVLRARAPREEQGAAFLAGPSWDLPAAPGRDPAAGRGAEASAAGPPGPPTRPPGPWRWKGARGQEPSETLGRGNPTALQLFLQISEEEEKGPRGAGISGRSQEQSVKTVPGASDLFYWPRRAGKLQGSHHKPLSKTANGLAGHEGWTIALPGRALAQNGSLGEGIHEPGGPRRGNSTNRRVRLKNPFYPLTQESYGAYAVMCLSVVIFGTGIIGNLAVMCIVCHNYYMRSISNSLLANLAFWDFLIIFFCLPLVIFHELTKKWLLEDFSCKIVPYIEVASLGVTTFTLCALCIDRFRAATNVQMYYEMIENCSSTTAKLAVIWVGALLLALPEVVLRQLSKEDLGFSGRAPAERCIIKISPDLPDTIYVLALTYDSARLWWYFGCYFCLPTLFTITCSLVTARKIRKAEKACTRGNKRQIQLESQMNCTVVALTILYGFCIIPENICNIVTAYMATGVSQQTMDLLNIISQFLLFFKSCVTPVLLFCLCKPFSRAFMECCCCCCEECIQKSSTVTSDDNDNEYTTELELSPFSTIRREMSTFASVGTHC
265,O43464,Non Druggable,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)",HTRA2 ,458,48841,MAAPRAGRGAGWSLRAWRALGGIRWGRRPRLTPDLRALLTSGTSDPRARVTYGTPSLWARLSVGVTEPRACLTSGTPGPRAQLTAVTPDTRTREASENSGTRSRAWLAVALGAGGAVLLLLWGGGRGPPAVLAAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVSSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTE
266,O43759,Druggable,Synaptogyrin-1,SYNGR1,233,25456,MEGGAYGAGKAGGAFDPYTLVRQPHTILRVVSWLFSIVVFGSIVNEGYLNSASEGEEFCIYNRNPNACSYGVAVGVLAFLTCLLYLALDVYFPQISSVKDRKKAVLSDIGVSAFWAFLWFVGFCYLANQWQVSKPKDNPLNEGTDAARAAIAFSFFSIFTWAGQAVLAFQRYQIGADSALFSQDYMDPSQDSSMPYAPYVEPTGPDPAGMGGTYQQPANTFDTEPQGYQSQGY
267,O60291,Druggable,E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1),MGRN1 ,552,60753,MGSILSRRIAGVEDIDIQANSAYRYPPKSGNYFASHFFMGGEKFDTPHPEGYLFGENMDLNFLGSRPVQFPYVTPAPHEPVKTLRSLVNIRKDSLRLVRYKDDADSPTEDGDKPRVLYSLEFTFDADARVAITIYCQASEEFLNGRAVYSPKSPSLQSETVHYKRGVSQQFSLPSFKIDFSEWKDDELNFDLDRGVFPVVIQAVVDEGDVVEVTGHAHVLLAAFEKHMDGSFSVKPLKQKQIVDRVSYLLQEIYGIENKNNQETKPSDDENSDNSNECVVCLSDLRDTLILPCRHLCLCTSCADTLRYQANNCPICRLPFRALLQIRAVRKKPGALSPVSFSPVLAQSLEHDEHSCPFKKSKPHPASLASKKPKRETNSDSVPPGYEPISLLEALNGLRAVSPAIPSAPLYEEITYSGISDGLSQASCPLAAIDHILDSSRQKGRPQSKAPDSTLRSPSSPIHEEDEEKLSEDVDAPPPLGGAELALRESSSPESFITEEVDESSSPQQGTRAASIENVLQDSSPEHCGRGPPADIYLPALGPDSCSVGIDE
268,P01019,Druggable,Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4],AGT ,476,52070,MAPAGVSLRATILCLLAWAGLAAGDRVYIHPFHLVIHNESTCEQLAKANAGKPKDPTFIPAPIQAKTSPVDEKALQDQLVLVAAKLDTEDKLRAAMVGMLANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTELDVAAEKIDRFMQAVTGWKTGCSLMGASVDSTLAFNTYVHFQGKMKGFSLLAEPQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFTESACLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHTELNLQKLSNDRIRVGEVLNSIFFELEADEREPTESTQQLNKPEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLSTA
269,P02768,Non Druggable,Albumin,ALB,609,69367,MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL
270,P04201,Druggable,Proto-oncogene Mas,MAS1 MAS,325,37465,MDGSNVTSFVVEEPTNISTGRNASVGNAHRQIPIVHWVIMSISPVGFVENGILLWFLCFRMRRNPFTVYITHLSIADISLLFCIFILSIDYALDYELSSGHYYTIVTLSVTFLFGYNTGLYLLTAISVERCLSVLYPIWYRCHRPKYQSALVCALLWALSCLVTTMEYVMCIDREEESHSRNDCRAVIIFIAILSFLVFTPLMLVSSTILVVKIRKNTWASHSSKLYIVIMVTIIIFLIFAMPMRLLYLLYYEYWSTFGNLHHISLLFSTINSSANPFIYFFVGSSKKKRFKESLKVVLTRAFKDEMQPRRQKDNCNTVTVETVV
271,P04899,Druggable,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),GNAI2,355,40451,MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEDGYSEEECRQYRAVVYSNTIQSIMAIVKAMGNLQIDFADPSRADDARQLFALSCTAEEQGVLPDDLSGVIRRLWADHGVQACFGRSREYQLNDSAAYYLNDLERIAQSDYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSAYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKITHSPLTICFPEYTGANKYDEAASYIQSKFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF
272,P07101,Non Druggable,Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH),TH TYH,528,58600,MPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTAAPAASYTPTPRSPRFIGRRQSLIEDARKEREAAVAAAAAAVPSEPGDPLEAVAFEEKEGKAVLNLLFSPRATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVRQVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG
273,P07550,Druggable,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),ADRB2 ,413,46459,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
274,P07550,Druggable,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),ADRB2 ,413,46459,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
275,P07602,Non Druggable,Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)],PSAP ,524,58113,MYALFLLASLLGAALAGPVLGLKECTRGSAVWCQNVKTASDCGAVKHCLQTVWNKPTVKSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIVDSYLPVILDIIKGEMSRPGEVCSALNLCESLQKHLAELNHQKQLESNKIPELDMTEVVAPFMANIPLLLYPQDGPRSKPQPKDNGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDEVKEMPMQTLVPAKVASKNVIPALELVEPIKKHEVPAKSDVYCEVCEFLVKEVTKLIDNNKTEKEILDAFDKMCSKLPKSLSEECQEVVDTYGSSILSILLEEVSPELVCSMLHLCSGTRLPALTVHVTQPKDGGFCEVCKKLVGYLDRNLEKNSTKQEILAALEKGCSFLPDPYQKQCDQFVAEYEPVLIEILVEVMDPSFVCLKIGACPSAHKPLLGTEKCIWGPSYWCQNTETAAQCNAVEHCKRHVWN
276,P07949,Druggable,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],RET ,1114,124319,MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAASTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS
277,P08311,Druggable,"Cathepsin G (CG) (EC 3.4.21.20) [Cleaved into: Cathepsin G, C-terminal truncated form]",CTSG,255,28837,MQPLLLLLAFLLPTGAEAGEIIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMRSFKLLDQMETPL
278,P08588,Druggable,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),ADRB1,477,51323,MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
279,P08588,Druggable,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),ADRB1 ,477,51323,MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
280,P08908,Druggable,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A),HTR1A ,422,46107,MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
281,P0DMS8,Druggable,Adenosine receptor A3,ADORA3,318,36185,MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSIINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
282,P0DMS9,Druggable,Transmembrane domain-containing protein TMIGD3,TMIGD3,266,30327,MEGSPAGPIEQKEARWESSWEEQPDWTLGCLSPESQFRIPGLPGCILSFQLKVCFLPVMWLFILLSLALISDAMVMDEKVKRSFVLDTASAICNYNAHYKNHPKYWCRGYFRDYCNIIAFSPNSTNHVALRDTGNQLIVTMSCLTKEDTGWYWCGIQRDFARDDMDFTELIVTDDKGTLANDFWSGKDLSGNKTRSCKAPKVVRKADRSRTSILIICILITGLGIISVISHLTKRRRSQRNRRVGNTLKPFSRVLTPKEMAPTEQM
283,P0DTQ4,Non Druggable,L-tyrosine decarboxylase (TDC) (TyrDC) (EC 4.1.1.25) (Levodopa decarboxylase) (L-dopa decarboxylase) (EC 4.1.1.-),tyrDC ,620,70053,MKNEKLAKGEMNLNALFIGDKAENGQLYKDLLIDLVDEHLGWRQNYMPQDMPVISSQERTSESYEKTVNHMKDVLNEISSRMRTHSVPWHTAGRYWGHMNSETLMPSLLAYNFAMLWNGNNVAYESSPATSQMEEEVGHEFAHLMSYKNGWGHIVADGSLANLEGLWYARNIKSLPFAMKEVKPELVAGKSDWELLNMPTKEIMDLLESAEDEIDEIKAHSARSGKHLQAIGKWLVPQTKHYSWLKAADIIGIGLDQVIPVPVDHNYRMDINELEKIVRGLAEEQIPVLGVVGVVGSTEEGAVDSIDKIIALRDELMKDGIYYYVHVDAAYGGYGRAIFLDEDNNFIPYEDLQDVHEEYGVFKEKKEHISREVYDAYKAIELAESVTIDPHKMGYIPYSAGGIVIQDIRMRDVISYFATYVFEKGADIPALLGAYILEGSKAGATAASVWAAHHVLPLNVAGYGKLIGASIEGSHHFYNFLNDLTFKVGDKEIEVHTLTHPDFNMVDYVFKEKGNDDLVAMNKLNHDVYDYASYVKGNIYNNEFITSHTDFAIPDYGNSPLKFVNSLGFSDEEWNRAGKVTVLRAAVMTPYMNDKEEFDVYAPKIQAALQEKLEQIYDVK
284,P11021,Druggable,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),HSPA5 ,654,72333,MKLSLVAAMLLLLSAARAEEEDKKEDVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSGDQDTGDLVLLDVCPLTLGIETVGGVMTKLIPRNTVVPTKKSQIFSTASDNQPTVTIKVYEGERPLTKDNHLLGTFDLTGIPPAPRGVPQIEVTFEIDVNGILRVTAEDKGTGNKNKITITNDQNRLTPEEIERMVNDAEKFAEEDKKLKERIDTRNELESYAYSLKNQIGDKEKLGGKLSSEDKETMEKAVEEKIEWLESHQDADIEDFKAKKKELEEIVQPIISKLYGSAGPPPTGEEDTAEKDEL
285,P12931,Druggable,Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src),SRC SRC1,536,59835,MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
286,P14138,Druggable,Endothelin-3 (ET-3) (Preproendothelin-3) (PPET3),EDN3,238,25454,MEPGLWLLFGLTVTSAAGFVPCSQSGDAGRRGVSQAPTAARSEGDCEETVAGPGEETVAGPGEGTVAPTALQGPSPGSPGQEQAAEGAPEHHRSRRCTCFTYKDKECVYYCHLDIIWINTPEQTVPYGLSNYRGSFRGKRSAGPLPGNLQLSHRPHLRCACVGRYDKACLHFCTQTLDVSSNSRTAEKTDKEEEGKVEVKDQQSKQALDLHHPKLMPGSGLALAPSTCPRCLFQEGAP
287,P14416,Druggable,D(2) dopamine receptor (Dopamine D2 receptor),DRD2,443,50619,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
288,P14416,Non Druggable,D(2) dopamine receptor (Dopamine D2 receptor),DRD2,443,50619,MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
289,P16389,Druggable,Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2),KCNA2,499,56717,MTVATGDPADEAAALPGHPQDTYDPEADHECCERVVINISGLRFETQLKTLAQFPETLLGDPKKRMRYFDPLRNEYFFDRNRPSFDAILYYYQSGGRLRRPVNVPLDIFSEEIRFYELGEEAMEMFREDEGYIKEEERPLPENEFQRQVWLLFEYPESSGPARIIAIVSVMVILISIVSFCLETLPIFRDENEDMHGSGVTFHTYSNSTIGYQQSTSFTDPFFIVETLCIIWFSFEFLVRFFACPSKAGFFTNIMNIIDIVAIIPYFITLGTELAEKPEDAQQGQQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGVILFSSAVYFAEADERESQFPSIPDAFWWAVVSMTTVGYGDMVPTTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETEGEEQAQYLQVTSCPKIPSSPDLKKSRSASTISKSDYMEIQEGVNNSNEDFREENLKTANCTLANTNYVNITKMLTDV
290,P16473,Druggable,Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R),TSHR ,764,86830,MRPADLLQLVLLLDLPRDLGGMGCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTLKKLPLSLSFLHLTRADLSYPSHCCAFKNQKKIRGILESLMCNESSMQSLRQRKSVNALNSPLHQEYEENLGDSIVGYKEKSKFQDTHNNAHYYVFFEEQEDEIIGFGQELKNPQEETLQAFDSHYDYTICGDSEDMVCTPKSDEFNPCEDIMGYKFLRIVVWFVSLLALLGNVFVLLILLTSHYKLNVPRFLMCNLAFADFCMGMYLLLIASVDLYTHSEYYNHAIDWQTGPGCNTAGFFTVFASELSVYTLTVITLERWYAITFAMRLDRKIRLRHACAIMVGGWVCCFLLALLPLVGISSYAKVSICLPMDTETPLALAYIVFVLTLNIVAFVIVCCCYVKIYITVRNPQYNPGDKDTKIAKRMAVLIFTDFICMAPISFYALSAILNKPLITVSNSKILLVLFYPLNSCANPFLYAIFTKAFQRDVFILLSKFGICKRQAQAYRGQRVPPKNSTDIQVQKVTHDMRQGLHNMEDVYELIENSHLTPKKQGQISEEYMQTVL
291,P16662,Druggable,"UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (UGT2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)",UGT2B7 ,529,60721,MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSASILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFGDITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTFEKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVLGRPTTLSETMGKADVWLIRNSWNFQFPYPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSGENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTMSSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAAHDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND
292,P17124,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40201,MISNGTGSSFCLDSPPCRITVSVVLTVLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSSFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHMGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHNAQETSLRSNSSQLARNQSREPMRQEEKPLKLQVWSGTEVTAPRGATDR
293,P20711,Non Druggable,Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC),DDC ,480,53926,MNASEFRRRGKEMVDYMANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE
294,P21333,Druggable,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),FLNA,2647,280739,MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP
295,P21333,Druggable,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),FLNA ,2647,280739,MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP
296,P21333,Druggable,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),FLNA ,2647,280739,MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP
297,P21554,Druggable,Cannabinoid receptor 1 (CB-R) (CB1) (CANN6),CNR1,472,52858,MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
298,P21728,Druggable,D(1A) dopamine receptor (Dopamine D1 receptor),DRD1,446,49293,MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
299,P21728,Non Druggable,D(1A) dopamine receptor (Dopamine D1 receptor),DRD1,446,49293,MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
300,P21731,Druggable,Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor),TBXA2R,343,37431,MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
301,P21917,Druggable,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),DRD4,419,43901,MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
302,P21917,Druggable,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),DRD4,419,43901,MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
303,P21917,Non Druggable,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),DRD4,419,43901,MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
304,P21918,Non Druggable,D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor),DRD5 ,477,52951,MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLLIIWTLLGNVLVCAAIVRSRHLRANMTNVFIVSLAVSDLFVALLVMPWKAVAEVAGYWPFGAFCDVWVAFDIMCSTASILNLCVISVDRYWAISRPFRYKRKMTQRMALVMVGLAWTLSILISFIPVQLNWHRDQAASWGGLDLPNNLANWTPWEEDFWEPDVNAENCDSSLNRTYAISSSLISFYIPVAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSSAACAPDTSLRASIKKETKVLKTLSVIMGVFVCCWLPFFILNCMVPFCSGHPEGPPAGFPCVSETTFDVFVWFGWANSSLNPVIYAFNADFQKVFAQLLGCSHFCSRTPVETVNISNELISYNQDIVFHKEIAAAYIHMMPNAVTPGNREVDNDEEEGPFDRMFQIYQTSPDGDPVAESVWELDCEGEISLDKITPFTPNGFH
305,P22309,Druggable,UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1),UGT1A1 ,533,59591,MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVLAPDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDSAMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLEFEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQREVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
306,P24530,Druggable,Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type),EDNRB ,442,49644,MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKSCLCCWCQSFEEKQSLEEKQSCLKFKANDHGYDNFRSSNKYSSS
307,P25021,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40098,MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDR
308,P25098,Druggable,Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2),GRK2 ,689,79574,MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL
309,P25100,Druggable,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a),ADRA1D ,572,60463,MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGDVNGTAAVGGLVVSAQGVGVGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERFCGITEEAGYAVFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEVVLRIHCRGAATGADGAHGMRSAKGHTFRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRRPLWRVYGHHWRASTSGLRQDCAPSSGDAPPGAPLALTALPDPDPEPPGTPEMQAPVASRRKPPSAFREWRLLGPFRRPTTQLRAKVSSLSHKIRAGGAQRAEAACAQRSEVEAVSLGVPHEVAEGATCQAYELADYSNLRETDI
310,P25101,Druggable,Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR),EDNRA ,427,48722,METLCLRASFWLALVGCVISDNPERYSTNLSNHVDDFTTFRGTELSFLVTTHQPTNLVLPSNGSMHNYCPQQTKITSAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLVTAIEIVSIWILSFILAIPEAIGFVMVPFEYRGEQHKTCMLNATSKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYNEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCYQSKSLMTSVPMNGTSIQWKNHDQNNHNTDRSSHKDSMN
311,P25102,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Hrh2,358,40253,MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
312,P25116,Druggable,Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor),F2R ,425,47441,MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT
313,P25788,Druggable,Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),PSMA3 ,255,28433,MSSIGTGYDLSASTFSPDGRVFQVEYAMKAVENSSTAIGIRCKDGVVFGVEKLVLSKLYEEGSNKRLFNVDRHVGMAVAGLLADARSLADIAREEASNFRSNFGYNIPLKHLADRVAMYVHAYTLYSAVRPFGCSFMLGSYSVNDGAQLYMIDPSGVSYGYWGCAIGKARQAAKTEIEKLQMKEMTCRDIVKEVAKIIYIVHDEVKDKAFELELSWVGELTNGRHEIVPKDIREEAEKYAKESLKEEDESDDDNM
314,P28223,Druggable,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),HTR2A ,471,52603,MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
315,P30546,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,491,55957,MTCPNSSCVFEDKMCQGNKTAPANDAQLTPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLMSRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILGWRHFQPKTPEPREDKCETDFYNVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDMKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSPGVFSQEKEEKDGELGKFYCFPLDTVQAQPEAEGSGRGYATINQSQNQLEMGEQGLSMPGAKEALEDQILGDSQSFSRTDSDTPAEPAPAKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIICWIPYFIFFMVIAFCESCCNQHVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
316,P30556,Druggable,Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1),AGTR1 ,359,41061,MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
317,P30793,Non Druggable,GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I),GCH1 ,250,27903,MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRSEEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDAIFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQVQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKTREEFLTLIRS
318,P31389,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,488,55620,MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
319,P29274,Druggable,Adenosine receptor A2a,ADORA2A ,412,44707,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
320,P31390,Non Druggable,Histamine H1 receptor (H1R) (HH1R),Hrh1,486,55693,MSFANTSSTFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFFSFLWVIPILGWHHFMPPAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPSFSELKLRSDDTKEGAKKPGRESPWGVLKRPSRDPSVGLDQKSTSEDPKMTSPTVFSQEGERETRPCFRLDIMQKQSVAEGDVRGSKANDQALSQPKMDEQSLNTCRRISETSEDQTLVDQQSFSRTTDSDTSIEPGPGRVKSRSGSNSGLDYIKITWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPMHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
321,P31930,Non Druggable,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",UQCRC1,480,52646,MAASVVCRAATAGAQVLLRARRSPALLRTPALRSTATFAQALQFVPETQVSLLDNGLRVASEQSSQPTCTVGVWIDVGSRFETEKNNGAGYFLEHLAFKGTKNRPGSALEKEVESMGAHLNAYSTREHTAYYIKALSKDLPKAVELLGDIVQNCSLEDSQIEKERDVILREMQENDASMRDVVFNYLHATAFQGTPLAQAVEGPSENVRKLSRADLTEYLSTHYKAPRMVLAAAGGVEHQQLLDLAQKHLGGIPWTYAEDAVPTLTPCRFTGSEIRHRDDALPFAHVAIAVEGPGWASPDNVALQVANAIIGHYDCTYGGGVHLSSPLASGAVANKLCQSFQTFSICYAETGLLGAHFVCDRMKIDDMMFVLQGQWMRLCTSATESEVARGKNILRNALVSHLDGTTPVCEDIGRSLLTYGRRIPLAEWESRIAEVDASVVREICSKYIYDQCPAVAGYGPIEQLPDYNRIRSGMFWLRF
322,P32121,Druggable,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),ARRB2,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
323,P32121,Druggable,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),ARRB2 ,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
324,P32121,Druggable,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),ARRB2 ,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
325,P32121,Druggable,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),ARRB2 ,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
326,P32121,Druggable,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),ARRB2 ,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
327,P32298,Druggable,G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1),GRK4 ,578,66583,MELENIVANSLLLKARQGGYGKKSGRSKKWKEILTLPPVSQCSELRHSIEKDYSSLCDKQPIGRRLFRQFCDTKPTLKRHIEFLDAVAEYEVADDEDRSDCGLSILDRFFNDKLAAPLPEIPPDVVTECRLGLKEENPSKKAFEECTRVAHNYLRGEPFEEYQESSYFSQFLQWKWLERQPVTKNTFRHYRVLGKGGFGEVCACQVRATGKMYACKKLQKKRIKKRKGEAMALNEKRILEKVQSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNLGNPGFDEQRAVFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLATEIPEGQRVRGRVGTVGYMAPEVVNNEKYTFSPDWWGLGCLIYEMIQGHSPFKKYKEKVKWEEVDQRIKNDTEEYSEKFSEDAKSICRMLLTKNPSKRLGCRGEGAAGVKQHPVFKDINFRRLEANMLEPPFCPDPHAVYCKDVLDIEQFSVVKGIYLDTADEDFYARFATGCVSIPWQNEMIESGCFKDINKSESEEALPLDLDKNIHTPVSRPNRGFFYRLFRRGGCLTMVPSEKEVEPKQC
328,P35348,Druggable,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c),ADRA1A ,466,51487,MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
329,P35367,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,487,55784,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
330,P35368,Druggable,Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor),ADRA1B,520,56836,MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF
331,P35408,Druggable,Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor),PTGER4 ,488,53119,MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI
332,P35414,Druggable,Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11),APLNR ,380,42660,MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRSSREKRRSADIFIASLAVADLTFVVTLPLWATYTYRDYDWPFGTFFCKLSSYLIFVNMYASVFCLTGLSFDRYLAIVRPVANARLRLRVSGAVATAVLWVLAALLAMPVMVLRTTGDLENTTKVQCYMDYSMVATVSSEWAWEVGLGVSSTTVGFVVPFTIMLTCYFFIAQTIAGHFRKERIEGLRKRRRLLSIIVVLVVTFALCWMPYHLVKTLYMLGSLLHWPCDFDLFLMNIFPYCTCISYVNSCLNPFLYAFFDPRFRQACTSMLCCGQSRCAGTSHSSSGEKSASYSSGHSQGPGPNMGKGGEQMHEKSIPYSQETLVVD
333,P35462,Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,400,44195,MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
334,P35462,Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,400,44195,MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
335,P35462,Non Druggable,D(3) dopamine receptor (Dopamine D3 receptor),DRD3,400,44195,MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
336,P43699,Non Druggable,Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP),NKX2-1 ,371,38596,MSMSPKHTTPFSVSDILSPLEESYKKVGMEGGGLGAPLAAYRQGQAAPPTAAMQQHAVGHHGAVTAAYHMTAAGVPQLSHSAVGGYCNGNLGNMSELPPYQDTMRNSASGPGWYGANPDPRFPAISRFMGPASGMNMSGMGGLGSLGDVSKNMAPLPSAPRRKRRVLFSQAQVYELERRFKQQKYLSAPEREHLASMIHLTPTQVKIWFQNHRYKMKRQAKDKAAQQQLQQDSGGGGGGGGTGCPQQQQAQQQSPRRVAVPVLVKDGKPCQAGAPAPGAASLQGHAQQQAQHQAQAAQAAAAAISVGSGGAGLGAHPGHQPGSAGQSPDLAHHAASPAALQGQVSSLSHLNSSGSDYGTMSCSTLLYGRTW
337,P45880,Druggable,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),VDAC2,294,31567,MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQGLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTEFGGSIYQKVCEDLDTSVNLAWTSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINAGGHKVGLALELEA
338,P46059,Non Druggable,"Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)",SLC15A1 ,708,78806,MGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDNLSTAIYHTFVALCYLTPILGALIADSWLGKFKTIVSLSIVYTIGQAVTSVSSINDLTDHNHDGTPDSLPVHVVLSLIGLALIALGTGGIKPCVSAFGGDQFEEGQEKQRNRFFSIFYLAINAGSLLSTIITPMLRVQQCGIHSKQACYPLAFGVPAALMAVALIVFVLGSGMYKKFKPQGNIMGKVAKCIGFAIKNRFRHRSKAFPKREHWLDWAKEKYDERLISQIKMVTRVMFLYIPLPMFWALFDQQGSRWTLQATTMSGKIGALEIQPDQMQTVNAILIVIMVPIFDAVLYPLIAKCGFNFTSLKKMAVGMVLASMAFVVAAIVQVEIDKTLPVFPKGNEVQIKVLNIGNNTMNISLPGEMVTLGPMSQTNAFMTFDVNKLTRINISSPGSPVTAVTDDFKQGQRHTLLVWAPNHYQVVKDGLNQKPEKGENGIRFVNTFNELITITMSGKVYANISSYNASTYQFFPSGIKGFTISSTEIPPQCQPNFNTFYLEFGSAYTYIVQRKNDSCPEVKVFEDISANTVNMALQIPQYFLLTCGEVVFSVTGLEFSYSQAPSNMKSVLQAGWLLTVAVGNIIVLIVAGAGQFSKQWAEYILFAALLLVVCVIFAIMARFYTYINPAEIEAQFDEDEKKNRLEKSNPYFMSGANSQKQM
339,P46734,Druggable,Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2),MAP2K3 ,347,39318,MESPASSQPASMPQSKGKSKRKKDLRISCMSKPPAPNPTPPRNLDSRTFITIGDRNFEVEADDLVTISELGRGAYGVVEKVRHAQSGTIMAVKRIRATVNSQEQKRLLMDLDINMRTVDCFYTVTFYGALFREGDVWICMELMDTSLDKFYRKVLDKNMTIPEDILGEIAVSIVRALEHLHSKLSVIHRDVKPSNVLINKEGHVKMCDFGISGYLVDSVAKTMDAGCKPYMAPERINPELNQKGYNVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPADRFSPEFVDFTAQCLRKNPAERMSYLELMEHPFFTLHKTKKTDIAAFVKEILGEDS
340,P46934,Druggable,E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4),NEDD4 ,1319,149114,MAQSLRLHFAARRSNTYPLSETSGDDLDSHVHMCFKRPTRISTSNVVQMKLTPRQTALAPLIKENVQSQERSSVPSSENVNKKSSCLQISLQPTRYSGYLQSSNVLADSDDASFTCILKDGIYSSAVVDNELNAVNDGHLVSSPAICSGSLSNFSTSDNGSYSSNGSDFGSCASITSGGSYTNSVISDSSSYTFPPSDDTFLGGNLPSDSTSNRSVPNRNTTPCEIFSRSTSTDPFVQDDLEHGLEIMKLPVSRNTKIPLKRYSSLVIFPRSPSTTRPTSPTSLCTLLSKGSYQTSHQFIISPSEIAHNEDGTSAKGFLSTAVNGLRLSKTICTPGEVRDIRPLHRKGSLQKKIVLSNNTPRQTVCEKSSEGYSCVSVHFTQRKAATLDCETTNGDCKPEMSEIKLNSDSEYIKLMHRTSACLPSSQNVDCQININGELERPHSQMNKNHGILRRSISLGGAYPNISCLSSLKHNCSKGGPSQLLIKFASGNEGKVDNLSRDSNRDCTNELSNSCKTRDDFLGQVDVPLYPLPTENPRLERPYTFKDFVLHPRSHKSRVKGYLRLKMTYLPKTSGSEDDNAEQAEELEPGWVVLDQPDAACHLQQQQEPSPLPPGWEERQDILGRTYYVNHESRRTQWKRPTPQDNLTDAENGNIQLQAQRAFTTRRQISEETESVDNRESSENWEIIREDEATMYSNQAFPSPPPSSNLDVPTHLAEELNARLTIFGNSAVSQPASSSNHSSRRGSLQAYTFEEQPTLPVLLPTSSGLPPGWEEKQDERGRSYYVDHNSRTTTWTKPTVQATVETSQLTSSQSSAGPQSQASTSDSGQQVTQPSEIEQGFLPKGWEVRHAPNGRPFFIDHNTKTTTWEDPRLKIPAHLRGKTSLDTSNDLGPLPPGWEERTHTDGRIFYINHNIKRTQWEDPRLENVAITGPAVPYSRDYKRKYEFFRRKLKKQNDIPNKFEMKLRRATVLEDSYRRIMGVKRADFLKARLWIEFDGEKGLDYGGVAREWFFLISKEMFNPYYGLFEYSATDNYTLQINPNSGLCNEDHLSYFKFIGRVAGMAVYHGKLLDGFFIRPFYKMMLHKPITLHDMESVDSEYYNSLRWILENDPTELDLRFIIDEELFGQTHQHELKNGGSEIVVTNKNKKEYIYLVIQWRFVNRIQKQMAAFKEGFFELIPQDLIKIFDENELELLMCGLGDVDVNDWREHTKYKNGYSANHQVIQWFWKAVLMMDSEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQSFTVEQWGTPEKLPRAHTCFNRLDLPPYESFEELWDKLQMAIENTQGFDGVD
341,P47747,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40557,MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
342,P48230,Druggable,Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein) (IL-TMP),TM4SF4 ,202,21396,MCTGGCARCLGGTLIPLAFFGFLANILLFFPGGKVIDDNDHLSQEIWFFGGILGSGVLMIFPALVFLGLKNNDCCGCCGNEGCGKRFAMFTSTIFAVVGFLGAGYSFIISAISINKGPKCLMANSTWGYPFHDGDYLNDEALWNKCREPLNVVPWNLTLFSILLVVGGIQMVLCAIQVVNGLLGTLCGDCQCCGCCGGDGPV
343,P49407,Druggable,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),ARRB1 ,418,47066,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR
344,P51149,Druggable,Ras-related protein Rab-7a (EC 3.6.5.2),RAB7A ,207,23490,MTSRKKVLLKVIILGDSGVGKTSLMNQYVNKKFSNQYKATIGADFLTKEVMVDDRLVTMQIWDTAGQERFQSLGVAFYRGADCCVLVFDVTAPNTFKTLDSWRDEFLIQASPRDPENFPFVVLGNKIDLENRQVATKRAQAWCYSKNNIPYFETSAKEAINVEQAFQTIARNALKQETEVELYNEFPEPIKLDKNDRAKASAESCSC
345,P54849,Druggable,Epithelial membrane protein 1 (EMP-1) (CL-20) (Protein B4B) (Tumor-associated membrane protein),EMP1 ,157,17563,MLVLLAGIFVVHIATVIMLFVSTIANVWLVSNTVDASVGLWKNCTNISCSDSLSYASEDALKTVQAFMILSIIFCVIALLVFVFQLFTMEKGNRFFLSGATTLVCWLCILVGVSIYTSHYANRDGTQYHHGYSYILGWICFCFSFIIGVLYLVLRKK
346,P55085,Druggable,"Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]",F2RL1 ,397,44126,MRSPSAAWLLGAAILLAASLSCSGTIQGTNRSSKGRSLIGKVDGTSHVTGKGVTVETVFSVDEFSASVLTGKLTTVFLPIVYTIVFVVGLPSNGMALWVFLFRTKKKHPAVIYMANLALADLLSVIWFPLKIAYHIHGNNWIYGEALCNVLIGFFYGNMYCSILFMTCLSVQRYWVIVNPMGHSRKKANIAIGISLAIWLLILLVTIPLYVVKQTIFIPALNITTCHDVLPEQLLVGDMFNYFLSLAIGVFLFPAFLTASAYVLMIRMLRSSAMDENSEKKRKRAIKLIVTVLAMYLICFTPSNLLLVVHYFLIKSQGQSHVYALYIVALCLSTLNSCIDPFVYYFVSHDFRDHAKNALLCRSVRTVKQMQVSLTSKKHSRKSSSYSSSSTTVKTSY
347,P57771,Druggable,Regulator of G-protein signaling 8 (RGS8),RGS8,180,20917,MAALLMPRRNKGMRTRLGCLSHKSDSCSDFTAILPDKPNRALKRLSTEEATRWADSFDVLLSHKYGVAAFRAFLKTEFSEENLEFWLACEEFKKTRSTAKLVSKAHRIFEEFVDVQAPREVNIDFQTREATRKNLQEPSLTCFDQAQGKVHSLMEKDSYPRFLRSKMYLDLLSQSQRRLS
348,P58406,Non Druggable,Histamine H3 receptor (H3R) (HH3R),Hrh3,445,48541,MERAPPDGLMNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVETGEAGLGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
349,P60021,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40098,MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDR
350,P61752,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40098,MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDR
351,P63244,Druggable,"Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",RACK1 ,317,35077,MTEQMTLRGTLKGHNGWVTQIATTPQFPDMILSASRDKTIIMWKLTRDETNYGIPQRALRGHSHFVSDVVISSDGQFALSGSWDGTLRLWDLTTGTTTRRFVGHTKDVLSVAFSSDNRQIVSGSRDKTIKLWNTLGVCKYTVQDESHSEWVSCVRFSPNSSNPIIVSCGWDKLVKVWNLANCKLKTNHIGHTGYLNTVTVSPDGSLCASGGKDGQAMLWDLNEGKHLYTLDGGDIINALCFSPNRYWLCAATGPSIKIWDLEGKIIVDELKQEVISTSSKAEPPQCTSLAWSADGQTLFAGYTDNLVRVWQVTIGTR
352,P70174,Non Druggable,Histamine H1 receptor (H1R) (HH1R),Hrh1 ,488,55682,MSLPNTSSASEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFLSFLWVIPILGWHHFTPLAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPTFLEIKLRSEDAKEGAKKPGKESPWGVQKRPSRDPTGGLDQKSTSEDPKVTSPTVFSQEGERETVTRPCFRLDVMQTQPVPEGDARGSKANDQTLSQPKMDEQSLSTCRRISETSEDQTLVDRQSFSRTTDSDTSIEPGLGKVKARSRSNSGLDYIKVTWKRLRSHSRQYVSGLHLNRERKAAKQLGCIMAAFILCWIPYFIFFMVIAFCNSCCSEPVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
353,P81030,Non Druggable,Muscarinic toxin 1 (MT1) (MTx1),,66,7518,LTCVTSKSIFGITTENCPDGQNLCFKKWYYIVPRYSDITWGCAATCPKPTNVRETIRCCETDKCNE
354,P86419,Non Druggable,Rho-elapitoxin-Da1b (Rho-Da1b) (Rho-EPTX-Da1b),,66,7521,LTCVTKDTIFGITTQNCPAGQNLCFIRRHYINHRYTEITRGCTATCPKPTNVRETIHCCNTDKCNE
355,P86434,Druggable,Putative uncharacterized protein ADORA2A-AS1 (ADORA2A antisense RNA 1) (ADORA2A antisense gene protein 1),ADORA2A,159,17238,MEQDWQPGEEVTPGPEPCSKGQAPLYPIVHVTELKHTDPNFPSNSNAVGTSSGWNRIGTGCSHTWDWRFSCTQQALLPLLGAWEWSIDTEAGGGRREQSQKPCSNGGPAAAGEGRVLPSPCFPWSTCQAAIHKVCRWQGCTRPALLAPSLATLKEHSYP
356,P97292,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Hrh2,397,44794,MEPNGTVHSCCLDSIALKVTISVVLTTLIFITVAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVMPFSAIYQLSFKWSFGQVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGMVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIVCWFPYFTAFVYRGLRGDDAVNEVVEGIVLWLGYANSALNPILYATLNRDFRMAYQQLFHCKLASHNSHKTSLRLNNSLLSRSQSREGRWQEEKPLKLQVWSGTELTHPQGSPVRTRLSHSSCLLSLSLLSFIWKLGTWIHHRRPFQPSLHISA
357,Q01650,Non Druggable,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),SLC7A5 ,507,55010,MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNITLLNGVAIIVGTIIGSGIFVTPTGVLKEAGSPGLALVVWAACGVFSIVGALCYAELGTTISKSGGDYAYMLEVYGSLPAFLKLWIELLIIRPSSQYIVALVFATYLLKPLFPTCPVPEEAAKLVACLCVLLLTAVNCYSVKAATRVQDAFAAAKLLALALIILLGFVQIGKGDVSNLDPNFSFEGTKLDVGNIVLALYSGLFAYGGWNYLNFVTEEMINPYRNLPLAIIISLPIVTLVYVLTNLAYFTTLSTEQMLSSEAVAVDFGNYHLGVMSWIIPVFVGLSCFGSVNGSLFTSSRLFFVGSREGHLPSILSMIHPQLLTPVPSLVFTCVMTLLYAFSKDIFSVINFFSFFNWLCVALAIIGMIWLRHRKPELERPIKVNLALPVFFILACLFLIAVSFWKTPVECGIGFTIILSGLPVYFFGVWWKNKPKWLLQGIFSTTVLCQKLMQVVPQET
358,Q01959,Druggable,Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3),SLC6A3 ,620,68495,MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV
359,Q71UN9,Druggable,Prostanoid FP receptor (Fragment),PTGFR,13,1439,CWSPFLVTMANIG
360,Q76MS7,Non Druggable,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),HRH2,359,40098,MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDR
361,Q7KZ00,Druggable,Endothelin receptor subtype B1 (Fragment),ETB1,17,2093,SIDSLKYNSIFIFRYRA
362,Q7Z6G3,Druggable,N-terminal EF-hand calcium-binding protein 2 (EF-hand calcium-binding protein 2) (Neuronal calcium-binding protein 2) (Synaptotagmin-interacting protein 2) (Stip-2),NECAB2 ,386,43194,MCERAARLCRAGAHRLLREPPQQGRALGGLLRWVGARMGEPRESLAPAAPADPGPASPRGGTAVILDIFRRADKNDDGKLSLEEFQLFFADGVLNEKELEDLFHTIDSDNTNHVDTKELCDYFVDHMGDYEDVLASLETLNHSVLKAMGYTKKVYEGGSNVDQFVTRFLLKETANQIQSLLSSVESAVEAIEEQTSQLRQNHIKPSHSAAQTWCGSPTPASAPNHKLMAMEQGKTLPSATEDAKEEGLEAQISRLAELIGRLESKALWFDLQQRLSDEDGTNMHLQLVRQEMAVCPEQLSEFLDSLRQYLRGTTGVRNCFHITAVRLSDGFTFVIYEFWETEEAWKRHLQSPLCKAFRHVKVDTLSQPEALSRILVPAAWCTVGRD
363,Q838D6,Non Druggable,L-tyrosine decarboxylase (TDC) (EC 4.1.1.25) (Levodopa decarboxylase) (L-dopa decarboxylase) (EC 4.1.1.-),tdc ,620,70053,MKNEKLAKGEMNLNALFIGDKAENGQLYKDLLIDLVDEHLGWRQNYMPQDMPVISSQERTSESYEKTVNHMKDVLNEISSRMRTHSVPWHTAGRYWGHMNSETLMPSLLAYNFAMLWNGNNVAYESSPATSQMEEEVGHEFAHLMSYKNGWGHIVADGSLANLEGLWYARNIKSLPFAMKEVKPELVAGKSDWELLNMPTKEIMDLLESAEDEIDEIKAHSARSGKHLQAIGKWLVPQTKHYSWLKAADIIGIGLDQVIPVPVDHNYRMDINELEKIVRGLAEEQIPVLGVVGVVGSTEEGAVDSIDKIIALRDELMKDGIYYYVHVDAAYGGYGRAIFLDEDNNFIPYEDLQDVHEEYGVFKEKKEHISREVYDAYKAIELAESVTIDPHKMGYIPYSAGGIVIQDIRMRDVISYFATYVFEKGADIPALLGAYILEGSKAGATAASVWAAHHVLPLNVAGYGKLIGASIEGSHHFYNFLNDLTFKVGDKEIEVHTLTHPDFNMVDYVFKEKGNDDLVAMNKLNHDVYDYASYVKGNIYNNEFITSHTDFAIPDYGNSPLKFVNSLGFSDEEWNRAGKVTVLRAAVMTPYMNDKEEFDVYAPKIQAALQEKLEQIYDVK
364,Q86TI2,Druggable,Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9),DPP9 ,863,98263,MATTGTPTADRGDAAATDDPAARFQVQKHSWDGLRSIIHGSRKYSGLIVNKAPHDFQFVQKTDESGPHSHRLYYLGMPYGSRENSLLYSEIPKKVRKEALLLLSWKQMLDHFQATPHHGVYSREEELLRERKRLGVFGITSYDFHSESGLFLFQASNSLFHCRDGGKNGFMVSPMKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYL
365,Q86UL8,Druggable,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)",MAGI2 ,1455,158754,MSKSLKKKSHWTSKVHESVIGRNPEGQLGFELKGGAENGQFPYLGEVKPGKVAYESGSKLVSEELLLEVNETPVAGLTIRDVLAVIKHCKDPLRLKCVKQGGIVDKDLRHYLNLRFQKGSVDHELQQIIRDNLYLRTVPCTTRPHKEGEVPGVDYIFITVEDFMELEKSGALLESGTYEDNYYGTPKPPAEPAPLLLNVTDQILPGATPSAEGKRKRNKSVSNMEKASIEPPEEEEEERPVVNGNGVVVTPESSEHEDKSAGASGEMPSQPYPAPVYSQPEELKEQMDDTKPTKPEDNEEPDPLPDNWEMAYTEKGEVYFIDHNTKTTSWLDPRLAKKAKPPEECKENELPYGWEKIDDPIYGTYYVDHINRRTQFENPVLEAKRKLQQHNMPHTELGTKPLQAPGFREKPLFTRDASQLKGTFLSTTLKKSNMGFGFTIIGGDEPDEFLQVKSVIPDGPAAQDGKMETGDVIVYINEVCVLGHTHADVVKLFQSVPIGQSVNLVLCRGYPLPFDPEDPANSMVPPLAIMERPPPVMVNGRHNYETYLEYISRTSQSVPDITDRPPHSLHSMPTDGQLDGTYPPPVHDDNVSMASSGATQAELMTLTIVKGAQGFGFTIADSPTGQRVKQILDIQGCPGLCEGDLIVEINQQNVQNLSHTEVVDILKDCPIGSETSLIIHRGGFFSPWKTPKPIMDRWENQGSPQTSLSAPAIPQNLPFPPALHRSSFPDSTEAFDPRKPDPYELYEKSRAIYESRQQVPPRTSFRMDSSGPDYKELDVHLRRMESGFGFRILGGDEPGQPILIGAVIAMGSADRDGRLHPGDELVYVDGIPVAGKTHRYVIDLMHHAARNGQVNLTVRRKVLCGGEPCPENGRSPGSVSTHHSSPRSDYATYTNSNHAAPSSNASPPEGFASHSLQTSDVVIHRKENEGFGFVIISSLNRPESGSTITVPHKIGRIIDGSPADRCAKLKVGDRILAVNGQSIINMPHADIVKLIKDAGLSVTLRIIPQEELNSPTSAPSSEKQSPMAQQSPLAQQSPLAQPSPATPNSPIAQPAPPQPLQLQGHENSYRSEVKARQDVKPDIRQPPFTDYRQPPLDYRQPPGGDYQQPPPLDYRQPPLLDYRQHSPDTRQYPLSDYRQPQDFDYFTVDMEKGAKGFGFSIRGGREYKMDLYVLRLAEDGPAIRNGRMRVGDQIIEINGESTRDMTHARAIELIKSGGRRVRLLLKRGTGQVPEYDEPAPWSSPAAAAPGLPEVGVSLDDGLAPFSPSHPAPPSDPSHQISPGPTWDIKREHDVRKPKELSACGQKKQRLGEQRERSASPQRAARPRLEEAPGGQGRPEAGRPASEARAPGLAAADAADAARAGGKEAPRAAAGSELCRREGPGAAPAFAGPGGGGSGALEAEGRAGARAGPRPGPRPPGGAPARKAAVAPGPWKVPGSDKLPSVLKPGASAASR
366,Q86UW7,Druggable,Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2) (CAPS-2),CADPS2 ,1296,147735,MLDPSSSEEESDEGLEEESRDVLVAAGSSQRAPPAPTREGRRDAPGRAGGGGAARSVSPSPSVLSEGRDEPQRQLDDEQERRIRLQLYVFVVRCIAYPFNAKQPTDMARRQQKLNKQQLQLLKERFQAFLNGETQIVADEAFCNAVRSYYEVFLKSDRVARMVQSGGCSANDFREVFKKNIEKRVRSLPEIDGLSKETVLSSWIAKYDAIYRGEEDLCKQPNRMALSAVSELILSKEQLYEMFQQILGIKKLEHQLLYNACQLDNADEQAAQIRRELDGRLQLADKMAKERKFPKFIAKDMENMYIEELRSSVNLLMANLESLPVSKGGPEFKLQKLKRSQNSAFLDIGDENEIQLSKSDVVLSFTLEIVIMEVQGLKSVAPNRIVYCTMEVEGEKLQTDQAEASRPQWGTQGDFTTTHPRPVVKVKLFTESTGVLALEDKELGRVILYPTSNSSKSAELHRMVVPKNSQDSDLKIKLAVRMDKPAHMKHSGYLYALGQKVWKRWKKRYFVLVQVSQYTFAMCSYREKKSEPQELMQLEGYTVDYTDPHPGLQGGCMFFNAVKEGDTVIFASDDEQDRILWVQAMYRATGQSYKPVPAIQTQKLNPKGGTLHADAQLSGKDADRFQKHGMDEFISANPCKLDHAFLFRILQRQTLDHRLNDSYSCLGWFSPGQVFVLDEYCARYGVRGCHRHLCYLAELMEHSENGAVIDPTLLHYSFAFCASHVHGNRPDGIGTVSVEEKERFEEIKERLSSLLENQISHFRYCFPFGRPEGALKATLSLLERVLMKDIATPIPAEEVKKVVRKCLEKAALINYTRLTEYAKIEETMNQASPARKLEEILHLAELCIEVLQQNEEHHAEGREAFAWWPDLLAEHAEKFWALFTVDMDTALEAQPQDSWDSFPLFQLLNNFLRNDTLLCNGKFHKHLQEIFVPLVVRYVDLMESSIAQSIHRGFEQETWQPVKNIANSLPNVALPKVPSLPLNLPQIPNISTASWMPSLYESTNGSATSEDLFWKLDALQMFVFDLHWPEQEFAHHLEQRLKLMASDMLEACVKRTRTAFELKLQKASKTTDLRIPASVCTMFNVLVDAKKQSTKLCALDGGQEQQYHSKIDDLIDNSVKEIISLLVSKFVSVLEGVLSKLSRYDEGTFFSSILSFTVKAAAKYVDVPKPGMDLADTYIMFVRQNQDILREKVNEEMYIEKLFDQWYSSSMKVICVWLTDRLDLQLHIYQLKTLIKIVKKTYRDFRLQGVLEGTLNSKTYDTVHRRLTVEEATASVSEGGGLQGITMKDSDEEEEG
367,Q86Y07,Druggable,Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2),VRK2,508,58141,MPPKRNEKYKLPIPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTKGQSINVHTPNSQKVDSQKAATKQVNKAHNRLIEKKVHSERSAESCATWKVQKEEKLIGLMNNEAAQESTRRRQKYQESQEPLNEVNSFPQKISYTQFPNSFYEPHQDFTSPDIFKKSRSPSWYKYTSTVSTGITDLESSTGLWPTISQFTLSEETNADVYYYRIIIPVLLMLVFLALFFL
368,Q8QGR0,Non Druggable,Muscarinic toxin 7 (MT-7) (MT7) (Muscarinic toxin 1) (m1-toxin),,86,9771,MKTLLLTLVVVTIVCLDLGYTLTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK
369,Q8TEY7,Druggable,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1) (hVDU1),USP33 ,942,106727,MTGSNSHITILTLKVLPHFESLGKQEKIPNKMSAFRNHCPHLDSVGEITKEDLIQKSLGTCQDCKVQGPNLWACLENRCSYVGCGESQVDHSTIHSQETKHYLTVNLTTLRVWCYACSKEVFLDRKLGTQPSLPHVRQPHQIQENSVQDFKIPSNTTLKTPLVAVFDDLDIEADEEDELRARGLTGLKNIGNTCYMNAALQALSNCPPLTQFFLDCGGLARTDKKPAICKSYLKLMTELWHKSRPGSVVPTTLFQGIKTVNPTFRGYSQQDAQEFLRCLMDLLHEELKEQVMEVEEDPQTITTEETMEEDKSQSDVDFQSCESCSNSDRAENENGSRCFSEDNNETTMLIQDDENNSEMSKDWQKEKMCNKINKVNSEGEFDKDRDSISETVDLNNQETVKVQIHSRASEYITDVHSNDLSTPQILPSNEGVNPRLSASPPKSGNLWPGLAPPHKKAQSASPKRKKQHKKYRSVISDIFDGTIISSVQCLTCDRVSVTLETFQDLSLPIPGKEDLAKLHSSSHPTSIVKAGSCGEAYAPQGWIAFFMEYVKRFVVSCVPSWFWGPVVTLQDCLAAFFARDELKGDNMYSCEKCKKLRNGVKFCKVQNFPEILCIHLKRFRHELMFSTKISTHVSFPLEGLDLQPFLAKDSPAQIVTYDLLSVICHHGTASSGHYIAYCRNNLNNLWYEFDDQSVTEVSESTVQNAEAYVLFYRKSSEEAQKERRRISNLLNIMEPSLLQFYISRQWLNKFKTFAEPGPISNNDFLCIHGGVPPRKAGYIEDLVLMLPQNIWDNLYSRYGGGPAVNHLYICHTCQIEAEKIEKRRKTELEIFIRLNRAFQKEDSPATFYCISMQWFREWESFVKGKDGDPPGPIDNTKIAVTKCGNVMLRQGADSGQISEETWNFLQSIYGGGPEVILRPPVVHVDPDILQAEEKIEVETRSL
370,Q8TF71,Non Druggable,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),SLC16A10 MCT10 TAT1,515,55493,MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHEPPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSLSMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGCSFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIFMFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGIPLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVYLQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAIGFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREISKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII
371,Q8WUI4,Druggable,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),HDAC7 HDAC7A,952,102927,MDLRVGQRPPVEPPPEPTLLALQRPQRLHHHLFLAGLQQQRSVEPMRLSMDTPMPELQVGPQEQELRQLLHKDKSKRSAVASSVVKQKLAEVILKKQQAALERTVHPNSPGIPYRTLEPLETEGATRSMLSSFLPPVPSLPSDPPEHFPLRKTVSEPNLKLRYKPKKSLERRKNPLLRKESAPPSLRRRPAETLGDSSPSSSSTPASGCSSPNDSEHGPNPILGSEALLGQRLRLQETSVAPFALPTVSLLPAITLGLPAPARADSDRRTHPTLGPRGPILGSPHTPLFLPHGLEPEAGGTLPSRLQPILLLDPSGSHAPLLTVPGLGPLPFHFAQSLMTTERLSGSGLHWPLSRTRSEPLPPSATAPPPPGPMQPRLEQLKTHVQVIKRSAKPSEKPRLRQIPSAEDLETDGGGPGQVVDDGLEHRELGHGQPEARGPAPLQQHPQVLLWEQQRLAGRLPRGSTGDTVLLPLAQGGHRPLSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLASCPDSWVPRVPGADKEEVEAVTALASLSVGILAEDRPSEQLVEEEEPMNL
372,Q91ZY1,Non Druggable,Histamine H4 receptor (H4R) (HH4R),Hrh4,391,44023,MSESNGTDVLPLTAQVPLAFLMSLLAFAITIGNAVVILAFVADRNLRHRSNYFFLNLAISDFFVGVISIPLYIPHTLFNWNFGSGICMFWLITDYLLCTASVYSIVLISYDRYQSVSNAVRYRAQHTGILKIVAQMVAVWILAFLVNGPMILASDSWKNSTNTEECEPGFVTEWYILAITAFLEFLLPVSLVVYFSVQIYWSLWKRGSLSRCPSHAGFIATSSRGTGHSRRTGLACRTSLPGLKEPAASLHSESPRGKSSLLVSLRTHMSGSIIAFKVGSFCRSESPVLHQREHVELLRGRKLARSLAVLLSAFAICWAPYCLFTIVLSTYRRGERPKSIWYSIAFWLQWFNSLINPFLYPLCHRRFQKAFWKILCVTKQPAPSQTQSVSS
373,Q91ZY2,Non Druggable,Histamine H4 receptor (H4R) (HH4R),Hrh4,391,44249,MSESNSTGILPPAAQVPLAFLMSSFAFAIMVGNAVVILAFVVDRNLRHRSNYFFLNLAISDFLVGLISIPLYIPHVLFNWNFGSGICMFWLITDYLLCTASVYNIVLISYDRYQSVSNAVSYRAQHTGIMKIVAQMVAVWILAFLVNGPMILASDSWKNSTNTKDCEPGFVTEWYILTITMLLEFLLPVISVAYFNVQIYWSLWKRRALSRCPSHAGFSTTSSSASGHLHRAGVACRTSNPGLKESAASRHSESPRRKSSILVSLRTHMNSSITAFKVGSFWRSESAALRQREYAELLRGRKLARSLAILLSAFAICWAPYCLFTIVLSTYPRTERPKSVWYSIAFWLQWFNSFVNPFLYPLCHRRFQKAFWKILCVTKQPALSQNQSVSS
374,Q92993,Druggable,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (cPLA(2)-interacting protein),KAT5 ,513,58582,MAEVGEIIEGCRLPVLRRNQDNEDEWPLAEILSVKDISGRKLFYVHYIDFNKRLDEWVTHERLDLKKIQFPKKEAKTPTKNGLPGSRPGSPEREVPASAQASGKTLPIPVQITLRFNLPKEREAIPGGEPDQPLSSSSCLQPNHRSTKRKVEVVSPATPVPSETAPASVFPQNGAARRAVAAQPGRKRKSNCLGTDEDSQDSSDGIPSAPRMTGSLVSDRSHDDIVTRMKNIECIELGRHRLKPWYFSPYPQELTTLPVLYLCEFCLKYGRSLKCLQRHLTKCDLRHPPGNEIYRKGTISFFEIDGRKNKSYSQNLCLLAKCFLDHKTLYYDTDPFLFYVMTEYDCKGFHIVGYFSKEKESTEDYNVACILTLPPYQRRGYGKLLIEFSYELSKVEGKTGTPEKPLSDLGLLSYRSYWSQTILEILMGLKSESGERPQITINEISEITSIKKEDVISTLQYLNLINYYKGQYILTLSEDIVDGHERAMLKRLLRIDSKCLHFTPKDWSKRGKW
375,Q969S0,Druggable,UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4) (YEA4 homolog),SLC35B4 ,331,37424,MRPALAVGLVFAGCCSNVIFLELLARKHPGCGNIVTFAQFLFIAVEGFLFEADLGRKPPAIPIRYYAIMVTMFFTVSVVNNYALNLNIAMPLHMIFRSGSLIANMILGIIILKKRYSIFKYTSIALVSVGIFICTFMSAKQVTSQSSLSENDGFQAFVWWLLGIGALTFALLMSARMGIFQETLYKRFGKHSKEALFYNHALPLPGFVFLASDIYDHAVLFNKSELYEIPVIGVTLPIMWFYLLMNIITQYVCIRGVFILTTECASLTVTLVVTLRKFVSLIFSILYFQNPFTLWHWLGTLFVFIGTLMYTEVWNNLGTTKSEPQKDSKKN
376,Q96A54,Druggable,Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I),ADIPOR1 ,375,42616,MSSHKGSVVAQGNGAPASNREADTVELAELGPLLEEKGKRVIANPPKAEEEQTCPVPQEEEEEVRVLTLPLQAHHAMEKMEEFVYKVWEGRWRVIPYDVLPDWLKDNDYLLHGHRPPMPSFRACFKSIFRIHTETGNIWTHLLGFVLFLFLGILTMLRPNMYFMAPLQEKVVFGMFFLGAVLCLSFSWLFHTVYCHSEKVSRTFSKLDYSGIALLIMGSFVPWLYYSFYCSPQPRLIYLSIVCVLGISAIIVAQWDRFATPKHRQTRAGVFLGLGLSGVVPTMHFTIAEGFVKATTVGQMGWFFLMAVMYITGAGLYAARIPERFFPGKFDIWFQSHQIFHVLVVAAAFVHFYGVSNLQEFRYGLEGGCTDDTLL
377,Q96MV8,Druggable,Palmitoyltransferase ZDHHC15 (EC 2.3.1.225) (Acyltransferase ZDHHC15) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15) (DHHC-15),ZDHHC15 ,337,39331,MRRGWKMALSGGLRCCRRVLSWVPVLVIVLVVLWSYYAYVFELCLVTVLSPAEKVIYLILYHAIFVFFTWTYWKSIFTLPQQPNQKFHLSYTDKERYENEERPEVQKQMLVDMAKKLPVYTRTGSGAVRFCDRCHLIKPDRCHHCSVCAMCVLKMDHHCPWVNNCIGFSNYKFFLQFLAYSVLYCLYIATTVFSYFIKYWRGELPSVRSKFHVLFLLFVACMFFVSLVILFGYHCWLVSRNKTTLEAFCTPVFTSGPEKNGFNLGFIKNIQQVFGDKKKFWLIPIGSSPGDGHSFPMRSMNESQNPLLANEETWEDNEDDNQDYPEGSSSLAVETET
378,Q96NY7,Druggable,Chloride intracellular channel protein 6 (Parchorin),CLIC6 ,704,73012,MAEAAEPEGVAPGPQGPPEVPAPLAERPGEPGAAGGEAEGPEGSEGAEEAPRGAAAVKEAGGGGPDRGPEAEARGTRGAHGETEAEEGAPEGAEVPQGGEETSGAQQVEGASPGRGAQGEPRGEAQREPEDSAAPERQEEAEQRPEVPEGSASGEAGDSVDAEGPLGDNIEAEGPAGDSVEAEGRVGDSVDAEGPAGDSVDAEGPLGDNIQAEGPAGDSVDAEGRVGDSVDAEGPAGDSVDAEGRVGDSVEAGDPAGDGVEAGVPAGDSVEAEGPAGDSMDAEGPAGRARRVSGEPQQSGDGSLSPQAEAIEVAAGESAGRSPGELAWDAAEEAEVPGVKGSEEAAPGDARADAGEDRVGDGPQQEPGEDEERRERSPEGPREEEAAGGEEESPDSSPHGEASRGAAEPEAQLSNHLAEEGPAEGSGEAARVNGRREDGEASEPRALGQEHDITLFVKVKLTALGCSRIAIKKYLRAGYDGESIGNCPFSQRLFMILWLKGVIFNVTTVDLKRKPADLQNLAPGTNPPFMTFDGEVKTDVNKIEEFLEEKLAPPRYPKLGTQHPESNSAGNDVFAKFSAFIKNTKKDANEIHEKNLLKALRKLDNYLNSPLPDEIDAYSTEDVTVSGRKFLDGDELTLADCNLLPKLHIIKIVAKKYRDFEFPSEMTGIWRYLNNAYARDEFTNTCPADQEIEHAYSDVAKRMK
379,Q96NY7,Druggable,Chloride intracellular channel protein 6 (Parchorin),CLIC6,704,73012,MAEAAEPEGVAPGPQGPPEVPAPLAERPGEPGAAGGEAEGPEGSEGAEEAPRGAAAVKEAGGGGPDRGPEAEARGTRGAHGETEAEEGAPEGAEVPQGGEETSGAQQVEGASPGRGAQGEPRGEAQREPEDSAAPERQEEAEQRPEVPEGSASGEAGDSVDAEGPLGDNIEAEGPAGDSVEAEGRVGDSVDAEGPAGDSVDAEGPLGDNIQAEGPAGDSVDAEGRVGDSVDAEGPAGDSVDAEGRVGDSVEAGDPAGDGVEAGVPAGDSVEAEGPAGDSMDAEGPAGRARRVSGEPQQSGDGSLSPQAEAIEVAAGESAGRSPGELAWDAAEEAEVPGVKGSEEAAPGDARADAGEDRVGDGPQQEPGEDEERRERSPEGPREEEAAGGEEESPDSSPHGEASRGAAEPEAQLSNHLAEEGPAEGSGEAARVNGRREDGEASEPRALGQEHDITLFVKVKLTALGCSRIAIKKYLRAGYDGESIGNCPFSQRLFMILWLKGVIFNVTTVDLKRKPADLQNLAPGTNPPFMTFDGEVKTDVNKIEEFLEEKLAPPRYPKLGTQHPESNSAGNDVFAKFSAFIKNTKKDANEIHEKNLLKALRKLDNYLNSPLPDEIDAYSTEDVTVSGRKFLDGDELTLADCNLLPKLHIIKIVAKKYRDFEFPSEMTGIWRYLNNAYARDEFTNTCPADQEIEHAYSDVAKRMK
380,Q96QK1,Non Druggable,Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35),VPS35,796,91707,MPTTQQSPQDEQEKLLDEAIQAVKVQSFQMKRCLDKNKLMDALKHASNMLGELRTSMLSPKSYYELYMAISDELHYLEVYLTDEFAKGRKVADLYELVQYAGNIIPRLYLLITVGVVYVKSFPQSRKDILKDLVEMCRGVQHPLRGLFLRNYLLQCTRNILPDEGEPTDEETTGDISDSMDFVLLNFAEMNKLWVRMQHQGHSRDREKRERERQELRILVGTNLVRLSQLEGVNVERYKQIVLTGILEQVVNCRDALAQEYLMECIIQVFPDEFHLQTLNPFLRACAELHQNVNVKNIIIALIDRLALFAHREDGPGIPADIKLFDIFSQQVATVIQSRQDMPSEDVVSLQVSLINLAMKCYPDRVDYVDKVLETTVEIFNKLNLEHIATSSAVSKELTRLLKIPVDTYNNILTVLKLKHFHPLFEYFDYESRKSMSCYVLSNVLDYNTEIVSQDQVDSIMNLVSTLIQDQPDQPVEDPDPEDFADEQSLVGRFIHLLRSEDPDQQYLILNTARKHFGAGGNQRIRFTLPPLVFAAYQLAFRYKENSKVDDKWEKKCQKIFSFAHQTISALIKAELAELPLRLFLQGALAAGEIGFENHETVAYEFMSQAFSLYEDEISDSKAQLAAITLIIGTFERMKCFSEENHEPLRTQCALAASKLLKKPDQGRAVSTCAHLFWSGRNTDKNGEELHGGKRVMECLKKALKIANQCMDPSLQVQLFIEILNRYIYFYEKENDAVTIQVLNQLIQKIREDLPNLESSEETEQINKHFHNTLEHLRLRRESPESEGPIYEGLIL
381,Q96SB3,Druggable,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),PPP1R9B,817,89334,MMKTEPRGPGGPLRSASPHRSAYEAGIQALKPPDAPGPDEAPKGAHHKKYGSNVHRIKSMFLQMGTTAGPSGEAGGGAGLAEAPRASERGVRLSLPRASSLNENVDHSALLKLGTSVSERVSRFDSKPAPSAQPAPPPHPPSRLQETRKLFERSAPAAAGGDKEAAARRLLRQERAGLQDRKLDVVVRFNGSTEALDKLDADAVSPTVSQLSAVFEKADSRTGLHRGPGLPRAAGVPQVNSKLVSKRSRVFQPPPPPPPAPSGDAPAEKERCPAGQQPPQHRVAPARPPPKPREVRKIKPVEVEESGESEAESAPGEVIQAEVTVHAALENGSTVATAASPAPEEPKAQAAPEKEAAAVAPPERGVGNGRAPDVAPEEVDESKKEDFSEADLVDVSAYSGLGEDSAGSALEEDDEDDEEDGEPPYEPESGCVEIPGLSEEEDPAPSRKIHFSTAPIQVFSTYSNEDYDRRNEDVDPMAASAEYELEKRVERLELFPVELEKDSEGLGISIIGMGAGADMGLEKLGIFVKTVTEGGAAHRDGRIQVNDLLVEVDGTSLVGVTQSFAASVLRNTKGRVRFMIGRERPGEQSEVAQLIQQTLEQERWQREMMEQRYAQYGEDDEETGEYATDEDEELSPTFPGGEMAIEVFELAENEDALSPVDMEPEKLVHKFKELQIKHAVTEAEIQQLKRKLQSLEQEKGRWRVEKAQLEQSVEENKERMEKLEGYWGEAQSLCQAVDEHLRETQAQYQALERKYSKAKRLIKDYQQKEIEFLKKETAQRRVLEESELARKEEMDKLLDKISELEGNLQTLRNSNST
382,Q99418,Druggable,"Cytohesin-2 (ARF exchange factor) (ARF nucleotide-binding site opener) (Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2)",CYTH2 ,400,46546,MEDGVYEPPDLTPEERMELENIRRRKQELLVEIQRLREELSEAMSEVEGLEANEGSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPFYEMLAARKKRISVKKKQEQP
383,Q99494,Druggable,DAT1 protein (Fragment),DAT1,106,10954,CGVGNGLRDVSIPGRMQGPTGACPIPGRMQGPHRSVYYPRTHAGPPLERVLPQDACRAPTGACPIPGPDACRAPTGACTTPGRMQGPHAGSLQTTLCLALSRDLQE
385,Q99685,Druggable,Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL),MGLL,303,33261,MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
79,A0A3Q7SL85,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,422,47089,MISNGTGSSFCLDSPPCRITVSVVLTVLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSSFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHMGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHNAQETSLRSSSSQLARNQSREPMRQEEKPLKLQVWSGTEVTAPRGATDRKPALSCTVCSSNLLSCCKSLWGLRFLQRHMRGPSEEQPGEPLSEEPPRTPPQEAVRTIPSEAV
80,A0A3Q7SL94,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,359,40174,MISNGTGSSFCLDSPPCRITVSVVLTVLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPVRVAVSLVLIWVISITLSFLSIHLGWNSRNETSSFNHTIPKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRIHHMGSWKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAINEAFEAVVLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHNAQETSLRSSSSQLARNQSREPMRQEEKPLKLQVWSGTEVTAPRGATDR
386,Q9BPV8,Druggable,P2Y purinocepto,P2RY13 GPR86 GPR94 FKSG77,354,40789,MTAAIRRQRELSILPKVTLEAMNTTVMQGFNRSERCPRDTRIVQLVFPALYTVVFLTGILLNTLALWVFVHIPSSSTFIIYLKNTLVADLIMTLMLPFKILSDSHLAPWQLRAFVCRFSSVIFYETMYVGIVLLGLIAFDRFLKIIRPLRNIFLKKPVFAKTVSIFIWFFLFFISLPNTILSNKEATPSSVKKCASLKGPLGLKWHQMVNNICQFIFWTVFILMLVFYVVIAKKVYDSYRKSKSKDRKNNKKLEGKVFVVVAVFFVCFAPFHFARVPYTHSQTNNKTDCRLQNQLFIAKETTLFLAATNICMDPLIYIFLCKKFTEKLPCMQGRKTTASSQENHSSQTDNITLG
387,Q9BSK4,Druggable,Protein fem-1 homolog A (FEM1a) (FEM1-alpha) (Prostaglandin E receptor 4-associated protein),FEM1A EPRAP,669,73639,MDLRTAVYNAARDGKLQLLQKLLSGRSREELDELTGEVAGGGTPLLIAARYGHLDVVEYLVDRCGASVEAGGSVHFDGETIEGAPPLWAASAAGHLDVVRSLLRRGASVNRTTRTNSTPLRAACFDGHLEVVRYLVGEHQADLEVANRHGHTCLMISCYKGHREIARYLLEQGAQVNRRSAKGNTALHDCAESGSLEILQLLLGCKARMERDGYGMTPLLAASVTGHTNIVEYLIQEQPGQEQVAGGEAQPGLPQEDPSTSQGCAQPQGAPCCSSSPEEPLNGESYESCCPTSREAAVEALELLGATYVDKKRDLLGALKHWRRAMELRHQGGEYLPKPEPPQLVLAYDYSREVNTTEELEALITDPDEMRMQALLIRERILGPSHPDTSYYIRYRGAVYADSGNFERCIRLWKYALDMQQSNLEPLSPMTASSFLSFAELFSYVLQDRAAKGSLGTQIGFADLMGVLTKGVREVERALQLPREPGDSAQFTKALAIILHLLYLLEKVECTPSQEHLKHQTVYRLLKCAPRGKNGFTPLHMAVDKDTTNVGRYPVGRFPSLHVVKVLLDCGADPDSRDFDNNTPLHIAAQNNCPAIMNALIEAGAHMDATNAFKKTAYELLDEKLLARGTMQPFNYVTLQCLAARALDKNKIPYKGFIPEDLEAFIELH
388,Q9BXX6,Druggable,Dopamine D3 receptor (Fragment),DRD3,90,9656,MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLE
389,P85092,Non Druggable,Toxin AdTx1 (Rho-elapitoxin-Da1a) (Rho-Da1a) (Rho-EPTX-Da1a),,65,7291,LTCVTSKSIFGITTEDCPDGQNLCFKRRHYVVPKIYDSTRGCAATCPIPENYDSIHCCKTDKCNE
390,Q9BYZ0,Druggable,Beta-2 adrenergic receptor (Beta-2 adrenoceptor) (Beta-2 adrenoreceptor) (Fragment),ADRB2,275,31547,VLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIY
391,Q9H244,Druggable,P2Y purinoceptor 12 (P2Y12) (ADP-glucose receptor) (ADPG-R) (P2T(AC)) (P2Y(AC)) (P2Y(cyc)) (P2Y12 platelet ADP receptor) (P2Y(ADP)) (SP1999),P2RY12 ,342,39439,MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTRDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM
392,Q9H3N8,Non Druggable,Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144),HRH4 G,390,44496,MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
393,Q9H6Z9,Druggable,Prolyl hydroxylase EGLN3 (EC 1.14.11.-) (Egl nine homolog 3) (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3),EGLN3,239,27261,MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED
81,A0A3Q7UYJ2,Non Druggable,Histamine H1 receptor,HRH1,487,55784,MNLPNSSCIFEDKMCEGNKTTIANPKLMPLVVFLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHHFMSQTSGHREDKCETDFYDVTWFKIMTAIINFYLPTLLMLWFYARIYKAVRQHCQHRELINGSLPSFSEPKLKPENPKAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDSEEMKSPSVFSQEEDREVDKLQCFPLNIVQVQTEAEGSVRSYVAINQSQSMLEMDEQGLNMRGANETSEDQILGDSQSFSRTDSDTPTESGSGKGKPRSESSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
394,Q9HAW7,Druggable,UDP-glucuronosyltransferase 1A7 (UGT1A7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-7) (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G),UGT1A7 ,530,59819,MARAGWTGLLPLYVCLLLTCGFAKAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLGRSLNCTVKTYSTSYTLEDQDREFMVFADARWTAPLRSAFSLLTSSSNGIFDLFFSNCRSLFNDRKLVEYLKESCFDAVFLDPFDACGLIVAKYFSLPSVVFARGIFCHYLEEGAQCPAPLSYVPRLLLGFSDAMTFKERVWNHIMHLEEHLFCPYFFKNVLEIASEILQTPVTAYDLYSHTSIWLLRTDFVLEYPKPVMPNMIFIGGINCHQGKPVPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
395,A0A3Q7V7K2,Non Druggable,Histamine H1 receptor,HRH1,487,55543,MTLPNSSCSFEDKMCEGNKTTIASPQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHHFMSQSSGHRDDRCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPRAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDPDETKSPGVFSQEEDREVDKLQCFPLNIVQMQTEAEGSGRSFIAIDQSQSPVGMDEQSLNMHVANEMSEDQILGDSQSFSRTDSDTPTESASGKGKPRSGSSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
396,A0A452EC28,Non Druggable,Histamine H1 receptor,HRH1,489,55654,MTCPNSSCIFEDKMCEGNKTAPASDAQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNILYLLRCRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASVTILAAWFLSFLWIIPILSWRHFQPKTPEPPGHKCETDFYKVTWFKIMTAIVNFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDVKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSLGIFSQEKDGELGNFYCFPLDTVQTQPEAEGSGRGYAAINQSQNQFEMGEQGLNMPGAKEALEDQIQGDSQSFSRTDSDTPAEPAARGKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIVCWIPYFIFFMVVAFCESCSNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
397,Q9HAW8,Druggable,UDP-glucuronosyltransferase 1A10 (UGT1A10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-10) (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J),UGT1A10 ,530,59810,MARAGWTSPVPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLERSLNCTVKTYSTSYTLEDQNREFMVFAHAQWKAQAQSIFSLLMSSSSGFLDLFFSHCRSLFNDRKLVEYLKESSFDAVFLDPFDTCGLIVAKYFSLPSVVFTRGIFCHHLEEGAQCPAPLSYVPNDLLGFSDAMTFKERVWNHIVHLEDHLFCQYLFRNALEIASEILQTPVTAYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
398,A0A452FM69,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,375,41714,MASNGTASSSCLDPAAFKVTVTVVLTLLILITIAGNVVVCLAVGLNRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFHQLSCQWGFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPLRVAVSLVLIWVISITLSFLSIHLEWNGRPENRSDSHAVPKCKVQVNLVYGLVDGLVTFYLPLLVMCVTYYRILRIAREQARRIRNVGPWRAATLREHKATATLAAVMGAFVVCWLPYFTVFIYRGLRGDSAVDKTVEDVVLWLGYANSALNPVLYAALNRDFRTAYQQLFRCSPAGHDARRTSLGSNSSQLVRRPGREPRWPEERPLRLQVWSGTEVTAPQGAADRAGRKTKGIHVWPRTEA
399,A0A452S5S2,Non Druggable,Histamine H1 receptor,HRH1,487,55402,MTLPNSSCTFEDKMCEGNKTTIASPQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSRWSLGQPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWIIPILGWHHFMSQSSGHRDDRCETDFYDVTWFKIMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLKPENPKAGAKKPGKESPWEVLKRKSKDASGEPVLKPPSQDPDETKSPGVFSQEEDGEVDKLQCFPLNIVQMQTEAEGSGRSFIAIDQSQSPVGMDEQSLNMHVANEMSEDQILGDSQSFSRTDSDTPTESASGKGKPRSGSSTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
400,Q9HC97,Druggable,G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor),GPR35,309,34072,MNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQQWTETRIYMTNLAVADLCLLCTLPFVLHSLRDTSDTPLCQLSQGIYLTNRYMSISLVTAIAVDRYVAVRHPLRARGLRSPRQAAAVCAVLWVLVIGSLVARWLLGIQEGGFCFRSTRHNFNSMAFPLLGFYLPLAVVVFCSLKVVTALAQRPPTDVGQAEATRKAARMVWANLLVFVVCFLPLHVGLTVRLAVGWNACALLETIRRALYITSKLSDANCCLDAICYYYMAKEFQEASALAVAPSAKAHKSQDSLCVTLA
401,Q9HD26,Druggable,Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10) (PIST),GOPC CAL FIG,462,50520,MSAGGPCPAAAGGGPGGASCSVGAPGGVSMFRWLEVLEKEFDKAFVDVDLLLGEIDPDQADITYEGRQKMTSLSSCFAQLCHKAQSVSQINHKLEAQLVDLKSELTETQAEKVVLEKEVHDQLLQLHSIQLQLHAKTGQSADSGTIKAKLSGPSVEELERELEANKKEKMKEAQLEAEVKLLRKENEALRRHIAVLQAEVYGARLAAKYLDKELAGRVQQIQLLGRDMKGPAHDKLWNQLEAEIHLHRHKTVIRACRGRNDLKRPMQAPPGHDQDSLKKSQGVGPIRKVLLLKEDHEGLGISITGGKEHGVPILISEIHPGQPADRCGGLHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEIEFEVVYVAPEVDSDDENVEYEDESGHRYRLYLDELEGGGNPGASCKDTSGEIKVLQGFNKKAVTDTHENGDLGTASETPLDDGASKLDDLHTLYHKKSY
402,Q9JI35,Non Druggable,Histamine H3 receptor (H3R) (HH3R),HRH3,445,48735,MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
403,Q9HAW9,Druggable,UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H),UGT1A8 ,530,59742,MARTGWTSPIPLCVSLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLGKSLNCTVKTYSTSYTLEDLDREFMDFADAQWKAQVRSLFSLFLSSSNGFFNLFFSHCRSLFNDRKLVEYLKESSFDAVFLDPFDACGLIVAKYFSLPSVVFARGIACHYLEEGAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLFCQYFSKNALEIASEILQTPVTAYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
404,Q9N2B0,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,487,55588,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFRQQISVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVQKHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDGEVDKLHCFPLDIVQMQTVAEGSSRDYVAINQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
405,Q9N2B2,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,487,55635,MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTXKEMKSPVVFSQEDDREVDKLHCFPLDIVPMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
406,Q9NPG8,Druggable,Palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) (Zinc finger protein 374),ZDHHC4 ,344,39787,MDFLVLFLFYLASVLMGLVLICVCSKTHSLKGLARGGAQIFSCIIPECLQRAVHGLLHYLFHTRNHTFIVLHLVLQGMVYTEYTWEVFGYCQELELSLHYLLLPYLLLGVNLFFFTLTCGTNPGIITKANELLFLHVYEFDEVMFPKNVRCSTCDLRKPARSKHCSVCNWCVHRFDHHCVWVNNCIGAWNIRYFLIYVLTLTASAATVAIVSTTFLVHLVVMSDLYQETYIDDLGHLHVMDTVFLIQYLFLTFPRIVFMLGFVVVLSFLLGGYLLFVLYLAATNQTTNEWYRGDWAWCQRCPLVAWPPSAEPQVHRNIHSHGLRSNLQEIFLPAFPCHERKKQE
407,Q9NY31,Druggable,Dopamine D3 receptor (Fragment),DRD3,56,5882,MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLK
408,Q9NYG2,Druggable,Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3),ZDHHC3,299,34170,MMLIPTHHFRNIERKPEYLQPEKCVPPPYPGPVGTMWFIRDGCGIACAIVTWFLVLYAEFVVLFVMLIPSRDYVYSIINGIVFNLLAFLALASHCRAMLTDPGAVPKGNATKEFIESLQLKPGQVVYKCPKCCSIKPDRAHHCSVCKRCIRKMDHHCPWVNNCVGENNQKYFVLFTMYIALISLHALIMVGFHFLHCFEEDWTKCSSFSPPTTVILLILLCFEGLLFLIFTSVMFGTQVHSICTDETGIEQLKKEERRWAKKTKWMNMKAVFGHPFSLGWASPFATPDQGKADPYQYVV
409,Q9NYL2,Druggable,Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),MAP3K20 ,800,91155,MSSLGASFVQIKFDDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKLLKIEKEAEILSVLSHRNIIQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEAPVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHTTHMSLVGTFPWMAPEVIQSLPVSETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWEADAKKRPSFKQIISILESMSNDTSLPDKCNSFLHNKAEWRCEIEATLERLKKLERDLSFKEQELKERERRLKMWEQKLTEQSNTPLLPSFEIGAWTEDDVYCWVQQLVRKGDSSAEMSVYASLFKENNITGKRLLLLEEEDLKDMGIVSKGHIIHFKSAIEKLTHDYINLFHFPPLIKDSGGEPEENEEKIVNLELVFGFHLKPGTGPQDCKWKMYMEMDGDEIAITYIKDVTFNTNLPDAEILKMTKPPFVMEKWIVGIAKSQTVECTVTYESDVRTPKSTKHVHSIQWSRTKPQDEVKAVQLAIQTLFTNSDGNPGSRSDSSADCQWLDTLRMRQIASNTSLQRSQSNPILGSPFFSHFDGQDSYAAAVRRPQVPIKYQQITPVNQSRSSSPTQYGLTKNFSSLHLNSRDSGFSSGNTDTSSERGRYSDRSRNKYGRGSISLNSSPRGRYSGKSQHSTPSRGRYPGKFYRVSQSALNPHQSPDFKRSPRDLHQPNTIPGMPLHPETDSRASEEDSKVSEGGWTKVEYRKKPHRPSPAKTNKERARGDHRGWRNF
410,Q9NZ20,Druggable,Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3),PLA2G3,509,57167,MGVQAGLFGMLGFLGVALGGSPALRWYRTSCHLTKAVPGNPLGYLSFLAKDAQGLALIHARWDAHRRLQSCSWEDEPELTAAYGALCAHETAWGSFIHTPGPELQRALATLQSQWEACRALEESPAGARKKRAAGQSGVPGGGHQREKRGWTMPGTLWCGVGDSAGNSSELGVFQGPDLCCREHDRCPQNISPLQYNYGIRNYRFHTISHCDCDTRFQQCLQNQHDSISDIVGVAFFNVLEIPCFVLEEQEACVAWYWWGGCRMYGTVPLARLQPRTFYNASWSSRATSPTPSSRSPAPPKPRQKQHLRKGPPHQKGSKRPSKANTTALQDPMVSPRLDVAPTGLQGPQGGLKPQGARWVCRSFRRHLDQCEHQIGPREIEFQLLNSAQEPLFHCNCTRRLARFLRLHSPPEVTNMLWELLGTTCFKLAPPLDCVEGKNCSRDPRAIRVSARHLRRLQQRRHQLQDKGTDERQPWPSEPLRGPMSFYNQCLQLTQAARRPDRQQKSWSQ
411,Q9N2B1,Non Druggable,Histamine H1 receptor (H1R) (HH1R),HRH1,487,55623,MSLPNSSCLLEDKMCESNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLHCFPLDIVHMQTAAEGSSRDYVAVNQSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETASGKGKLRSGSNTGLGYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
412,Q9P0G3,Druggable,Kallikrein-14 (hK14) (EC 3.4.21.-) (Kallikrein-like protein 6) (KLK-L6),KLK14 ,267,29122,MSLRVLGSGTWPSAPKMFLLLTALQVLAIAMTQSQEDENKIIGGHTCTRSSQPWQAALLAGPRRRFLCGGALLSGQWVITAAHCGRPILQVALGKHNLRRWEATQQVLRVVRQVTHPNYNSRTHDNDLMLLQLQQPARIGRAVRPIEVTQACASPGTSCRVSGWGTISSPIARYPASLQCVNINISPDEVCQKAYPRTITPGMVCAGVPQGGKDSCQGDSGGPLVCRGQLQGLVSWGMERCALPGYPGVYTNLCKYRSWIEETMRDK
413,Q9P0N8,Druggable,E3 ubiquitin-protein ligase MARCHF2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCHF2),MARCHF2 ,246,26995,MTTGDCCHLPGSLCDCSGSPAFSKVVEATGLGPPQYVAQVTSRDGRLLSTVIRALDTPSDGPFCRICHEGANGECLLSPCGCTGTLGAVHKSCLEKWLSSSNTSYCELCHTEFAVEKRPRPLTEWLKDPGPRTEKRTLCCDMVCFLFITPLAAISGWLCLRGAQDHLRLHSQLEAVGLIALTIALFTIYVLWTLVSFRYHCQLYSEWRKTNQKVRLKIREADSPEGPQHSPLAAGLLKKVAEETPV
414,Q9QYN8,Non Druggable,Histamine H3 receptor (H3R) (HH3R),Hrh3,445,48588,MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
415,Q9UGC6,Druggable,Regulator of G-protein signaling 17 (RGS17),RGS17 ,210,24359,MRKRQQSQNEGTPAVSQAPGNQRPNNTCCFCWCCCCSCSCLTVRNEERGENAGRPTHTTKMESIQVLEECQNPTAEEVLSWSQNFDKMMKAPAGRNLFREFLRTEYSEENLLFWLACEDLKKEQNKKVIEEKARMIYEDYISILSPKEVSLDSRVREVINRNLLDPNPHMYEDAQLQIYTLMHRDSFPRFLNSQIYKSFVESTAGSSSES
416,Q9UHI5,Non Druggable,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8),SLC7A8 ,535,58382,MEEGARHRNNTEKKHPGGGESDASPEAGSGGGGVALKKEIGLVSACGIIVGNIIGSGIFVSPKGVLENAGSVGLALIVWIVTGFITVVGALCYAELGVTIPKSGGDYSYVKDIFGGLAGFLRLWIAVLVIYPTNQAVIALTFSNYVLQPLFPTCFPPESGLRLLAAICLLLLTWVNCSSVRWATRVQDIFTAGKLLALALIIIMGIVQICKGEYFWLEPKNAFENFQEPDIGLVALAFLQGSFAYGGWNFLNYVTEELVDPYKNLPRAIFISIPLVTFVYVFANVAYVTAMSPQELLASNAVAVTFGEKLLGVMAWIMPISVALSTFGGVNGSLFTSSRLFFAGAREGHLPSVLAMIHVKRCTPIPALLFTCISTLLMLVTSDMYTLINYVGFINYLFYGVTVAGQIVLRWKKPDIPRPIKINLLFPIIYLLFWAFLLVFSLWSEPVVCGIGLAIMLTGVPVYFLGVYWQHKPKCFSDFIELLTLVSQKMCVVVYPEVERGSGTEEANEDMEEQQQPMYQPTPTKDKDVAGQPQP
417,Q9ULC8,Druggable,Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378),ZDHHC8,765,81443,MPRSPGTRLKPAKYIPVATAAALLVGSSTLFFVFTCPWLTRAVSPAVPVYNGIIFLFVLANFSMATFMDPGVFPRADEDEDKEDDFRAPLYKNVDVRGIQVRMKWCATCHFYRPPRCSHCSVCDNCVEDFDHHCPWVNNCIGRRNYRYFFLFLLSLSAHMVGVVAFGLVYVLNHAEGLGAAHTTITMAVMCVAGLFFIPVIGLTGFHVVLVTRGRTTNEQVTGKFRGGVNPFTRGCCGNVEHVLCSPLAPRYVVEPPRLPLAVSLKPPFLRPELLDRAAPLKVKLSDNGLKAGLGRSKSKGSLDRLDEKPLDLGPPLPPKIEAGTFSSDLQTPRPGSAESALSVQRTSPPTPAMYKFRPAFPTGPKVPFCGPGEQVPGPDSLTLGDDSIRSLDFVSEPSLDLPDYGPGGLHAAYPPSPPLSASDAFSGALRSLSLKASSRRGGDHVALQPLRSEGGPPTPHRSIFAPHALPNRNGSLSYDSLLNPGSPGGHACPAHPAVGVAGYHSPYLHPGATGDPPRPLPRSFSPVLGPRPREPSPVRYDNLSRTIMASIQERKDREERERLLRSQADSLFGDSGVYDAPSSYSLQQASVLSEGPRGPALRYGSRDDLVAGPGFGGARNPALQTSLSSLSSSVSRAPRTSSSSLQADQASSNAPGPRPSSGSHRSPARQGLPSPPGTPHSPSYAGPKAVAFIHTDLPEPPPSLTVQRDHPQLKTPPSKLNGQSPGLARLGPATGPPGPSASPTRHTLVKKVSGVGGTTYEISV
418,Q9ULD4,Druggable,Bromodomain and PHD finger-containing protein 3,BRPF3 ,1205,135745,MRKPRRKSRQNAEGRRSPSPYSLKCSPTRETLTYAQAQRIVEVDIDGRLHRISIYDPLKIITEDELTAQDITECNSNKENSEQPQFPGKSKKPSSKGKKKESCSKHASGTSFHLPQPSFRMVDSGIQPEAPPLPAAYYRYIEKPPEDLDAEVEYDMDEEDLAWLDMVNEKRRVDGHSLVSADTFELLVDRLEKESYLESRSSGAQQSLIDEDAFCCVCLDDECHNSNVILFCDICNLAVHQECYGVPYIPEGQWLCRCCLQSPSRPVDCILCPNKGGAFKQTSDGHWAHVVCAIWIPEVCFANTVFLEPIEGIDNIPPARWKLTCYICKQKGLGAAIQCHKVNCYTAFHVTCAQRAGLFMKIEPMRETSLNGTIFTVRKTAYCEAHSPPGAATARRKGDSPRSISETGDEEGLKEGDGEEEEEEEVEEEEQEAQGGVSGSLKGVPKKSKMSLKQKIKKEPEEAGQDTPSTLPMLAVPQIPSYRLNKICSGLSFQRKNQFMQRLHNYWLLKRQARNGVPLIRRLHSHLQSQRNAEQREQDEKTSAVKEELKYWQKLRHDLERARLLIELIRKREKLKREQVKVQQAAMELELMPFNVLLRTTLDLLQEKDPAHIFAEPVNLSEVPDYLEFISKPMDFSTMRRKLESHLYRTLEEFEEDFNLIVTNCMKYNAKDTIFHRAAVRLRDLGGAILRHARRQAENIGYDPERGTHLPESPKLEDFYRFSWEDVDNILIPENRAHLSPEVQLKELLEKLDLVSAMRSSGARTRRVRLLRREINALRQKLAQPPPPQPPSLNKTVSNGELPAGPQGDAAVLEQALQEEPEDDGDRDDSKLPPPPTLEPTGPAPSLSEQESPPEPPTLKPINDSKPPSRFLKPRKVEEDELLEKSPLQLGNEPLQRLLSDNGINRLSLMAPDTPAGTPLSGVGRRTSVLFKKAKNGVKLQRSPDRVLENGEDHGVAGSPASPASIEEERHSRKRPRSRSCSESEGERSPQQEEETGMTNGFGKHTESGSDSECSLGLSGGLAFEACSGLTPPKRSRGKPALSRVPFLEGVNGDSDYNGSGRSLLLPFEDRGDLEPLELVWAKCRGYPSYPALIIDPKMPREGLLHNGVPIPVPPLDVLKLGEQKQAEAGEKLFLVLFFDNKRTWQWLPRDKVLPLGVEDTVDKLKMLEGRKTSIRKSVQVAYDRAMIHLSRVRGPHSFVTSSYL
419,Q9Y4G8,Druggable,Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1),RAPGEF2 ,1499,167417,MKPLAIPANHGVMGQQEKHSLPADFTKLHLTDSLHPQVTHVSSSHSGCSITSDSGSSSLSDIYQATESEAGDMDLSGLPETAVDSEDDDDEEDIERASDPLMSRDIVRDCLEKDPIDRTDDDIEQLLEFMHQLPAFANMTMSVRRELCAVMVFAVVERAGTIVLNDGEELDSWSVILNGSVEVTYPDGKAEILCMGNSFGVSPTMDKEYMKGVMRTKVDDCQFVCIAQQDYCRILNQVEKNMQKVEEEGEIVMVKEHRELDRTGTRKGHIVIKGTSERLTMHLVEEHSVVDPTFIEDFLLTYRTFLSSPMEVGKKLLEWFNDPSLRDKVTRVVLLWVNNHFNDFEGDPAMTRFLEEFENNLEREKMGGHLRLLNIACAAKAKRRLMTLTKPSREAPLPFILLGGSEKGFGIFVDSVDSGSKATEAGLKRGDQILEVNGQNFENIQLSKAMEILRNNTHLSITVKTNLFVFKELLTRLSEEKRNGAPHLPKIGDIKKASRYSIPDLAVDVEQVIGLEKVNKKSKANTVGGRNKLKKILDKTRISILPQKPYNDIGIGQSQDDSIVGLRQTKHIPTALPVSGTLSSSNPDLLQSHHRILDFSATPDLPDQVLRVFKADQQSRYIMISKDTTAKEVVIQAIREFAVTATPDQYSLCEVSVTPEGVIKQRRLPDQLSKLADRIQLSGRYYLKNNMETETLCSDEDAQELLRESQISLLQLSTVEVATQLSMRNFELFRNIEPTEYIDDLFKLRSKTSCANLKRFEEVINQETFWVASEILRETNQLKRMKIIKHFIKIALHCRECKNFNSMFAIISGLNLAPVARLRTTWEKLPNKYEKLFQDLQDLFDPSRNMAKYRNVLNSQNLQPPIIPLFPVIKKDLTFLHEGNDSKVDGLVNFEKLRMIAKEIRHVGRMASVNMDPALMFRTRKKKWRSLGSLSQGSTNATVLDVAQTGGHKKRVRRSSFLNAKKLYEDAQMARKVKQYLSNLELEMDEESLQTLSLQCEPATNTLPKNPGDKKPVKSETSPVAPRAGSQQKAQSLPQPQQQPPPAHKINQGLQVPAVSLYPSRKKVPVKDLPPFGINSPQALKKILSLSEEGSLERHKKQAEDTISNASSQLSSPPTSPQSSPRKGYTLAPSGTVDNFSDSGHSEISSRSSIVSNSSFDSVPVSLHDERRQRHSVSIVETNLGMGRMERRTMIEPDQYSLGSYAPMSEGRGLYATATVISSPSTEELSQDQGDRASLDAADSGRGSWTSCSSGSHDNIQTIQHQRSWETLPFGHTHFDYSGDPAGLWASSSHMDQIMFSDHSTKYNRQNQSRESLEQAQSRASWASSTGYWGEDSEGDTGTIKRRGGKDVSIEAESSSLTSVTTEETKPVPMPAHIAVASSTTKGLIARKEGRYREPPPTPPGYIGIPITDFPEGHSHPARKPPDYNVALQRSRMVARSSDTAGPSSVQQPHGHPTSSRPVNKPQWHKPNESDPRLAPYQSQGFSTEEDEDEQVSAV
420,Q9Y5N1,Non Druggable,Histamine H3 receptor (H3R) (HH3R) (G-protein coupled receptor 97),HRH3 ,445,48671,MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
421,Q9Y5S8,Druggable,NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1),NOX1 ,564,64871,MGNWVVNHWFSVLFLVVWLGLNVFLFVDAFLKYEKADKYYYTRKILGSTLACARASALCLNFNSTLILLPVCRNLLSFLRGTCSFCSRTLRKQLDHNLTFHKLVAYMICLHTAIHIIAHLFNFDCYSRSRQATDGSLASILSSLSHDEKKGGSWLNPIQSRNTTVEYVTFTSIAGLTGVIMTIALILMVTSATEFIRRSYFEVFWYTHHLFIFYILGLGIHGIGGIVRGQTEESMNESHPRKCAESFEMWDDRDSHCRRPKFEGHPPESWKWILAPVILYICERILRFYRSQQKVVITKVVMHPSKVLELQMNKRGFSMEVGQYIFVNCPSISLLEWHPFTLTSAPEEDFFSIHIRAAGDWTENLIRAFEQQYSPIPRIEVDGPFGTASEDVFQYEVAVLVGAGIGVTPFASILKSIWYKFQCADHNLKTKKIYFYWICRETGAFSWFNNLLTSLEQEMEELGKVGFLNYRLFLTGWDSNIVGHAALNFDKATDIVTGLKQKTSFGRPMWDNEFSTIATSHPKSVVGVFLCGPRTLAKSLRKCCHRYSSLDPRKVQFYFNKENF
422,Q9Y5Y4,Druggable,Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294),PTGDR2 ,395,43268,MSANATLKPLCPILEQMSRLQSHSNTSIRYIDHAAVLLHGLASLLGLVENGVILFVVGCRMRQTVVTTWVLHLALSDLLASASLPFFTYFLAVGHSWELGTTFCKLHSSIFFLNMFASGFLLSAISLDRCLQVVRPVWAQNHRTVAAAHKVCLVLWALAVLNTVPYFVFRDTISRLDGRIMCYYNVLLLNPGPDRDATCNSRQVALAVSKFLLAFLVPLAIIASSHAAVSLRLQHRGRRRPGRFVRLVAAVVAAFALCWGPYHVFSLLEARAHANPGLRPLVWRGLPFVTSLAFFNSVANPVLYVLTCPDMLRKLRRSLRTVLESVLVDDSELGGAGSSRRRRTSSTARSASPLALCSRPEEPRGPARLLGWLLGSCAASPQTGPLNRALSSTSS
423,Q9Y6H1,Non Druggable,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP),CHCHD2 ,151,15513,MPRGSRSRTSRMAPPASRAPQMRAAPRPAPVAQPPAAAPPSAVGSSAAAPRQPGLMAQMATTAAGVAVGSAVGHTLGHAITGGFSGGSNAEPARPDITYQEPQGTQPAQQQQPCLYEIKQFLECAQNQGDIKLCEGFNEVLKQCRLANGLA
424,R4GJQ4,Non Druggable,G_PROTEIN_RECEP_F1_2 domain-containing protein,HRH4,401,45649,MLNMHNSTAETPCMMGPCNGTVSPQPLTPQFPLGVLIFLALLMVLLALVTILGNVLVILAFILDKNLRHRNNYFFLNLAISDFAVGVFCMPLYIPYALTGTWHLGKGLCKLWLLLDYLMCSASVFNIVLISYDRFLSVTKAVSYRTQQGMMSNPVVKMVAIWVFAFLLYSPAVLLWEYMAGYSMVEEGQCYAEFFNNWYFLLCASTLEFFVPLISVTYFNLSIFYNIQRRQRRGSIQYCESPGSRSMTWRFCFLLRRGSSLSETEDSASSVMRSLRPSLASNSTSPTSPVADKRDFSASFRANSQSRLQRDKKVAKSLAIIVCVFVICWAPYTLLMIIRGACQGKCVHPILYEITFWLLWINSSLNPFLYPLCHVRFQMAFMKILCPQKLTMLRSNDTPSV
425,S4R2Z8,Druggable,Adenosine receptor A2 (Fragment),ADORA2A,108,11453,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRI
426,S4R429,Druggable,Adenosine receptor A2a (Fragment),ADORA2A,29,3077,MPIMGSSVYITVELAIAVLAILGNVLVCW
427,S5RC53,Druggable,Adenosine receptor A1,ADORA1,210,24054,MVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIRNDHFRCQPAPPIDEDLPEERPDD
428,S9W3X9,Non Druggable,Histamine H1 receptor,HRH1 ,486,55225,MTFPNSSSVSEDTMNDRNKTATADPQLMPLVVVLSAVSLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAIVMPMNILYLLMSRWSLGHPLCLFWLSMDYVASTASIFSVFILCIDRYRSVRQPLKYLKYRTKTRASATILAAWFLSFLWVIPILGWHRFISKPLQHREGKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKTVRRHCQHRELINGSLPSFSEIKPKPDNPKVGTKKQRKESPWEVLKRKPKDAGGGPVLKPPSQDPKEIKSLGVSSPEDGELDKFHCFSLNVVQPQTEAEGSGGGHAAVNQSQSQLETDEQGLNMHGVTEILEGQILGDSQSFSRTDSDTPTEPTPGKSKSRSGSNTGLDYIKFTWKRLRSQSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCESCSNQHVHMFTIWLGYLNSTLNPLIYPLCNENFKKTFKKILHIRS
429,S9YDG2,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2 ,414,46284,MASNSTDPSSCLNHTAFRVTVSLVLTALILITIAGNVVVCLAVGLTRRLRSLTNCFIVSLAITDLLLGLLVLPFSAFHELSCQWGFGEAFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRAETNSTNHTISKCKVQVNLVYGLVDGLVTFYLPLLVMCITYYRIFKIARDQAKRVHHINSWRTATLREHKATVTLAAVMGAFIVCWFPYFTVFVYRGLRGDDAINETFEAIVLWLGYANSALNPILYATLSRDFRTAYQRLFRCRPAGHVADRTSLRDSSSQLKRNQSQEPRWQEERPLRLQVWSGTEVTAPQGATDRRPALSCTTCSSNLLSCCKSLWGIRLLQRHVGGPSEEQLGEPLSKEPPRTLPSEAV
430,X5DP70,Druggable,Dopamine receptor D3 isoform B,DRD3,134,14311,MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVHCSGHARSLPAWHGTELLSARGPHDHGRLGTGLCCVLPSSVWL
431,U3HYT0,Non Druggable,Histamine H2 receptor (Gastric receptor I),HRH2,371,41364,MDPCNNITDSTKPMSFPLQVLVGSFLTILIVFTLCGNIVVCLAVTLDRRLRSLTNCIIVSLAITDLLLALLVLPFSAIYELTHEWPFGSTLCNIYSSLDVMLCTASILNLLMISLDRYFAVTTPLRYRQVVTPSRVAVGLVIIWAVSLMVSFLPIHLGWNTNGTAVQNTTPNCTKTCDLEVNPIYGLVDALLTFYIPLVIMCVTYYRIFKIAREQAKRINHTWCYSSNSPMPPMVKEHKATVTLAVVLGAFVVCWFPYFTVFTYRGVWGDSGVKGAPMSIVLWLGYANSALNPILYGTLNRDFRVAYQHLLHCWRTGGARSSRLSPPQKGRPRGRNCRQGPDRQEGQEGKSLKLEIRNGKGTSLVDGALQR
432,U3IW30,Non Druggable,Histamine H1 receptor,HRH1,473,54254,MTENATVNSTNTHSALLGLFLGSISLITVVMNILVLCAVKTEKKLQTVGNLYIVSLSVADLIVGAAVMPLNIVYLLNSYVWTLGVTACSFWLSMDYVASTASIFNLFILCIDRYRSVQQPLKYLKYRTKMRALLMILGAWLLSFLWVIPILGWHIFAGAEKKKEIVKCETDFSTVTWFKVFTAFVNFYLPSILMLCFYCKIFIAVRKHCQHRELINRSYLSFSESKSVQPGKTKDKQSICLQKQILDENTPPRDKQRSPQPKNTEAKLHFSDPDSSSKVIVSRRNSEVLKWSCFPLTTAQSEPGLDKTGEKSVTKDNKNEEDLFSQDSDLSDASDSQTFTEEVPCGEESSPNPERACSPQEKTENRDSKGLTYLRKTWQRLHTRSKNHLRRLHVNRERKAAKQLGVIMAAFMLCWIPYFVLYMVIAFHHDERYSTLQMVTIWLGYLNSTLNPFLYPLCNHNFKKTFKKILHIP
433,S4R3A7,Druggable,Adenosine receptor A2a (Fragment),ADORA2A,83,8681,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACF
434,U3KIB4,Non Druggable,Histamine H1 receptor,HRH1,469,53099,MSNNTTENSSNAPSALLGLFLGSISLITIVMNILVLCAVKTEKKLQTVGNLYIVSLSIADLIVGAAVMPLHIVDLLSPRWPLGLAACLFWLSMDYVASTASIFNLFVLCMDRYRSVQQPLKYLKYRTKMRASLLILGVWLLSFTWVIPILGWHVFANSGKRNVAGDKCETEFFQVTWFKVLTAIFNFYLPSLLMLWFYCKIFRTVRKHCQHRELTDGSYWSAMEKNVHQTKTKDEKNICLQKQILGENSPGTDKQAEPQRMEAELHFSHPDKAPKALSNGKVPKWSCLSLSTAKPEPGSDKAGKKGACATRKAGDKEQPDSQDSDSSVASDTHTFTEVTPRAEQPSPSPSPTGACCPQARTERRDSRALGLLRKTWHTLHSHSRSIHQHRNREKKAAKQLGVIMAAFMLCWIPYFVLFMVVTFQDHQQLSELHRVTIWLGYINSTLNPFLYPLCNHNFKKTFKKILHIH
435,W5PY26,Non Druggable,Histamine H1 receptor,HRH1,489,55675,MTCPNSSCIFEDEMCEGNKTAPASDAQLMPLVVVLSAISLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGVVVMPMNIIYLLRCRWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLKYLRYRTKTRASITILAAWFLSFLWIIPILSWRHFQLKTPEPLGHKCETDFYKVTWFKIMTAIVNFYLPTLLMLWFYAKIYKAVRQHCQHRELINGSFPSFSDVKMKPENLQVGAKKPGKESPWEVLKRKPKDTGGGPVLKPPSQEPKEVTSLGVFSQEKDGEPDNFYCFPLDTVQTQPEAEGSGRGYAAINQSQNQFEMGEQGLNMPGAKEALEDQIQGDSQSFSRTDSDTPAEPAAPGKGKSRSESSTGLEYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFIVCWIPYFVFFMVVAFCESCSNERVHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
436,X5D2G4,Druggable,D(3) dopamine receptor (Dopamine D3 receptor) (Fragment),DRD3,400,44195,MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
437,X5DNB4,Druggable,Adenosine receptor A2 (Fragment),ADORA2A,412,44707,MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
438,X5DQM5,Druggable,Beta-2 adrenergic receptor (Beta-2 adrenoceptor) (Beta-2 adrenoreceptor) (Fragment),ADRB2,413,46459,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
439,P07550,Druggable,ADRB2_HUMAN,ADRB2,413,46459,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
440,P32121,Druggable,ARRB2_HUMAN,ARRB2 ,409,46106,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC
441,P25098,Druggable,ARBK1_HUMAN,GRK2 ,689,79574,MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL
442,P34947,Druggable,GRK5_HUMAN,GRK5 GPRK5,590,67787,MELENIVANTVLLKAREGGGGKRKGKSKKWKEILKFPHISQCEDLRRTIDRDYCSLCDKQPIGRLLFRQFCETRPGLECYIQFLDSVAEYEVTPDEKLGEKGKEIMTKYLTPKSPVFIAQVGQDLVSQTEEKLLQKPCKELFSACAQSVHEYLRGEPFHEYLDSMFFDRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGDLIRGRVGTVGYMAPEVLNNQRYGLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSHKFSEEAKSICKMLLTKDAKQRLGCQEEGAAEVKRHPFFRNMNFKRLEAGMLDPPFVPDPRAVYCKDVLDIEQFSTVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGPNGTLPPDLNRNHPPEPPKKGLLQRLFKRQHQNNSKSSPSSKTSFNHHINSNHVSSNSTGSS
443,Q86YN6,Druggable,PRGC2_HUMAN,PPARGC1B ,1023,113222,MAGNDCGALLDEELSSFFLNYLADTQGGGSGEEQLYADFPELDLSQLDASDFDSATCFGELQWCPENSETEPNQYSPDDSELFQIDSENEALLAELTKTLDDIPEDDVGLAAFPALDGGDALSCTSASPAPSSAPPSPAPEKPSAPAPEVDELSLLQKLLLATSYPTSSSDTQKEGTAWRQAGLRSKSQRPCVKADSTQDKKAPMMQSQSRSCTELHKHLTSAQCCLQDRGLQPPCLQSPRLPAKEDKEPGEDCPSPQPAPASPRDSLALGRADPGAPVSQEDMQAMVQLIRYMHTYCLPQRKLPPQTPEPLPKACSNPSQQVRSRPWSRHHSKASWAEFSILRELLAQDVLCDVSKPYRLATPVYASLTPRSRPRPPKDSQASPGRPSSVEEVRIAASPKSTGPRPSLRPLRLEVKREVRRPARLQQQEEEDEEEEEEEEEEEKEEEEEWGRKRPGRGLPWTKLGRKLESSVCPVRRSRRLNPELGPWLTFADEPLVPSEPQGALPSLCLAPKAYDVERELGSPTDEDSGQDQQLLRGPQIPALESPCESGCGDMDEDPSCPQLPPRDSPRCLMLALSQSDPTFGKKSFEQTLTVELCGTAGLTPPTTPPYKPTEEDPFKPDIKHSLGKEIALSLPSPEGLSLKATPGAAHKLPKKHPERSELLSHLRHATAQPASQAGQKRPFSCSFGDHDYCQVLRPEGVLQRKVLRSWEPSGVHLEDWPQQGAPWAEAQAPGREEDRSCDAGAPPKDSTLLRDHEIRASLTKHFGLLETALEEEDLASCKSPEYDTVFEDSSSSSGESSFLPEEEEEEGEEEEEDDEEEDSGVSPTCSDHCPYQSPPSKANRQLCSRSRSSSGSSPCHSWSPATRRNFRCESRGPCSDRTPSIRHARKRREKAIGEGRVVYIQNLSSDMSSRELKRRFEVFGEIEECEVLTRNRRGEKYGFITYRCSEHAALSLTKGAALRKRNEPSFQLSYGGLRHFCWPRYTDYDSNSEEALPASGKSKYEAMDFDSLLKEAQQSLH
444,P16234,Druggable,PGFRA_HUMAN,PDGFRA ,1089,122670,MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYPMSEEESSDVEIRNEENNSGLFVTVLEVSSASAAHTGLYTCYYNHTQTEENELEGRHIYIYVPDPDVAFVPLGMTDYLVIVEDDDSAIIPCRTTDPETPVTLHNSEGVVPASYDSRQGFNGTFTVGPYICEATVKGKKFQTIPFNVYALKATSELDLEMEALKTVYKSGETIVVTCAVFNNEVVDLQWTYPGEVKGKGITMLEEIKVPSIKLVYTLTVPEATVKDSGDYECAARQATREVKEMKKVTISVHEKGFIEIKPTFSQLEAVNLHEVKHFVVEVRAYPPPRISWLKNNLTLIENLTEITTDVEKIQEIRYRSKLKLIRAKEEDSGHYTIVAQNEDAVKSYTFELLTQVPSSILDLVDDHHGSTGGQTVRCTAEGTPLPDIEWMICKDIKKCNNETSWTILANNVSNIITEIHSRDRSTVEGRVTFAKVEETIAVRCLAKNLLGAENRELKLVAPTLRSELTVAAAVLVLLVIVIISLIVLVVIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHHPEKPKKELDIFGLNPADESTRSYVILSFENNGDYMDMKQADTTQYVPMLERKEVSKYSDIQRSLYDRPASYKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSDHPAVARMRVDSDNAYIGVTYKNEEDKLKDWEGGLDEQRLSADSGYIIPLPDIDPVPEEEDLGKRNRHSSQTSEESAIETGSSSSTFIKREDETIEDIDMMDDIGIDSSDLVEDSFL
445,P09619,Druggable,PGFRB_HUMAN,PDGFRB ,1106,123968,MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL
446,P08172,Druggable,ACM2_HUMAN,CHRM2,466,51715,MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
447,Q5JY77,Druggable,GASP1_HUMAN,GPRASP1 ,1395,156865,MTGAEIESGAQVKPEKKPGEEVVGGAEIENDVPLVVRPKVRTQAQIMPGARPKNKSKVMPGASTKVETSAVGGARPKSKAKAIPVSRFKEEAQMWAQPRFGAERLSKTERNSQTNIIASPLVSTDSVLVAKTKYLSEDRELVNTDTESFPRRKAHYQAGFQPSFRSKEETNMGSWCCPRPTSKQEASPNSDFKWVDKSVSSLFWSGDEVTAKFHPGNRVKDSNRSMHMANQEANTMSRSQTNQELYIASSSGSEDESVKTPWFWARDKTNTWSGPREDPNSRSRFRSKKEVYVESSSGSEHEDHLESWFGAGKEAKFRSKMRAGKEANNRARHRAKREACIDFMPGSIDVIKKESCFWPEENANTFSRPMIKKEARARAMTKEEAKTKARARAKQEARSEEEALIGTWFWATDESSMADEASIESSLQVEDESIIGSWFWTEEEASMGTGASSKSRPRTDGERIGDSLFGAREKTSMKTGAEATSESILAADDEQVIIGSWFWAGEEVNQEAEEETIFGSWFWVIDAASVESGVGVSCESRTRSEEEEVIGPWFWSGEQVDIEAGIGEEARPGAEEETIFGSWFWAENQTYMDCRAETSCDTMQGAEEEEPIIGSWFWTRVEACVEGDVNSKSSLEDKEEAMIPCFGAKEEVSMKHGTGVRCRFMAGAEETNNKSCFWAEKEPCMYPAGGGSWKSRPEEEEDIVNSWFWSRKYTKPEAIIGSWLWATEESNIDGTGEKAKLLTEEETIINSWFWKEDEAISEATDREESRPEAEEGDIIGSWFWAGEEDRLEPAAETREEDRLAAEKEGIVGSWFGAREETIRREAGSCSKSSPKAEEEEVIIGSWFWEEEASPEAVAGVGFESKPGTEEEEITVGSWFWPEEEASIQAGSQAVEEMESETEEETIFGSWFWDGKEVSEEAGPCCVSKPEDDEEMIVESWFWSRDKAIKETGTVATCESKPENEEGAIVGSWFEAEDEVDNRTDNGSNCGSRTLADEDEAIVGSWFWAGDEAHFESNPSPVFRAICRSTCSVEQEPDPSRRPQSWEEVTVQFKPGPWGRVGFPSISPFRFPKEAASLFCEMFGGKPRNMVLSPEGEDQESLLQPDQPSPEFPFQYDPSYRSVQEIREHLRAKESTEPESSSCNCIQCELKIGSEEFEELLLLMEKIRDPFIHEISKIAMGMRSASQFTRDFIRDSGVVSLIETLLNYPSSRVRTSFLENMIRMAPPYPNLNIIQTYICKVCEETLAYSVDSPEQLSGIRMIRHLTTTTDYHTLVANYMSGFLSLLATGNAKTRFHVLKMLLNLSENLFMTKELLSAEAVSEFIGLFNREETNDNIQIVLAIFENIGNNIKKETVFSDDDFNIEPLISAFHKVEKFAKELQGKTDNQNDPEGDQEN
448,P49407,Druggable,ARRB1_HUMAN,ARRB1 ARR1,418,47066,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR
449,Q9Y2K6,Druggable,UBP20_HUMAN,USP20 ,914,102003,MGDSRDLCPHLDSIGEVTKEDLLLKSKGTCQSCGVTGPNLWACLQVACPYVGCGESFADHSTIHAQAKKHNLTVNLTTFRLWCYACEKEVFLEQRLAAPLLGSSSKFSEQDSPPPSHPLKAVPIAVADEGESESEDDDLKPRGLTGMKNLGNSCYMNAALQALSNCPPLTQFFLECGGLVRTDKKPALCKSYQKLVSEVWHKKRPSYVVPTSLSHGIKLVNPMFRGYAQQDTQEFLRCLMDQLHEELKEPVVATVALTEARDSDSSDTDEKREGDRSPSEDEFLSCDSSSDRGEGDGQGRGGGSSQAETELLIPDEAGRAISEKERMKDRKFSWGQQRTNSEQVDEDADVDTAMAALDDQPAEAQPPSPRSSSPCRTPEPDNDAHLRSSSRPCSPVHHHEGHAKLSSSPPRASPVRMAPSYVLKKAQVLSAGSRRRKEQRYRSVISDIFDGSILSLVQCLTCDRVSTTVETFQDLSLPIPGKEDLAKLHSAIYQNVPAKPGACGDSYAAQGWLAFIVEYIRRFVVSCTPSWFWGPVVTLEDCLAAFFAADELKGDNMYSCERCKKLRNGVKYCKVLRLPEILCIHLKRFRHEVMYSFKINSHVSFPLEGLDLRPFLAKECTSQITTYDLLSVICHHGTAGSGHYIAYCQNVINGQWYEFDDQYVTEVHETVVQNAEGYVLFYRKSSEEAMRERQQVVSLAAMREPSLLRFYVSREWLNKFNTFAEPGPITNQTFLCSHGGIPPHKYHYIDDLVVILPQNVWEHLYNRFGGGPAVNHLYVCSICQVEIEALAKRRRIEIDTFIKLNKAFQAEESPGVIYCISMQWFREWEAFVKGKDNEPPGPIDNSRIAQVKGSGHVQLKQGADYGQISEETWTYLNSLYGGGPEIAIRQSVAQPLGPENLHGEQKIEAETRAV
450,Q8TEY7,Druggable,UBP33_HUMAN,USP33 ,942,106727,MTGSNSHITILTLKVLPHFESLGKQEKIPNKMSAFRNHCPHLDSVGEITKEDLIQKSLGTCQDCKVQGPNLWACLENRCSYVGCGESQVDHSTIHSQETKHYLTVNLTTLRVWCYACSKEVFLDRKLGTQPSLPHVRQPHQIQENSVQDFKIPSNTTLKTPLVAVFDDLDIEADEEDELRARGLTGLKNIGNTCYMNAALQALSNCPPLTQFFLDCGGLARTDKKPAICKSYLKLMTELWHKSRPGSVVPTTLFQGIKTVNPTFRGYSQQDAQEFLRCLMDLLHEELKEQVMEVEEDPQTITTEETMEEDKSQSDVDFQSCESCSNSDRAENENGSRCFSEDNNETTMLIQDDENNSEMSKDWQKEKMCNKINKVNSEGEFDKDRDSISETVDLNNQETVKVQIHSRASEYITDVHSNDLSTPQILPSNEGVNPRLSASPPKSGNLWPGLAPPHKKAQSASPKRKKQHKKYRSVISDIFDGTIISSVQCLTCDRVSVTLETFQDLSLPIPGKEDLAKLHSSSHPTSIVKAGSCGEAYAPQGWIAFFMEYVKRFVVSCVPSWFWGPVVTLQDCLAAFFARDELKGDNMYSCEKCKKLRNGVKFCKVQNFPEILCIHLKRFRHELMFSTKISTHVSFPLEGLDLQPFLAKDSPAQIVTYDLLSVICHHGTASSGHYIAYCRNNLNNLWYEFDDQSVTEVSESTVQNAEAYVLFYRKSSEEAQKERRRISNLLNIMEPSLLQFYISRQWLNKFKTFAEPGPISNNDFLCIHGGVPPRKAGYIEDLVLMLPQNIWDNLYSRYGGGPAVNHLYICHTCQIEAEKIEKRRKTELEIFIRLNRAFQKEDSPATFYCISMQWFREWESFVKGKDGDPPGPIDNTKIAVTKCGNVMLRQGADSGQISEETWNFLQSIYGGGPEVILRPPVVHVDPDILQAEEKIEVETRSL
451,P24588,Druggable,AKAP5_HUMAN,AKAP5 AKAP79,427,47088,METTISEIHVENKDEKRSAEGSPGAERQKEKASMLCFKRRKKAAKALKPKAGSEAADVARKCPQEAGASDQPEPTRGAWASLKRLVTRRKRSESSKQQKPLEGEMQPAINAEDADLSKKKAKSRLKIPCIKFPRGPKRSNHSKIIEDSDCSIKVQEEAEILDIQTQTPLNDQATKAKSTQDLSEGISRKDGDEVCESNVSNSTTSGEKVISVELGLDNGHSAIQTGTLILEEIETIKEKQDVQPQQASPLETSETDHQQPVLSDVPPLPAIPDQQIVEEASNSTLESAPNGKDYESTEIVAEETKPKDTELSQESDFKENGITEEKSKSEESKRMEPIAIIITDTEISEFDVTKSKNVPKQFLISAENEQVGVFANDNGFEDRTSEQYETLLIETASSLVKNAIQLSIEQLVNEMASDDNKINNLLQ
452,Q96B67,Druggable,ARRD3_HUMAN,ARRDC3 KIAA1376,414,46395,MVLGKVKSLTISFDCLNDSNVPVYSSGDTVSGRVNLEVTGEIRVKSLKIHARGHAKVRWTESRNAGSNTAYTQNYTEEVEYFNHKDILIGHERDDDNSEEGFHTIHSGRHEYAFSFELPQTPLATSFEGRHGSVRYWVKAELHRPWLLPVKLKKEFTVFEHIDINTPSLLSPQAGTKEKTLCCWFCTSGPISLSAKIERKGYTPGESIQIFAEIENCSSRMVVPKAAIYQTQAFYAKGKMKEVKQLVANLRGESLSSGKTETWNGKLLKIPPVSPSILDCSIIRVEYSLMVYVDIPGAMDLFLNLPLVIGTIPLHPFGSRTSSVSSQCSMNMNWLSLSLPERPEAPPSYAEVVTEEQRRNNLAPVSACDDFERALQGPLFAYIQEFRFLPPPLYSEIDPNPDQSADDRPSCPSR
453,O14745,Druggable,NHRF1_HUMAN,SLC9A3R1 NHERF NHERF1,358,38868,MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL
454,P46934,Druggable,NEDD4_HUMAN,NEDD4 ,1319,149114,MAQSLRLHFAARRSNTYPLSETSGDDLDSHVHMCFKRPTRISTSNVVQMKLTPRQTALAPLIKENVQSQERSSVPSSENVNKKSSCLQISLQPTRYSGYLQSSNVLADSDDASFTCILKDGIYSSAVVDNELNAVNDGHLVSSPAICSGSLSNFSTSDNGSYSSNGSDFGSCASITSGGSYTNSVISDSSSYTFPPSDDTFLGGNLPSDSTSNRSVPNRNTTPCEIFSRSTSTDPFVQDDLEHGLEIMKLPVSRNTKIPLKRYSSLVIFPRSPSTTRPTSPTSLCTLLSKGSYQTSHQFIISPSEIAHNEDGTSAKGFLSTAVNGLRLSKTICTPGEVRDIRPLHRKGSLQKKIVLSNNTPRQTVCEKSSEGYSCVSVHFTQRKAATLDCETTNGDCKPEMSEIKLNSDSEYIKLMHRTSACLPSSQNVDCQININGELERPHSQMNKNHGILRRSISLGGAYPNISCLSSLKHNCSKGGPSQLLIKFASGNEGKVDNLSRDSNRDCTNELSNSCKTRDDFLGQVDVPLYPLPTENPRLERPYTFKDFVLHPRSHKSRVKGYLRLKMTYLPKTSGSEDDNAEQAEELEPGWVVLDQPDAACHLQQQQEPSPLPPGWEERQDILGRTYYVNHESRRTQWKRPTPQDNLTDAENGNIQLQAQRAFTTRRQISEETESVDNRESSENWEIIREDEATMYSNQAFPSPPPSSNLDVPTHLAEELNARLTIFGNSAVSQPASSSNHSSRRGSLQAYTFEEQPTLPVLLPTSSGLPPGWEEKQDERGRSYYVDHNSRTTTWTKPTVQATVETSQLTSSQSSAGPQSQASTSDSGQQVTQPSEIEQGFLPKGWEVRHAPNGRPFFIDHNTKTTTWEDPRLKIPAHLRGKTSLDTSNDLGPLPPGWEERTHTDGRIFYINHNIKRTQWEDPRLENVAITGPAVPYSRDYKRKYEFFRRKLKKQNDIPNKFEMKLRRATVLEDSYRRIMGVKRADFLKARLWIEFDGEKGLDYGGVAREWFFLISKEMFNPYYGLFEYSATDNYTLQINPNSGLCNEDHLSYFKFIGRVAGMAVYHGKLLDGFFIRPFYKMMLHKPITLHDMESVDSEYYNSLRWILENDPTELDLRFIIDEELFGQTHQHELKNGGSEIVVTNKNKKEYIYLVIQWRFVNRIQKQMAAFKEGFFELIPQDLIKIFDENELELLMCGLGDVDVNDWREHTKYKNGYSANHQVIQWFWKAVLMMDSEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQSFTVEQWGTPEKLPRAHTCFNRLDLPPYESFEELWDKLQMAIENTQGFDGVD
455,Q9Y397,Druggable,ZDHC9_HUMAN,ZDHHC9 ,364,40916,MSVMVVRKKVTRKWEKLPGRNTFCCDGRVMMARQKGIFYLTLFLILGTCTLFFAFECRYLAVQLSPAIPVFAAMLFLFSMATLLRTSFSDPGVIPRALPDEAAFIEMEIEATNGAVPQGQRPPPRIKNFQINNQIVKLKYCYTCKIFRPPRASHCSICDNCVERFDHHCPWVGNCVGKRNYRYFYLFILSLSLLTIYVFAFNIVYVALKSLKIGFLETLKETPGTVLEVLICFFTLWSVVGLTGFHTFLVALNQTTNEDIKGSWTGKNRVQNPYSHGNIVKNCCEVLCGPLPPSVLDRRGILPLEESGSRPPSTQETSSSLLPQSPAPTEHLNSNEMPEDSSTPEEMPPPEPPEPPQEAAEAEK
456,Q8IZN3,Druggable,ZDH14_HUMAN,ZDHHC14,488,53388,MPPGGGGPMKDCEYSQISTHSSSPMESPHKKKKIAARRKWEVFPGRNKFFCNGRIMMARQTGVFYLTLVLILVTSGLFFAFDCPYLAVKITPAIPAVAGILFFFVMGTLLRTSFSDPGVLPRATPDEAADLERQIDIANGTSSGGYRPPPRTKEVIINGQTVKLKYCFTCKIFRPPRASHCSLCDNCVERFDHHCPWVGNCVGKRNYRFFYMFILSLSFLTVFIFAFVITHVILRSQQTGFLNALKDSPASVLEAVVCFFSVWSIVGLSGFHTYLISSNQTTNEDIKGSWSNKRGKENYNPYSYGNIFTNCCVALCGPISPSLIDRRGYIQPDTPQPAAPSNGITMYGATQSQSDMCDQDQCIQSTKFVLQAAATPLLQSEPSLTSDELHLPGKPGLGTPCASLTLGPPTPPASMPNLAEATLADVMPRKDEHMGHQFLTPDEAPSPPRLLAAGSPLAHSRTMHVLGLASQDSLHEDSVRGLVKLSSV
457,Q08499,Druggable,PDE4D_HUMAN,PDE4D DPDE3,809,91115,MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT
458,P78352,Druggable,DLG4_HUMAN,DLG4 PSD95,724,80495,MDCLCIVTTKKYRYQDEDTPPLEHSPAHLPNQANSPPVIVNTDTLEAPGYELQVNGTEGEMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNAYLSDSYAPPDITTSYSQHLDNEISHSSYLGTDYPTAMTPTSPRRYSPVAKDLLGEEDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAKIHDLREQLMNSSLGSGTASLRSNPKRGFYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDASDEEWWQARRVHSDSETDDIGFIPSKRRVERREWSRLKAKDWGSSSGSQGREDSVLSYETVTQMEVHYARPIIILGPTKDRANDDLLSEFPDKFGSCVPHTTRPKREYEIDGRDYHFVSSREKMEKDIQAHKFIEAGQYNSHLYGTSVQSVREVAEQGKHCILDVSANAVRRLQAAHLHPIAIFIRPRSLENVLEINKRITEEQARKAFDRATKLEQEFTECFSAIVEGDSFEEIYHKVKRVIEDLSGPYIWVPARERL
459,Q5JWF2,Druggable,GNAS1_HUMAN,GNAS GNAS1,1037,111025,MGVRNCLYGNNMSGQRDIPPEIGEQPEQPPLEAPGAAAPGAGPSPAEEMETEPPHNEPIPVENDGEACGPPEVSRPNFQVLNPAFREAGAHGSYSPPPEEAMPFEAEQPSLGGFWPTLEQPGFPSGVHAGLEAFGPALMEPGAFSGARPGLGGYSPPPEEAMPFEFDQPAQRGCSQLLLQVPDLAPGGPGAAGVPGAPPEEPQALRPAKAGSRGGYSPPPEETMPFELDGEGFGDDSPPPGLSRVIAQVDGSSQFAAVAASSAVRLTPAANAPPLWVPGAIGSPSQEAVRPPSNFTGSSPWMEISGPPFEIGSAPAGVDDTPVNMDSPPIALDGPPIKVSGAPDKRERAERPPVEEEAAEMEGAADAAEGGKVPSPGYGSPAAGAASADTAARAAPAAPADPDSGATPEDPDSGTAPADPDSGAFAADPDSGAAPAAPADPDSGAAPDAPADPDSGAAPDAPADPDAGAAPEAPAAPAAAETRAAHVAPAAPDAGAPTAPAASATRAAQVRRAASAAPASGARRKIHLRPPSPEIQAADPPTPRPTRASAWRGKSESSRGRRVYYDEGVASSDDDSSGDESDDGTSGCLRWFQHRRNRRRRKPQRNLLRNFLVQAFGGCFGRSESPQPKASRSLKVKKVPLAEKRRQMRKEALEKRAQKRAEKKRSKLIDKQLQDEKMGYMCTHRLLLLGAGESGKSTIVKQMRILHVNGFNGEGGEEDPQAARSNSDGEKATKVQDIKNNLKEAIETIVAAMSNLVPPVELANPENQFRVDYILSVMNVPDFDFPPEFYEHAKALWEDEGVRACYERSNEYQLIDCAQYFLDKIDVIKQADYVPSDQDLLRCRVLTSGIFETKFQVDKVNFHMFDVGGQRDERRKWIQCFNDVTAIIFVVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNKQDLLAEKVLAGKSKIEDYFPEFARYTTPEDATPEPGEDPRVTRAKYFIRDEFLRISTASGDGRHYCYPHFTCAVDTENIRRVFNDCRDIIQRMHLRQYELL
460,Q9NUE0,Druggable,ZDH18_HUMAN,ZDHHC18,388,42031,MKDCEYQQISPGAAPLPASPGARRPGPAASPTPGPGPAPPAAPAPPRWSSSGSGSGSGSGSLGRRPRRKWEVFPGRNRFYCGGRLMLAGHGGVFALTLLLILTTTGLFFVFDCPYLARKLTLAIPIIAAILFFFVMSCLLQTSFTDPGILPRATVCEAAALEKQIDNTGSSTYRPPPRTREVLINGQMVKLKYCFTCKMFRPPRTSHCSVCDNCVERFDHHCPWVGNCVGRRNYRFFYAFILSLSFLTAFIFACVVTHLTLRAQGSNFLSTLKETPASVLELVICFFSIWSILGLSGFHTYLVASNLTTNEDIKGSWSSKRGGEASVNPYSHKSIITNCCAVLCGPLPPSLIDRRGFVQSDTVLPSPIRSDEPACRAKPDASMVGGHP
461,P48736,Druggable,PK3CG_HUMAN,PIK3CG,1102,126454,MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA
462,O60503,Druggable,ADCY9_HUMAN,ADCY9 KIAA0520,1353,150701,MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRWWDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALTLLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFPSPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKRHATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRAKESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTCPSCGITFAPKSEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNIREKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQEEVIKNSPVKTFASPTFSSLLDVFLSTTVFLTLSTTCFLKYEAATVPPPPAALAVFSAALLLEVLSLAVSIRMVFFLEDVMACTKRLLEWIAGWLPRHCIGAILVSLPALAVYSHVTSEYETNIHFPVFTGSAALIAVVHYCNFCQLSSWMRSSLATVVGAGPLLLLYVSLCPDSSVLTSPLDAVQNFSSERNPCNSSVPRDLRRPASLIGQEVVLVFFLLLLLVWFLNREFEVSYRLHYHGDVEADLHRTKIQSMRDQADWLLRNIIPYHVAEQLKVSQTYSKNHDSGGVIFASIVNFSEFYEENYEGGKECYRVLNELIGDFDELLSKPDYSSIEKIKTIGATYMAASGLNTAQAQDGSHPQEHLQILFEFAKEMMRVVDDFNNNMLWFNFKLRVGFNHGPLTAGVIGTTKLLYDIWGDTVNIASRMDTTGVECRIQVSEESYRVLSKMGYDFDYRGTVNVKGKGQMKTYLYPKCTDHRVIPQHQLSISPDIRVQVDGSIGRSPTDEIANLVPSVQYVDKTSLGSDSSTQAKDAHLSPKRPWKEPVKAEERGRFGKAIEKDDCDETGIEEANELTKLNVSKSV
463,Q13557,Druggable,KCC2D_HUMAN,CAMK2D CAMKD,499,56369,MASTTTCTRFTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSAAKSLLKKPDGVKESTESSNTTIEDEDVKARKQEIIKVTEQLIEAINNGDFEAYTKICDPGLTAFEPEALGNLVEGMDFHRFYFENALSKSNKPIHTIILNPHVHLVGDDAACIAYIRLTQYMDGSGMPKTMQSEETRVWHRRDGKWQNVHFHRSGSPTVPIKPPCIPNGKENFSGGTSLWQNI
464,Q9H6Z9,Druggable,EGLN3_HUMAN,EGLN3,239,27261,MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED
465,P12931,Druggable,SRC_HUMAN,SRC SRC1,536,59835,MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
466,O14964,Druggable,HGS_HUMAN,HGS HRS,777,86192,MGRGSGTFERLLDKATSQLLLETDWESILQICDLIRQGDTQAKYAVNSIKKKVNDKNPHVALYALEVMESVVKNCGQTVHDEVANKQTMEELKDLLKRQVEVNVRNKILYLIQAWAHAFRNEPKYKVVQDTYQIMKVEGHVFPEFKESDAMFAAERAPDWVDAEECHRCRVQFGVMTRKHHCRACGQIFCGKCSSKYSTIPKFGIEKEVRVCEPCYEQLNRKAEGKATSTTELPPEYLTSPLSQQSQLPPKRDETALQEEEELQLALALSQSEAEEKERLRQKSTYTSYPKAEPMPSASSAPPASSLYSSPVNSSAPLAEDIDPELARYLNRNYWEKKQEEARKSPTPSAPVPLTEPAAQPGEGHAAPTNVVENPLPETDSQPIPPSGGPFSEPQFHNGESEESHEQFLKALQNAVTTFVNRMKSNHMRGRSITNDSAVLSLFQSINGMHPQLLELLNQLDERRLYYEGLQDKLAQIRDARGALSALREEHREKLRRAAEEAERQRQIQLAQKLEIMRQKKQEYLEVQRQLAIQRLQEQEKERQMRLEQQKQTVQMRAQMPAFPLPYAQLQAMPAAGGVLYQPSGPASFPSTFSPAGSVEGSPMHGVYMSQPAPAAGPYPSMPSTAADPSMVSAYMYPAGATGAQAAPQAQAGPTASPAYSSYQPTPTAGYQNVASQAPQSLPAISQPPQSSTMGYMGSQSVSMGYQPYNMQNLMTTLPSQDASLPPQQPYIAGQQPMYQQMAPSGGPPQQQPPVAQQPQAQGPPAQGSEAQLISFD
467,Q15599,Druggable,NHRF2_HUMAN,SLC9A3R2 NHERF2,337,37414,MAAPEPLRPRLCRLVRGEQGYGFHLHGEKGRRGQFIRRVEPGSPAEAAALRAGDRLVEVNGVNVEGETHHQVVQRIKAVEGQTRLLVVDQETDEELRRRQLTCTEEMAQRGLPPAHDPWEPKPDWAHTGSHSSEAGKKDVSGPLRELRPRLCHLRKGPQGYGFNLHSDKSRPGQYIRSVDPGSPAARSGLRAQDRLIEVNGQNVEGLRHAEVVASIKAREDEARLLVVDPETDEHFKRLRVTPTEEHVEGPLPSPVTNGTSPAQLNGGSACSSRSDLPGSDKDTEDGSAWKQDPFQESGLHLSPTAAEAKEKARAMRVNKRAPQMDWNRKREIFSNF
468,P40337,Druggable,VHL_HUMAN,VHL,213,24153,MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD
469,Q9P0N8,Druggable,MARH2_HUMAN,MARCHF2 ,246,26995,MTTGDCCHLPGSLCDCSGSPAFSKVVEATGLGPPQYVAQVTSRDGRLLSTVIRALDTPSDGPFCRICHEGANGECLLSPCGCTGTLGAVHKSCLEKWLSSSNTSYCELCHTEFAVEKRPRPLTEWLKDPGPRTEKRTLCCDMVCFLFITPLAAISGWLCLRGAQDHLRLHSQLEAVGLIALTIALFTIYVLWTLVSFRYHCQLYSEWRKTNQKVRLKIREADSPEGPQHSPLAAGLLKKVAEETPV
470,O75608,Druggable,LYPA1_HUMAN,LYPLA1 ,230,24670,MCGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID
471,Q7Z5Y6,Druggable,BMP8A_HUMAN,BMP8A,402,44798,MAARPGPLWLLGLTLCALGGGGPGLRPPPGCPQRRLGARERRDVQREILAVLGLPGRPRPRAPPAASRLPASAPLFMLDLYHAMAGDDDEDGAPAEQRLGRADLVMSFVNMVERDRALGHQEPHWKEFRFDLTQIPAGEAVTAAEFRIYKVPSIHLLNRTLHVSMFQVVQEQSNRESDLFFLDLQTLRAGDEGWLVLDVTAASDCWLLKRHKDLGLRLYVETEDGHSVDPGLAGLLGQRAPRSQQPFVVTFFRASPSPIRTPRAVRPLRRRQPKKSNELPQANRLPGIFDDVRGSHGRQVCRRHELYVSFQDLGWLDWVIAPQGYSAYYCEGECSFPLDSCMNATNHAILQSLVHLMKPNAVPKACCAPTKLSATSVLYYDSSNNVILRKHRNMVVKACGCH
472,Q68DH5,Druggable,LMBD2_HUMAN,LMBRD2,695,81172,MSGAALGLEIVFVFFLALFLLHRYGDFKKQHRLVIIGTLLAWYLCFLIVFILPLDVSTTIYNRCKHAAANSSPPENSNITGLYATANPVPSQHPCFKPWSYIPDGIMPIFWRVVYWTSQFLTWILLPFMQSYARSGGFSITGKIKTALIENAIYYGTYLLIFGAFLIYVAVNPHLHLEWNQLQTIGIAAANTWGLFLLVLLLGYGLVEIPRSYWNGAKRGYLLMKTYFKAAKLMTEKADAEENLEDAMEEVRKVNESIKYNHPLRKCVDTILKKCPTEYQEKMGRNMDDYEDFDEKHSIYPSEKSLVKLHKQVIYSVQRHRRTQVQWQILLEQAFYLEDVAKNETSATHQFVHTFQSPEPENRFIQYFYNPTFEWYWECLLRPWFYKILAVVLSIFSVIVVWSECTFFSTTPVLSLFAVFIQLAEKTYNYIYIEIACFLSIFFLSICVYSTVFRIRVFNYYYLASHHQTDAYSLLFSGMLFCRLTPPLCLNFLGLTHMDSSISHKNTQPTAYTSIMGSMKVLSFIADGFYIYYPMLVVILCIATYFSLGTRCLNLLGFQQFMGDDDMTSDLVNEGKELIRKEKRKRQRQEEGENRRREWKERYGHNREDSTRNRNIHTDPKESNFSDVNTNRSAFKYTRANNRTERDRIELLQDAEPLDFNAETFTDDPLESESGRYQPGGRYLSMSRSDIFNDV
473,Q8NCT1,Druggable,ARRD4_HUMAN,ARRDC4,418,45479,MGGEAGCAAAVGAEGRVKSLGLVFEDERKGCYSSGETVAGHVLLEASEPVALRALRLEAQGRATAAWGPSTCPRASASTAALAVFSEVEYLNVRLSLREPPAGEGIILLQPGKHEFPFRFQLPSEPLVTSFTGKYGSIQYCVRAVLERPKVPDQSVKRELQVVSHVDVNTPALLTPVLKTQEKMVGCWFFTSGPVSLSAKIERKGYCNGEAIPIYAEIENCSSRLIVPKAAIFQTQTYLASGKTKTIRHMVANVRGNHIASGSTDTWNGKTLKIPPVTPSILDCCIIRVDYSLAVYIHIPGAKKLMLELPLVIGTIPYNGFGSRNSSIASQFSMDMSWLTLTLPEQPEAPPNYADVVSEEEFSRHIPPYPQPPNCEGEVCCPVFACIQEFRFQPPPLYSEVDPHPSDVEESQPVSFIL
474,A0A0R4J0N8,Non Druggable,A0A0R4J0N8_MOUSE,Cxcr4,359,40412,MEPISVSIYTSDNYSEEVGSGDYDSNKEPCFRDENVHFNRIFLPTIYFIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAMADWYFGKFLCKAVHIIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKAVYVGVWIPALLLTIPDFIFADVSQGDISQGDDRYICDRLYPDSLWMVVFQFQHIMVGLVLPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYVGISIDSFILLGVIKQGCDFESIVHKWISITEALAFFHCCLNPILYAFLGAKFKSSAQHALNSMSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
475,Q9PTF7,Non Druggable,Q9PTF7_DANRE,cxcr4b ,353,39445,MEFYDSIILDNSSDSGSGDYDGEELCDLSVSNDFQKIFLPTVYGIIFVLGIIGNGLVVLVMGFQKKSKNMTDKYRLHLSIADLLFVLTLPFWAVDAVSGWHFGGFLCVTVNMIYTLNLYSSVLILAFISLDRYLAVVRATNSQNLRKLLAGRVIYIGVWLPATFFTIPDLVFAKIHNSSMGTICELTYPQEANVIWKAVFRFQHIIIGFLLPGLIILTCYCIIISKLSKNSKGQTLKRKALKTTVILILCFFICWLPYCAGILVDALTMLNVISHSCFLEQGLEKWIFFTEALAYFHCCLNPILYAFLGVRFSKSARNALSISSRSSHKMLTKKRGPISSVSTESESSSALTS
476,Q504H4,Non Druggable,Q504H4_DANRE,cxcr4b,353,39444,MEFYDSIILDNSSDSGSGDYDGEELCDLSVSNDFQKIFLPTVYGIIFVLGIIGNGLVVLVMGFQKKSKNMTDKYRLHLSIADLLFVLTLPFWAVDAVSGWHFGGFLCVTVNMIYTLNLYSSVLILAFISLDRYLAVVRATNSQNLRKLLAGRVIYIGVWLPATFFTIPDLVFAKIHNSSMGTICELTYPQEANVIWKAVFRFQHIIIGFLLPGLIILTCYCIIISKLSKNSKGQTLKRKALKTTVILILCFFICWLPYCAGILVDALTMLNVISHSCFLEQGLEKWIFFTEALAYFHCCLNPILYAFLGVRFSKSARNALSISSRSSHKMLTKKRGPISSVSTKSESSSALTS
477,F8W4X7,Non Druggable,F8W4X7_DANRE,cxcr4a,283,31724,MTDKYRLHLSVADLLFVLTLPFWAVDAAKDWYFGGFMCVAVHMIYTVNLYSSVLILAFISLDRYLAVVRATNSQGPRKLLANRIIYVGVWLPAALLTVPDLVFAKAESSAIRTFCERIYPQDSFVTWVVAFRFQHILVGFVLPGLVILICYCIIISKLSRGSKGTQKRKALKTTVVLIVCFFVCWLPYCGGILLDTLMMLEVIPHSCELEQGLQKWIFVTEALAYFHCCLNPILYAFLGVKFKKSARSALSPSRGSSLKILSKKRTGMSSVSTESESSSFHSS
478,F1QCB2,Non Druggable,F1QCB2_DANRE,cxcr4a,360,40181,MAYYEHIVFEDDLSADNSSEFGSGDIGANFEVPCDVEVSHDFQRIFLPTVYGIIFVLGLIGNGLVVLVMGCQKKSRTMTDKYRLHLSVADLLFVLTLPFWAVDAAKDWYFGGFMCVAVHMIYTVNLYSSVLILAFISLDRYLAVVRATNSQGPRKLLANRIIYVGVWLPAALLTVPDLVFAKAESSAIRTFCERIYPQDSFVTWVVAFRFQHILVGFVLPGLVILICYCIIISKLSRGSKGTQKRKALKTTVVLIVCFFVCWLPYCGGILLDTLMMLEVIPHSCELEQGLQKWIFVTEALAYFHCCLNPILYAFLGVKFKKSARSALSPSRGSSLKILSKKRTGMSSVSTESESSSFHSS
479,Q7ZU02,Non Druggable,Q7ZU02_DANRE,cxcr4a,360,40109,MAYYGHIVFEDDLSADNSSEFGSGDIGANFEVPCDVEVSHDFQRIFLPTVYGIIFALGLIGNGLVVLVMGCQKKSRTMTDKYRLHLSVADLLFVLTLPFWAVDVAKDWYFGGFMCVAVHMIYTVNLYSSVLILAFISLDRYLAVVRATNSQGPRKLLANRIIYVGVWLPAALLTVPDLVFAKAESSAIRTFCERIYPQDSFVTWVVAFRFQHILVGFVLPGLVILICYCIIISKLSRGSKGTQKRKALKTTVVLIVCFFVCWLPYCGGILLDTLMMLEVIPHSCELEQGLQKWIFVTEALAYFHCCLNPILYAFLGVKFKKSARSALSPSRGSSLKILSKKRTGMSSVSTESESSSFHSS
480,Q8UUW8,Non Druggable,Q8UUW8_DANRE,cxcr4a,360,40215,MAYYEHIVFEDDLSADNSSEFGSGDIGANFEVPCDVEVSHDFQRIFLPTVYGIIFVLGLIGNGLVVLVMGCQKKSRTMTDKYRLHLSVADLLFVLTLPFWAVDAAKDWYFGGFMCVAVHMIYTVNLYSSVLILAFISLDRYLAVVRATNSQGPRKLLANRIIYVGVWLPAALLTVPDLVFAKAESSAIRTFCERIYPQDSFVTWVVAFRFQHILVGFVLPGLVILICYCIIISKLSRGSKGTQKRKALKTTVVLIVCFFVCWLPYCGGILLDTLMMLEVIPHSCELEQGLQKWIFVTEALAYFHCCLNPILYAFLGVKFKKSARSALSPSRGSSLKFLSKKRTGMSSVSTESESSSFHSS
481,F6Y9M7,Non Druggable,F6Y9M7_HORSE,CXCR4,353,39938,MDGFRIYTSDNYTEDDVGSGDYDSLKEPCFREENAHFNQIFLPTVYFIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREGDGRYICDRFYPSDLWLVVFQFQHIMVGLILPGIVILSCYCVIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIQRGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
482,A0A2K6KID5,Non Druggable,A0A2K6KID5_RHIBE,CXCR4,415,46782,MEGISENAVFPNVPNRPTPQRSGRLGEEVPFVHFLALPANILQAPKGLRFKTPFSLPTTCCLKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
483,A0A2I2ZTQ3,Non Druggable,A0A2I2ZTQ3_GORGO,CXCR4,423,47481,MEGISENAPLPNVPNAPSDKHEDGKRPTPLRSARLGEEVPFVHFLTLPPNIPQAPKGLRFKTAFSLPTTSCLKPTMIYTSDNYTEEMGSGDYDSIKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
484,A0A2K6P0L5,Non Druggable,A0A2K6P0L5_RHIRO,CXCR4,415,46782,MEGISENAVFPNVPNRPTPQRSGRLGEEVPFVHFLALPANILQAPKGLRFKTPFSLPTTCCLKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
485,F7F4S0,Non Druggable,F7F4S0_ORNAN,CXCR4,336,37871,GSGDYDNYKEPCYRQENADFNRIFLPTIYSIIFLTGIVGNLLVIIVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAAVSWCFGIFLCKAIHVIYTVNLYGSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPAVLLTIPDLIFAETSQLDERYICERFYPHDTWLISFRFQHIVVGLILPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFILLGVIKQGCAFQNTVHKWVSITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
486,A0A0D9RUS6,Non Druggable,A0A0D9RUS6_CHLSB,CXCR4,352,39723,MEGISIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
487,A0A2K5H8D5,Non Druggable,A0A2K5H8D5_COLAP,,408,46021,MEGISENAVPTPRRSGRLGEEVPFVHFLTLPASILQAPKGLRFKTAFSLRTTCCLKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
488,A0A5F7ZJL0,Non Druggable,A0A5F7ZJL0_MACMU,CXCR4,382,43273,MCPAVREFGIVQRSEEWFDLPFDTAQLPAPRHALRIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
489,A0A2K5XJP9,Non Druggable,A0A2K5XJP9_MANLE,CXCR4,408,46094,MEGISENTVPTPRRSGRLGEEVPFVHFLTLPPSILQAPKGLRLKTAFSLPTTRCWKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRFICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
490,A0A2K6C0G1,Non Druggable,A0A2K6C0G1_MACNE,CXCR4,409,46145,MEGISENAVPTPRRSGRLGGEEVPFVHFLTLPPNILQAPKGLRFKTAFSLPTTCCWKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
491,A0A7N9CYN8,Non Druggable,A0A7N9CYN8_MACFA,,382,43273,MCPAVREFGIVQRSEEWFDLPFDTAQLPAPRHALRIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
492,A0A2K5KP70,Non Druggable,A0A2K5KP70_CERAT,,408,46038,MEGISENAVPTPRRSGRLGEEVPFVHFLTLPPNILQAPKGLRLKTAFSLPTTCCWKRRMICIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRFICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
493,A0A3S5ZPQ6,Non Druggable,A0A3S5ZPQ6_CHICK,CXCR4,362,40485,MDGSMDGLDLSSGILIEFADNGSEEIGSADYGDYGEPCFQHENADFNRIFLPTIYSIIFLTGIIGNGLVIIVMGYQKKQRSMTDKYRLHLSVADLLFVITLPFWSVDAAISWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKIVYVGVWLPAVLLTVPDIIFASTSEVEGRYLCDRMYPHDNWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILTFFACWLPYYIGISIDTFILLGVIRHRCSLDTIVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKSKRGGHSSVSTESESSSFHSS
494,I3M7N9,Non Druggable,I3M7N9_ICTTR,CXCR4,352,39613,MEGISIYTSDNYSEELGSGDYDSIKEPCFREESAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKAVYVGVWIPALLLTIPDLIFANISEAEGKYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
495,H0XSI0,Non Druggable,H0XSI0_OTOGA,CXCR4,352,39778,MEGISIFTSDNYTEELGSGDYDTMKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGEFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYAGVWLPAFLLTIPDVIFASVREADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFDNTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
496,W5PLA4,Non Druggable,W5PLA4_SHEEP,CXCR4,353,39939,MEGIRIFTSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGQFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPAVLLTIPDLIFADIKEADERYICDRFYPSDLWLVVFQFQHIVVGLLLPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILTFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
497,G1P5E3,Non Druggable,G1P5E3_MYOLU,CXCR4,353,40029,MDGFHIYPSDNYTEEDMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLAIPDFIFANVRVGEDRYICDRFYPNDVWMVVFQFQHIMVGLVLPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILTFFACWLPYYIGLSIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKSSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
498,A0A3B3HNF4,Non Druggable,A0A3B3HNF4_ORYLA,LOC100049444,375,42328,MEYFYESIVFDNSSEGILDGSGDFEFPEEAYKEALSRDFKKIFLPTVYGVIFVLGIVGNGLVVVVMGYQKKVKNMTDKYRLHLSVADLLLVLTLPFWAVDAVKTWYFGGFVCVSAHVIYTVNLYSSVLILAFISLDRYLAIVRATNSQATRKLLASRVIYVGVWLPAAFLTVPDLVFARVKSVSSPSFSFRNDSVEMEDSRTICERFYPVESRVVWTVIFRFQHILVGFILPGLVILVCYCIIIAKLSKGTKGQTLKKRALKTTVILILCFFCCWLPYCIGIFLDTLMMLNVVRTTYELQQALDKWISITEALAYFHCCLNPILYAFLGVRFKKTARSTLTMSSKSSQKVNLMTKKRGQVSSVSTESESSSVLSS
499,A0A452EIP6,Non Druggable,A0A452EIP6_CAPHI,CXCR4,353,39939,MEGIRIFTSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGQFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPAVLLTIPDLIFADIKEADERYICDRFYPSDLWLVVFQFQHIVVGLLLPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILTFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
500,A4IG54,Non Druggable,A4IG54_DANRE,ackr3b cxcr7b,362,41002,MSVNVNDFNDILDALGELNFSTLDDNVSHVEVCHSTFSQRALLYALSVLYIFLFIIGLAANALVVWVNVRAERTRYETHLYILNLAIADLCVVATLPVSISSLLQLGHWPFGGAMCKITHLIFSVNLFSSIFFLTCMSVDRYLSVKLFGDTPSQRKRRTRQIICVGVWLLALIAALPEIYFLQAEKSDHSDAIVCKAVYPVESMKEWTVGIQMSFFMLGFAIPFPVIAVFYVLLANTIHPSVDQERRISRHLIFTYIVVFLVCWLPYHGALLLDTLAFLNVLPFNCTLENALYAALHLTQCFSLFHCCANPIIYNFINKNYRYDLMKAFIFKYSTKTGLARLIDASHVSETEYSAVENQGPL
501,H2P7G7,Non Druggable,H2P7G7_PONAB,CXCR4,352,39713,MDGISIYTSDNYTEEMGSGDYDSIKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
502,A0A2I3SCD8,Non Druggable,A0A2I3SCD8_PANTR,CXCR4,423,47584,MEGISENAPLLNVPNAPSDKHEDGKRPTPRRSARLGEEVPFVHFLALPPNIPQAPKGLRFKTAFSLPTTSCLKPRMIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
503,G1K8R1,Non Druggable,G1K8R1_ANOCA,CXCR4,355,39751,MDLPPGIFIFMTENSTDEPGSGDDGDYQEVCLQQENADFNRIFLPTIFSIIFLTGIIGNGLVIVVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWSVDAVISWYFGNFLCKAVHFIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAERIVYVGVWLPALLLTVPDIIFASTSEVGGKYVCQRFYPHETWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILIVAFFACWLPYHIGISIDTFVLLGFIENGCTFEAILQKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
504,A0A2R9C6K7,Non Druggable,A0A2R9C6K7_PANPA,CXCR4,423,47584,MEGISENAPLLNVPNAPSDKHEDGKRPTPRRSARLGEEVPFVHFLALPPNIPQAPKGLRFKTAFSLPTTSCLKPRMIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
505,A0A2I3H1J1,Non Druggable,A0A2I3H1J1_NOMLE,CXCR4,375,42181,MEGISENAPLPNVPNAPTPRRSARLGEDIYTSDNYTEEMGSGDYDSIKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
506,A0A286XNY4,Non Druggable,A0A286XNY4_CAVPO,CXCR4,346,39075,KEGYNEIYTSDNYSEELGSGDYDSTKEPCFRDENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVVTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKAVYVGVWIPALLLTIPDLIFADYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENNVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
507,G3SXW5,Non Druggable,G3SXW5_LOXAF,CXCR4,352,39804,LPLLQFFTMDNETEEVGSGDYDSIKEPCFREENAHFNRFFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVAGWYFGKFLCQAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFANVTESEEKYICDRFYPSDLWMVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYVGISIDAFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
508,A0A384CGV1,Non Druggable,A0A384CGV1_URSMA,CXCR4,353,39977,MDAFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
509,A0A2K6GCZ2,Non Druggable,A0A2K6GCZ2_PROCO,CXCR4,352,39727,MEGISIYTSDNYTEELGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHIIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYAGVWLPALLLTIPDFIFANVSEADDRYICDRLYPNDLWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALSSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
510,A0A0N8EUK5,Non Druggable,A0A0N8EUK5_HETGA,CXCR4,353,39715,MEGGISIYTSDNYSEELGSGDYDSAKEPCFRNENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLVERAVYVGVWIPAVLLTIPDFIFANVIEGEGKYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
511,G3W1V5,Non Druggable,G3W1V5_SARHA,CXCR4,362,40483,MGSNSGDDLYPYTGPIIEFHDNSTDGFGSGDYDGKEPCFRHENADFNRIFLPTVYSIIFLTGIVGNGLVIIVVGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAAASWYFGNFLCKAVHVIYTVNLYGSVLILAFISLDRYLAIVHATNSQRPRKLLAEKIVYLGVWLPAVLLTVPDFIFANTSEGNGRTFCDREYPHEKWMISFQFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDIFVLLEVIKQDCDFDNAVHKWISITEAVAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
512,U3FG72,Non Druggable,U3FG72_CALJA,CXCR4,352,39803,MEGISIYTSDNYTEEIGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIRQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
513,A0A2Y9FUW6,Non Druggable,A0A2Y9FUW6_PHYMC,CXCR4,353,39866,MDGFHIFSSDNYTEDDLGSGDYDSIKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREGDGRYICDRFYPNDLWVVVFQFQHIVVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
514,A0A452SH46,Non Druggable,A0A452SH46_URSAM,CXCR4,353,39977,MDAFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
515,A0A4X2KAR1,Non Druggable,A0A4X2KAR1_VOMUR,CXCR4,363,40569,MSSNSGDDLDSFTGFIIEFHDNNGTDGFGSGDYDGKEPCFRHENEDFNRIFLPTVYSIIFLTGIVGNGLVIIVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAAASWYFGNFLCKAVHVIYTVNLYGSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYLGVWLPAVLLTIPDIIFANTGEANGRYFCDRMYPNDNWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFALLEVIKQDCDFDSAVHKWISITEAVAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
516,A0A3Q7U138,Non Druggable,A0A3Q7U138_VULVU,CXCR4,353,40123,MEELHIYPSDNYTEEDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVEAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADERYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFEKTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
517,A0A4W2F1R8,Non Druggable,A0A4W2F1R8_BOBOX,CXCR4,353,39939,MEGIRIFTSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWLPAVLLTIPDLIFADIKEVDERYICDRFYPSDLWLVVFQFQHIVVGLLLPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILTFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
518,A0A2Y9N1S4,Non Druggable,A0A2Y9N1S4_DELLE,CXCR4,353,39825,MDGFHIFSSDNYTEDDLGSGDYDSIKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVKEGDGRYICDRFYPSDLWLVVFQFQHIVVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
519,A0A2K6S140,Non Druggable,A0A2K6S140_SAIBB,CXCR4,392,44004,MKLGARTTGADPVTFSTQENAAFPNVPKAPNGKHEDGKRDPRPGGIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIRQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
520,A0A4W2FXA3,Non Druggable,A0A4W2FXA3_BOBOX,CXCR4,353,39911,MEGIRIFTSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWLPAVLLTIPDLIFADIKEVDERYICDRFYPSDLWLAVFQFQHIVVGLLLPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILTFFACWLPYYIGISIDSFILLEIIQQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
521,A0A2K5PL25,Non Druggable,A0A2K5PL25_CEBIM,CXCR4,405,45613,MEGISENAAFPNVPKAPTPGRIARLGEEVAFVHFLTLPSTIPQAPKDLRCRTVFSLHVIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIRQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
522,A8KBU0,Non Druggable,A8KBU0_DANRE,ackr3b ,362,40998,MSVNVNDFNDILDALGELNFSTLDDNVSHVEVCHSTFSQRALLYALSVLYIFLFIIGLAANALVVWVNVRAERTRYETHLYILNLAIADLCVVATLPVSISSLLQLGHWPFGGAICKITHLIFSVNLFSSIFFLTCMSVDRYLSVKLFGDTPSQRKRRTRQIICVGVWLLALIAALPEIYFLQAEKSDHSDAIVCKAVYPVESMKEWTVGIQMSFFMLGFAIPFPVIAVFYILLANTIHPSVDQERRISRHLIFTYIVVFLVCWLPYHGALLLDTLAFLNVLPFNCTLENALYAALHLTQCFSLFHCCANPIIYNFINKNYRYDLMKAFIFKYSTKTGLARLIDASHVSETEYSAVENQGPL
523,M3XT32,Non Druggable,M3XT32_MUSPF,CXCR4,353,39963,MDGFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
524,A0A663D9W7,Non Druggable,A0A663D9W7_PONAB,CR201_G0035416,352,39713,MDGISIYTSDNYTEEMGSGDYDSIKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
525,K7FNW3,Non Druggable,K7FNW3_PELSI,CXCR4,427,47075,MFTSAQGLCGCHLPPGRSLTQAATEGGGAGGIRDQGAPERLRSLWGRSGKLQSAARGMESLELRSGGMADSLEQYSGFTIDFPDNGTDELGSGHDYGDFEEPCFGLENANFNRIFLPVIYSIIFLTGIVGNGLVIVVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWSVDAAISWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKIVYIGVWLPAVLLTVPDIIFASTSEVEGRYVCDRIYPHDNWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTLILLRVIRHGCNFETTVHKLISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
526,D2HXY3,Non Druggable,D2HXY3_AILME,PANDA_017529,357,40349,MSIPLPLLQIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
527,A0A096NR01,Non Druggable,A0A096NR01_PAPAN,CXCR4,352,39707,MEGISIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFASVSEADDRFICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
528,A0A2K5D8M0,Non Druggable,A0A2K5D8M0_AOTNA,,413,46734,MEGISENAAFPNFPKAPTPGRRARLGEEVPFVHFLTLPPNIPQAPKDLRCKTVFSLHTTCCLKRRMIYTSDNYTEEMGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEAEDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIRQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
529,A0A5F5Y2X7,Non Druggable,A0A5F5Y2X7_FELCA,CXCR4,400,45491,MDGFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPSDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTERSERVGHQEKHLLEQQDFNTDIRHANNFPELPTMCTGIHQRAQFPLALKLCSKPLN
530,A0A6P4WGF7,Non Druggable,A0A6P4WGF7_PANPR,CXCR4,353,39963,MDGFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
531,B5LVX6,Non Druggable,B5LVX6_PANLE,CXCR4,353,39963,MDGFRIYPSDNYTEDDLGSGDYDSMKEPCFREENAHFNRIFLPTVYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVLTLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREADGRYICDRFYPNDSWLVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGYQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFESTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
532,G1SGF1,Non Druggable,G1SGF1_RABIT,CXCR4,366,41336,MEGISIYTSDNYTEELGSGDYDSIKEPCFREENAHFNRIFLPTIYSIIFLTGIVGNGLVILVMGYQKKQRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGKFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQKPRKLLAEKVVYVGVWIPALLLTIPDFIFANVREAEGRYICDRFYPSDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSKIKEPGTTQRELGVGSLRHNIKGKI
533,H2M6V1,Non Druggable,H2M6V1_ORYLA,LOC101160103,369,40125,MSYYEHIVLDYDLNDTGSGSGLGSGEVGVDLEEPCGMEHLMTAELQQVFLPVVYSLIFILGITGNGLVVMVLGCQRRSKCSLTDRYRLHLSAADLLFVLALPFWAVDAALADWRFGAVTCVGVHVIYTVNLYGSVLILAFISLDRYLAVVRATDTNSGGLRQLLAHRLVYVGAWMPAGLLAVPDLIFARTQEGGEGSTLCQRFYPDDNAPLWVAVFHLQLVLVGLVIPGLVLSVCYCVIVTRLTRGPLGGQRQKRRAVRTTIALVLCFFICWLPYGAGISVDALLRLEVLPRSCRLEAALGVWLSVAEPMAFAHCCLNPLLYAFLGAGFKSSARRALTLSRASSLKVLPRRRPGASTTTESESSSLHSS
534,A0A4W4ET28,Non Druggable,A0A4W4ET28_ELEEL,LOC113585300,354,39710,MDYYEQRIVFDYDNSTEGSAFDDLEGLCDIALSADFQRIFLPAVYGIIFVLGVVGNGLVVLVMGFQKKSTNMTDKYRLHLSVADLLFVLSLPFWAVDAASTWYFGWFLCKAVNMIYTVNLYSSVLILAFISLDRYLAVVHATNSQSKRRLLADRMIYVAVWLPAMLLTVPDLVFAKVRSSGTGDICERIYPSHANVWKAAFRFQHIIVGFVLPGLVILVCYCMIISRLSTASKGQTLKRRALKTTVILILCFFTCWLPYCGGILVDTLMMLNVIAPSCYREQTLQRWIFLTEALAFFHCCLNPILYAFLGVKFSKSARSALSTSSRSSLKMLTKKRGPISSVSTESESSSMPSS
535,A0A3L8SP42,Non Druggable,A0A3L8SP42_CHLGU,DV515_00005688,366,40918,MALSMDSSLDSLDLSSGLLIELSENGTDEIGSGDYGDYKEPCFQHENADFNRIFLPTIYSIIFLTGIIGNGLVIIVMGYQKKQRSMTDKYRLHLSVADLLFVITLPFWSVDAAISWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPALLLTVPDLIFASTSEVEGKYLCDRMYPHENWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFILLGVIRHHCSLETIVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
536,U3KH57,Non Druggable,U3KH57_FICAL,CXCR4,366,41021,MALSMDSSLDSLDLSSGLLIEFSENGTDEIGSGDYGDYEEPCYQHENADFNRIFLPTIYSIIFITGIIGNGLVIMVMGYQKKQRNMTDKYRLHLSVADLLFVITLPFWSVDAAISWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPALLLTVPDVIFAGTSEIEGKYLCDRMYPHENWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFMLLGVIRHRCSLETIVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
537,H0ZNK3,Non Druggable,H0ZNK3_TAEGU,CXCR4,446,49821,MPGAADKERPEAPARSPRARRHRRGGARRGCPGGGGDSPALYKAARPARRAEACLEQRRVVSLREARLRQSNALRARIRPMALSMDSSLDSLDLSSGLLIELSENGTDEIGSGDYGDYKEPCYQNENADFNRIFLPTIYSIIFLTGIIGNGLVIIVMGYQKKQRSMTDKYRLHLSVADLLFVITLPFWSVDAAIGWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPALLLTVPDLIFASTSEIERKYLCDRMYPHENWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFILLGVIRRRCSLETIVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
538,A0A218V3G3,Non Druggable,A0A218V3G3_9PASE,CXCR4 RLOC_00006181,366,40929,MALSMDSSLDSLDLSSGLLIELSENGTDEIGSGDYGEYNEPCYQIENADFNRIFLPTIYSIIFLTGIIGNGLVIIVMGYQKKQRSMTDKYRLHLSVADLLFVITLPFWSVDAAISWYFGNVLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWLPALLLTVPDLIFASTSEVEGKYLCDRMYPHENWLISFRFQHILVGLVLPGLIILTCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDTFILLGVIRHRCSLETIVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQNALTSVSRGSSLKILSKGKRAGHSSVSTESESSSFHSS
539,A0A4W4HCM7,Non Druggable,A0A4W4HCM7_ELEEL,LOC113582600,357,39859,MSYYEHIIIENDGNISESGLADLGIDLEVPCNREVSQDFQKIFLPTVYGIIFFLGFIGNGLVVLIMGYQNKSRTMTDKYRLHLSVADLLFVLSLPFWAVDAASDWYFGGFMCVAMHMIYTVNLYSSVLILAFISLDRYLAVVRATSSQAPRKLLAERAIYVGVWLPAALLTVPDLVFARTVDLGTRVMCERIYPAESNVAWMVAFRFQHILVGFVLPGFVILVCYCIIISKLSRGSKGTQKRKALKTTVVLIVCFFGCWLPYCGGILIDTLMTLEIIPHSCELEEGLEKWIFGTEALAYFHCCLNPILYAFLGVKFKKSARNALLTGRGSSLKSLPKKRCGMSSVSTESESSSFHSS
540,H2QJP1,Non Druggable,H2QJP1_PANTR,ACKR3,362,41463,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
541,A4IF77,Non Druggable,A4IF77_BOVIN,ACKR3 ,362,41173,MDLHLLDYSEPGNFSDISWPCNGSDCIAVDTLQCGHIPNKSVLLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFASTSGRKKRLVRRAVCVLVWLLAFGVSLPDTYYLKTVTSASNNETYCRAFYPEHSVKEWLISMELVSVILGFAIPFCIIAVFYFLLARAIASSSDQEKQSSRKIILSYVVVFLVCWLPYHLVVLLDIFSILHYIPFTCQLEAFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASHVSETEYSALEQNAK
542,F1SM08,Non Druggable,F1SM08_PIG,ACKR3,362,41202,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTLQCSGLPNKSVLLYTLAFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFAHTSSRKKQAVRRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFSVIAVFYCLLARAVSSSSDPEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYLPFSCQLENFLFTALHVTQCLSLVHCCVNPVLYSFIHRSYRYELMKAFIFKYSAKTGLTKLIDASRASETEYSALEQTTK
543,G3QNR5,Non Druggable,G3QNR5_GORGO,ACKR3,362,41463,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
544,M3WH59,Non Druggable,M3WH59_FELCA,ACKR3,406,46340,MQTVFVRSYSLLETALDCFQSQMHGRYRHDKRLSCGRLLPALSTMDLHLFDYSEPGNFSDVSWPCNGSDCIVVDTVLCPHMPNKSLLLYTLAFVHIFIFVIGMIANSVVVWVTIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSLTHFAGTSSRRKKAVRRTVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAVPSCVIAVFYCLLARAISASGDQEKQTSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYLPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
545,F7D7T0,Non Druggable,F7D7T0_HORSE,ACKR3,362,41544,MDLHLFDYPEPANFSDMSWPCNSSDCIGVDMVLCPNMPNKSILLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFNNTSSRKKKIARRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFSVIAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHIVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
546,G1KK52,Non Druggable,G1KK52_ANOCA,ACKR3,364,41578,MNAVDLPPIFEFVEGGNLTETNLTCSNGDCITVDSLSCPNTLNKTALLYTLSVFYIFIFMIGLVANFVVVWMNFQAKTTGYETHLYIFNLAVADLCVLITLPVWVVSLVQQSQWHLGEITCKITHLVFSINLYGSIFFLACMSVDRYLSVAYFTTSSNAKKKRIRRCICIFVWLFAFFVSLPDTYYLKTISTNNETYCRPVYPEESAREWLAGMELSSVLLGFIIPFPVIAVFYCLLAKAISASNDQERKSNGKVIFAYVVVFLVCWLPYHVAVFLDLLLAFHFIPFSCQMENFLYTALHVTQCFSLVHCCINPILYSFINRNYKYELMKAFIFKYSAKTGLTKLIDTSRVSEMEYSALDQNAK
547,F7AW12,Non Druggable,F7AW12_ORNAN,ACKR3,363,41462,MDFASIFDYPEPGNFNDTNFTCTSGDCILVDTVLCPNTLNKSALLYTLSIFYIFIFVIGLIANSVVVWVNLQAKTTGYETHRYILNLAIADLCVVITLPIWVVSLIQHNQWPLGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSITYFTNSSSRTKKVTRCVICTFVWLLAICVSLPDTYYLKTITSATSNETYCRSFYPEDSVKEWLIGMELVSVILGFAIPFAVIAVFYFLLARTITTSNDQEKHSNRKIIFSYVVVFLVCWLPYHAVVLLDIFSILHFIPFSCQMENFLYAALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNTK
548,F7AC75,Non Druggable,F7AC75_MONDO,ACKR3,330,37873,MDLFSFDYSEPGNFTDLNWTCPNGDCITVDTVMCPSTTSRNVLLYTLSIFYIFIFVVGMIANSVVVWVNLQAKTTGYETHRELTCKIAHLIFSINLFGSIFFLTCMSVDRYLSVTYFSNTSSHKKKVVRRLICILVWLLAICVSLPDSYYLKTVTLAANNETYCRSIYPEHSIKEWLLGMELLSVILGFIIPFSIIAIFYFLLARAITASGDQEKHSSQKIIFSYVIVFLICWLPYHAVVLLDIFSFLHFIPFNCQLENFLYTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNAK
549,A0A2K6JWM5,Non Druggable,A0A2K6JWM5_RHIBE,ACKR2,384,43480,MATTASPQPLTTEDAGPENSTFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYTLQVTESIGFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
550,A0A2K6NMH8,Non Druggable,A0A2K6NMH8_RHIRO,ACKR2,384,43468,MATTASPQPLTTEDAGPENSTFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYTLQVTESTGFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
551,A0A0D9SBE2,Non Druggable,A0A0D9SBE2_CHLSB,ACKR2,384,43408,MAATASPQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATTVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
552,G1RIE0,Non Druggable,G1RIE0_NOMLE,ACKR3,362,41453,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLIGMELVSVILGFAIPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
553,H0Y2B6,Non Druggable,H0Y2B6_OTOGA,ACKR3,362,41231,MDLHLFDYPESGNFSDITWPCNSSDCIAVDTVLCPAMPNKSVLLYTLSFLYIFIFVIGMIANSVVVWVNVQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLACMSVDRYLSITYFSNTSSSRKKAVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSIVLGFAVPFSIIAIFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCQLEHGLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
554,K7GIC8,Non Druggable,K7GIC8_PELSI,ACKR3,364,41588,MSAIDLTSILDLLDVGNFSDSNWTCNNGDCIIVDTLSCPSTLNKSVLLYTLSIFYIFIFVIGLVANSVVVWVNLQAKTTGYETHLYIFNLAIADLCVVITLPVWVVSLIQHNQWHMGEITCKITHLIFSINLYGSIFFLACMSVDRYLSVAYFTNSSNCKKKIIRRCICIFVWLLAFCVSLPDTYYLKTVSSNNETYCRPLYPEESFKEWLVGMELISVVLGFAIPFPIIALFYFLLARTISASSDQERKSNGKIIFFYVIVFLVCWLPYHAVVLLDIFSVLHFIPFSCQMESFLYAALHVTQCFSLIHCCVNPILYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNAK
555,A0A0D9SBS8,Non Druggable,A0A0D9SBS8_CHLSB,ACKR3,362,41409,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLICWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
556,A0A2K6KIV8,Non Druggable,A0A2K6KIV8_RHIBE,ACKR3,362,41395,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
557,U3I3B4,Non Druggable,U3I3B4_ANAPP,ACKR3,488,54862,MDQAVSFSGNTDKIVSKSHNHFRKGGAAVGSAVAAPRGSECASHPHTGPRSPTHLTTYLPQTTPYNPLSPPCRPKTGGRAVGPGRAALWRRFPLAAIRAGRRRAALTRCQRRVAEVTRTLKRANMSALDLTSILDFLEKANLTEINWMCNNSDCITVDATTCPGTLNKSALLYTLSFFCIFIFVIGLVANSVVVWVNLQAKMTGYETHLYIFNLAVADLCVVITLPVWVVSLVQHNQWHMGEITCKITHLIFSINLYGSIFFLACMSVDRYLSVAYFTSSSNRKQKIVRRCICILVWLLAFSASLPDTYFLKTVSSNNETYCRPVYPEESFKEWLIGMELISVVLGFLIPFPVIALFYFLLAKAISASSDQERKSSGKIIFSYVVVFLVCWLPYHATVLLDIFYSLHFIPFSCQMENFLYATLHITQCFSLVHCCVNPILYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNAK
558,V9GYB7,Non Druggable,V9GYB7_HUMAN,ACKR2,233,26787,MAATASPQPLATEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRI
559,V9GYX0,Non Druggable,V9GYX0_HUMAN,ACKR2,170,19569,MAATASPQPLATEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWA
560,F6YY14,Non Druggable,F6YY14_HORSE,ACKR2,401,45487,MPLRCQPCAELQDCPPNMAATASPLPLTTEVTSSENSSSFYDYEYYLEDVAFMLCRKDEVVSFGKVFLPVFYSLIFVLGLGGNLLLLVILLWYVPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLGKYLEIVHAQPHLRLRTRARSLLLAAIVWAVALAISIPDMVFVQTHEYPTGVWSCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGSVLIRLRPPGQGRALRIAIALVVAFFVLWFPYNLTLFLHSLLDLKVFGDCEVSQHLDYALQVTESIAFLHCCFTPILYAFSSRRFRQYLKAFLAAVLRRQQTPRPAQAPPSSCSESTRLTPQGEMTSMNDLGERQAEDSPNTGDMGKN
561,A0A2K6QF18,Non Druggable,A0A2K6QF18_RHIRO,ACKR3,362,41409,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAIPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
562,A0A250XZ57,Non Druggable,A0A250XZ57_CASCN,ACKR3 ,361,41473,MDFHLFDYAEPGNYSHLNWPCNSSDCIPIDMVQCPAMPNKSVLLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSIVQHDQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSITYFSSTSSCRKKMVRRIVCVLVWLLAFCMSLPDTYYLKTITYASNETYCRPFYPEHSIKEWLIGMELVSVILGFVVPFSIIAVFYFLLARAISASGDQEKHSSRKMVFSYVVVFLVCWLPYHVVLLLDIASVLHYVPFSCQLEDALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
563,F7HZX1,Non Druggable,F7HZX1_CALJA,ACKR3 ,362,41507,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSILLYTLSFIYIFIFVIGMIANSVVVWVNVQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTITSASNNETYCRSFYPEHSIKEWLIGMELVSVILGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLICWLPYHVAVLLDIFSILHYIPFTCRLEYALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
564,H0VQC7,Non Druggable,H0VQC7_CAVPO,ACKR3,362,41403,MDLHLFDYSEPGNYSDISWPCNSSDCIGVEAVQCPNMPHKSVLLYTLSFLYIFIFVIGMIANSVVVWVNIQAKTTGYDMHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTSTSSCKKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVILGFAVPFSIIAIFYFLLAKAISASGDQEKQSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
565,A0A2J8PAV6,Non Druggable,A0A2J8PAV6_PANTR,ACKR2,384,43527,MAATASPQPLTTEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKIFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLVTIVWAVSLAVSIPDMVFVQTHENPRGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLRPAGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCEVSQHLDYALQVTESIAFLHCCFSPILYAFSSHRFRQYLKAFLAAVLGWHLAPGTAQASLSSCSESSILTAQEEMTGMNDLGERQFENSPNKEDVGNKSA
566,G1PIH1,Non Druggable,G1PIH1_MYOLU,ACKR3,362,41506,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTMTCPNMANKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVSHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSHRKKVVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELMSVVLGFVIPFCIIAVFYFLLARALSASGDQETHSSRKIIFSYVVVFLVCWLPYHVVVLLDVCSILHYIPFTCQLENFLFSALHITQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
567,G3IN06,Non Druggable,G3IN06_CRIGR,Ackr3,362,41519,MDVHLFDYAEPGNYSDINWPCNSSDCIVVDTMQCPAMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLACMSVDRYLSITYFTSTSSYKKKLARRVVCILVWLLAFFVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVILGFAIPFTIIAIFYFLLARAMSASGDQEKHSSRKIIFSYVVVFLVCWLPYHAVVLLDIFSILHYIPFTCQLENVLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
568,W5NQ57,Non Druggable,W5NQ57_SHEEP,ACKR3,362,41134,MDLHLLDYSEPGNFSDISWPCNGSDCIAVDTLQCGHVPNKSVLLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFASTSGRKKRLVRRAVCVLVWLLAFGVSLPDTYYLKTVTSASNNETYCRAFYPEHSVKEWLISMELVSVVLGFAIPFSVIAVFYFLLARAIASSSDQEKQSSRKIILSYVVVFLVCWLPYHLVVLLDIFSILHYIPFTCQLEAFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNAK
569,A0A2R8PYR8,Non Druggable,A0A2R8PYR8_DANRE,ackr3a,360,40284,MWEELNFTDSNNNSSRVEAQMCPASFNRSALLNAMCTLYAFIFVVGLAANALVVWVNMRSQRHYHETHMYILNLAVADLCVVATLPVWVSSLAQGGHWAFGQAACKLTHLLFSVNLFASIFFLTCMSVDRYLSVVRFREISHRRGRQVRRLVCAITWLLALFASVPDTYFLRSVKSQYSHVTLCLPVYPEDNPLQWMVGIQLSFVVLGFAIPFPIIAVSYALLANTLASTSTHSPSNGDQDRSVSKKVILMYIVVFIACWAPYHAVLLADALAMLGVLPLGCSSENGLFVALHLTQCLSLLHCCVNPVVYSFAHRHYRYDLMKAFIFKYSTRTGLARLIDGSQGIETEYAMVENNPPTVT
570,A0A2K5UF52,Non Druggable,A0A2K5UF52_MACFA,ACKR2,407,45987,MLGLTIFSPHTSTGHRDWALPSNMAATASLQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFSGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
571,A0A2K5KLY6,Non Druggable,A0A2K5KLY6_CERAT,ACKR2,384,43452,MAATASPQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLMRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
572,A0A2K5XD96,Non Druggable,A0A2K5XD96_MANLE,ACKR2,384,43438,MAATASPQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLMRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSDSSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
573,A0A452DNS6,Non Druggable,A0A452DNS6_CAPHI,ACKR3,362,41092,MDLHLLDYSEPGNFSDISWPCNGSDCIAVDTLQCGHVPNKSVLLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFASTSGRKKRLVRRAVCVLVWLLAFGVSLPDTYYLKTVTSASNNETYCRAFYPEHSVKEWLISMELVSVVLGFAIPFSVIAVFYFLLARAIAASSDQEKQSSRKTILSYVVVFLVCWLPYHLVVLLDIFSVLHYIPFTCQLEAFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNAK
574,A0A2R8ZE81,Non Druggable,A0A2R8ZE81_PANPA,ACKR3,362,41463,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
575,A0A1S3FRU6,Non Druggable,A0A1S3FRU6_DIPOR,Ackr3,362,41353,MDLHLFDYAEPGNYSDITWPCNSSDCIVVDTLQCPAMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAVADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFANTSSCRKKTVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAIPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDVFSILHYIPFTCQLENALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
576,A0A1U7R951,Non Druggable,A0A1U7R951_MESAU,Ackr3,362,41459,MDVHLFDYAEPGNYSDINWPCNSSDCIVVDTVQCPAMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLACMSVDRYLSITYFTSTSSYKKKMARRVVCILVWLLAFFVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVILGFAIPFTIIAIFYFLLARAMSASGDQEKHSSRKIIFSYVVVFLVCWLPYHAVVLLDIFSILHYIPFTCQLENVLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNAK
577,A0A2K6AS51,Non Druggable,A0A2K6AS51_MACNE,ACKR2,384,43466,MAATASLQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFSGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
578,H2P913,Non Druggable,H2P913_PONAB,ACKR3,362,41483,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYMLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLICWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
579,A0A5F7ZN48,Non Druggable,A0A5F7ZN48_MACMU,ACKR2,407,46047,MLGLTIFFPHTSTGHRDWALPSNMAATASLQPLTTEDAGPENSSFYYYDYLDEVTFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRQMTEVYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTTNFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFSGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYARIGCVLVRLRPPGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSRRFRQYLKAFLAAVLGWHLAPGTAQAPLSNCSESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSA
580,G1NS69,Non Druggable,G1NS69_MELGA,ACKR3,364,41689,MNALDLTSIFDFLEKANLTEINWMCNNSDCITVDATACPGTLNKSALLYTLSFFCIFIFVIGLVANSVVVWVNLQAKMTGYETHLYIFNLAVADLCVVITLPVWVVSLVQHNQWHMGEITCKITHLIFSINLYGSIFFLACMSVDRYLSVARFTNSSNRKKKIVRRCICILVWLLAFSASLPDTYFLKTVSTSNETYCRPLYPEESFKEWLIGMELISVVLGFLIPFPVIALFYFLLAKTISASSDQERKSSGKIIFSYVVVFLVCWLPYHTTVLLDIFYSLHFIPFSCQMENFLYATLHITQCFSLVHCCVNPILYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNTK
581,A0A2K5UMM7,Non Druggable,A0A2K5UMM7_MACFA,ACKR3,399,45239,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRPVLLVIDHRGCRLHPVPLMSPRQFVSDLVLSIQVTTRGWSGSPESAALMASVCPCPASRHKVNTPLMLRRLCEASC
582,A0A287BKA0,Non Druggable,A0A287BKA0_PIG,ACKR2,385,43948,MATSDSPLPLTTMVTSSENSSSFYDYEYYLDEAAFMLCRKDEVLSFGRVFLPIFYSLIFVLGLGGNLLLLVVLLWYVPRKRMTETYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFIGCMSLDKYLEIVWAWPHHQLRTRAKSLLLVTVVWVVALAVSIPDMVFVRTHENHPNVWDCYADFGGHGTIWKLFLRFQQNLLGFLLPLLAMTFFYARIGCVLVRLRPPGQGRALRMAVALVVAFFVLWFPYNLTLFLHSLLDLQVFGDCKVSQHLDYGLQVTESIAFLHCCITPVLYAFSSRRFRRHLKDLLAAVLRRHQAPYLAQAPPSSSSESSRLTAQEDVTRMNDLEGRQAEDAPNKENVGSSA
583,A0A2K6T558,Non Druggable,A0A2K6T558_SAIBB,ACKR3,373,42618,MIGRLIAPLSTMDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTITSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEYALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
584,G3SRP4,Non Druggable,G3SRP4_LOXAF,ACKR3,342,39179,MDVHLFDYMEPGNFSDISWSCNSSDCIGVDTVLCPHMPYKSALLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSVTYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSAANNETYCRSFYPEHSIKEWLIGMELLSVVLGFAIPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHAVVLLDVFSILHLIPFTCHLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMRVSEAEYSALEQNAK
585,A0A2K5X9Y2,Non Druggable,A0A2K5X9Y2_MANLE,ACKR3,362,41379,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSIAYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAIPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
586,A0A2K6ARL8,Non Druggable,A0A2K6ARL8_MACNE,ACKR3,362,41395,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
587,A0A2K6EHR0,Non Druggable,A0A2K6EHR0_PROCO,ACKR3,362,41288,MDLHLFDYSEPGNFSDIAWPCNSSDCIVVDTVLCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFSSTSSSRKKIARRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCQLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLINASRVSETEYSALEQSTK
588,A0A384C287,Non Druggable,A0A384C287_URSMA,ACKR3,362,41296,MDLHLFDYPEPGNFSDIGWPCNSSDCIAVDTVLCPSMPSKSVLLYTLSFLYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSVTRFASTSSRRKKAVRRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFCVIAVFYCLLARALAASSDQEKQSSRRIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFISRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
589,A0A2K5BWX5,Non Druggable,A0A2K5BWX5_AOTNA,ACKR3,362,41481,MDLHLFDYSEPGNFSDISWPCNSSDCIMVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNVQAKTTGYDTHCYILNLAIADLWVILTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKTVRRVVCVLVWLLAFCVSLPDTYYLKTITSASNNETYCRSFYPEHSVKEWLIGMELVSVILGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEYALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
590,A0A2K5L2K2,Non Druggable,A0A2K5L2K2_CERAT,ACKR3,362,41395,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
591,U3KL67,Non Druggable,U3KL67_FICAL,ACKR3,364,41557,MSALDLTSILDFLETANLTEINWTCNNSECITVDATTCSGTLNKSALLYTLSFFYIFIFVIGLVANSVVVWVNLQAKMTGYETHLYIFNLAIADLCVVITLPVWVVSLVQHNQWHMGEITCKITHLIFSINLYSSIFFLACMSVDRYLSVAYFTNSSSRKKKIVRRCICVLVWLLAFSASLPDTYYLKTVSSTSETYCRPVYPEESFKEWLIGMELISVVLGFLIPFPVIAVFYFLLAKSVSASGDQERKSNGRIIFSYVVVFLVCWLPYHVAVLLDIFYSLHFIPFSCQMENFLYATLHVTQCFSLVHCCVNPILYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSEAEYSALEQNAK
592,A0A4X1T9Z1,Non Druggable,A0A4X1T9Z1_PIG,ACKR3,362,41202,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTLQCSGLPNKSVLLYTLAFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFAHTSSRKKQAVRRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFSVIAVFYCLLARAVSSSSDPEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYLPFSCQLENFLFTALHVTQCLSLVHCCVNPVLYSFIHRSYRYELMKAFIFKYSAKTGLTKLIDASRASETEYSALEQTTK
593,A0A2K5PER2,Non Druggable,A0A2K5PER2_CEBIM,ACKR3,362,41479,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTITSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAIPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEYALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
594,A0A2Y9F8T9,Non Druggable,A0A2Y9F8T9_PHYMC,ACKR3,362,41431,MDLHVFDYSEPGNFSDIGWPCNSSDCIVVDTVQCATMPNKNVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFTNTSSRKKKTVRRAVCVLAWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELISVVLGFALPFSIIAVFYFLLARAIASSSDQEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
595,A0A5F7ZVH9,Non Druggable,A0A5F7ZVH9_MACMU,ACKR3,385,43854,MGRKRLVQAPRGKQVIGLPALSTMDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
596,A0A4W2EVC4,Non Druggable,A0A4W2EVC4_BOBOX,ACKR3,362,41192,MDLHLLDYSEPGNFSDISWPCNGSDCIAVDTLQCGHIPNKSVLLYTLSFVYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFASTSGRKKRLVRRAVCVLVWLLAFGVSLPDTYYLKTVTSASNNETYCRAFYPEHSVKEWLISMELVSVILGFAIPFCIIAVFYFLLARAIASSSDQEKQSSRKIILSYVVVFLVCWLPYHLVVLLDIFSILHYIPFTCQLEAFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNAK
597,A0A2I2U8A0,Non Druggable,A0A2I2U8A0_FELCA,ACKR2,505,56457,MVQRGVAGDTCFPKTLDCLWVGGVAPSGGRSFELDSFQMRGNSLWLCSGGGAGAGPKGMLCSSLRTGCVQGTVQRGDSHSLYTSLRKKDPGAAALLDKVGHPQASWSGSELQNWVCPPNMASTTSPLPPTTEVASSENSSSFYDYEYYLDSVAFMLCRKDEVMSFGRIFLPVFYSLIFVLGLGGNLFLLVVLLRYMPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHTQLHHRLRTRAKSLLLAAMVWTMALAVSIPDMVFVQTHENPTGVWNCYADFGGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYSRIGSVLVRLRPPGQGRALKIVVALVVTFFVLWFPYNLTLFLHSLLDLQIFGDCKVSQHLDYALQVTESIAFLHCCFTPILYAFSSRHFRGYLKAFLITVLRHNQAPRPAQAPLSSCSESSRLTAQEEMTGMNDLGERQAEHSPDMNDSGENEA
598,A0A2Y9MS64,Non Druggable,A0A2Y9MS64_DELLE,ACKR3,417,47507,MLQMCFILRKQGRSVTTLEPGRRGKRKSSVALIWGQGCSGHSQLQAGCLIAARDTMDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVQCANMPNKNVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFTNTSSRKKKMARRTVCVLAWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELISVVLGFALPFSIIAVFYFLLARAISSSSDQEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
599,V9GZ70,Non Druggable,V9GZ70_HUMAN,ACKR2,142,16267,MAATASPQPLATEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDK
600,A0A6P4VJM2,Non Druggable,A0A6P4VJM2_PANPR,ACKR3,362,41209,MDLHLFDYSEPGNFSDVSWPCNGSDCIVVDTVLCPHMPNKSLLLYTLAFVHIFIFVIGMIANSVVVWVTIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSLTYFAGTSSRRKKAVRRTVCALVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAVPSCVIAVFYCLLARAISASGDQEKQTGRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYLPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
601,A0A4U1EZ32,Non Druggable,A0A4U1EZ32_MONMO,ACKR3 ,362,41522,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVQCANMPNKNVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFTNTSSRKKKMARRTVCVLAWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELISVVLGFALPFSIIAVFYFLLARAISSSSDQEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
602,V9GYM0,Non Druggable,V9GYM0_HUMAN,ACKR2,124,14199,MAATASPQPLATEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLY
603,M3XTJ7,Non Druggable,M3XTJ7_MUSPF,ACKR3,362,41575,MDLHLFDYSEPGNFSDMSWPCNSSDCIVVDTVLCPNMPNKGVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFANTSSRRKKVVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFCIIAIFYCLLARALTASSDQERQTSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
604,G1SA86,Non Druggable,G1SA86_NOMLE,ACKR2,384,43444,MAATASPQPLTTEDAGSENTSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMAEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGNFLCKTVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAASIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLRPAGQGRALKIAAALVVAFFVLWFPYNLTVFLHTLLDLQVFGNCEVSQHLDYALQVTESIAFLHCCFSPILYAFSSHRFRRYLKAFLAAMLGWHLAPGTAQASLSSCYESSILTAQEEMTGMNDLGERQSENSPNKEDVGNKSV
605,G1T081,Non Druggable,G1T081_RABIT,ACKR3,336,37888,MDLHLFDYAEPGNFSDVVWPCNSSGDCIAVDTVQCPGLANKSVLLYTLALVYIFIFVIGMIANSVVVWVNVQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVTRFAGTSSCRKQRVRRGVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAIAASGDQEKQSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYLPFTCQLENALFTALHVTQCLSLVHCCVNPVLYSFINRNYRTWSKSGSESSSV
606,A0A452T2F5,Non Druggable,A0A452T2F5_URSMA,ACKR1,387,40102,MRLLTPHPRPGGAQPQSQGAPQPRSPPPARPPGCIRQACPPPSVQPSSAMGNCLQHQVAEGDSTKFTFGDDIWDEFNDSYDLNYNYSNVEAAAPCHSCSLLDESSLPFFILTSVLGILAGGAVLFALLRPLFHWRVCPERPLLVQLAVGSALFSIAVPVLAPGLRGVQGAALCHLAHMLWYGSAFAQALLIGCHACLGPKMGRGQVPDITLRLGVGLWGMAILLGLPVTLAXXXXXXXXXXXXXXXXAALARRGLFRRLHHVAPRFVRSQGTDENTGQGAVSLGQRPVGLVCVLVASGGGCGLGLSRAVQGLGPVDVSGPAGPGLAAAPGRGCGHSALRGRTPAPGPVLPPDCAQLPARPAPPAHTACSSGHPGRQVLAPLPPVHLN
607,A0A2U3V3E2,Non Druggable,A0A2U3V3E2_TURTR,ACKR3,362,41522,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVQCANMPNKNVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSVAYFTNTSSRKKKMTRRAVCVLAWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELISVVLGFALPFSIIAVFYFLLARAISSSSDQEKHSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
608,A0A663D8X1,Non Druggable,A0A663D8X1_PONAB,CR201,362,41483,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYMLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLICWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
609,A0A1U7TIE0,Non Druggable,A0A1U7TIE0_CARSF,ACKR3,362,41482,MDLHLFDYSEPGNFSDITWSCNSSDCIVVDTVMCPNMPNKSILLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVITIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSKKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVILGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVIVFLVCWLPYHVAVLLDIFSILHYIPFTCQLEYALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
610,A0A6D2Y3D6,Non Druggable,A0A6D2Y3D6_PANTR,CK820,362,41463,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
611,A0A3Q7R3H7,Non Druggable,A0A3Q7R3H7_VULVU,ACKR3,362,41434,MDLHLFDYAEPGNFSDMSWPCNSSDCIVVDTVLCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSITYFASTSSRRKKVVRRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFCVIAVFYCLLARAISASSDQEKQSSRKIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNAK
612,A0A452RJ24,Non Druggable,A0A452RJ24_URSAM,ACKR3,362,41296,MDLHLFDYPEPGNFSDIGWPCNSSDCIAVDTVLCPSMPSKSVLLYTLSFLYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVVTIPVWVVSLVQHNQWPMGELTCKITHLIFSINLFGSIFFLTCMSVDRYLSVTRFASTSSRRKKAVRRAVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSVKEWLISMELVSVVLGFAIPFCVIAVFYCLLARALAASSDQEKQSSRRIIFSYVVVFLVCWLPYHVVVLLDIFSILHYIPFTCQLENFLFTALHVTQCLSLVHCCVNPVLYSFISRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQNTK
613,A0A4X2KQE2,Non Druggable,A0A4X2KQE2_VOMUR,ACKR3,362,41235,MDPFSFDYSEPGNFTDLNWTCTNGDCITVDTIMCPSATGRNILSYTLSIFYIFIFVVGMIANSVVVWVNLQAKTTGYETHLYILNLAIADLCVVVTIPIWVVSLVQHNQWPMGELTCKIAHLIFSINLFSSIFFLTCMSVDRYLSVTYFTNTSSHKKKVVRRLICILVWLLAICVSLPDAYYLKTVTLAANNETYCRSIYPEHSIKEWLLGMELLSVVLGFIIPFSIIAVFYFLLARAISASGDQEKHSNQKIIFSYVVVFLICWLPYHAVVLLDIFSFLHFIPFSCQLENFLYTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRASEAEYSALEQGAK
614,A0A096MKX4,Non Druggable,A0A096MKX4_PAPAN,ACKR3,380,43377,MNKKSQKREVIGLPALSTMDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
615,I3NBZ2,Non Druggable,I3NBZ2_ICTTR,ACKR2,384,43657,MATAISPLPLTTEDASSENSSFYDYYYLDEVAFLLCRKDDVLSFSRVFLPVFYSLIFVLGLTGNLLLLVVLLRYVPCRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMMSTLYTINFYSGIFFISCMSLDKYLEIVHAQPLHRLRTRAKSLLLAAIVWAVALAISIPDMVFVQIHENPKGVWNCYADFGGHGTIWKLFLRFQQNLLGFLLPLLTMIFFYSRIGCVLVKLKPPGQGRALRVAASLVLAFFLLWFPYNLTLFLHSLLDLHIFGDCQVSHHLDYALQVTESLAFLHCCFTPVLYAFSSRRFRRYLKAFLAAMLRRRLAPGTAQASLSNCSESSRLTNQEEMTDMKDPGERQTEGAINKGTEGNSSA
616,H0XI23,Non Druggable,H0XI23_OTOGA,ACKR2,389,44339,MATTISPLPLTTEDVSPENSSFLYDYDYLDEMTFMLCRKDAVVAFSKVFLPVFYSLIFVLGLSGNLLLLVVLLRYVPRRQMAEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMNLDKYLEIVHAQPHHRLRTRAKSLLLAAIVWALALAVSIPDMVLVQMHENPRGMWSCYADFSGHGTTWKFFLRFQQNLLGFLLPLLAMVFFYSRIGCVLVRLRPPGQGRALRMAAALVVAFFVLWFPYNLTLFLYSLLDLQVFGDCEVSQHLDYALQVTESIAFLHCCFTPILYAFSSRRFRQYLKAFLATVLGRHVTRDMSQPSKSDCSESSSLTAQEEMTGMNDYGERQAENSPNNRAMGNTLVRGDG
617,Q63ZL5,Non Druggable,Q63ZL5_XENLA,ackr4,356,40515,MEEKINTTIRATTENYDEYGDTTFDYGNYEELCEKKEVRQFAQIFLPAFYAVAFVIGVAGNSLVVAIYSYYKKMKSKTDVYLLNLAVADLLLLFTLPFWATDAAVGWQFGIFMCKITSALYTINFSSGMQFLACISLDRYFAVTKAPSAQPVGKMGRVICLFVWSTSMLLSIPDLYFSTVKEHNNKHACLPVYPKDKVKQTTVLIQILEIVFCFLLPFLVMVFCYASMAKIVLKTPNIKRSRSLKVLLAVVGVFLVTQLPYNVIKFWRAIDIIYALITSCSMSRTIDIMIQVTESLALFHCCLNPVLYAFMGTTFKCYISKIAKRCGSLRRQRIHSTEEFSMHSENHVEETSSFSI
618,A0A287B139,Non Druggable,A0A287B139_PIG,ACKR1,373,40165,MAFISPWHLSWNHTPDKRIPALLSAGPEPSCVMGNCLHPDARQVAGENSTFEFEEEMWDEFLESYSTDYNYTNLEAAAPCHSCSLLDYSSRPFFILASILGTLASGAVLYLLLRPLSRWRLQQDRSVLVQLAVGSALFSIVLPVLTPELSGAAIASLCHLAHLVSYSSAFAQALLIGSQACLGPMLDAGQIPGLRLGITVGLWGGAALLSLPITLASDTSHGFCTPTFSGSWEILRYIHAAACLAIFVLLPLGLLGAKGLKKVLGGGPCPWVNILWVWFIFWWPQGIMLGLDSLVRSRALLLSSCVAQQALDQLLDLAEALAILHCVATPLLLAWVCYQAMHTSPPSLPLSAKESAHLDTLGGKSSLSYHLST
619,H2MUA5,Non Druggable,H2MUA5_ORYLA,ackr3 ,381,42846,MSLSEFEDLWENFGELNFSETFSNITSVEAMVCATAFNRSALLYSMCVLYTFIFVIGLAANALVLWVNIRAQSDSTPRHETHTYIAHLAVADLCVCATLPIWVSSLAQHGHWPFGEVACKLTHLLFSVNLFGSIFFLACMSVDRYFSLLQPREEGAQRRKLIRRGVCLGVWLLALVASLPDTHFLHTVKSTHSDTMLCRPVYPEENHTEWMVGVQLSFILLGFLLPFPVIAVFYALLARAFAHSSSSSSSSPVEQERRVSRRVILAYIVVFLACWGPYHSVLLADSLSQLGLVPLTCGLENVLYVALHLTQCLSLLHCCFNPILYNFINRNYRYDLMKAFIFKYSTRTGLARLIEAPNMSETEYSAVAVENPPLISKTTSE
620,A0A3Q1LTZ4,Non Druggable,A0A3Q1LTZ4_BOVIN,ACKR2,443,50679,MMESPVVVHERWFASTLAAEPPLCFHHSTWWYPAHGKCWLNDSRLFLCRELQDWVRPPTMATTASPLPPTTKVASSENSSSFYDYEYYLEDMIFMLCRKDEVLSFGRVFLPVFYSLIFVLGLVGNLLLLAVLLRFVPRRRMTETYLLNLAISNLLFVVTLPFWGISVAWHWVFGSVLCKVVSTLYTVNFYSGIFFISCMSLDKYLEIVCARPYHRLRTRAKSLLLAASVWAMALAVSIPDMVFVRTHENSPGVWECYADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGSVLVSLRPPGQRRALRMAVALVVAFFVLWFPYNLTLFLHSLLDLQVFGDCRVSQHLDYALQVTESIAFLHCCFTPVLYAFSSHRFRQYLKAFLATVLRRQQALPSSYSESSGLTVQEDVMGMSDLGERPAESSPTRLSISSGLLRLDS
621,W5MSX2,Non Druggable,W5MSX2_LEPOC,ACKR2,336,38871,VSVFFSLVLLTITITCNVETEGQYDYSDYYNLSQFHDYGICEKKHVRAFARIFLPILYAFVSVLGFIGNGLLAGILIKYIKLKRMTDIYLLNLAVSDLLFVATLPFWAVYAHSEWVFGSILCKVITLIYTINLYSSIFFIICISMDSYLNIVWTFSTKNLKTSRKSFAICSMVWTISILASIPDLKFIELQEFNGQKICILDFGDVDMSPWRIFMKFQLNIVGFFIPFLTMVFFYSRISCVMARTRPTQKSRNPLKLAVILVAVFFLLWFPYNLVVFLHSLQDLHLISDCNTSRHLDFAVQVTESLAFVHACLNPILYAFVNQRFLNCLNKILKRI
622,A0A3Q7SJV8,Non Druggable,A0A3Q7SJV8_VULVU,ACKR2,384,44026,MAPTASPLPLTTEVTSSENSSSFYDYEYYLDQVAFMLCRKDEVLAFGRIFLPIFYSLIFVLGLGGNLLLLVVLLRYIPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGNFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTRAKSLLLAAMVWAMALAVSIPDMVFVRTHENPMGVWNCYADFGGHATIWKLFLRFQQNFLGFILPLLVMIFFYSRIGSVLVRLRPPGQGRALRIVIALVVAFFVLWFPYNLTLFLHSLLDLQVFGECKVARHLDYAMQVTESIAFLHCCFTPILYAFSSRHFRQYLKAFLVTVLRRHQTPCPAQAPLSSCSESSSLTAQEEVTNMNNLGERQAEHSPNKNDMGKN
623,Q5Y7A2,Non Druggable,Q5Y7A2_HUMAN,ACKR1 ,336,35553,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYGANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
624,A0A1L8FWL7,Non Druggable,A0A1L8FWL7_XENLA,ackr4,356,40514,MEEKINTTIRATTENYDEYGDTTFDYGNYEELCEKKEVRQFAQIFLPAFYAVAFVIGVAGNSLVVAIYSYYKKMKSKTDVYLLNLAVADLLLLFTLPFWATNAAVGWQFGIFMCKITSALYTINFSSGMQFLACISLDRYFAVTKAPSAQPVGKMGRVICLFVWSTSMLLSIPDLYFSTVKEHNNKHACLPVYPKDKVKQTTVLIQILEIVFCFLLPFLVMVFCYASMAKIVLKTPNIKRSRSLKVLLAVVGVFLVTQLPYNVIKFWRAIDIIYALITSCSMSRTIDIMIQVTESLALFHCCLNPVLYAFMGTTFKCYISKIAKRCGSLRRQRIHSTEEFSMHSENHVEETSSFSI
625,F7BNT5,Non Druggable,F7BNT5_MACMU,ACKR1,396,41982,METPSTPPWRASPDTTRQNSLSSPFMLSLKLELVSGEKRGKSLRGADSRPSPSVCEPNGAMGNCLHPAELSPSTQNSSQLNSEDLWNFSYDGNDSFPDVDYDANLEAAAPCHSCNLLDDSALPFFILVSVLGILASGTVLFMFFRPLFHWQLCPGWPILAQLAVGSALFSIVVPILAPGLGNTRSSALCSLGYCVWYGSAFAQALLLGCHASLGPKLGAGHVPGLTLGLSVGLWGVAALLTLPITLASGASGGLCTPVYSMELKALQATHAVACLAVFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
626,A0A4W4GKS1,Non Druggable,A0A4W4GKS1_ELEEL,ackr3,366,40814,MSANMNELTDLLDLLSGENFSFMDDNGSHVETVVCQSAFNQRALLYTLSILYIFIFVIGLAANALVVWVNVRGSRERHETHLYVLNLAIADLCVVATLPVSVSSLLQHGHWPFGDAMCKITHLVFSVNLFGSIFFLTCMSVDRYLSVVRFGDAPGGQGERRRTRQLICMGVWLLALLAALPDTYFLQAVRSTHSDATTCRSVYPAETTWEWMVGVQLSSIALGFAVPFPVIVVFYVLLARAVRSSADHERRAGRRLVFTYVMVFLACWLPFHGVLLLDTLALLGAVPLGCTLENVLYVALHVTQCLSLLHCCVNPVIYNFIDKNYRYDLMKAFIFKYSTKTGLARLIDTSRTSETECSAMVGQGHL
627,Q53ZP8,Non Druggable,Q53ZP8_MOUSE,Ackr1 ,334,36694,MGNCLYPVETLSLDKNGTQFTFDSWNYSFEDNYSYELSSDYSLTPAAPCYSCNLLDRSSLPFFMLTSVLGMLASGSILFAILRPFFHWQICPSWPILAELAVGSALFSIAVPILAPGLHSAHSTALCNLGYWVWYTSAFAQALLIGCYACLNPRLNIGQLRGFTLGLSVGLWGAAALSGLPVALASDVYNGFCTFPSSRDMEALKYTHYAICFTIFTVLPLTLLAAKGLKIALSKGPGPWVSVLWIWFIFWWPHGMVLIFDALVRSKTVLLYTCQSQKILDAMLNVTEALSMLHCVATPLLLALFCHQTTRRSLSSLSLPTRQASQMDALAGKS
628,M3Z6I5,Non Druggable,M3Z6I5_MUSPF,ACKR2,384,43674,MASTTSPLPPTTEVASSENSSSFYDYEYYLDQVAFMLCRKDEVVAFGKIFLPIFYSLIFVLGLGGNLLLLVVLLLYIPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGNFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTRAKSLLLAATVWAVALAVSIPDMVFVQTHENPTGVWNCYADFGGHATIWKLFLRFQQNLLGFLLPLLVMIFFYSRIGCVLVRLRPPGQGRALRIVIALMVAFFVLWFPYNLTLFLHSLLDLQIFGECEVAKQLDYALQVTESIAFLHCCFTPILYAFSSRHFRQYLKAFLITVLRRHQAPGPAQAPLSSCSESSRLTAQEEMTGMNDLGERQAELSPSKSDMGEN
629,Q7TSL2,Non Druggable,Q7TSL2_MOUSE,Ackr1 ,334,36692,MGNCLYPVETLSLDKNGTQFTFDSWNYSFEDNYSYELSSDYSLTPAAPCYSCNLLDRSSLPFFMLTSVLGMLASGSILFAILRPFFHWQICPSWPILAELAVGSALFSIAVPILAPGLHSAHSTALCNLGYWVWYTSAFAQALLIGCYACLNPRLNIGQLRGFTLGLSVGLWGAAALLGLPVALASDAYNGFCTFPSSRDMEALKYTHYAICFTIFTVLPLTLLAAKGLKIALSKGPGPWVSVLWIWFIFWWPHGMVLIFDALVRSKTVLLYTCQSQKILDAMLNVTEALSMLHCVATPLLLALFCHQTTRRSLSSLSLPTRQASQMDALAGKS
630,Q3LST0,Non Druggable,Q3LST0_HUMAN, ACKR1,336,35641,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLTQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
631,Q5Y7A4,Non Druggable,Q5Y7A4_HUMAN, ACKR1 ,336,35611,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
632,A0A2J8K5T9,Non Druggable,A0A2J8K5T9_PANTR,ACKR1,336,35611,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPILAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSNLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
633,A0A0A6YWZ3,Non Druggable,A0A0A6YWZ3_MOUSE,Ackr1,174,19112,MGNCLYPVENLSLDKNGTQFTFDSWNYSFEDNYSYELSSDYSLTPAAPCYSCNLLGRSSLPFFMLTSVLGMLASGGILFAILRPFFHWQICPSWPILAELAVGSALFSIAVPILAPGLHSAHSTALCNLGYWRHGSFEVHALCHLFYHLHCIATDSFGSQGAEDSTEQGAWPLG
634,A0A2R9ABS7,Non Druggable,A0A2R9ABS7_PANPA,ACKR2,436,49260,MSAWKGITLCLHFPEEEAPGAAALLPGLWWTFSSKSFSLRTTGRRDWALPSNMAATASPQPLTTEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLVTIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLRPAGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCEVSQHLDYALQVTESIAFLHCCFSPILYAFSSHRFRQYLKAFLAAVLGWHLAPGTAQASLSSCSESSILTAQEEMTGMNDLGERQFENSPNKEDVGNKSA
635,A0A337S1Y2,Non Druggable,A0A337S1Y2_FELCA,ACKR1,339,36596,MGNCLQHRVADEDATKFTLGEDIWDEFNDSYDMNYNYSIVEAAAPCRSCPLLDDSSLPFFVLASVLGILAGAAVLFALLRPLFQWRVCPERPVLVQLAVGSTLFSIVVPILAPGLNGVQSTALCRLAHLLWYGSAFAQALLIGCHACLGPKLDVGHVAGITLWLTVGLWGGALLLGLPVTLASDTSRGLCSLSFNKSPRFLPLLHVVASFTAFTLLPLGLLGTKALTKAWGRWPGPCVSVLWVWFVFWWPHGVALGLDFLVRSKSLVLSTCLAQQALDLLLHLAEALAILHGVATPLLLALFYHQTTRTPLPSLPLSVRRPSHLDPPGGKSQLPSHLST
636,Q5U1W0,Non Druggable,Q5U1W0_RAT,Ackr2,382,43264,MPTIASPLPLATTGPENGSSIYDYDYLDDVTVLVCSKDEVLSFGRVFLPVVYSLIFVLGLAGNLLLLVVLLHSVPQRRRMIELYLLNLAVSNLLFVVTMPFWAISVAWHWVFGSFLCKVVSTLYSINFYCGIFFITCMSLDKYLEIVHAQPLHRPKTRFRNLLLIVMVWITALAVSVPEMVFVKVHQTLDGVWHCYADFGGHATIWKLYLRFQMNLLGFLFPLLAMIFFYSRIGCVLVRLRPPGQGRALRTAAALVVVFFLLWFPYNLTLFLHSLLDLHVFGNCEISHRLDYMLQVTESLAFSHCCFTPVLYAFSSHSFRQYLKAVLSVVLRRHQAPGTAHAPPCSHSESSRVTAQEDVVSMNDLGERQADISLNKGEIGNN
637,A0A140T9K6,Non Druggable,A0A140T9K6_HUMAN,ACKR3,210,24166,MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLI
638,A5YC96,Non Druggable,A5YC96_DANRE,ackr3a ,313,35070,TLYAFIFVVGLAANALVVWVNMRSQRHYHETHMYILNLAVADLCVVATLPVWVSSLAQGGHWAFGQAACKLTHLLFSVNLFASIFFLTCMSVDRYLSVVRFREISQRRGRQIRRLVCAITWLLALFASVPDTYFLRSVKSQYSHVTLCLPVYPQDNPLQWMVGIQLSFVVLGFAIPFPIIAVSYALLANTLASTSTHSPSNGDQDRSVSKKVILMYIVVFIACWAPYHAVLLADALAMLGVLPLGCSSENGLFVALHLTQCLSLLHCCVNPVVYSFAHRHYRYDLMKAFIFKYSTRTGLARLIDGSQGNETEY
639,F7DSK9,Non Druggable,F7DSK9_HORSE,ACKR1,366,39246,MALILEPQPLTEQSLPFSACPAPSSAMGNCMHGGVHLVPEENPTTFVFEGDMLDEFNDSYELEYNNTDLEAAAPCHSCILLDDSSLPFFILASILGILASGAFLFTLLRPLFHWQLCPDRPILVQLAVGSALFSIVVPIVAPGLSGVYSTHLCHLAHLVWYSSAFALALLIGCRACLGPKLSASQVPCLTLGLTVGLWGVATLLGLPVLANDVPHGLCALTFSRGRGVLPAIHAAACFSIFFLLPLGLLGAKGLKKALGRGPCPWVDILWVWFIFWWPHGLFLGLDFLVRSKSLKLSTCLAQQALDLLLELTDALAILHCVATPLLLALFCYQATRTAAPSLPLSARESSHLDTIGGKSFPPVKLN
640,A0A2U9Q293,Non Druggable,A0A2U9Q293_HUMAN,ACKR1,139,14792,AELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYVSGMAQPLPRLCC
641,F1N018,Non Druggable,F1N018_BOVIN,ACKR1,527,56595,MNDTQGAPTQTHTSQVAGITWIQPTSTTNTPSHKHVTFELSFLGSSSRGWRNSESHQLPFPSNFPAHLLPPSHTSPLAPSSFLVLGESLCAGKPPGFSASLSTFRKTWSPPFSFPECGSSPADSSLKTGSPWGQCRKWSWGSDRQWAWGKHFLNALPTPWPCPGLMPSLVPGAYLGTTATDRTTPAHLSARPAPSSIMGNCLYPVADDNSTKLAIKEDFLIDFPEDYYPDYNETDVEAAAPCHSCSLLNYSSLPFFILVSILGILASGTILYALLRPLFRWQLYQDRSTLVQLAVGSALFSIVVPILARGLSGALITSLCHLAHLVAYGSAFAQALLIGYHACLGPQLGAGQVPGLRLGVTVGLWGVAALLSLPVVLGSDTSQGLCTVTFSGEWETLRYIHAAACFAIFVLLPLGLLGTKGLKTVLGRAPCPWVDVLWVWFIFWWPQGMTLGLDSLVRSKAIVVSTCPAQQALDMLLDVAEALAILHCVATPLLLAWVCYQATHTSPPSLPLPTTQTSHLDTFGGKS
642,F7GTL4,Non Druggable,F7GTL4_MACMU,ACKR3 ,362,41395,MDLHVFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLAFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTSSSRKKMVRRVVCVLVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSVIAVFYFLLARAISASGDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK
643,A0A250YFN5,Non Druggable,A0A250YFN5_CASCN,ACKR1 ,334,36041,MGNCFYRVDSSFSLDKNESQISFDYPWNYSYDENNSLEDYSMLDSAAPCHSCNLLDDSSLPFFILASVLGVLASGAVLFALLRPLFHWQLCPGWPILAQLAVGSALFSIVVPILAPGINSAHSTSLCRLGYWVWYSSAFAQALLIGCHACLGPKLGAGQTLGLTIGLTVGLWGVAALLGLPITFASDTFYGFCTLASRRGLGPLQSTHAAACFATFTLLPLGLLVTKGLKKALGRGPDPRLNILWVWFIFWWPHGVVLGFDSLVRSRVLLLPSCLAQQILDLMLHVAEALAMLHCVAAPLLLAVFYHQSTHTSLPSLPLPARGSSHLDTFGGKS
644,A0A4X2JW79,Non Druggable,A0A4X2JW79_VOMUR,ACKR2,370,42082,MTVTPPASSTSTSLENTSIYDYYYLDNFLATVCRKEAILSFGQMFLPIFYSLVFVLGLGGNLFFLTVLLYSARRRQVTEVYLLNLVVSNLLFVVTLPFWGASVAWHWVFGEALCKIICTLYTASFYSSIFFLSCMSLDKYLDVVHAQTHHHLWTPAKSWLLSGGVWTVALVLSIPDLVFARVQEGPGGMQSCHLDFGDNGRLWKVLLRFKQSILGFILPLFAMVFFYTRIGCILTVLRPRGRGRALWAAAALVVAFFVLWCPYNITLFLHSLQDLQVLEGCEISKHLDYALQVTESIAFTHCCLSPFLYLFVHHRLRKHLKKVLEAIFKRSRESSAARPSQTSYSSSYSTTQEEMTSTDNREESLQDRGI
645,A0A1S3GCJ5,Non Druggable,A0A1S3GCJ5_DIPOR,Ackr2,376,42184,MASTTSPLPGTPNNVTSVNHSFYDYDYLEGIEFLLCHKEDVQSFARIFLPLVYSMIFVLGLIGNFLLLVVLLRYVPGPRRRAEIYLLNLAVSNLCFVVTLPFWAISVAWHWIFGNWLCKLVSALYTTNFYSGIFFISCMSLDTYLEIVHRQPCSRPRTPGQGLLFAAAVWAVALALSIPDLIFVQIHEDPPHGWNCYADFGGHATPWKLVLRFLQNLLGFLLPFSIMSFFYVRIGCAVIRLKPRGGGRAVRLTVGLVVVFFVLWFPYNLTLFLHSLLDLQVFGSCAVSTHLDYALQVTESLAFCHCCGTPLLYAFCSPRFRQYLKVLLATVLRESPTSGDSVHTSPSTCSVSSRHTAPEDMITLDDLEKSQAGNLP
646,F7GHG6,Non Druggable,F7GHG6_MONDO,ACKR4,350,39931,MDLEHNQSTDYYYEENEVNGTQDYSQYEILCVKEEVRNFAKVFLPTFYTVAFIAGIAGNSTVVAIYAYYKKQKTKTDVYIMNLAVADLLLLITLPFWAVNAVHGWVLGIPMCKLTSALFTINFVSGMQFLACISIDRYSAITKDPGHQRLGRPCWIICFSVWLIAILLSIPQLVFNTVNDKKRCLPIFSHYLGTTIQASIQILEICIGFVLPFLIMGTCYSITARKLIKMPNVKKSRPLQVLLAVVAVFIVTQLPYNIVKFWQAIDIIYSLIIDCEMSKRMDVAIQITKSLALFHSCLNPILYAFMGSSFKMHITKMVKKYGYWRRQRSNPEDIPFDSEGLTEPTSTFSI
647,A0A1C8Y868,Non Druggable,A0A1C8Y868_HUMAN,ACKR1 ,336,35500,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYGANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFCWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
648,A9JRH6,Non Druggable,A9JRH6_DANRE,ackr4b ,403,45031,LLWTADSSFLNGVSHHKQITMGVLLEYEHDYQYHDHDNDSNDSAYDEDYFGDLHTVCDKQEVRSFAGVFLPVIYTLALVLGLAGNSLVVFIYLSHKRLRTLTDVFILNLAFADLLLLFTLPFWAADAVNGWQIGTAACKITSALYTTNFSCSMLLLSCISIDRYRALAKGSAHTPARNNSRKHRIIMCLVVWGIAIVLGLPDMVFYTVRVQHSSERYTCRAVYPHSMARAAKATLEILEVSLSFILPFLVMMFCYCRVGVALSQAATAGVHGGRRWRAFRVLIAVVGVFLLTQLPYNVVKLIKTLDVIYILVTECDVSKNLDLANQITESLALTHCCLNPVLYVFIGSSFKMHIIKLAKHWSQTGRGYRHGNEQPAIEISLKSATQTHTNSSSGNEDTSTFTI
649,H2M351,Non Druggable,H2M351_ORYLA,ackr4,366,40776,MEDYEYDEGNETYDYNDEHSVCDKATVRSFGGVFLPIIYALALVVGLTGNALVVVVYTSRLRLRTLTDVCILNLAIADLLLLFTLPFWAADAVHGWTLGSAACKLMSFLYSTNFSCGMLLLACISVDRYRAVTHSSTGRAETGQRARRQWLLVCVALWALASFLGLPELVFSGVKTSHHRTSCTAFYPRNMARPAKAALELLEVILRFLLPFAVMIVCYTLMGRALTRVPGVRRERKWRALRVLFAVVAVFLLTQLPYNVVKLCRALDIIYVLVTVCDVSKGLDHALQVTESLALTHACINPLLYAFMGSSFRSHVLRAAKHLGERLGKHSRPESKEPAVEIALRTQSQNNSQSDSDDRDTSTFTI
650,Q8QFR6,Non Druggable,Q8QFR6_XENLA,ackr3,370,42187,MSAADFAAAMDYMESMNSSDFNLSCSNGDCIILESLSCPNTLNKSALLYTLAIVYIFIFVMGLLANSMVIWLNLQSKTTGYETHLYIFNLAIADLCVLLTLPVWVVSLVQHNQWPMGEMTCKITHLVFSINLYSSIFFLTCMSVDRYLCVSLNGTAGQRRRKIVRRLVCVLVWLVAFVFSLPDTYYLKTVSSPVTNETYCRSMYPEETFKEWLLGMEIVSIMLGFVIPFPIIAIFYCLLACTLSSSSSSSGDQERRISGRLIVSYVVVFMVCWLPYHAMVILDVMSFLQLIPFSCFLDNFFYAALHITQCYSLLHCCINPILYSFIHRNYRYEIMKAFIFRYSSKTGLTKLIESSKVSEAEYSAVDQIPK
651,Q5BKI9,Non Druggable,Q5BKI9_XENTR,ackr3 ,361,41378,MDYMESMNSTEFNLSCSNGDCIILESLSCPNTLNKSALLYTLAIVYIFIFVMGLLANSMVIWLNLQAKTTGYETHLYIFNLAIADLCVLLTLPVWVVSLVQHNQWPMGEMTCKITHLVFSINLYSSIFFLTCMSVDRYLCVSLNGTAGQRRRKIIRRLVCVLVWLVAFVVSLPDTYYLKTVSSPVTNETYCRSMYPEETFKEWLLGMEIVSIMLGFVIPFPIIAIFYCLLAWTLSSSSSSSGDQERRISGRLIVSYVVVFMVCWLPYHAMVILDVMSFLQLLPFSCFLDNFLYAALHITQCYSLLHCCINPILYSFIHRNYRYEIMKAFIFRYSSKTGLTKLIESSKVSEAEYSAVDQIPK
652,G0TQY8,Non Druggable,G0TQY8_HUMAN,DARC ,336,35613,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYGANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWFSHLDTLGSKS
653,G9G806,Non Druggable,G9G806_HUMAN,DARC ,336,35588,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFCWQLCPGWPVLTQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
654,K7F405,Non Druggable,K7F405_PELSI,ACKR2,331,38612,LASTSYHRPISTDNPANMTNYEYQYLEEEDYIQFVVCTKENVRAFGKVFLPVLYTIVFLLGLTGNCLLFAILIKYTKNKKMTEVYLLNLTVSDLLFVITLPFWATYAASQWVFGNAFCKIISIIYSINFYSGIFFVSCMSLDKYLEIVHAWSNKNLRAPRKSFFISSLVWVLSILLSIPECIFVQVQDLHNGRQVCHLNYGPHHFNWKLLFQFQQILLGFFLPFLCMVFFYSRVACVLTELRSTGKKKALRLVVTLVVVFFVLWFPYNVTLFLHLLQHLHVIKDCETSKHLDYALQVTECLAFIHCCLNPLLYAFVNKRFRLHLKKIFGAV
655,F1R6D3,Non Druggable,F1R6D3_DANRE,ackr3a,398,44420,WINIAHSTSIKGKMTEIQSSSPNEKLGLSASELTEFFAMWEELNFTDSNNNSSRVEAQMCPASFNRSALLNAMCTLYAFIFVVGLAANALVVWVNMRSQRHYHETHMYILNLAVADLCVVATLPVWVSSLAQGGHWAFGQAACKLTHLLFSVNLFASIFFLTCMSVDRYLSVVRFREISHRRGRQVRRLVCAITWLLALFASVPDTYFLRSVKSQYSHVTLCLPVYPEDNPLQWMVGIQLSFVVLGFAIPFPIIAVSYALLANTLASTSTHSPSNGDQDRSVSKKVILMYIVVFIACWAPYHAVLLADALAMLGVLPLGCSSENGLFVALHLTQCLSLLHCCVNPVVYSFAHRHYRYDLMKAFIFKYSTRTGLARLIDGSQGIETEYAMVENNPPTVT
656,A0A0R4J0J4,Non Druggable,A0A0R4J0J4_MOUSE,Ackr1,334,36613,MGNCLYPVENLSLDKNGTQFTFDSWNYSFEDNYSYELSSDYSLTPAAPCYSCNLLGRSSLPFFMLTSVLGMLASGGILFAILRPFFHWQICPSWPILAELAVGSALFSIAVPILAPGLHSAHSTALCNLGYWVWYTSAFAQALLIGCYACLNPRLNIGQLRGFTLGLSVGLWGAAALLGLPVALASDAYNGFCAFPSSRDMEALKYMHYAICFTIFTVLPPTLLAAKGLKIALSKGPGPWVSVLWIWFIFWWPHGMVLIFDALVRSKIVLLYTCQSQKILDAMLNVTEALSMLHCVATPLLLALFCHQTTRRSLSSLSLPTRQASQMDALAGKS
657,H0YPR1,Non Druggable,H0YPR1_TAEGU,ACKR2,413,47074,MEEVPKSLVQASGRMERGEEASLPGAAWNGYLSNFSHGTTAGSHWSNTTSGVTATTTGTWLDAANSSEYLYEYLDEEDYGLYGLCTKEEVLSFSRVFLPSFYTVIFLVGMAGNALLFTVLLMHIKKKKKMTELYLMNLVVSDFFLLLTLPFWALYISQWVTWDILCPFLSAMYTLNFYSGIFFVSCMSLDMYLQIVHAWSPHSSTVWRNSILILLVMWILSIALSIPDGLFTSTRQTHNKTIMCAQDYGQEHLFWKVVFRVTQNILGFLFPFLFMTFCYSRIACVLNTSQIPGSRRALCLVLTLVGVFFVLWCPYNVVLILHSLQDVGVIRSCESSRKLDYALQITESLSFVHCCLNPLLYAFVKKRFRAYLWKIPQAIFRRGAFFSIQDSQTSLSCSRYAAEIEMLSITNAS
658,G3U7G7,Non Druggable,G3U7G7_LOXAF,ACKR2,382,43346,MAASTSPPLLTTEDTNSENSSYYYYDYFVDIPFMLCRKDAVMSFGKIFLPVFYSLIFVLGLGGNLLLLTVLLRYVPRRQMAEIYLMNLAISNLLFVVTLPFWGISAAWHWVFGNFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTRAKSLILSAVVWGVALAISIPDMVFVQTHENPKGMWRCYPDFGGHGTFWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLKPPGQSRALRMAAALVVAFFVLWFPYNLALFLHSLLDLQVFGDCNISHRLDYALQVTESIAFLHCCFTPVLYAFSSRRFRQYLKTFLATVLGWHLAPSTAQASLSTCSGSSCLTAQEEMTSMNELGKKHADSSPNKGDVGKN
659,A0A2Y9EPX4,Non Druggable,A0A2Y9EPX4_PHYMC,ACKR2,391,44207,MCPPAMAATTSPLPPTTKVASSEDSSSFYDYEYYLDGVAFMLCRKDEVLSFGRVFLPLFYGLIFVLGLGGNLLLLVVLLRYVPRRRMTEIYLLNLAISNLLFVVTLPFWGISVAWHWVFGNFLCKVVSTLYTINLYSGIFFISCMSLDKYLEIVCTQLHHRRRTRAKSLLLAAVLWAVALAVSIPDMVFVRTHENAPGTWDCFADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGSVLVRLRPPGQSRALRMAIGLVVAFFVLWFPYNVTLFLHSLLDLQVFGDCKVSQHVDYALQVTESIAFLHCCFTPVLYAFSSRRFRQYLKAFLATVLRRHQVPYLAQAPPSSYSESSRLSGQEDITGMNDLGERQAEDSPNKGDAGKNSA
660,A3F9C6,Non Druggable,A3F9C6_PIG,ACKR4 ,350,39922,MALEHNQSTDYYYEENEMNDTHDYSQYEVICIKEEVRKFAKVFLPAFFTVAFIIGLAGNSIVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKIMCKVTSALYTVNFVSGMQFLACISIDRYWAVTKGPSQPGVGKLCLLICFCVWMAAILLSIPQLVFYTVNHKARCVPIFPYQLGTSMKALIQMLEICIGFIIPFLIMGVCYFITARTLIKMPNIKKSRPLKVLLTVVLVFIVTQLPYNIVKLCQAIDIIYSLITDCDMSKRMDVAIQITESIALFHSCLNPVLYVFMGASFKNYIMKVAKKYGSWRRQRQNVEEIPFDSEDVTEPTSTFSI
661,A0A4X1TJL8,Non Druggable,A0A4X1TJL8_PIG,ACKR2,385,43948,MATSDSPLPLTTMVTSSENSSSFYDYEYYLDEAAFMLCRKDEVLSFGRVFLPIFYSLIFVLGLGGNLLLLVVLLWYVPRKRMTETYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFIGCMSLDKYLEIVWAWPHHQLRTRAKSLLLVTVVWVVALAVSIPDMVFVRTHENHPNVWDCYADFGGHGTIWKLFLRFQQNLLGFLLPLLAMTFFYARIGCVLVRLRPPGQGRALRMAVALVVAFFVLWFPYNLTLFLHSLLDLQVFGDCKVSQHLDYGLQVTESIAFLHCCITPVLYAFSSRRFRRHLKDLLAAVLRRHQAPYLAQAPPSSSSESSRLTAQEDVTRMNDLEGRQAEDAPNKENVGSSA
662,H2QNE3,Non Druggable,H2QNE3_PANTR,ACKR4 ,350,39934,MALEQNQSTDYYYEENEMNGTYDYSQYELICIKEDVREFAKVFLPVFLTIAFVIGLAGNSMVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKIMCKITSALYTLNFVSGMQFLACISIDRYVAVTKVPSQSGVGKPCWIICFCVWMAAILLSIPQLVFYTVNDNARCIPIFPRYLGTSMKALIQMLEICIGFVVPFLIMGVCYFITARTLMKMPNIKISRPLKVLFTVVIVFIVTQLPYNIVKFCRAIDIIYSLITSCNMSKRMDIAIQITESIALFHSCLNPILYVFMGASFKNYVMKVAKKYGSWRRQRQSVEEFPFDSEGPTEPTSTFSI
663,A0A6P4T6F8,Non Druggable,A0A6P4T6F8_PANPR,ACKR2,386,43902,MASTASPLPPTTEVASSENSSSFYDYEYYLDSVAFMLCRKDEVMSFSRIFLPVFYSLIFVLGLGGNLFLLVVLLRYMPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHTQPHHRLRTRAKSLLLAAMVWTVALAVSIPDMVFVQTHENPTGVWNCYADFGGHGTIWKLFLRFQQNLLGFLLPLLVMIFFYSRIGSVLVRLRPPGQGRALKIVVALVVAFFVLWFPYNLTLFLHSLLDLQVFGDCKVSQHLDYALQVTESIAFLHCCFTPILYAFSSRHFRGHLKAFLITVLRHNQAPRPAQAPLSSCSESSTLTAQEEMTGMNDLGERQAEHSPDMNDTGENEA
664,A0A6D2XTS4,Non Druggable,A0A6D2XTS4_PANTR,CK820_G0005316,384,43527,MAATASPQPLTTEDADSENSSFYYYDYLDEVAFMLCRKDAVVSFGKIFLPVFYSLIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLVTIVWAVSLAVSIPDMVFVQTHENPRGVWNCHADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLRPAGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGNCEVSQHLDYALQVTESIAFLHCCFSPILYAFSSHRFRQYLKAFLAAVLGWHLAPGTAQASLSSCSESSILTAQEEMTGMNDLGERQFENSPNKEDVGNKSA
665,A0A2Y9LW12,Non Druggable,A0A2Y9LW12_DELLE,ACKR2,414,46889,MVCCTWKILVDSRLSLCRELQHWMCPPAMAATASPLPPSTKVASSENSSSFYDYEYFLGDAAFMLCRKDEVLSFGRVFLPLFYGLIFVLGLGGNLLLLVVLLRYVPRRRMTEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKVVSTLYTINIYSGIFFISCMSLDKYLEIVCAQPHHRLRTRAKSLLLAAVVWAVALAVSIPDMVFVRTHENAPGVWDCFADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGSVLARLRPPGQSRALRMAIGLVVAFFVLWFPYNVTLFLHSLLDLQVFGDCKVSQHLDYALQVTESIAFLHCCFTPVLYAFSSRRFRQYLKAFLATVLRRHQAPYLAQAPPSSYSESSRLSGQEDITGMNDLGERQAEDSPNKGDTRKNSA
666,A0A2J8WXT8,Non Druggable,A0A2J8WXT8_PONAB,CR201_G0006325,384,43317,MAATASPQPLTTEDAGSENSSFYYYDYLDEVAFMLCRKDAVVSFGKVFLPVFYSMIFVLGLSGNLLLLMVLLRYVPRRRMVEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPYHRLRTRAKSLLLATIVWAVSLAVSIPDMVFVQTHENPKGVWNCHADFGGHGAIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLRPAGQGRALKIAAALVVAFFVLWFPYNLTLFLHTLLDLQVFGTCEVSQHLDYALQVTESIAFLHCCFSPILYAFSSHHFRQYLKAFLAAVLGWHLAPGTAQASLSSCSESSILPAQEEMTGMNDLGERQSENSPNKEDVGNKLA
667,A0A5F7ZCI8,Non Druggable,A0A5F7ZCI8_MACMU,ACKR1,336,35557,MGNCLHPAELSPSTQNSSQLNSEDLWNFSYDGNDSFPDVDYDANLEAAAPCHSCNLLDDSALPFFILVSVLGILASGTVLFMFFRPLFHWQLCPGWPILAQLAVGSALFSIVVPILAPGLGNTRSSALCSLGYCVWYGSAFAQALLLGCHASLGPKLGAGHVPGLTLGLSVGLWGVAALLTLPITLASGASGGLCTPVYSMELKALQATHAVACLAVFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
668,A0A3Q8I5V1,Non Druggable,A0A3Q8I5V1_HUMAN,ACKR1,336,35641,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYDANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSMELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
669,A0A3G2KJS0,Non Druggable,A0A3G2KJS0_HUMAN,ACKR1,336,35625,MGNCLHRAELSPSTENSSQLDFEDVWNSSYGVNDSFPDGDYEANLEAAAPCHSCNLLDDSALPFFILTSVLGILASSTVLFMLFRPLFRWQLCPGWPVLAQLAVGSALFSIVVPVLAPGLGSTRSSALCSLGYCVWYGSAFAQALLLGCHASLGHRLGAGQVPGLTLGLTVGIWGVAALLTLPVTLASGASGGLCTLIYSTELKALQATHTVACLAIFVLLPLGLFGAKGLKKALGMGPGPWMNILWAWFIFWWPHGVVLGLDFLVRSKLLLLSTCLAQQALDLLLNLAEALAILHCVATPLLLALFCHQATRTLLPSLPLPEGWSSHLDTLGSKS
670,F1RA46,Non Druggable,F1RA46_DANRE,ackr4a ,383,43508,XTETIHSAFRQSFNPFERMENSEEHFYDYPEYENSSSNFSYDDYQTICEKGDVRSFARIFLPAVFGLSLVIGLAGNALIVAVYAYCKQLKTMTDTFILHLAVADLLLLLTLPFWAVDAVHGWQLGITICKLVSGLYTINFTCSMMLLAYISMDRYLALSVGSRNQGLGRVFQKQHCGKLCVVVWMAAFLLGIPDLVFSTVRELPHKKSCLAMYPSDMALRAKASLEMVEVVIGFLLPLLVMLFCYTRVGRALLKLSEDRKWKKWQYIRVLLAMVGVFLVTQLPYNVVKFCRALDIMYTFVTHCGVSKKLDWATQITESLALTHCCLNPVVYTFVGSSFRQHVLKCAKDFGDRGRRLAHAREQQEVNISLNSHSHSRDTSTFSI
671,A0A1D5PZ18,Non Druggable,A0A1D5PZ18_CHICK,ACKR4,385,44176,MRRTNSDHFTEAHLSYSISYQAADKSFVMGWVVNNSTDYWIEDDEHYLNSDVDYNTYEFLCEKEDVRKFMKVFLPVFYALTFTVGVAGNSLVVAIYAYCKKPKTKTDVYIMHLAIADLLLLFTLPFWAANAVQGWELGNSMCKLTSSLYTMNFSSSMLFLACISLDRYRATSESQRHRRAGKHCSVTCICVWLSAVLLSIPELIFNQVITHNNRNECLPIFPTNMETLLKATIQILEVILEFLLPFLVMVTCYSVTARAIFRSANAKKSRPFMVLLAVVAAFIITQLPYNIIKFWRAIDSIYLLITDCEASKTIDVALQVTKSIALFHTCLNPILYAFLGASFKMRVMKIAKNYGYWRRQQQHEVPEEISMNSEARTEETISFTI
672,G1TG81,Non Druggable,G1TG81_RABIT,ACKR2,401,45115,MAGKLMCAGGGAQERDEIQDRVRLPSMATTASSLPLTKEGAGPENSSSFYDYDYLDDVAFMLCRKDAVLSFGKVFLPVFYSLLFVLGLGGNLLLLVVLLRHVPRRRMTEIYLLNLAISNLLFVVTLPFWAISVAWHWVFGSFLCKMMSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTRTASLLLAALVWTVAVAISIPDMVFVQINENPKGVWNCYAEFGGHGAIWKLFLRFQQNLVGFLLPLIAMIFFYSRIGCVLVRLRPPGRGRALRIAAALVVAFFVFWFPYNLTLFLHSLMDLQVFGDCQVSQHLDYALQVTESIAFLHCCFTPVLYAFSSRRFRQYLKTFLATVLGRHLAPGTAQASLSNCSESSRVTTHEEMTGMSDLGKRQAEGSP
673,H2TRG5,Non Druggable,H2TRG5_TAKRU,ackr3,378,42479,MSLSTSELEDLFKLFGDPNVSDTLSNISSVDTMMCATSFDRNALLYSMCVLYTFIFVIGLAANALVLWVNIRAQRDSTPRHETHMYIAHLAVADLCVCATLPVWVSSLAQHGHWPFGEVACKLTHLLFSVNLFGSIFFLACMSVDRYLSVTMRQNNEDRTNRKLIRRGVCVGVWLLALIASLPDTYFLQTVKATHGDTMLCRPVYPEEHPREWMVGVQLSFNLLGFVLPFPIIAVFYLLLAGAFTSSSSYSSSSTVEQERRVSRRVILAYIVVFLGCWGPYHGVLLADSLSQLGLVPLTCSLENVIYVALHLTQCLSLLHCCFNPILYNFINRNYRYDLMKAFIFKYSTRTGLARLIEATNISEAEYSAVALDNPPQI
674,W5UJM4,Non Druggable,W5UJM4_ICTPU,ACKR3,380,42922,MFYVAGARVPVWKITMNVNMNELTDLLDMLREQNFSFLEENGSRVETIVCQTAFSQNAMLYSLSILYVFIFIIGLAANTLVVWVNIRSSRERHETHLYILNLAIADLCVVATLPISISSLLQHGHWPFGDAMCKITHLIFSVNLFSSIFFLTCMSVDRYISVARCGDSPGHSKRRWIRQVICVGIWVLALLAALPDTYFLQAVKSTHSDITVCKSMYPAEKLYEWTVGVQLSFIVLGFAIPFPVIAVFYALLARLISSSADQERCASRHLVFTYIVVFLVCWLPYHGTLLLDTLALVNALPLSCTLENTLYVALHVTQCLSLLHCCVNPVVYNFINRNYRYDLMKAFIFKYSTKSGLAKLIDVTRASETEYSAVESQGPL
675,H0V6Y3,Non Druggable,H0V6Y3_CAVPO,ACKR2,417,46588,MRQTNAPLRSRAAEPGPRGIAGIPGAPALGVSSAMVTTASPSNLTTEDAAPENGSFYYDYEYLDSVLFLVCTKEEVLSFARIFLPVFYSLIFVLGLGGNSLLLVVLLRYVPRRRMAEVYLLNLAVSNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPLHRLRTRAKSLLLAALVWAVALAISVPDMVFVQVHEHPKGVWSCYPDFGGHGTSWKLFLRFQQNLLGFLLPLLAMIFFYSRIGCVLVRLQPRGLGRALRMAVALVVAFFTFWFPYNLTLFLHSLLDLQIFGDCQVSRDLDYAMQVTESLAFLHCCFTPVLYAFCSRRFRQYLKALLATVLRWRLGPGPTQASLSRGSESSRLTAQEDVTGLNELAQGSAVGSLKQEVVGSH
676,G3V9V6,Non Druggable,G3V9V6_RAT,Ackr4 ,350,39683,MALEQNQSVEYDYEDTEMNYTHDYSQYEVICIKEEVRQFAKVFLPAFFTVAFVIGLAGNSIVVAIYAYYKKQRTKTDVYILNLAVADLLLLVTLPFWAVNAVHGWILGKMMCKVTSALYTVNFVSGMQFLACISIDRYWAITKAPSQSGVGKPCWIICCCVWTAAILLSIPQLVFYTVNENARCTPVFPHHLGTSLKASIQMLEIFIGFVVPFLIMGVCYAMTARELIKMPNIKKSRPLRVLLAVVVVFIVTQLPYNVVKFCQAIDAIYLLITNCDMSKRMDVAIQVTESIALFHSCLNPILYVFMGASFKNYIVKVAKKYGSWRRQRRNVEEIPFDSEGPTEPTSSFTI
677,H2ZSI2,Non Druggable,H2ZSI2_LATCH,ACKR2,343,39913,LLPSISPLLFEDFNTSDDNYSSYYDYYAYSQFEACRKDGVKAFSQIFLPIFYMLICCLGLIGNILLVVILIRYAKIKTMTEVYLLNLAVSDLLFVFTLPFWTVYAATEWKFGNAFCKIVSTVYTTNIYSGVFFIICLSLDRYLEIVHTWSLTKVKSFRSSALLSSMVWIFSIMLSVPEVVFSELMVEHGRQVCIHNYGNQATAWRIILRFQLNCIGFLLPLLVMVFFYSCITHALLQSRSLGKQKTLMLVITLVVVFFILWCPYNVVLFLHSLQDLHVFLDCELSKHLDYAMQVTESLAFIHCCLNPILYAFVNKRFRLHLLKVWKRVCRRREAATFNFTETS
678,G1PUN6,Non Druggable,G1PUN6_MYOLU,ACKR2,386,43743,LDMATSPQPLTTKVASSENSSAFYDYEYYLDQAAFMPCMKDQVLAFGRVFLPVFYSLVFVLGLSGNLLLLVVLLRYVPRRRMTEVYLLNLAISNLLFVVTLPFWITTVAWHWVFGNFLCKMVSTLYTINLYSGIFFISLMSLDKYLQIVHAQPHHWLRPRARRWLLAVIVWAVALAVSIPDMVFVRIHENHQGVWNCHADFGGHGTVWKLILRFQQNILGFILPLFAMIFFYSRIGSALVRLRPPGQGRALKVAVSLVVAFFVLWFPYNLILFLHSLMDLKVFGDCETSNYLDYALQVTESIAFLHCCSTPILYAFSIRCFCQYLKAFLAELFGRRQGPCPAQAPLSSCCESSSLTVQEEMTSMNDLEEGQAEGSPNKGAVGGNKA
679,A0A2K6KI32,Non Druggable,A0A2K6KI32_RHIBE,ACKR4,350,39780,MALEQNQSTDYYYEENETNGTYDYTQYELICIKEDVREFAKVFLPVFLTIAFVIGLAGNSTVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKTMCKITSALYTLNFVSGMQFLACISIDRYVAVTKGPSQSAVGKPCWVICSCVWMAAILLSIPQLVFYTVNDNARCIPIFPHYLGTSMKASIQMLEICIGFVVPFLIMGVCYFITARTLMKMPNIKISRPLKVLLTVVLVFIVTQLPYNIVKFCRAIDIIYSLITNCNMSKRMDIAIQITESVALFHSCLNPILYVFMGASFKNYIMKVAKKYGSWRRQRQSVEEFRFDSEGPTEPTSTFSI
680,A0A2K6NUN0,Non Druggable,A0A2K6NUN0_RHIRO,ACKR4,350,39780,MALEQNQSTDYYYEENETNGTYDYTQYELICIKEDVREFAKVFLPVFLTIAFVIGLAGNSTVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKTMCKITSALYTLNFVSGMQFLACISIDRYVAVTKGPSQSAVGKPCWVICSCVWMAAILLSIPQLVFYTVNDNARCIPIFPHYLGTSMKASIQMLEICIGFVVPFLIMGVCYFITARTLMKMPNIKISRPLKVLLTVVLVFIVTQLPYNIVKFCRAIDIIYSLITNCNMSKRMDIAIQITESVALFHSCLNPILYVFMGASFKNYIMKVAKKYGSWRRQRQSVEEFRFDSEGPTEPTSTFSI
681,H2V912,Non Druggable,H2V912_TAKRU,ackr4,370,41084,MDDYYNEDEDSSLNDTYDYNYEYGICDKEAVRSFAGVFLPVIYALTLVVGLAGNALVVVVYASKVRLRTLTDVCILNLAVSDLLLLFTLPFWAADAVHGWRLGSWACKLNSFLYSTNFSCGMLLLACISVDRCSAVVRGVRGRTSASPRVRRRWLLVCLALWAVASFLGLPELIFSTVKHSHHRMACTEIYSPSMARPAKAAVELLEVLLRFLAPFLVMVVCYGWMGMVLSRAAGVQRERKWRALRVLLAVVAVFLLTQLPYNVVKLCRAMDIIYAVVTDCEVSKGLDRALQVTEGLALAHACINPLLYAFMGSSFRGHVLRVVKHLGQRLGRHPRPAPEEPAVEIALKSPNQPQSQSGSEEQDTSTFSI
682,H3B8H5,Non Druggable,H3B8H5_LATCH,ACKR3,366,42143,MSAIDLNSLLDYLDELNSTADSSSCNDSDCFSLETLACPRTLNKTALLHTISYFYIFIFVIGLLANSVVVWVNLRTKRNHFETHLYVLNLAVADLCVVITLPIWVASLVNHGQWHMGGFMCKITHLIFSVNLFGSIFFLTCMSVDRYVSVTLFRDSNNRNKRIIRRLICIFMWLFAFGASIPDTYFLQIIAEPFTNDVYCRVTYPLEYFWEWLVGMELLCIVLGFVIPFPIIAIFYILLASAITASSDQERKTSRKIIFSYVIVFLVCWLPYHTVLLIEALTMLQVLPFSCDLEDFLYVAIHVTQCFSLIHCCINPILYNFINRNYRYDLMKAFIFKYSTKTGLTKLIDASKVSETEYSMVEPSGV
683,M3W144,Non Druggable,M3W144_FELCA,ACKR4,350,40046,MALEHNQSTDYYYEENEVNGTHDYSQYEVICIKEEVRKFAKVFLPAFFTIAFIIGIAGNSIVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGRIMCKVTSALYTVNFVSGMQFLACISIDRYWAVTKAPSQSGVGKPCWLICFFVWMVAILLSIPQLVFYTVNHKARCIPIFPYHLGTSVKASIQMLEICIGFVIPFLIMGVCYFVTARTLIRMPNIKKSRPLKVLLTVVIVFIVTQLPYNIVRFCQVIDIIYSLITDCDMSKRMDVAIQITESIALFHSCLNPVLYVFMGASFKNYIMKVAKKYGSWRRQRQNVDEIPFDSEDPTEPTSTFSI
684,G1MLW0,Non Druggable,G1MLW0_AILME,ACKR2,384,43447,MASTASPVPPTTEAASSENSSSFYDYEYYLDQVAFMLCRKDEVLAFGRIFLPIFYSLIFVLGLGGNLLLLVVLLRYVPRRRMTEVYLLNLAISNLLFVVTLPFWGVSVAWHWVFGSFLCKMVSTLYTVNFYSGIFFLSCMSLDKYLEIVHAQPHHGLRTQAKSLLLAALVWAVAVAVSVPDMVFVQTHENPPGVWNCYPDFGGHSTIWKLFLRFQQNVLGFLLPLLVMIFFYSRIGCVLVRLRPPGQGRALRIVIALVVAFFVLWFPYNLTLFLHSMLDLQVFGECKVTKHLDYALQVTESIAFLHCCFTPILYAFSSRHFRQYLKAFLVTMLRRHQASGPAQAPLSSCSESSRLTAQEEMTGMNDLGERQAESSPDKSDMGGN
685,A0A2I2Y9C3,Non Druggable,A0A2I2Y9C3_GORGO,ACKR4,350,39899,MALEQNQSTDYYYEENEMNGTYDYSQYELICIKEDVREFAKVFLPVFLTIAFVIGLAGNSMVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKIMCKITSALYTLNFVSGMQFLACISIDRYVAVTKVPSQSGVGKPCWIICFCVWMAAILLSIPQLVFYTVNDNARCIPIFPRYLGTSMKALIQMLEICIGFVVPFLIMGVCYFITARTLMKMPNIKISRPLKVLLTVVIVFIVTQLPYNIVKFCRAIDIIYSLITSCNMSKRMDIAIQITESIALFHSCLNPILYVFMGASFKNYVMKVAKKYGSWRRQRQSVEEFPFDSEGPTEPTSTFSI
686,A0A2U3WYQ0,Non Druggable,A0A2U3WYQ0_ODORO,ACKR2,391,44655,MCPPNMASTTSPLPPTTEVASSENSSSFYDYEYYLDQVAFMLCRKDEVLAFGRIFLPIFYSLIFVLGLGGNLLLLVVLLWYIPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMMSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTREKSLLLAAMVWAVALAVSIPDMVFVQTHENPTGVWNCYADFGGHATIWKLFLRFQQNLLGFLLPLLVMVFFYSRIGCVLVRLKPPGQGRALRIVVALVVAFFVLWFPYNLTLFLHSLLDLQVFGECKVIKHLDYALQVTESIAFLHCCFTPILYAFSSRHFRQYLKAFLVTVLRRPQAPGPAPAPLSSSSESSRLTTQEEMTSMHDLRERQAESSPNKSDMGENQA
687,A0A452RTI3,Non Druggable,A0A452RTI3_URSAM,ACKR2,384,43564,MASTASPVPSTTEVASSENSSSFYDYEYYLDQVAFMLCRKDEVLAFGRIFLPIFYSLIFMLGLGGNLLLLVVLLRYVPRRRMTEVYLLNLAISNLLFVVTLPFWGISVAWHWVFGSFLCKMVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHGRRTRAKSLLLAALVWAVAVAVSVPDMVFVQTHENPPGVWNCYPDFGGHATIWKLFLRFQQNLLGFLLPLLVMTFFYSRIGCVLVRLRPPGQGRALRIVIALVVAFFVLWFPYNLTLFLHSMLDLQVFGECKVTKHLDYALQVTESIAFLHCCFTPILYAFSSRHFRQYLKAFLVTVLRRHQASGPAQAPLSSCSESSRLTAQEEMTGMNDLGERQAESSPDKSEMGGN
688,A0A671F6K7,Non Druggable,A0A671F6K7_RHIFE,ACKR2 ,386,43865,MAASASAVPLTTEVATSENSSSFYDYEYYLDQVAFMLCRKDEVHSFGKVFLPVFYSLVFVLGLGGNLLLLVVLLRYMPRRPMTEVYLLNLAMSNLLFVVTLPFWGISVVWHWVFGNFLCKMVSTLYTTNLYSGIFFISCMSLDKYLEVVHAQPHHRLRTRAKRWHLTAMVWVAALAVSIPEMVFVQTHEHPLGVWSCYPDFGGHATIWKLVFRFQQNLLGFLLPLLVMLFFYSRIGSVLVRMKTPGQGRALRITVALVLAFFVLWFPYNLTLFLHSLMDLSVFGDCRISQRLDYALQVTESVAFLHCCFTPILYAFSSRRFRHYLKALLATTLGRHQAPGPAQAPLSSCSENSSLTAQEEVTGMNDLGERQTEDAPNKRDVGKSEA
689,F7EFK6,Non Druggable,F7EFK6_XENTR,ackr4,356,40760,MEEKINTTQRPTTENYDEYGDTTFDYSNYEELCEKKGVRQFAQIFLPAFYAVAFVIGVAGNSLVVAIYAYYKKMKSKTDVYLLNLAVADLLLLFTLPFWATDAAVGWQFGIFMCKITSAMYTINFSSGMQFLACISLDRYFAVTKAPNPQPIRKICWVTCLFVWSTSMLLSIPDLYFSTVKEHNNKHACLPVYPKDTIKQTTVLIQILEIVFCFLLPFLVMLFCYASMAKIVLQTPNIKRSRSLKVLLAVVGVFLITQLPYNVIKFWRAIDIIYALITSCSMSRTIDIMIQVTESLALFHSCLNPILYAFMGTTFKSYISKIAKRYGALRRQRIQSTEEYAMHSENHVEETSSFSI
690,A0A2U4CAM3,Non Druggable,A0A2U4CAM3_TURTR,ACKR2,391,44190,MCPPAMAATASPPPPSTKVASSENSSSFYDYEYFLGDVAFMLCRKDEVLSFGRVFLPLFYGLIFVLGLSGNLLLLVVLLRYVPRRRMTEIYLLNLAISNLLFLVTLPFWGISVAWHWVFGSFLCKVVSTLYTINFYSGIFFISCMSLDKYLEIVHAQPHHRLRTRAKSLLLAAAVWAVALAVSIPDMVFVRTQENAPGVWDCFADFGGHGTIWKLFLRFQQNLLGFLLPLLAMIFFYSRIGSVLARLRPPGQSRALRMAIGLVVAFFVLWFPYNVTLFLHSLLDLQVFGDCKVSQHLDYALQVTESIAFLHCCFTPVLYAFSSRRFRQYLKAFLATVLRRHQAPYLAQTPPSSYSESSRLSGQEDITGMNDLGERQAEDSPNKGDTRKNSA
691,A0A6P5L9Q2,Non Druggable,A0A6P5L9Q2_PHACI,ACKR2,399,45296,MNMKAPSQSSREAAETDELTEKIRFFSNMTATLPPASSTSTSLENTSIYDYYYLDNFLSTVCRKEAILSFGQMFLPIFYSLVFVLGLSGNLFFLTVLLYSARRRQVTEVYLLNLVVSNLLFVVTLPFWGASVAWHWVFGEVLCKIICTLYTAGFYSSIFFLSCMSLDKYLDVVHAQTHHHPWTPAKSWLLSGGVWTVALVLSIPDLVFARVQEGTGGMQSCHLDFGDNGPLWKVLLRFKQSILGFILPLFAMVFFYTRIGYILTVLRPRGRGRALWAAAALVVAFFVLWCPYNITLFLHSLQDLQVLEGCEVSKRLDYALQVTESIAFTHCCLSPFLYLFVHHRLRKHLKKVLEAIFKRSRESSAAHPSQTSYSNSYSTTQEEMTSTDSRGESLQDHGI
692,A0A5F4WH17,Non Druggable,A0A5F4WH17_CALJA,ACKR2,384,43450,MAATASPQRLTTEDAGSENSSFYDYDYLDEIPFMLCRKDAVRSFGKIFLPVFYSLIFVLGLSGNLLLLTLLLRYVPRRRMAEVYLLNLAISNLLFVVTLPFWGISVAWHWFFGSFLCKMVSTLYTINLYSGIFFIGCMSLDKYLEIVHAQPYHRLRTRAKSLLLITIVWAVSLAISIPGMVFVQTHENPKGVWNCHADFSGHGTIWKLFLRLQQNLLGFLLPLLAMIFFYSRIGCVLVTLRPPGRGRALKIAVALVVAFFVLWFPYNLTLFLHSLLDLQVFGDCKVSQHLDYALQVTESIAFLHCCFSPILYAFSSHRFRQYLKTFLAAVLGWHLAPGTAQGSLSSCPESSSLTAQEEMTGMNDLGERQIENFPNKEDVGNKAA
693,G1K8T0,Non Druggable,G1K8T0_ANOCA,ACKR4,373,42443,MFHNINDSDLLYHLPASSMESATNPSELYYDSYYDESNATVDYALHEMPCLKEEVRTFNKSFLPAFYSIAFLIGLPGNSLVIAIYAYIKKLKTRTDVYIMHLAIADLLLLFTLPFWATNAVHGWVFGNPLCKITTAIYTMTFSVSMQFLAWISVDRYNAIVKSPSQQRTTKLCSKICFFVWMAGTFLCLPDLIFNQVKEFHGKIACVSTFPESLSKIIKVTIEVGEMALCFVLPFFIMLTCYSAVARALFKSPSVKKTQPLKVLAAVVSVFIVTQLPYNVIKLWRAIDIIYPLITNCKASKAMDVAFEVTNSIALFHSCLNPLLYFFMGASLKMHMVKLAKRYGYWRRQQNIPPEEIPMDYEESAEQTSSLII
694,F6VNE0,Non Druggable,F6VNE0_HORSE,ACKR4,350,39880,MALEHNQSTDYYYEENEMNNTHDYSQYEVICIKEEVRKFAKVFLPAFFSVAFIIGLAGNSTVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKIMCKVTSALYTVNFVSGMQFLACISIDRYWAVTKAPSPSGVGKPCRLICFCVWMAAILLSIPQLVFYTVNHKARCIPIFPYHLGTSMKASIQMLEICIGFVIPFLIMGVCYFLTARTLIKTPNIKKSRPLKVLLTVVIVFIVTQLPYNIVKFCQAIDIIYSLITDCDMSKRMDVAIQVTESIALFHSCLNPILYVFMGASFKNYIMKVAKKYGSWRRQRQNVEEIPFDSEDPTEPTSTFSI
695,A0A5F8GN37,Non Druggable,A0A5F8GN37_MONDO,ACKR2,388,44140,MPFSDTVKFIGKVCLPSNMAATFPPASSAPTSLENTSLYDYYYFENFPDTVCRKEAILSFGQVFLPIFYSLVFVLGLGGNLFFLIVLLYSARSRRVTEIYLLNLVVSNLLFTITLPFWGVSAAWHWGFGEVLCKIICTLYTTSLYGSIFFLGCMSLDKYLDVVHAQTHHRQWTSAKSRLLTGGVWTVALVLSIPDLVFARLQEGPSGRQNCHLDFGENGPVWKLVLRFQQSALGFILPLFTMAFFYTRIVCVLTVLRPRGRSRALWRAALLVVTFFALWGPYNITLFLHSLQDLQVLESCEVSKHLDYALQVTESIAFLHSCLSPFLYLFVHHRLKKHLKKVLEVIFKRCRESAAHPSQASYSNSYSTDQEEMTSTGNLEQSLQDHRI
696,G1QT16,Non Druggable,G1QT16_NOMLE,ACKR4,350,39928,MALEQNQSTDYYYEENEMNGTYDYSQYELICIKEDVREFAKVFLPVFLTIAFVIGLAGNSMVVAIYAYYKKQRTKTDVYILNLAVADLLLLFTLPFWAVNAVHGWVLGKIMCKITSALYTLNFVSGMQFLACISIDRYVAVTKVPSQSGVGKPCWIICFCVWMVAILLSIPQLVFYTVNDNARCIPIFPRYLGTSMKASIQMLEICIGFVVPFLIMGVCYFITARTLMKMPNIKISRPLKVLLTVVIVFIVTQLPYNIVKFCRAIDIIYSLITNCNMSKRMDIAIQITESIALFHSCLNPILYVFMGASFKNYVMKVAKKYGSWRRQRQSVEEFPFDSEGPTEPTSTFSI
697,A0A6P6CBQ6,Non Druggable,A0A6P6CBQ6_PTEVA,ACKR2,383,43298,MASPLPLTTEAAPSDNSSSFYDYEDYLDQVAFMLCMKEEVLSFGKVFLPIFYSLVFVLGLGGNLLLLVVLLRYVPRRRMTEVYLLNLAFSNLLFVVTLPFWSITVVWHWVFGSFLCKMVSALYTINLYSGIFFISCMSLDRYLEIVHAQPHSRLRTPARCRLLAAMVWAVALVVSIPDVVFVRTHEYPTGVWNCYPDFGGHGTPWKLLLRFQQNLLGFLLPLLAMIFFYSRIASVLVRVRPPGQGRALRIAAALVVAFFVLWFPYNLTLFLHSLMDLKVFGDCKVSQHLDYALQVTESFAFFHCCFTPILYAFSSCHFRQCLKAFLATALGRHQAPCPAQAPLSSSSDISNLTAQEEMTSMNDLEEKQAEDFPTDGEVGGNEA
698,A0A6P5LH55,Non Druggable,A0A6P5LH55_PHACI,ACKR2,371,42095,MTATLPPASSTSTSLENTSIYDYYYLDNFLSTVCRKEAILSFGQMFLPIFYSLVFVLGLSGNLFFLTVLLYSARRRQVTEVYLLNLVVSNLLFVVTLPFWGASVAWHWVFGEVLCKIICTLYTAGFYSSIFFLSCMSLDKYLDVVHAQTHHHPWTPAKSWLLSGGVWTVALVLSIPDLVFARVQEGTGGMQSCHLDFGDNGPLWKVLLRFKQSILGFILPLFAMVFFYTRIGYILTVLRPRGRGRALWAAAALVVAFFVLWCPYNITLFLHSLQDLQVLEGCEVSKRLDYALQVTESIAFTHCCLSPFLYLFVHHRLRKHLKKVLEAIFKRSRESSAAHPSQTSYSNSYSTTQEEMTSTDSRGESLQDHGI
